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Objectives: To determine whether randomised 
controlled trials (RCTs) lead to the same effect size 
and variance as non-randomised studies (NRSs) of 
similar policy interventions, and whether these findings 
can be explained by other factors associated with the 
interventions or their evaluation.
Data sources: Two RCTs were resampled to compare 
randomised and non-randomised arms. Comparable 
field trials were identified from a series of health 
promotion systematic reviews and a systematic review 
of transition for youths with disabilities. Previous 
methodological studies were sought from 14 electronic 
bibliographic databases (Applied Social Sciences Index 
and Abstracts, Australian Education Index, British 
Education Index, CareData, Dissertation Abstracts, 
EconLIT, Educational Resources Information Centre, 
International Bibliography of the Sociological Sciences, 
ISI Proceedings: Social Sciences and Humanities, PAIS 
International, PsycINFO, SIGLE, Social Science Citation 
Index, Sociological Abstracts) in June and July 2004. 
These were supplemented by citation searching for key 
authors, contacting review authors and searching key 
internet sites.
Review methods: Analyses of previous resampling 
studies, replication studies, comparable field studies 
and meta-epidemiology investigated the relationship 
between randomisation and effect size of policy 
interventions. New resampling studies and new analyses 
of comparable field studies and meta-epidemiology 
were strengthened by testing pre-specified associations 
supported by carefully argued hypotheses.
Results: Resampling studies offer no evidence that 
the absence of randomisation directly influences the 
effect size of policy interventions in a systematic way. 
Prior methodological reviews and meta-analyses of 
existing reviews comparing effects from RCTs and non-
randomised controlled trials (nRCTs) suggested that 
effect sizes from RCTs and nRCTs may indeed differ in 
some circumstances and that these differences may well 
be associated with factors confounded with design. No 
consistent explanations were found for randomisation 
being associated with changes in effect sizes of policy 
interventions in field trials.
Conclusions: From the resampling studies we have 
no evidence that the absence of randomisation directly 
influences the effect size of policy interventions in a 
systematic way.   At the level of individual studies, non-
randomised trials may lead to different effect sizes, but 
this is unpredictable. Many of the examples reviewed 
and the new analyses in the current study reveal that 
randomisation is indeed associated with changes in 
effect sizes of policy interventions in field trials. Despite 
extensive analysis, we have identified no consistent 
explanations for these differences. Researchers 
mounting new evaluations need to avoid, wherever 
possible, allocation bias. New policy evaluations should 
adopt randomised designs wherever possible.
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Controlled before-and-after study  A controlled 
trial in which outcomes are measured before and 
after exposure to the intervention.
Controlled clinical trial  A controlled trial 
of a clinical intervention in which people 
are allocated to receive one of two or more 
interventions, but not randomly. This term is 
used when we report the work of other authors 
using the same term.
Non-randomised controlled trial  A controlled 
trial in which people are allocated to receive one 
of two or more interventions, but not randomly. 
This term includes controlled trials of clinical 
and non-clinical interventions.
Non-randomised study  A study with a design 
that does not include randomisation, with or 
without a control group, e.g. controlled trial, 
cohort studies, case-controlled studies, surveys.
Randomised controlled trial  A study in 
which people are allocated at random (by 
chance alone) to receive one of two or more 
interventions. One of these interventions is the 
standard of comparison or control.
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and Abstracts
BEI British Education Index
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study
CCT clinical controlled trial (not 
randomised)
CDSR Cochrane Database of 
Systematic Reviews
CI confidence interval
CONSORT Consolidated Standards of 
Reporting Trials
DARE Database of Abstracts of 
Reviews of Effects
df degrees of freedom
DoPHER Database of Promoting Health 
Effectiveness Reviews
EPDS Edinburgh Postnatal 
Depression Score
EPPI-
Centre
Evidence for Policy and 
Practice Information and Co-
ordinating Centre
ERIC Educational Resources 
Information Centre
IBSS International Bibliography of 
the Sociological Sciences
ICC intracluster correlation 
coefficient
MRC Medical Research Council
MSM men who have sex with men
nRCT non-randomised controlled 
trial
NRS non-randomised study
PAIS Public Affairs Information 
Service
PHSE Personal, Social and Health 
Education
RCT randomised controlled trial
sdUAI sero-discordant or unknown 
status unprotected anal 
intercourse
SIGLE System for Information on 
Grey Literature in Europe
SMD standardised mean difference
SSCI Social Science Citation Index
TREND Transparent Reporting 
of Evaluations with 
Nonrandomized Designs
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Background
While the randomised controlled trial (RCT) is 
generally regarded as the design of choice for 
assessing the effects of health care, within the social 
sciences there is considerable debate about the 
relative suitability of RCTs and non-randomised 
studies (NRSs) for evaluating public policy 
interventions.
Objectives
To determine whether RCTs provide the same 
effect size and variance as NRSs of similar policy 
interventions, and whether these findings can be 
explained by other associated factors.
Methods
This study employed four approaches:
1.  Resampling studies: comparing controlled 
trials that are identical in all respects other 
than the use of randomisation by ‘breaking’ 
the randomisation in a trial to create smaller 
non-randomised trials and smaller randomised 
trials by resampling randomised and non-
randomised comparisons from the data.
2.  Replication studies: comparing randomised 
and non-randomised arms of controlled trials 
mounted simultaneously in the field.
3.  Investigating comparable ‘field’ studies: 
controlled trials drawn from systematic reviews 
that include both randomised and non-
randomised studies. These include structured 
narrative reviews and sensitivity analyses within 
meta-analyses.
4.  Meta-epidemiology: investigating associations 
between randomisation and effect size using 
a pool of more diverse randomised and non-
randomised studies within broadly similar 
areas. These more diverse studies can be 
drawn from across reviews addressing different 
questions, or from broad sections of literature.
This study sought earlier reports of all four 
approaches and conducted new analyses for three 
of these approaches (1, 3 and 4 above) across a 
range of public policy sectors. The new analyses 
were strengthened by testing pre-specified 
associations supported by carefully argued 
hypotheses. Data were drawn from: two RCTs 
of policy interventions for resampling studies; 
comparable studies drawn from systematic reviews 
of health promotion and of transition for youths 
with disabilities; and a systematic search for prior 
work. The search strategy comprising free text 
terms for RCT and non-randomised studies (e.g. 
non-experimental, pseudorandom, semi-random) 
was applied to 14 electronic bibliographic databases 
spanning health, education, social policy and social 
science in June and July 2004 [Applied Social 
Sciences Index and Abstracts (ASSIA), Australian 
Education Index (AEI), British Education Index 
(BEI), CareData, Dissertation Abstracts, EconLIT, 
Educational Resources Information Centre (ERIC), 
International Bibliography of the Sociological 
Sciences (IBSS), ISI Proceedings: Social Sciences 
and Humanities, PAIS International (Public Affairs 
Information Service), PsycINFO, SIGLE (System 
for Information on Grey Literature in Europe), 
Social Science Citation Index (SSCI), Sociological 
Abstracts]. This was supplemented by citation 
searching for key authors, contacting review 
authors and searching key internet sites.
For investigating comparable field studies, 
and the meta-regression, studies were coded 
for characteristics of the population, policy 
intervention and evaluation. Differences in effect 
sizes between studies were investigated using 
random-effects meta-regression to allow for 
unexplained heterogeneity between studies as well 
as the known uncertainty in estimated effect sizes 
(measured by their standard errors). Associations 
between different characteristics of the studies and 
whether or not they employed randomisation were 
measured using chi-squared tests.
Results
Reviews of methodological 
studies and empirical reviews
Prior methodological reviews included a review 
of within-study comparisons of randomised and 
non-randomised participants, six single meta-
analyses and one review of meta-analyses. Between 
Executive summaryExecutive summary
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them these covered interventions for preventing 
juvenile delinquency, treatment of alcohol abuse, 
and other psychological, mental health or health-
care interventions. These studies investigated 
whether randomisation influenced effect sizes. 
Most also investigated the influence of other 
variables or modifiers of effect such as population, 
sample size, attrition, intervention, type of control 
group and publication status. The results suggest 
that effect sizes from RCTs and non-randomised 
controlled trials (nRCTs) may indeed differ in 
some circumstances and that these differences may 
well be associated with factors confounded with 
design. Inter-relationships among variables make it 
difficult to determine the likely impact of any one 
factor.
A systematic review of meta-analyses of existing 
reviews comparing effects from RCTs and nRCTs 
found that the effect sizes were similar in five 
reviews, dissimilar in eight reviews, and mixed 
in three. Most reviews appeared to ignore the 
variability associated with effect size. Considerable 
variation in the studies pooled within reviews, in 
terms of population, intervention, outcome and 
other methodological details, makes it difficult to 
separate the potential effect of random assignment 
from the potential effects of all the other variables.
Resampling studies
Re-analysis of data from two trials suggests that 
nRCTs can give the same answers as RCTs. This 
was a tightly controlled examination in which the 
only factor that was different between the RCTs and 
nRCTs was randomisation.
Comparable ‘field’ studies 
and meta-epidemiology
In the examination of trials sampled from 
systematic reviews we found considerable variation, 
with RCTs producing smaller effect sizes than 
nRCTs in systematic reviews conducted at the 
Evidence for Policy and Practice Information and 
Co-ordinating Centre (EPPI-Centre) (using within 
review comparisons and meta-epidemiology) 
and larger effect sizes than nRCTs in the studies 
reviewed by Colorado State University (using meta-
epidemiology alone).
Investigation of potential confounding factors in 
the EPPI-Centre reviews suggests that RCTs have 
smaller effect sizes, even though their sample 
sizes tend to be smaller with participants allocated 
individually (both attributes associated to some 
extent with effect size) and their theoretical 
frameworks more readily apparent. Other 
attributes commonly associated with quality were 
not associated with randomisation or effect size: 
attrition rates, time to follow-up or quality of 
reporting.
Conclusions
From the resampling studies we have no evidence 
that the absence of randomisation directly 
influences the effect size of policy interventions in 
a systematic way. At the level of individual studies, 
non-randomised trials may lead to different 
effect sizes, but this is unpredictable. Many of 
the examples reviewed and the new analyses in 
the current study reveal that randomisation is 
indeed associated with changes in effect sizes 
of policy interventions in field trials. Despite 
extensive analysis, we have identified no consistent 
explanations for these differences.
Recommendations 
for research
1.  Policy evaluations should adopt randomised 
designs whenever possible.
2.  Policy evaluations should also adopt other 
standard procedures for minimising bias and 
conducting high-quality assessment of effects of 
intervention, particularly blinded allocation of 
either individuals or groups and the avoidance 
of small sample sizes.
3.  Feasibility studies of randomising geographical 
areas, communities and regions should be 
carried out for evaluating policy interventions 
in a range of sectors, implemented within 
interventions, communities and across regions.
4.  Feasibility studies of blinded allocation 
should be carried out for policy interventions 
in a range of sectors, implemented within 
interventions, communities and across regions.
5.  Clear descriptions should be included 
in systematic reviews of how judgements 
of equivalence (or otherwise) have been 
reached when comparing the effects found in 
randomised and non-randomised studies of 
policy interventions.
6.  Research is required into the reasons for 
choosing randomisation or not, particularly 
in the presence and absence of an explicit 
collective plan of action.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
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T
he NHS Research and Development 
Methodology Programme identified the need 
to investigate the implications of randomised and 
non-randomised evaluation designs for assessing 
the effectiveness of policy interventions.
The work of Sacks1 and the classic paper by Schulz2 
showed that the benefit ascribed to a clinical 
intervention depends on the methodology used 
in the study. For instance, the effect size tends to 
be more pronounced in historically controlled 
than in randomised controlled trials (RCTs) of the 
same intervention, and in poorly randomised than 
in rigorously randomised studies. Concurrently 
controlled and randomised studies produce 
more similar results,3 although the researchers 
urge caution when interpreting this finding, as 
the number of studies included in the review was 
small. While research comparing the effect sizes 
produced by different study designs is growing 
in clinical topics, little work has been done with 
respect to policy/management interventions. These 
are defined as those interventions that are not 
confined to an individual practitioner, and include, 
but are not limited to, health. Examples would 
include peer-led teaching and health promotion in 
schools. Non-randomised studies (NRSs) in these 
areas may be cross-sectional or before and after 
(i.e. either with or without baseline measurements), 
and many of the randomised studies may be cluster 
randomised.
The Research and Development Methodology 
Programme required the compilation of existing 
studies that compare findings of randomised and 
�non-randomised studies of policy interventions in 
order to: (1) analyse effect sizes in which similar 
interventions have been examined by different 
methods and (2) extract and summarise the 
information bearing on the effects of study type 
and quality of study findings, with the ultimate aim 
of learning about biases (mean bias and spread of 
biases) associated with different study types.
Defining policy and 
intervention
The study required a definition of ‘policy 
interventions’ that would facilitate selection of 
systematic reviews of policy interventions and 
individual trials of policy interventions. The term 
‘policy intervention’ is used throughout the UK 
government’s policy hub website (www.policyhub.
gov.uk/search_result.asp), but without a definition. 
We have been unable to find a definition of 
‘policy intervention’. The closest we have found in 
dictionaries are definitions of ‘policy’ as:
a course of action or principle adopted or 
proposed by a government, party, individual, 
etc.
Oxford English Dictionary
a plan of action adopted by an individual or 
social group
WordNet, a lexical database for the 
English language (www.cogsci.princeton.
edu/cgi-bin/webwn)
policy (plan) noun [C] a set of ideas or a plan 
of what to do in particular situations that has 
been agreed officially by a group of people, 
a business organization, a government or a 
political party
Cambridge Advanced Learner’s 
Dictionary
We are not alone in struggling to define ‘policy’ 
and ‘policy intervention’. In seeking a sound and 
operational definition of policy intervention, we 
have referred to the public policy literature and the 
literature about evaluation and evidence-informed 
policy/practice.
Jenkins4 observed that:
Pursuit of the question ‘what is public policy?’ 
leads one down the tangled path towards a 
definition where many have been before and 
Chapter 1  
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from which few have emerged unscathed. 
There is, as Lineberry and Masotti (1975) 
point out, little in the way of a consistent 
conceptualization of the term ‘policy’ itself 
and pages could be, and have been, filled with 
competing definitions. The problem may be to 
provide an account that captures the detail and 
density of the activities embraced by the policy 
arena. With this detail in mind, it is worth 
considering the following definition of public 
policy:
‘a set of interrelated decisions taken by a 
political actor or group of actors concerning 
the selection of goals and the means of 
achieving them within a specified situation, 
where those decisions should, in principle, be 
within the power of those actors to achieve’ 
(Roberts 1971)
[This definition] stresses the point that policy 
is more than a single decision. As Anderson 
(1975) has argued, ‘policy making typically 
involves a pattern of action extending over 
time and involving many decisions’.
The US has a strong history of employing 
controlled trials to evaluate ‘social programs’5 
that fall within our understanding of policy 
interventions. For instance, House6 cites 
the dictionary definition of intervention as 
‘interference that may affect the interests of others’. 
He goes on to talk about the inherently ‘messy’ 
social context within which emerge ‘complex 
disordered events we call interventions’ (House, 
p. 323). House distinguishes between generic 
development, policy-making and site-specific 
interventions (p. 325). ‘Policymaking interventions’ 
consist of ‘establishing rules and guidelines’; in the 
case of education, Standard Attainment Tests in 
the UK would be an up to date example of the type 
of educational intervention that House discusses 
under this heading.
Some of the literature refers to ‘social 
interventions’ and ‘policy analysis and evaluation 
research’. Haveman7 described social interventions 
as programmes that, when evaluated, can inform 
policy, but some ‘are’ policy. There is extensive 
literature on the ‘War on Poverty–Great Society’ 
developments in the US initiated in 1965, in 
which the various types of social intervention that 
represented local changes in policy were evaluated 
by government mandate and these evaluations 
were considered directly relevant to government 
policy.8
Defining ‘policy intervention’
The focus of our investigation was on evaluations 
of interventions for public policy or service 
organisation and management that:
•  are intended to serve communities or 
populations
•  require more than the efforts of individual 
practitioners to apply
•  are not a one-to-one service.
We have adapted the definition of public health 
interventions provided by Rychetnik et al.9 In order 
to embrace broader public policy, this definition of 
interventions is paraphrased as:
a set of actions with a coherent objective to 
bring about change or produce identifiable 
outcomes. These include policy, regulatory 
initiatives, single strategy projects or multi-
component programmes. Policy interventions 
are intended to serve communities or 
populations. They are distinguished from 
one-to-one services that are for the benefit of 
individuals.
These interventions require more than the efforts 
of individual practitioners to be applied. They 
may include legislation or regulation; setting 
of policy or strategy at the level of national or 
local government, or institutions; the provision 
or organisation of services; environmental 
modification; or facilitating lay or public delivered 
support/education. These interventions may fall 
within public policy for health, education, social 
care, welfare, housing, criminal justice, transport 
and urban renewal.10
Another interpretation of the term ‘policy 
intervention’ refers to intervening in policy 
making rather than policy intervention. Devlin 
et al.11 considered the parameters of policy-
making interventions in relation to service user 
perspectives on HIV policy. To paraphrase them:
policy interventions seek to influence decision-
making . . . and ensure that policy supports 
or at least does not impede [services]. These 
interventions relate therefore to local and 
national policy makers (within governmental 
and statutory sectors) and local and national 
resource allocators (for example government 
departments and local authorities). They 
can also involve seeking to influence 
those people or agencies charged with the 
production and supply of information to DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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support policy development and resource 
allocation. Therefore, they might also seek 
to influence applied and academic social 
researchers, epidemiologists, policy advisors 
and local public health surveillance personnel 
(collectively called, the research and policy 
community).
Examples of interventions that impact on policy-
makers and seek to influence their (drafting) policy 
and legislation might include:
•  lobbying government departments, local 
authorities, research bodies
•  taking part in national consultation 
processes undertaken by policy and lobbying 
organisations and government
•  joining professional associations, research/
policy forums
•  applying for funding from local authorities or 
government bodies
•  subscribing to information sources of national 
policy-makers and lobbyists.
This distinction between collectively effecting 
change through setting policy, and collectively 
effecting change through implementing prior 
policy decisions is apparent in the policy analysis 
literature.12 Harrison12 describes policy as a process, 
rather than simply as an output of a decision, or an 
input to management. The policy process begins 
within the arena of political science with setting 
agendas around problematic issues, and progresses 
to designing and evaluating efforts to solve these 
problems. Thus, a ‘policy intervention’ may be 
either a method for influencing the policy-making 
process, or a method for influencing the policy 
implementation process.
Evaluating public 
policy interventions
Within the area of public policy there has been 
wide debate about the suitability of experimental 
evaluation methods. While it has been suggested 
that the RCT should be the ‘gold standard’ and 
used whenever possible,13,14 others have argued 
that evaluating social and policy interventions is 
a complex task and that RCTs, and experimental 
designs in general, are not always practical or even 
desirable.15,16 Nutbeam17 suggests that complex 
multicomponent interventions (e.g. directed at 
communities or regions using a range of media, 
delivered in a number of settings) are more likely 
to be effective in bringing about population health 
gains than ‘single issue’ initiatives (e.g. directed 
at individuals or small groups, using fewer media, 
delivered in a particular setting), but are much 
harder to evaluate. For example, it might not be 
possible to allocate whole communities or regions 
to study groups randomly, and it is not easy to 
isolate the effects of competing interventions, 
thus confounding the results. The World Health 
Organization commenting on the evaluation of 
health promotion goes as far as saying:
The use of randomised control trials to 
evaluate health promotion initiatives is, in 
most cases, inappropriate, misleading and 
unnecessarily expensive.18
Oakley et al.19 have summarised the objections to 
RCTs for evaluating social interventions, arguably 
a category that includes all policy interventions, as: 
randomised experiments oversimplify causation, 
cannot be carried out in complex institutional and 
other settings or to test complex interventions, 
ignore the role of theory in understanding 
intervention effectiveness, are inappropriate in 
circumstances in which ‘blinding’ is impossible, are 
politically unacceptable and too expensive, have 
been tried and failed, are unethical because valued 
treatments are withheld from control groups and/
or experimental/quantitative research is inherently 
exploitative, and perfectly good alternatives to 
RCTs that pose none of these problems exist and 
should therefore be used instead. These objections 
focus largely on the science, ethics and feasibility 
of randomisation. They have led to a dearth of 
randomised studies in some policy areas, which 
needs to be taken into account when preparing 
research syntheses, and to research communities 
who remain disinclined to mount randomised 
evaluations. Oakley et al.19 used three recent UK 
trials of policy interventions (day care for preschool 
children, social support for disadvantaged families, 
and peer-led sex education for young people) to 
consider issues relating to the use of randomisation 
and suggest some practical strategies for its use in 
trials of social interventions. Their refutations of 
the objections to RCTs are supported by an analysis 
of the relevant theoretical literature.20
Indeed, experimental evaluations have long been 
considered the optimal design for evaluation in 
some fields of social policy, particularly in the 
US.5 Oakley21 cites examples of experimental 
policy evaluations that date back as far as the early 
decades of the twentieth century, and discusses 
how experimental methods became popular, 
particularly in the US, between the 1960s and the 
1980s to evaluate the effectiveness of public policy:Policy interventions and their evaluation
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This history is conveniently overlooked by 
those who contend that randomised controlled 
trials have no place in evaluating social 
interventions. It shows clearly that prospective 
experimental studies with random allocation 
to generate one or more control groups is 
perfectly possible in social settings. (p. 1239)
More recently there have been key trials that have 
evaluated the effectiveness of so-called ‘complex’ 
health promotion interventions. For example, the 
North Karelia Youth Program22 was a large-scale 
multicomponent intervention evaluated using an 
RCT involving over 4000 participants, featuring a 
range of activities including classroom education, 
media campaigns, changes to nutritional content 
of school meals, health screening, and health 
education initiatives in the workplace.
Particularly innovative are experimental 
evaluations of interventions addressing 
environmental or structural factors integrating 
sexual health and employment/economic policy. 
Examples include a matched controlled trial of 
the impact of an employment creation programme 
on teenage pregnancy23 and a cluster RCT of 
microcredit schemes for impoverished women to 
develop increased economic independence, social 
status, and power within sexual negotiations, 
thereby reducing HIV transmission.24
An analysis of the reasons for not adopting the 
RCT design concludes that, despite serious 
practical objections and partial remedies, RCTs 
are logically and empirically superior to all 
currently known alternatives.25 The view that the 
RCT is inappropriate to test the success of policy 
interventions is refuted by a bibliometric analysis, 
which concludes that between 6% and 15% of 
impact evaluations of childhood interventions 
in education and justice employ a randomised 
design.26
Our own experience of conducting RCTs supports 
their use for evaluating social interventions.19 
Our experience of conducting and evaluating 
systematic reviews reveals their widespread use 
elsewhere. Of the 75 evaluation studies identified 
in a recent systematic review of interventions 
to promote healthy eating and physical activity 
among young people,27,28 31 (41%) used an RCT 
design, 30 (40%) used a controlled trial (without 
randomisation), and 14 (19%) used only one study 
group with outcomes measured before and after 
the intervention. While the evidence base in this 
area is likely to comprise a vast range of evaluation 
designs, the role of experimental evaluation cannot 
be discounted.
Efforts to consolidate this evidence base have 
increased, together with a recent surge in 
production of systematic reviews of the effects of 
policy interventions.29,30 Reviews have recently 
been completed, or are in the process of being 
completed, in the areas of health (e.g. interventions 
to improve vaccination coverage),31 education 
(e.g. after school programmes)32 and criminology 
(e.g. ‘Scared straight’ interventions to discourage 
juvenile delinquency).33
Randomisation and effect 
sizes of clinical interventions
The RCT is widely regarded as the design of 
choice for evaluating the effectiveness of clinical 
interventions in health care, as it can provide 
the most internally valid estimate. The main 
benefit of the RCT is the use of a randomisation 
procedure that, when properly concealed, ensures 
that the subjects receiving the treatment and 
control are equal with respect to all conditions 
except for receiving the treatment or the control. 
With sufficient sample sizes, and a truly random 
generation of the allocation sequence, comparison 
groups should on average be equal with respect 
to both known and unknown prognostic factors 
at baseline.34 RCTs also have written protocols 
specifying, and thus standardising, important 
aspects of participant enrolment, intervention, 
observation and analysis.35
Our knowledge of the importance of certain design 
features of RCTs has been derived primarily in 
the field of clinical health-care interventions.2,36,37 
Meta-epidemiological techniques have successfully 
been used to investigate variations in the results 
of RCTs of the same intervention according 
to features of their study design.38 Substantial 
numbers of systematic reviews of RCTs have been 
identified, and results compared between the trials 
meeting and not meeting various design criteria 
such as proper randomisation, concealment of 
allocation and blinding. These comparisons have 
then been aggregated across the reviews to obtain 
an estimate of the systematic bias removed by the 
design feature.2,37 The results have been shown 
to be reasonably consistent across clinical fields, 
providing some evidence that meta-epidemiology 
may be a reliable investigative technique.39DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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The use of meta-epidemiology has also been 
extended from the comparison of design features 
within a particular study design to comparisons 
between study designs. A recent Health Technology 
Assessment report reviewed eight such examples:40 
seven considered medical interventions, while 
one considered psychological interventions. The 
conclusions of these reviews varied, partly due to 
variations in their methods and rigour but also 
because of limitations in the meta-epidemiological 
methods used. The only robust conclusion that can 
be drawn is that in some circumstances the results 
of randomised and non-randomised studies differ, 
but it cannot be proved that differences are not due 
to other confounding factors. The key lessons that 
can be learned from this work are:
•  The identification and selection of comparisons 
of randomised and non-randomised evidence 
should be systematic. This will not overcome 
the problem of selective publication of primary 
studies (if studies with positive results are 
more likely to be published, regardless of 
design, meta-epidemiological reviews will find 
designs showing intervention effects in the 
same direction if not of similar magnitude) 
but should at least ensure that all available 
comparisons are included regardless of 
whether designs show similar or conflicting 
results.
•  To reduce confounding from factors other 
than lack of randomisation, randomised and 
non-randomised studies should be assessed for 
differences in the participants, interventions 
and outcomes. The possibility of temporal 
confounding of study types (NRSs typically 
being performed prior to the RCTs) should 
also be assessed.
•  The similarity of randomised and non-
randomised studies should be assessed for 
differences in study methods other than 
allocation. Discrepancies and similarities 
between study designs could be partly 
explained by differences in other unevaluated 
aspects of methodological quality of the RCTs 
and/or the NRSs, such as blinding or intention-
to-treat analysis.
•  Sensible, objective criteria should be used to 
determine differences or equivalence of study 
findings as these can have a large influence 
on the conclusions drawn. The amount of 
data available is also important; for example 
in one review, for each intervention five RCTs 
on average were compared with four NRSs. 
Hence the absence of a statistically significant 
difference cannot be interpreted as evidence 
of ‘equivalency’, and clinically significant 
differences in treatment effects cannot be 
excluded.40
These previous investigations also suggest that 
there may be variability in the direction of bias 
introduced when randomisation is not used. 
Selection bias is commonly thought of as resulting 
from the systematic selection of either high or 
low risk participants to receive an intervention. 
This would lead to the intervention group being 
‘heavily weighted by the more severely ill’41 or 
alternatively including those least likely to suffer 
adverse consequences from an intervention (less 
severely ill). If in fact selection bias arises due 
to haphazard variations in case-mix, there will 
be a mixture of under- and overestimates of the 
treatment effect. The results might all be biased, 
but not all in the same direction.40 In these 
circumstances, an increase in the heterogeneity of 
treatment effect (beyond that expected by chance) 
rather than (or as well as) a systematic bias would 
be expected. Deeks et al.40 suggest that a formal 
statistical comparison should aim to compare the 
heterogeneity in treatment effects, and not just the 
average treatment effects between randomised and 
non-randomised groups.
Randomisation and effect 
size of policy interventions
The effects of policy interventions have been 
assessed through the use of RCTs, nRCTs and other 
study designs. The choice has been influenced by 
the relative rigour of the designs and the feasibility 
in the circumstances of applying prospective 
designs and random allocation of interventions. 
The weight given to each of these influences 
(rigour and feasibility) when embarking on policy 
evaluations may be driven by philosophy, as much 
as by research evidence.
Although studies largely from clinical areas have 
identified detailed design features of rigorous RCTs 
that reduce systematic bias in estimating effect 
sizes,39 meta-epidemiological investigations of 
medical and psychological interventions concluded 
that it is less clear what influences the differences 
in results drawn from randomised and non-
randomised studies, as results of NRSs sometimes, 
but not always, differ from results of randomised 
studies of the same intervention.40 There is growing 
evidence in the meta-analytic literature that even 
strong quasi-experimental designs assessing Policy interventions and their evaluation
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criminology are more likely to report a result 
in favour of treatment and less likely to report 
a harmful effect of treatment than randomised 
studies.42
Chapter 2 considers the methodologies 
appropriate for investigating the extent and 
possible causes of such differences.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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F
our approaches have been adopted in previous 
studies to investigate the relationship between 
randomisation and effect size of interventions:
1.  Comparing controlled trials that are 
identical in all respects other than the use of 
randomisation by ‘breaking’ the randomisation 
in a trial to create non-randomised trials. 
These are often called resampling studies.
2.  Comparing randomised and non-
randomised arms of controlled trials mounted 
simultaneously in the field. These are 
replication studies.
3.  Comparing similar controlled trials drawn 
from systematic reviews that include both 
randomised and non-randomised studies. 
These include structured narrative reviews and 
sensitivity analyses within meta-analyses.
4.  Investigating associations between 
randomisation and effect size using a pool of 
more diverse randomised and non-randomised 
studies within broadly similar areas. These 
more diverse studies can be drawn from across 
reviews addressing different questions, or from 
broad sections of literature. This is known as 
meta-epidemiology.
This study sought reports of all four approaches 
conducted by others, and built on their work by 
conducting original research with new analyses for 
three of these approaches (1, 3 and 4 above) across 
a range of public policy sectors.
The latter two approaches were strengthened in 
new analyses by testing pre-specified associations 
supported by carefully argued hypotheses.
Resampling of randomised 
controlled trials
Resampling studies re-analyse data from RCTs to 
explore widely used alternatives to randomisation 
such as: comparing areas, matching areas 
and adjusting for differences between groups 
using multivariate analysis. By ‘breaking’ the 
randomisation in the trials, this analysis creates 
non-randomised trials and explores the extent to 
which established alternatives to randomisation are 
able to find the same results as the original RCTs.
Because these studies are based on trials that are 
identical other than the use of randomisation, 
they explore the direct association between 
randomisation and effect size without being 
confounded by other factors that might influence 
effect size when calculated from similar, but not 
identical, field trials.
Such studies were sought in a methodological 
review described in Chapter 4. Two new re-
sampling studies are reported in Chapter 7. The 
data are drawn from two trials of social support for 
families with young children, one carried out in the 
UK, and the other in Canada. Both trials span the 
health and social care sectors.
Replication studies
Replication studies assess the effects of intervention 
from different comparisons within the same study. 
In order to investigate the role of randomisation, 
replication studies compare the effect sizes from 
randomised and non-randomised comparisons. 
Such studies were sought in the methodological 
review described in Chapter 4. We did not have 
access to data from other replication studies for 
new analyses.
Comparable field studies
Randomised and non-randomised evaluations 
drawn from a single review are comparable field 
studies for addressing the following questions. Do 
randomised and non-randomised evaluations lead 
to differences in effect sizes and variance? If so, 
are these differences due to the randomisation or 
to other factors associated with randomisation? 
If differences are due to characteristics of the 
interventions or their evaluation, is it possible to 
overcome these difficulties in the design or analysis 
of evaluations and/or research syntheses whether or 
not studies are randomised?
Chapter 2  
Methodology: design and data sourcesMethodology: design and data sources
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Extensive exploratory analyses would be 
expected to identify some associations between 
randomisation and other factors, if only by 
chance. To avoid the risk of identifying chance 
associations, we tested a limited number of well-
argued associations for which hypotheses rested on 
our understanding of policy interventions, research 
communities and evaluation methodology, or arose 
from previous research. By drawing on published 
literature, we proposed a series of potential 
confounders, and argued how these are likely to be 
interrelated (see Chapter 3).
We proposed several possible conclusions for an 
exploratory investigation of published evaluations:
•  There is no systematic difference between the 
effect sizes of RCTs of policy interventions and 
the effect sizes of non-randomised trials; so 
non-randomised trials may be adequate to evaluate 
policy interventions.
•  The effect sizes of RCTs of policy interventions 
are systematically different from the effect sizes 
of non-randomised trials; this difference 
cannot be explained by any other variables in 
the interventions or their evaluation, so it is 
assumed that randomisation is required to control 
for unidentifiable influences; and examples of 
RCTs that are ethically and scientifically sound 
should be sought to model future evaluations 
of the effects of policy interventions.
•  The effect sizes of RCTs of policy interventions 
are systematically different from the effect sizes of 
non-randomised trials; however, this difference 
can be explained by one or more other 
variables in the evaluation, such as baseline 
differences, that are amenable to statistical 
adjustment in order to take into account 
the difference; in these circumstances, non-
randomised trials with the appropriate corrections 
may be adequate to evaluate the impact of policy 
interventions.
•  Randomised trials of policy interventions lead 
to systematically different effect sizes compared with 
non-randomised trials; where this difference 
can be explained but not quantified by one 
or more other variables in the evaluation (but 
this difference is not amenable to adjustment) 
the strength of evidence to support decisions 
about policy interventions is necessarily 
weaker. An example may be small single 
centred randomised trials led by enthusiasts, 
compared with large multicentre uncontrolled 
trials attempting to assess the impact as an 
intervention is implemented more widely.
•  The variance of non-randomised trials is greater 
than that of RCTs. Deeks et al.40 have found 
that, while non-randomised controlled trials 
(nRCTs) do not differ systematically in their 
effect sizes, their variance is greater than 
that of RCTs. This suggests that confidence 
intervals (CIs) for individual nRCTs should 
be considered to be larger than stated, which 
means that statements of statistical significance 
should be treated with caution. If the purely 
statistical studies show that nRCTs differ 
from RCTs only in variance (not effect size), 
we would conclude that nRCTs are biased in 
ways that cannot be explained simply because 
they are non-randomised: other biases (e.g. 
selection or publication bias) are at work which 
lead us to conclude that nRCTs overstate the 
statistical significance of their interventions, 
but not necessarily the size of the effect.
Thus, any investigation of a possible association 
between randomisation and effect size needs to 
take into account the similarities or differences 
of interventions and evaluations in which this 
association is tested.
Meta-epidemiology
Our study extended the use of meta-epidemiology 
by Deeks et al.40 to policy interventions within 
health and other sectors to draw together 
systematically what is already known about the 
choice of study design for evaluating policy. 
Lessons learnt from that meta-epidemiological 
review were then applied to a meta-epidemiological 
study of policy evaluations using our own data sets.
Policy interventions
In attempting to distinguish ‘policy interventions’ 
from interventions examined in earlier 
methodological studies, our discussions and 
searches for relevant literature touched on the 
following issues:
Prior research
From the outset we were aware of a similar 
methodological study by Deeks et al.40 This study 
did not have any inclusion or exclusion criteria 
regarding type of intervention, other than they 
had to have ‘intended effects’. Two chapters of that 
report are particularly relevant to our work:DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
9
•  Chapter 3: a review of eight ‘meta-
epidemiological’ reviews that reviewed 
comparisons of RCTs and NRSs in which the 
original authors had specifically set out to 
examine the similarity/differences in results 
according to randomisation. Deeks et al.40 
reviewed interventions that were almost 
exclusively therapeutic in nature (i.e. aimed 
to treat or cure disease), but a handful related 
to the organisation of care and to educational 
interventions and were eligible for our study.
•  Chapter 5: a review of existing systematic 
reviews that included randomised and non-
randomised studies. This chapter included 
‘policy interventions’ as well as clinical/medical 
interventions. We have already drawn on the 
reviews within this chapter to outline the range 
of ‘policy interventions’ for this study. The 
study reported here extends the work of Deeks 
et al.40 by comparing the results of randomised 
and non-randomised evidence from a wider 
range of policy interventions.
Resistance to randomised 
controlled trials
As the purpose of this methodological study is to 
resolve questions about how essential RCTs are 
in areas where they are less readily available, we 
anticipated finding relevant studies (randomised 
and non-randomised) in areas where there 
has been some but not complete resistance to 
RCTs.14,43,44 These include circumstances in which:
•  it is difficult to stop contamination between 
intervention group(s) and control(s) (e.g. 
community wide interventions)
•  benefit may derive in part from an individual 
or group actively seeking to participate in 
the particular intervention (e.g. peer support 
provided by patient organisations)
•  randomisation is not feasible (e.g. legislation)
•  interventions are multicomponent (e.g. a 
combination of health service initiatives, face-
to-face health education in schools and in the 
community plus mass media).
Within this study we shall explore whether 
differences other than the presence or absence of 
randomisation could account for any variation that 
might be found in results, and comment on the 
extent to which resistance to RCTs is justified.
Complex interventions 
and their relationship with 
policy interventions
Although not directly relating to policy 
interventions, the Medical Research Council (MRC) 
framework for the development and evaluation of 
RCTs for complex interventions to improve health 
seemed to capture the essence of what we have 
been discussing. However, the MRC definition 
of complex interventions includes interventions 
that may be delivered by individuals (e.g. the 
different social/educational/treatment aspects 
of physiotherapy distinguish physiotherapy as a 
complex intervention) (see Appendix 1). We noted 
that in other less clinical areas, ‘multicomponent’ 
interventions was the term of choice, although this 
usually included multipractitioners too.
Level of policy making
Discussion distinguished policy interventions at 
different levels (national, regional, community 
and institution). These distinctions appeared to 
translate poorly to policy evaluations at these 
different levels. In particular it was noted that an 
evaluation of institution-wide policies may precede 
or follow national endorsement of a policy; the 
report may not clearly acknowledge which of 
these circumstances prevail, and whether it is the 
former or the latter may make little difference to 
the methodological challenges of evaluation. When 
a definition of policy intervention was applied 
to a set of evaluations (see below) it confirmed 
the observation above that social interventions as 
programmes, when evaluated, can inform policy, 
but that some ‘are’ policy.7
Implementation and its 
relationship with policy
We envisaged many clinical interventions also 
being ‘policy’; for instance, prescribing aspirin 
following a heart attack. In order to avoid 
replicating methodological research in the clinical 
area, we distinguished between, for example, a 
trial of aspirin treatment for heart attack (a trial 
of a clinical intervention) and a trial of methods 
to encourage greater use of aspirin treatment 
for heart attack (a trial of a social or educational 
intervention to increase uptake), and included the 
latter but not the former. We included other similar 
interventions such as interventions to increase the Methodology: design and data sources
10
uptake of vaccination or screening. This scope 
made reviews conducted by the Cochrane Effective 
Practice and Organisation of Care review group 
particularly relevant.
Developing operational 
definitions
Examining prior reviews
A draft definition of policy interventions, 
and illustrative examples, was developed 
through several rounds of discussion within the 
research team. It was refined by two researchers 
independently applying the emerging criteria 
and definitions to a set of systematic reviews to 
judge whether each review would be included or 
excluded. Twenty of these reviews were sampled 
from the Health Technology Assessment (HTA) 
report on evaluating NRSs40 (this was a subsample 
of a larger set originally chosen for their relevance 
on the basis of their titles only). The remaining 
20 were selected randomly from the Evidence for 
Policy and Practice Information and Co-ordinating 
Centre (EPPI-Centre) Database of Promoting 
Health Effectiveness Reviews (DoPHER; eppi.ioe.
ac.uk).
Different categories of policy intervention can 
be further distinguished by their details, either 
as elements of policy setting, or as elements of 
implementing policies such as legislation or 
regulation, provision or organisation or services, 
environmental modification, or facilitating 
education or support delivered by lay people. 
Examples are offered below.
Setting of policy/strategies
•  Government policy (e.g. policies on 
vaccination/immunisation/screening; fiscal/
economic incentives to participate in sport/
physical activity; nutritional policies such as the 
‘National School Fruit Scheme’).
•  Local government policy (e.g. provision/
sponsorship of community based activities to 
promote cultural diversity and social cohesion, 
and to prevent discrimination and violence, 
such as ‘Neighbourhood Renewal Strategies’; 
community-wide inter-agency strategies to 
promote health such as ‘Health Action Zones’).
•  Institutional policy (e.g. school-wide strategies 
to promote mental and emotional health, such 
as bullying/harassment prevention; curriculum 
review to prevent disaffection with school/
academic studies; health promoting hospitals).
Legislation/regulation
•  Environmental health regulations (e.g. waste 
disposal, pollution/emissions and its impact on 
health, smoking restrictions).
•  Taxation (e.g. on tobacco, alcohol).
•  Advertising/sponsorship regulation (e.g. on 
tobacco products).
•  Food standards regulations (e.g. nutritional 
content of school meals).
Provision/organisation of services
•  Education (e.g. increasing access to education 
through initiatives such as ‘Education Action 
Zones; vocational strategies to aid transition 
from school to work such as the ‘Connexions’ 
service; class sizes; training the trainer 
cascades).
•  Health promotion (e.g. increasing access to, 
and uptake of, facilities/resources; initiatives to 
promote health in the workplace; mass media 
campaigns; community development; social 
support).
•  Health care (e.g. increasing access to, and 
uptake of, facilities/resources; effective 
organisation of services; effective promotion, 
dissemination and uptake of evidence based 
clinical practice guidelines).
•  Social services (e.g. effective organisation of 
services; effective alliances with health and 
education sectors).
Environmental modification
•  Creation of safer cities (e.g. improved street 
lighting to prevent crime; traffic calming 
schemes, cycle paths/helmets, and speed 
cameras to prevent injuries).
•  Urban renewal (e.g. housing improvement 
programmes to promote better living 
conditions/health/sanitation/hygiene).
Facilitating lay/public delivered 
support/education
•  Facilitating one-to-one support (e.g. lay birth 
partners and fathers supporting women in 
childbirth; enabling carer/family support for 
chronic illness; peer-delivered counselling in 
schools).
•  Facilitating one-to-group support (e.g. peer-
delivered health promotion in schools).
•  Facilitating community action (e.g. health 
promotion delivered by the community).
•  Facilitating self-directed activities (e.g. self-
management of chronic disease; independent 
learning).DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
11
Some of the examples above reflect current UK 
intersectoral policy initiatives – attempts to set 
‘joined-up policy’. Some interventions may span 
health/education/housing and a number of other 
sectors. Finally, the categories could be viewed as a 
hierarchy with legislation providing a context for 
the setting of policy/strategy, which in turn affects 
how services are provided and organised, and 
which may also manifest as changes to the physical 
environment.
The draft criteria and definitions worked well, and 
minor revisions were made to improve the inter-
rater reliability for the handful of cases for which 
their relevance was questionable. From this sample:
•  The majority of reviews described interventions 
in health care and health promotion. Reviews 
in other areas (e.g. education) were in a 
minority.
•  Only around a quarter were included (n = 11; 
28%). The majority were excluded (n = 25; 
62.5%), and four (10%) were unclear.
•  Most of those included fell into the ‘Provision/
organisation of services’ and the ‘Setting of 
policy/strategies’ categories. We found none 
that had addressed ‘legislation/regulation’.
•  Many of those excluded were interventions 
delivered by individual practitioners (e.g. 
mostly health professionals).
•  At least five of those excluded were 
‘pharmacological’ interventions, such as 
vitamin/mineral supplementation, and in one 
case smoking cessation aids (e.g. lozenges, 
chewing gum).
•  One type of intervention that may be relevant, 
but usually involved some professional input, 
was activity under the broad heading of ‘self-
management’. An example was one of the 
reviews for which it was ‘unclear’ whether 
or not it was a ‘policy intervention’.45 It was 
about education for the self-management of 
asthma. Patients generally received written 
information (e.g. leaflets), and underwent a 
short interaction with a health professional 
(plus on-going consultations to monitor 
progress), but largely managed their illness on 
a day-to-day basis by themselves. This concept 
could be applied in many other contexts (e.g. 
self-learning/education/independent study 
initiatives). Perhaps a good example would 
be the development of policies or initiatives 
to promote distance learning as a way of 
encouraging greater access to further or higher 
education. The concept of self-management/
education/help could be considered a policy 
intervention although, in these circumstances, 
such interventions will likely incur some 
professional one-to-one input in order to help 
people initiate their own activities.
Applying draft criteria to sources 
of policy interventions
In order to develop more detailed operational 
definitions, draft criteria were applied by two 
researchers to abstracts and extracted data of 
outcome evaluations included in: (i) a map of 
studies of HIV health promotion for men who 
have sex with men (MSM); (ii) a map of studies 
of children and healthy eating; and (iii) a review 
of the promotion of sexual health/prevention 
of sexually transmitted diseases among women. 
Refining the criteria involved successive rounds of 
independent coding and reflective discussion.
For policy interventions
Policy interventions are those interventions which 
establish or modify collective plans for action so as to 
have systematic impact on the public. These policy 
interventions operate via institutions (e.g. hospitals, 
practitioner bodies, schools, public authorities, 
commercial bodies, patient organisations) and 
communities (e.g. geographical or social groups, 
networks, people with shared interests) and do not 
include personal policies of individuals.
Policy interventions require more than the authority 
of individual practitioners to instigate, more 
than the resources of individual practitioners to 
implement and more roles or skills than those of a 
single practitioner to implement. Their instigation 
and implementation depends upon interaction 
between organised groups of people. Groupings 
that make policy range in formality, geographic 
scope and purpose, but examples include local, 
national and international government, the 
regulatory bodies for practitioners and industry 
and governing bodies of institutions such as 
schools, health-care services and workplaces. 
Because of the involvement of social units in 
policy instigation and implementation, policy 
interventions are often better evaluated for their 
effectiveness through the allocation and study of 
social units (e.g. schools, communities, wards), as 
opposed to individuals.
Thus, a policy intervention required one or more of 
the following:
•  more than the authority of individual 
practitioners to instigate
  – consultants’ ward procedures are not policy Methodology: design and data sources
12
interventions because a single consultant 
has the authority to implement them, 
neither are teacher-led interventions 
confined to the classroom and falling 
within the curriculum
  – hospital wide procedures are policy 
interventions (e.g. complaints procedures) 
as are school procedures for engaging 
parents with pupils’ work [e.g. allowing 
parents to withdraw their children from 
Personal, Social and Health Education 
(PHSE) lessons]
•  more than the resources of individual 
practitioners to implement
  – interventions delivered largely within the 
resources of an individual practitioner 
with no additional costs other than their 
reasonable time are ‘practice interventions’ 
(e.g. prescribing paracetamol for infants 
with fever)
  – interventions requiring resources beyond 
the reach of individual practitioners 
in their conventional roles, such as 
interventions requiring additional budgets 
are policy interventions (e.g. widespread 
advertising for smoking cessation clinics; 
prescribing discounted access to fitness 
facilities)
•  more roles/skills than that of a single 
practitioner to implement
  – procedures implemented by many 
practitioners within the remit of their 
individual professional roles are not policy 
interventions (e.g. sharing the workload of 
facilitating parent craft classes)
  – procedures requiring a team of mixed roles 
are policy interventions (e.g. replacing 
doctors with nurses; or provision of 
specialist stroke units)
•  but may, nevertheless, be delivered by 
individual providers to individual recipients 
when the intention is to implement a policy
  – one-to-one treatments are not necessarily 
policy interventions (e.g. drugs, surgical 
treatments, counselling, therapy)
  – directives to consistently adopt a 
particular intervention are interventions to 
implement policy (e.g. prescribing aspirin 
following a heart attack, or counselling 
before and after HIV tests)
•  or may be evident by the use of clustered 
designs to evaluate their effectiveness, where 
clustering implies a collective decision about 
the implementation of different policy 
interventions in different arms of the trial
  – one-to-one interventions readily evaluated 
by random allocation of individuals to 
different treatments are largely practice 
interventions where such RCTs can inform 
practice decisions
  – higher units of allocation (e.g. practitioner, 
setting) are largely policy interventions 
where such RCTs can inform policy 
decisions.
For subcategories within 
policy intervention
In general, the categories of policy interventions 
described above (setting of policy/strategies, 
legislation/regulation, provision/organisation 
of services, environmental modification and 
facilitating lay/public delivered support/
education) could be readily applied. The reviewers 
identified the possible need for expansion of the 
‘Environmental modification’ category to include 
the modification of school meals. Any computer-
based interventions were considered policy 
interventions on the grounds of the costs and 
staffing required for computer support, in addition 
to the teaching staff required for implementing the 
intervention.
The level(s) at which policy 
has been enacted
Four categories were developed for policy level: 
policy for an institution, policy for a community, 
policy for a region and policy for a nation. In 
general, it was clear when policy interventions were 
being implemented ‘institution wide’, although 
this did not exclude them being implemented 
‘institution wide’ across a region or a nation. 
Also, it was often not possible to discern from the 
report whether the policy had been set nationally, 
regionally or institutionally, or whether institutions 
were obliged to adopt national or regional policy. 
These distinctions may have no discernible effect 
on the methodology of evaluation.
Applying operational definitions
Overall, the definitions and categories as described 
above (see Developing operational definitions) 
have proved possible to apply in a way that 
is consistent between two reviewers working 
independently. Limitations to the work done so far 
include characteristics of the studies appraised – 
EPPI-Centre reviews tend to focus on policy level 
interventions as described here, and so the tests 
done so far can only have limited powers to test the 
discriminatory powers of these tools for including 
or excluding policy interventions. However, the 
distribution of types of policy interventions that 
appeared in each EPPI-Centre review varied, DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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and discriminating between types of policy 
interventions appeared practical.
In developing our data sets we coded as policy 
evaluations those:
•  in which there was an explicit directive/policy 
for the intervention OR
•  beyond the capacity of individual providers 
(in terms of their roles/skills, resources, or 
authority).
These inclusion criteria match the focus of the 
commissioning brief on policy/management 
interventions which was ‘those interventions that 
are not confined to an individual practitioner . . . 
examples would include peer-led teaching and 
health promotion in schools’.
Explicit directives or policies include named 
policies such as national government legislation 
or programmes or, less formally, explicit collective 
action plans in which non-researchers had been 
involved in the decision-making. Collective action 
plans could be explicit either from descriptions 
of planning processes or from descriptions of 
the products of their planning processes, such 
as guidelines sponsored nationally or regionally 
by professional organisations or charities, or 
commercially available curricula.
Operating the second inclusion criterion requires 
a judgement about the roles, skills, resources and 
authority of individuals. For instance, distributing 
fruit to children at school would be judged a 
policy intervention because it would be beyond the 
authority/resources of an individual practitioner 
on the grounds that we do not expect teachers to 
pay for it out of their own pockets and if the school 
were to have a budget for it, it must also have a 
policy for it.
In addition to inclusion/exclusion criteria, we 
anticipated being able to separately identify and 
analyse evaluations of interventions that operate at 
different levels (national, regional, community, or 
institutional level) and in different policy sectors 
(housing, transport, health, crime and justice, etc.) 
or across policy sectors.
Data sources
Lipsey46 argues that the most suitable data 
sets for investigating the association between 
randomisation and effect size are either small 
numbers of evaluations that are nearly identical, 
except for randomisation, or large numbers of 
interventions allowing for diversity in the study 
population and design. In the first instance, any 
association between randomisation and effect size 
would be readily apparent. In the second, any 
association would need to be distinguished from 
associations of effect size with other variables, such 
as differences in the populations, interventions, 
outcomes or evaluation methods. Resampling 
studies, which draw on the data from individual 
RCTs, take Lipsey’s argument for comparing 
similar trials a step further.
Resampling studies data
We had access to two trials of policy interventions 
in which data were suitable for resampling studies.
Trial 1: The Social Support 
and Family Health Study
This study was an RCT which assessed whether 
increased postnatal support could influence 
maternal and child health outcomes.47
Two support interventions were set up. The first, 
the Support Health Visitor intervention, was the 
offer of 1 year of monthly supportive listening 
visits, the first to take place when the baby was 
approximately 10 weeks old. The primary focus 
for this intervention was on the mother and her 
needs. The second intervention, using the services 
of local community support organisations, entailed 
being assigned to one of eight community groups 
that offered drop-in sessions, home visiting and/or 
telephone support for a period of 1 year.
The trial compared maternal and child health 
outcomes for women who had been offered either 
of the support interventions with outcomes for 
control women who received standard services only. 
The primary outcomes were child injury, maternal 
smoking and maternal psychological well-being. 
Secondary outcomes were uptake and cost of 
health services, household resources, maternal and 
child health, experience of motherhood and child 
feeding.
No evidence of impact was found for either 
intervention on the primary outcomes. The 
Support Health Visitor intervention was popular 
with women and was associated with some of the 
secondary outcomes. Greater emphasis could, in 
future research, include the social support role of 
health visitors, developing more culturally sensitive Methodology: design and data sources
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outcome measures and exploring the role of social 
support on the delay of subsequent pregnancy.
Trial 2: The effectiveness of home 
visitation by public health nurses 
in preventing the recurrence of 
child physical abuse and neglect
Home visitation by public health nurses is known to 
be effective in preventing child abuse and neglect.48 
This RCT therefore aimed to investigate if home 
visitation by public health nurses to disadvantaged 
first-time mothers was effective in reducing 
recidivism.
Families with a history of one child being exposed 
to physical abuse or neglect were assigned to either 
a control or intervention group. The control group 
received standard treatment. The intervention 
group received a programme of home visitation 
by nurses in addition to the standard treatment. 
The main outcome was recurrence of child physical 
abuse and neglect, and analysis was by intention to 
treat.
At 3 years’ follow-up, recurrence of physical abuse 
did not differ between control and intervention 
groups, making the intervention ineffective. 
Although hospital records showed significantly 
higher recurrence of hospital attendance in the 
intervention group than in the control group, the 
authors concluded that this may be due to specific 
advice from public health nurses. No significant 
differences were found for secondary outcomes. 
This suggested that this home-based strategy was 
not effective, and that much more effort needed 
to be made towards prevention of child abuse or 
neglect before it becomes established as a pattern 
of behaviour in a family.
Similar studies drawn from 
systematic reviews
We sought readily available systematic review data 
stored on EPPI-Reviewer, software for storing and 
analysing data about primary research for inclusion 
in systematic reviews. This source includes data 
from reviews of health promotion (conducted by or 
in collaboration with the EPPI-Centre published 
1999–2004) and education (conducted by the EPPI-
Centre or by review groups supported by the EPPI-
Centre published before June 2004).
Of the 24 education systematic reviews, only seven 
included RCTs and NRSs; these included policy 
interventions of Interactive Communication 
Technology (ICT) for literacy (three reviews), 
out-of-home integrated care and education, paid 
adult support in mainstream schools, supporting 
pupils with emotional and behavioural difficulties 
in mainstream primary schools, and personal 
development planning for improving student 
learning. Between them they included 32 RCTs 
and 82 NRSs. This was considered too few studies 
to analyse further considering their diversity.
There were nine systematic reviews conducted 
by the EPPI-Centre between 1996 and 2004, and 
one Cochrane review conducted using EPPI-
Centre software. These reviews all included both 
randomised and non-randomised studies. These 
reviews were of health promotion, with studies 
often conducted in educational settings. Between 
them they addressed workplace health promotion, 
peer-delivered interventions, mental health, 
physical activity (two reviews), healthy eating (two 
reviews), cervical cancer and sexual lifestyle; (nine 
reviews with a total of 206 studies). See Appendix 2 
for summaries of these reviews.
Meta-epidemiological data
The studies described above, when combined 
as 206 controlled trials of health promotion, 
also provided a suitable data set for meta-
epidemiological investigations.
Another data set suitable for this approach was also 
available from ongoing work by Colorado State 
University reviewing and synthesising the past 20 
years of research and advancements in the area of 
transition for youths with disabilities (www.ncset.
org/publications/viewdesc.asp?id=714). These data 
from 126 studies are also held on EPPI-Centre 
software.
Reviews of reviews
For a review level analysis, data were sought from 
methodological studies and systematic reviews of 
randomised and non-randomised studies using 
systematic search strategies, selection criteria and 
data extraction procedures.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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n Chapter 1 we described divergent views on 
the appropriateness of RCTs for evaluating the 
effects of policy interventions. Here we build on 
our experience of reviewing policy interventions, 
and the relevant literature, to propose how 
randomisation and effect sizes may be associated in 
evaluations of policy interventions.
Our original objectives were to determine whether 
RCTs lead to the same effect size and variance 
as NRSs of similar policy interventions, and 
whether these findings can be explained by other 
factors associated with the interventions or their 
evaluation. To meet the second of these objectives 
we proposed a number of variables for which 
arguments could be mounted, hypothesising links 
between them, randomisation and effect size. 
These variables and hypotheses are presented 
below and summarised in Table 1.
Potential confounders 
associated with participants 
of the evaluation
The population of a given study may be related to 
both the design of an evaluation and its effect size.
Baseline characteristics
Groups in nRCTs may differ at baseline for a 
number of reasons. Recipients of the intervention 
may have self-selected, or those who declined 
to participate may have been assigned to 
the control/comparison group. Alternatively, 
recruitment may have favoured those most 
amenable to participation or those in most 
need, or excluded older people or those with 
comorbidities. Well-conducted RCTs, with their 
standardised procedures for recruitment and 
data analysed according to the intention to treat 
rather than receipt of the intervention, are more 
likely to have more equivalence between groups. 
Non-equivalence at baseline may influence the 
calculated effect size and variance.
Attrition
Attrition rates may be linked to the quality 
of the evaluation. Higher attrition may be 
expected in community and home settings than 
in organisational settings where it is easier to 
employ randomisation and good follow-up. 
High attrition may also be associated with losing 
a disproportionate number of people who are 
socially disadvantaged and more resistant to 
interventions, and hence lead to a misleadingly 
large effect size.49,50 For this reason, high attrition 
may be associated with both lack of randomisation 
and higher effect sizes. Potential technical solutions 
in primary research include greater investment 
in recruiting and retaining participants, perhaps 
using the NHS number for tracking. Other 
solutions for primary studies and systematic reviews 
include adjusting for attrition, assuming those lost 
to follow-up have poor outcomes.
Potential confounders 
associated with the 
intervention
There are arguments for linking the theoretical 
underpinning of intervention design, public 
involvement in developing interventions, and 
the geographical or organisational scope of 
interventions with the presence or absence of 
randomisation and effect size.
Theoretical underpinnings
Policy interventions pose serious challenges to 
evaluations of effectiveness because they may be 
large and difficult to replicate consistently, and 
have diffuse boundaries. Evaluation methodologies 
differ in their responses to such challenges. RCTs, 
and systematic reviews of RCTs, are the methods 
of choice employed by public health physicians 
wishing to elucidate causal effects in variable 
circumstances. These methodologies emphasise the 
need to reduce bias by employing randomisation, 
Chapter 3  
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preferably with blinded allocation to treatment and 
outcome measurement, minimising attrition, and 
analysing according to the intended treatment. 
Examples include community interventions 
for preventing smoking in young people,51 
computerised support for prescribing practice52 
and day care for preschool children.53
By contrast, many social scientists are known to 
employ different theories from experimentalists 
evaluating policy interventions. The relatively 
new profession of health promotion specialists21 
has favoured ‘an approach to evaluation that 
implicitly acknowledges the need for outcome 
data but explicitly concentrates on process or 
illuminative data that helps us understand the 
nature of that relationship’.54 The centrepiece of 
the health promotion paradigm is the concept 
of empowerment – enabling people to increase 
control over, and to improve, their own health. 
Empowerment claims to attribute responsibility 
to people not for the existence of a problem, 
but for finding a solution to it. The goal is then 
‘full and organised community participation 
and ultimate self-reliance’.55 This approach is 
endorsed by Arblaster56 in a systematic review of 
the effectiveness of health service interventions 
aimed at reducing inequalities in health. The 
review concluded that characteristics of successful 
interventions specifically aimed at reducing 
health differentials include ensuring interventions 
address the expressed or identified needs of the 
target population, and the involvement of peers 
in the delivery of interventions. The tradition of 
community development rests heavily on public 
involvement, and we expect community-based 
interventions to include the public more often 
in identifying the aims of the intervention, and/
or participating in its development. Examples 
include impact evaluations of a large-scale social 
marketing initiative to encourage fruit and 
vegetable consumption57 and of bar-based, peer-led 
community-level intervention to promote sexual 
health among gay men.58 With this understanding 
we anticipate evaluations of community 
development to be more theoretically informed 
from the tradition of social science, and less subject 
to randomisation. This expectation is supported 
by a comparison of the CONSORT (Consolidated 
Standards of Reporting Trials) statement (a 
checklist and flow chart, to help improve the 
quality of reports of RCTs) and the TREND 
(Transparent Reporting of Evaluations with 
Nonrandomized Designs) statement. The TREND 
statement, unlike the CONSORT statement, seeks 
information about theories used in designing 
behavioural interventions.36,59
In summary, the public health approach has 
tended to emphasise randomisation but not public 
involvement or community-based approaches, 
compared with health promotion where the reverse 
is so; with the expectation within public health 
that randomisation leads to more conservative 
estimates of effect size and the expectation within 
health promotion that public involvement leads to 
interventions with greater effect sizes.
Similarly, divergent views about appropriate 
methods for evaluating interventions are found in 
the areas of social welfare44 and education25 where 
The Centre for Evidence-Based Social Services 
(www.ex.ac.uk/cebss/introduction.html) and the 
Evidence-based (www.cemcentre.org/ebeuk/) 
Education Network UK stand out from many 
of their British professional colleagues in social 
welfare and education, respectively, as advocates for 
randomised evaluation.
Setting and boundaries 
of the intervention
In the area of public policy, community-wide 
interventions, or regional/national interventions 
may pose challenges in being less easily 
manipulated for the purposes of evaluation than 
individual or institutionally based interventions. 
Standardised implementation of interventions may 
be more difficult across large communities, regions 
or whole countries than in single organisations and 
therefore may be less effective or more variable in 
effectiveness.
Interventions with a broader reach (communities, 
regions, nations) have more diffuse boundaries 
than those set within institutions. Randomisation 
is less often applied to community, regional or 
national interventions. Clustered trials are more 
appropriate for these and some organisational level 
interventions, in order to reduce the likelihood of 
participants experiencing comparison interventions 
to which they have not been allocated. However, 
clustering reduces the power of a trial, so clustered 
evaluations are less likely to show statistically 
significant effectiveness. The solution is to 
increase the size of the trial, yet recruitment can 
be particularly challenging in community settings. 
Moreover, attrition may be greater in larger scale 
interventions, where tracking of individuals is more 
difficult than within an organisation (see Attrition).DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Providers of the intervention
Community development and peer delivery 
specialists value health promotion theory and 
process evaluations more than RCTs. These 
interventions may therefore be found to have less 
randomisation. Theories underpinning community 
development and peer delivery anticipate more 
effective interventions through their greater 
relevance. Characteristics of interventions effective 
for reducing health inequalities include community 
commitment and peer delivery.56 Examples in 
the area of smoking cessation include the non-
randomised evaluation of the Wessex Healthy 
School Award where the intervention was delivered 
by the school community.60
In contrast, clinicians design and deliver their 
own interventions and evaluations, and work in a 
culture that favours randomisation; for instance, 
many of the smoking cessations’ interventions 
for pregnant women are delivered by health 
professionals and evaluated by RCTs.61
Also, working in the area of criminology, Lipsey 
and Wilson62 have shown a statistical association 
between randomisation and effect size in 
‘demonstration’ projects in which the researcher 
had greater control of both the intervention and 
randomisation. Our data set of health promotion 
evaluations provides an opportunity to test this 
association in another area.
Potential confounders 
associated with outcomes
The design of the evaluation provides a wealth of 
potential confounders. Among these are the choice 
of outcome domains (e.g. knowledge, attitudes, 
behaviour or health) and the choice of outcome 
measures (‘hard’ or ‘soft’). These are considered 
below.
Choice of outcome domains
The impact of health education has traditionally 
been considered in terms of changes in knowledge, 
attitudes, behaviour and health. Kirkpatrick’s63 
hierarchy of outcomes from the policy area of 
professional training presents the higher level 
outcomes (health and behaviour) as harder to 
attain than lower level outcomes (knowledge 
and attitudes). The choice of outcomes may be 
strongly influenced by the intervention setting. 
Other broader health behaviour theories present 
knowledge and positive attitudes as necessary but 
not sufficient for improved behaviour and health 
in many theories of health behaviour.64 Thus there 
is support from these two different policy areas of 
professional training and health behaviour change 
for the argument that outcomes in the domains 
of knowledge, attitudes, behaviour and health 
are successively more difficult to influence and 
therefore associated with lower effect sizes.
The choice of outcomes may be strongly influenced 
by the intervention setting. For instance, the 
measurement of any health outcome may be 
easier in a clinical setting where randomisation 
is also more readily acceptable by staff. Following 
this argument, evaluations with health outcomes 
are more likely to be associated with patient 
populations than community populations. For 
instance, generating evidence about smoking 
cessation in pregnancy lends itself to short-term 
health outcomes such as birth weight, gestational 
age at birth, perinatal mortality, method of 
delivery, and measures of anxiety, depression and 
maternal health status in late pregnancy and after 
birth as seen in a systematic review of 64 RCTs 
(51 RCTs and six clustered RCTs).61 Such data 
can be easily collected in a clinical setting where 
randomisation is also feasible. Similarly, a review 
of smoking cessation for hospitalised adults where 
nine of the 17 included studies (16 RCTs, one 
quasi-RCT) measured death of the patient as well 
as abstinence from smoking.65 Both these reviews 
included randomised or quasi-randomised trials.
In contrast, a review of community interventions 
for preventing smoking in young people51 found 
that over half the controlled trials were non-
randomised, and outcomes were restricted to 
knowledge about the effects of smoking, attitudes 
to smoking, intentions to smoke in the future and 
smoking cessation.
Choice of outcome measures
The choice of particular outcomes or measures may 
be associated with randomisation, because some 
outcomes are more feasible in a clinical setting 
where randomisation is also readily accepted. For 
instance, both cluster or individual randomisation 
and the use of clinical outcome measures requiring 
blood tests may be difficult to impose elsewhere. 
For example, cotinine tests as markers for smoking 
cessation may be more common in clinical 
settings, and provide smaller effect sizes than 
unconfirmed reports of non-smoking. For instance, 
only one study out of 17 (6%) in a review of 
community interventions for preventing smoking Hypothetical associations between randomisation and effect sizes of policy interventions
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in young people51 used cotinine measurements 
to confirm non-smoking. Similarly, a review of 
community interventions for adults found 10 of 
32 studies included serum thiocyanate analysis 
and one included cotinine analysis to validate 
smoking status, giving a total of 34% of trials with 
biochemical validation of smoking cessation.66 In 
contrast, in a review of smoking cessation during 
pregnancy, when women often attend clinics or 
hospitals, 35 of 47 (74%) included studies with 
biochemically validated cessation as an outcome.61 
The implications of this are that ‘hard’ outcomes 
(in this case, validated smoking cessation) and 
randomisation are both easier in a clinical 
setting where clinical tests and access to medical 
records are easier. A parallel argument might be 
made in education sector evaluations where self-
reported understanding may be less reliable than 
examination results, so assessing learning within 
schools may be more objective. In both cases, 
evaluating interventions within an institution where 
testing is routine and randomisation is easier leads 
to more objective findings.
Potential confounders 
associated with design 
of the evaluation
The design of the evaluation provides a wealth 
of potential confounders: sample size; presence 
of a control group; concealment of allocation; 
follow-up; the number of clusters; and quality of 
reporting. Each of these is considered below.
Sample size
Larger sample sizes are more likely to be found in 
nRCTs or natural experiments that can provide 
convenience samples on a large scale. Smaller 
sample sizes, more commonly found in RCTs, 
are more likely to lead to spurious results, with 
those reporting positive findings more likely to be 
published.
Control group
Control groups are always found in RCTs, but only 
sometimes in NRSs. The lack of a control group 
may result in a misleading effect size as the study 
does not take into account possible simultaneous 
influences.
Blinding
Patients who know that they are on a new, 
experimental treatment are likely to have an 
opinion about its efficacy, as are their clinicians 
or the other study personnel who are measuring 
responses to therapy. These opinions, whether 
optimistic or pessimistic, can systematically 
distort both the other aspects of treatment and 
the reporting of treatment outcomes, thereby 
reducing our confidence in the study’s results. 
In addition, unblinded study personnel who 
are measuring outcomes may provide different 
interpretations of marginal findings or differential 
encouragement during performance tests, either 
one of which can distort their results.67 Blinding 
of community interventions is more challenging, 
and therefore linked with other characteristics of 
community interventions such as fewer randomised 
evaluations.
Follow-up
Longer term follow-up may be easier within 
institutions, where randomisation is also 
easier. However, long-term follow-up exposes 
interventions to additional scrutiny in terms of 
sustainability or maintenance of effect, and may 
reveal declining effect sizes. Alternatively, long-
term follow-up is also associated with greater 
attrition which in turn is associated with greater 
effect sizes.
Clustering
Clustered trials may be ‘natural experiments’ 
without randomisation, particularly if there are few 
clusters. Natural experiments may be more likely 
to have enthusiasts supporting the intervention, 
and non-enthusiasts supporting the comparisons, 
and therefore lead to greater effect sizes. This 
introduces bias from lack of blinding (see above).
Quality of reporting
The quality of reporting of some aspects of 
evaluation may be associated with researchers’ 
disciplines. In particular, triallists, who more often 
use randomisation, may also be more likely to 
report pre- and postintervention data. Natural 
experiments in particular may face challenges 
in collecting pre-intervention data because 
researchers have less influence. They may be 
invited to evaluate a policy intervention only 
after implementation has begun (for example, 
evaluation of Sure Start Plus, a UK Government 
pilot initiative to support pregnant young women 
and young parents under 18 years of age).68 
Although the CONSORT and TREND statements 
both encourage the reporting for baseline data for 
RCTs and non-randomised designs respectively, the DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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TABLE 1  Hypotheses linking randomisation and effect size through ‘effect moderators’ or ‘cofounders’
Potential confounder
Association with 
randomisation
Association with effect 
size
Possible technical 
solutions
Participants
Baseline characteristics
Groups may differ at baseline 
because: either recipients 
of the intervention have 
self-selected or those who 
declined to participate 
have been assigned to the 
control/comparison group; 
or recruitment favoured 
those most amenable to 
participation, or those in 
most need, or excluded 
older people or those with 
comorbidities
nRCTs are more likely to 
have more heterogeneous 
populations and non-
equivalence between groups
Heterogeneity and non-
equivalence at baseline may 
influence the calculated 
effect size and variance
Randomisation wherever 
possible; better matching 
and assessment of baseline 
characteristics elsewhere. 
More pragmatic trials 
reflecting ‘real world’ 
problems that will be more 
generalisable and more likely 
to be implemented
Attrition
Higher attrition may be 
expected in community 
and home settings than in 
organisational settings
Higher attrition may be 
expected in transient 
populations (e.g. commercial 
sex workers, asylum seekers, 
socially excluded people)
It is easier to employ 
randomisation and have good 
follow-up for trials set in 
organisations. Attrition and 
randomisation can be used 
as quality markers for trials
High attrition may be 
associated with losing a 
disproportionate number of 
socially disadvantaged people 
who are more resistant to 
health promotion/public 
health initiatives
Greater investment in 
recruiting and retaining 
participants – use of NHS 
number for tracking. 
Adjusting for attrition, 
assuming those lost to 
follow-up have poor 
outcomes
Innovative strategies for 
managing contact with 
transient populations (e.g. 
using ‘peer evaluators’)
Intervention
Theoretical underpinnings of the intervention
Public health triallists value 
experimental methodologies 
more than do health 
promotion specialists, who 
place more emphasis on 
involving the community in 
developing and delivering the 
intervention
Experimental 
methodologies in public 
health are associated with 
randomisation
Health promotion is 
associated with community 
development but not 
randomisation
Rigorous public health trials 
minimise effect sizes
Community development 
is mounted with the 
expectation that it will 
maximise effectiveness
Cross disciplinary research
Encourage a results driven 
culture among social 
scientists
Public involvement in developing the intervention
Empowerment theories 
attribute responsibility to 
people not for the existence 
of a problem, but for finding 
a solution to it
The goal of ‘full and 
organised community 
participation and ultimate 
self-reliance’55 is a feature 
of social work such as 
community development and 
youth work, rather than a 
feature of public health and 
randomised experiments
Successful interventions 
specifically aimed at reducing 
health differentials include 
ensuring interventions 
address the expressed or 
identified needs of the 
target population, and the 
involvement of peers in the 
delivery of interventions56
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Potential confounder
Association with 
randomisation
Association with effect 
size
Possible technical 
solutions
Setting and boundaries of the intervention
Interventions with a broader 
reach (communities, regions, 
nations) have more diffuse 
boundaries than those set 
within institutions
Randomisation is 
less often applied to 
community, regional or 
national interventions. 
Clustered trials are more 
appropriate for these and 
some organisational level 
interventions
Attrition may be greater in 
larger scale interventions, 
where tracking of individuals 
is more difficult than 
within an organisation (see 
Attrition)
Clustering reduces the 
power of a trial, so clustered 
evaluations are less likely to 
show effectiveness
Standardised implementation 
of interventions may be 
more difficult across large 
communities, regions or 
whole countries than in 
single organisations, and 
therefore may be less 
effective
Larger scale cluster trials for 
policy interventions
Greater investment in 
tracking participants – use 
NHS number
Provider of the intervention: Community/peer provider
Community development 
and peer delivery specialists 
value health promotion 
theory and process 
evaluations more than RCTs
These interventions may 
therefore be found to have 
less randomisation
Peers may be seen as 
more credible sources 
of information than 
professionally trained, 
health educators, and may 
be particularly helpful in 
reaching ‘at risk’ populations
Cross disciplinary research
Clinician
Many clinicians who design 
and provide interventions 
value RCTs
These interventions may 
therefore be found to have 
more randomisation
Methodological 
rigour associated with 
randomisation is likely to 
lead to lower effect sizes69
Researcher provider
Researchers have more 
control over the intervention 
and evaluation
Theoretically, the researcher 
would therefore be better 
able to randomise
Interventions will be found 
to be more consistently 
implemented by enthusiasts, 
and therefore more effective
Outcomes
Choice of outcome domains
Health outcomes are more 
readily measured in clinical 
settings
Clinical settings are more 
likely to mount RCTs, and 
have clinical providers, and 
long-term follow-up (see 
above)
Choice of outcome measures
Clinical outcomes are more 
commonly found in clinical 
settings
Choice of ‘hard’ or ‘soft’ 
outcomes can be associated 
with randomisation
If clinicians favour RCTs, 
clinical outcome measure 
may be associated with 
greater randomisation
Clinical outcomes will be 
found to be more resistant 
to change than ‘softer’ 
outcomes such as reported 
behaviour
TABLE 1  Hypotheses linking randomisation and effect size through ‘effect moderators’ or ‘cofounders’ (continued)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
21
Potential confounder
Association with 
randomisation
Association with effect 
size
Possible technical 
solutions
Evaluation design
Sample size
Sample size affects the 
choice of study design
Larger sample size may be 
more likely in NRSs
Smaller sample sizes are 
more likely to give spurious 
results; of these, those with 
positive results are more 
likely to be published
Weight of evidence by 
sample size
Control group
Study design is linked with 
the use of a control group
Control groups are always 
found in RCTs, but only 
sometimes in NRSs
Use of a control group leads 
to smaller effect sizes than 
uncontrolled evaluations
Blinding
Blinding of participants, 
recruiters, intervention 
providers and outcome 
assessors to the intervention 
allocation
Blinding is easier with 
randomisation
Poor concealment, more 
common in nRCTs, will 
be associated with greater 
effect sizes
Follow-up
Length of follow-up periods 
is linked with study design
Long follow-up may be easier 
within institutions, where 
randomisation is also easier
Long follow-up will be 
associated with declining 
effect size
Clustering
Clustered trials with few 
clusters are more likely to be 
‘natural experiments’
Natural experiments do not 
include randomisation
Natural experiments may 
be more likely to have 
enthusiasts supporting 
the intervention and non-
enthusiasts supporting the 
comparisons, and therefore 
lead to greater effect sizes
Quality of the reporting
Quality of reporting specific 
elements of a study is 
associated with researchers’ 
disciplines
Better reporting (of pre- and 
postintervention data) will 
be seen to be associated 
with triallists who also 
support randomisation
Reporting of pre- and 
postintervention data 
precludes effect sizes inflated 
by differences between 
groups
Adjusting for differences 
between groups, in primary 
studies and in reviews 
TABLE 1  Hypotheses linking randomisation and effect size through ‘effect moderators’ or ‘cofounders’ (continued)
CONSORT statement, introduced in 1996, has had 
much longer to influence the reporting of RCTs 
than the TREND statement, introduced in 2004, 
has had to influence non-randomised trials. Thus, 
a greater proportion of randomised studies than 
NRSs might be expected to report baseline data.
By influencing the reporting of studies, both 
statements have been able to influence the quality 
of the design and conduct of studies, and may be 
expected to reduce bias and, consequently, effect 
sizes.
Reporting of pre-and postintervention data 
precludes effect sizes inflated by differences 
between groups.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Introduction
The aim of this chapter is to review what is already 
known and to set the context for later chapters 
through identifying, examining and discussing 
a range of methodological studies that compare 
randomised and non-randomised designs 
outside the area of health. We were aware that 
methodological research on policy interventions 
had been published in the broader social sciences 
and wished to see what could be learned from this 
before conducting our own investigation within 
health.
A search was conducted to identify studies in 
areas such as education, psychology and social 
care, which had investigated the influence of 
evaluation methodology (principally differences 
between randomised and non-randomised studies), 
intervention attributes, characteristics of study 
populations and a range of other factors on effect 
sizes. The key characteristics of the studies were 
tabulated and described (in terms of their aims, 
methods, effect modifiers investigated, and results 
and conclusions). Particular attention was paid to 
the effect modifiers investigated and how these 
were characterised in order to investigate them 
further at the level of systematic reviews and 
primary studies. This chapter reports the results of 
the review of the methodological literature.
Methods
Although this was not intended to be a systematic 
review of the literature, we nevertheless adopted 
standard practices for literature searching, 
retrieval, extraction and synthesis, when possible.
In terms of inclusion criteria we were interested 
in capturing empirical studies examining 
the association between various population, 
intervention, outcome, and study characteristics 
and effect size. The principle characteristic of 
interest was whether or not randomisation had 
been used to assign participants to study groups. 
We were also interested in other methodological 
attributes such as methods for measuring 
outcomes, follow-up procedures, and sample 
size, together with any other variables that 
may be associated with presence or absence of 
randomisation, as potential ‘effect modifiers’. We 
anticipated capturing a range of types of study 
including within-study comparisons (i.e. RCTS 
that include a non-randomised control/comparison 
group to allow at least one non-experimental 
estimate of effect); single meta-analyses comparing 
the results of randomised and non-randomised 
trials; and meta-reviews (i.e. reviews of meta-
analyses which summarise the conclusions 
from individual meta-analyses with respect to 
associations between variables and effect sizes).
A search strategy was designed, tested and 
revised by the information scientist. Searching for 
studies that describe both randomised and non-
randomised evaluation designs is problematic in 
electronic bibliographic databases, particularly 
outside the health field. This is due to poor 
indexing of study designs in the controlled 
vocabulary (where one exists), the limited search 
capabilities of many databases, and the lack of 
abstracts describing the studies. The strategy 
underwent various revisions to balance sensitivity 
with specificity before being executed. The final 
strategy comprised free-text terms for RCTs, and 
NRSs (e.g. non-experimental, pseudorandom, 
semi-random) (see Appendix 3).
A number of electronic databases were searched:
•  Applied Social Sciences Index and Abstracts 
(ASSIA)
•  Australian Education Index (AEI)
•  British Education Index (BEI)
•  CareData
•  Dissertation Abstracts
•  EconLIT
•  Educational Resources Information Centre 
(ERIC)
•  International Bibliography of the Sociological 
Sciences (IBSS)
•  ISI Proceedings: Social Sciences and 
Humanities
•  PAIS International (Public Affairs Information 
Service)
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•  PsycINFO
•  SIGLE (System for Information on Grey 
Literature in Europe)
•  Social Science Citation Index (SSCI)
•  Sociological Abstracts.
Further details are given in Appendix 3, for both 
this and the search reported in Chapter 5.
In addition to this search, citation searching was 
undertaken to identify publications by authors 
known to have published widely on the issue of 
evaluation design and effects. These included 
William Shadish, Harris Cooper, Larry Hedges, 
Steven Glazerman and Dan Levvy. Authors of 
reviews included in Chapter 5 were contacted 
to identify further methodological publications. 
Finally, a number of internet sites were searched 
including the catalogue of the British Library, the 
Library of Congress, search engines (Copernic and 
Google) and information gateway sites [OMNI 
(www.intute.ac.uk/medicine/) and SOSIG (www.
intute.ac.uk/socialsciences/)].
Once literature searching was complete, relevant 
papers were retrieved and sifted to assess their 
relevance. They were classified according to their 
study type (i.e. replication studies, single meta-
analyses, reviews of meta-analyses, etc.), read and 
key details extracted and tabulated. They were 
not assessed for their methodological quality. The 
purpose was to identify hypotheses for testing with 
our own data (see Chapters 7–9).
Discussion of 
methodological literature
Type of studies
After sifting we identified one review of within-
study comparisons of randomised and non-
randomised participants,70,71 six single meta-
analyses42,46,72–75 and one review of meta-analyses.76 
These eight studies form the basis of this chapter. 
Their scope and methods are described in Table 2.
We also identified nine single within-study 
comparisons of randomised and non-randomised 
participants, seven of which were included in the 
review of such comparisons by Glazerman et al.70,71 
and consequently are not discussed any further 
(see Methods of analysis). In addition, six small 
concurrent comparisons of randomised/non-
randomised study participants were identified81–86 
and a number of commentary papers were found. 
These weaker sources of evidence were not 
tabulated.
Scope of the studies
The scope of the studies varied in terms of the 
interventions included, the populations included 
and the methodological focus. The topic areas 
examined by the eight studies varied. They 
included interventions for preventing juvenile 
delinquency,42,46 treatment of alcohol abuse73,87 
and psychological interventions.74–76 There was an 
overlap with the health field, with Heinsman and 
Shadish72 including interventions in the mental 
health and health-care fields.
In terms of the type of interventions evaluated, 
there was a strong focus on psychotherapy and 
psychosocial programmes, partly reflecting the 
specialist interests of the authors, many of whom 
were common to more than one publication (For 
example, Heinsman and Shadish, 1996;72 Shadish, 
1997;88 Shadish, 2000;75 Lipsey, 2003;46 Wilson and 
Lipsey, 200176). Some studies were broad in their 
inclusion of interventions, such as Weisburd et al.,42 
who included interventions aimed at communities, 
families, schools and labour markets.
In terms of scope, many of the studies had the 
primary aim of comparing effect sizes between 
randomised and non-randomised evaluation 
designs. In addition, some also examined the 
relationship between other modifiers and effects. 
For example, Shadish and Ragsdale74 also 
investigated the influence of sample size, attrition, 
type of control group, publication status and a 
number of other factors. In other studies the 
focus was broader, with randomisation only one 
variable of interest among many. For example, in 
the review by Lipsey46 [described in further detail 
in Reviews of meta-analyses of randomised and 
non-randomised studies (n = 6)], page 71 stated 
that the aim was to ‘illustrate the hazards and 
complexities of investigating moderator variables 
in meta-analysis’. Wilson and Lipsey76 in their 
review of meta-analyses [described further in 
Synthesis of meta-analyses (n = 1)] examined the 
association between a vast range of population, 
intervention and study, variables and effect size 
variance. Shadish et al.75 [described in further 
detail in Reviews of meta-analyses of randomised 
and non-randomised studies (n= 6)] had a slightly 
different focus, examining the characteristics of 
studies judged to be ‘clinically representative’, in 
terms of relationship to study design and effect size 
(see Effect modifiers).
Where random/non-random allocation was the key 
issue investigated, some studies sought to delineate 
the influence of different types of NRS on study DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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outcomes, rather than analysing all NRSs as one 
homogeneous group. For instance, Weisburd et 
al.42 classified five types of study. These included 
(1) correlational studies where an intervention is 
measured in only one group; (2) studies where a 
clear temporal sequence can be observed between 
an intervention and an outcome; (3) studies 
in which one group receives an intervention, 
compared with another group that does not; (4) 
studies in which intervention and comparison 
groups are compared, with other mediating factors 
controlled for/or with a matched comparison 
group; and (5) RCTs. Type (1) was considered 
non-experimental, type (2) was a ‘stronger non-
experimental/weaker quasi-experimental’, types (3) 
and (4) were considered quasi-experimental and 
(5) was an RCT. The authors reported mean effect 
sizes for each of these types, and also separately 
compared the quasi-experimental studies (3 or 4) 
and the higher quality quasi-experimental designs 
(4) with the RCTs (5).
The rationale and context for the studies varied. 
For example, Weisburd et al.42 posed the question 
of whether the type of research design used to 
evaluate a crime and justice intervention influences 
its conclusions. Writing from the perspective of 
the Campbell Collaboration Crime and Justice 
Coordinating Group, they acknowledged the 
gold standard status of the RCT for assessing 
effectiveness, but noted the lack of well-conducted 
RCTs in the crime and justice area and that 
systematic reviews that restrict their inclusion 
criteria to RCTs may be unrealistic. Their central 
question, therefore, was ‘What are the potential 
shortcomings of including NRSs within systematic 
reviews?’. Specifically, ‘Are they likely to over or 
under-estimate the effects of interventions?’.
In contrast, Moyer and Finney87 were interested in 
the generalisability of RCTs in the field of alcohol 
treatment. They suggested that participants 
recruited into RCTs may be more likely to 
benefit than those who receive treatment under 
more typical ‘real life’ conditions, which tend to 
prevail in NRSs. The study therefore investigated 
the extent to which RCTs had been used in 
the field, whether participants differ between 
the two designs, whether the interventions are 
implemented differently between the two designs; 
and whether ‘post-treatment’ functioning of 
participants between the designs differ, controlling 
for differences in participant characteristics and 
other methodological features.
In summary, while one of the central aims of 
each study was to examine the influence of 
randomisation on intervention effects, each did so 
from a variety of different perspectives.
Methods of analysis
As discussed in Type of studies, three main types of 
study were used to examine the influence of design 
and other characteristics on intervention effects.
Reviews of within-study 
comparisons (n = 1)
The first approach, as employed by only one 
study, was reviews of within-study comparisons, 
also referred to as the design replication study. As 
described earlier, this type of study uses an RCT 
to evaluate an intervention, the results of which 
are compared with one or more non-experimental 
comparison/control groups. The aim is to ascertain 
how similar the outcomes for the non-experimental 
groups are to those of the randomised groups 
of the same intervention. Glazerman et al.70,71 
systematically reviewed replication studies in the 
fields of welfare, job training and employment 
services. The review sought to ascertain whether 
non-randomised methods produce similar results 
to well-designed RCTs, which non-randomised 
methods were more likely to replicate the outcomes 
from well-designed RCTs and under which 
conditions they were likely to perform better, and 
whether averaging multiple effects from NRSs 
produced similar results to those obtained by well-
designed RCTs.
A study protocol was published on the Campbell 
Collaboration website (www.campbellcollaboration.
org) prior to initiation of the review. To be 
included, studies had to compare randomised and 
non-randomised groups from within the same 
study, and the same intervention in the same sites. 
Any differences other than the presence or absence 
of randomisation would confound the results.
Twelve studies relating to nine interventions were 
included. Quality assessment was performed on 
each of the studies and was found to be generally 
good. The analysis explored the analytic techniques 
used to adjust for differences between the 
comparison group and the randomised population 
and how selection bias varies according to the 
source of the comparison group. For example, 
the source of the comparison group was coded 
according to whether it was drawn from a national 
data set or from the control group of another RCT, 
or whether members from the same geographic Review of methodological literature
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TABLE 2  Study methods
Study Study aim Inclusion criteria Study identification Analysis
Review of within-study comparisons
Glazerman, 
200370,71
To assess the value of 
replication studies to 
assess the ability of 
NX designs to produce 
valid impacts of social 
programs on participants’ 
earnings
RCTs with an additional 
comparison group to 
allow at least one NX 
estimate of programme 
impact
The experimental/NX 
comparison had to be 
based on estimates from 
the same experiment 
and had to pertain to the 
same intervention in the 
same sites
Search not detailed here
12 studies pertaining to 
nine interventions were 
included
Design and context 
variables coded. To 
estimate the average bias 
reduction, both bivariate 
analyses (tabulations) 
and multivariate analyses 
(regression) were used. 
Bivariate analyses were 
sample size weighted
‘Single’ meta-analyses
Shadish, 
199674
To provide better 
estimates (than previous 
meta-analyses) of the 
differences between 
randomised experiments 
and non-equivalent 
control group designs, 
by controlling inclusion 
and coding and analysing 
potential moderator 
variables
Primary studies of marital 
or family psychotherapy 
or enrichment, taken 
from a sample of 100 
studies acquired for a 
previous meta-analysis. 
Included studies had to 
compare treatment to 
control conditions and 
allow effect sizes to be 
calculated. Studies in 
which allocation method 
was not clear or was 
haphazard were excluded
Studies were identified 
from a previous meta-
analysis77
100 studies were 
included (64 RCTs)
116 were excluded
Each study coded by 
effect size and design. 
Differences between 
RCTs and NRSs are 
presented by simple 
comparison of pooled 
effect size and variance. 
Effects of including the 
116 excluded studies 
was examined. Outliers 
were adjusted for. Effects 
of potential confounder 
variables were examined 
singly and in combination 
by regression analysis
Weisburd, 
200142
To determine whether 
the type of research 
design used in a 
crime and justice 
study influences the 
conclusions that are 
reached
Primary studies 
of criminal justice 
interventions that 
included crime or 
delinquency as an 
outcome measure 
and met minimal 
methodological 
requirements. Seven 
broad areas looked at: 
communities, families, 
schools, labour markets, 
places, policing and 
criminal justice
Studies identified for 
National Institute of 
Justice commissioned 
‘Maryland Report’ were 
included
308 studies were 
included (46 RCTs)
Each study coded 1, 
0 or –1 according 
to whether the 
investigator concluded 
the intervention had 
worked, had no detected 
effect or had backfired 
(IRR) as presented in the 
Maryland Report and 
also according a ‘scientific 
methods scale’ developed 
for the Maryland Report 
as an indicator of internal 
validity (SMS) where 1 
indicated correlational 
studies and 5 indicated 
RCTs
Cross-tabulated SMS 
score with mean IRR 
to give an indication of 
intervention outcomes 
according to study designDOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Study Study aim Inclusion criteria Study identification Analysis
Heinsman, 
199672
A methodological 
study using meta-
analysis to examine the 
defining feature of the 
randomised experiment, 
random assignment to 
conditions
Studies that included 
control conditions and 
allowed effect sizes 
to be estimated were 
selected. Studies in 
which allocation method 
was not clear or was 
haphazard were excluded 
Studies included in four 
existing meta-analyses in 
health, mental health and 
education were screened 
for inclusion
51 RCTs and 47 NRSs 
were included. Total 
number excluded not 
reported
Each study coded by 
design and effect sizes. 
Differences between 
RCTs and NRSs given 
across all interventions 
and according to each of 
the four topic areas both 
by simple comparison 
of randomised and non-
randomised experiments 
and by using a regression 
analysis
Shadish, 
200075
To study the 
relationship of clinical 
representativeness 
to outcome and 
to generalise by 
extrapolation from that 
research to a clinically 
representative target of 
interest
Studies of psychological 
therapies in any setting, 
excluding those that used 
psychotropic medication 
or were purely preventive
Studies were sourced 
from the Shadish and 
Heinsman88 meta-analysis 
that met their stage 
1 criteria for clinical 
representativeness 
(n = 41), 40 studies 
randomly sampled from 
each of the same meta-
analyses used by Shadish 
and Heinsman,88 and nine 
studies of ‘clinic therapy’ 
from Weisz et al.78
Authors refer to time 
lag bias; most of included 
studies are pre-1990. 
More recent studies may 
have non-significantly 
smaller effect sizes and 
may be significantly less 
clinically representative
Each study coded 
for effect size 
(independently/blind to 
other variable coding), 
clinical representativeness 
criteria, treatment 
characteristics and 
outcome characteristics. 
Correlation between 
effect size and clinical 
representativeness 
scores given in a scatter 
plot, then broken down 
by source of studies, 
random or non-random 
assignment and year 
of publication. Multiple 
regression analysis used 
to predict effect size 
from coded variables
Lipsey, 
200346
To illustrate the hazards 
and complexities 
associated with 
investigating and 
interpreting confounded 
moderator variables, by 
examining the difference 
in effect sizes associated 
with randomised vs non-
randomised designs
Studies of psychosocial 
intervention programmes 
to prevent or reduce 
juvenile delinquency. 
Studies had to use a 
control group design 
involving random 
assignment or 
matching or present 
pre-intervention data 
indicating the degree 
of initial equivalence 
between the treatment 
and control groups. Set 
in an English speaking 
country and reported 
1950 or later
Subset of studies drawn 
from a previous meta-
analysis79,80
382 studies included, 51% 
RCTs
(Note: this paper is about 
confounded moderator 
variables; the above the 
papers may be more 
useful for looking at 
effects of randomisation)
Each study coded 
for design and effect 
size. Analysis presents 
pooled effect sizes for 
studies with various 
combinations of 
moderator variables, 
and makes simple 
comparisons
continued
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Study Study aim Inclusion criteria Study identification Analysis
Moyer, 
200287
To compare 
the participants, 
methodological 
features and post-
treatment functioning 
in randomised and 
non-randomised studies 
of alcohol treatment 
(due to concerns about 
generalisability of findings 
from RCTs)
Alcohol treatment 
trials. Only those that 
randomised by individual 
were included
Details missing
324 studies included (232 
randomised)
Each study coded for 
methodological features 
and effect size. Examined 
the following with regard 
to randomisation or not: 
participant selection; 
participant characteristics; 
participant pre-
treatment characteristics 
across conditions; 
types of treatments; 
methodological features; 
participant post-
treatment functioning
Meta-reviews
Wilson, 
200176
To determine the 
influence of (study) 
method features 
relative to substantive 
intervention features on 
observed study outcomes
Meta-analyses 
of psychological 
interventions (i.e. 
treatments whose 
intention was to induce 
psychological change, 
whether emotional, 
attitudinal, cognitive or 
behavioural) for which 
standardised mean 
difference effect sizes 
could be estimated
Large number of 
psychology and sociology 
databases supported by 
manual searches
Identified 319 meta-
analyses, 76 of which 
contained both RCTs 
and non-randomised 
comparative studies
For each meta-analysis:
Coded (1) total effect 
size variance around 
the grand mean effect 
size and (2) effect size 
variance according to 
selected study features. 
Determined the 
proportion of effect size 
variance associated with 
the study features of 
interest (eta-squared) for 
each meta-analysis
Main analysis was 
the description and 
comparison of the mean 
eta-squared values and 
when appropriate the 
mean difference product 
moment correlation 
coefficient (r) indices for 
different subgroups
IRR, investigator reported result; NX, non-experimental; SMS, scientific methods scale.
TABLE 2  Study methods (continued)
area as the randomised population were sampled. 
The adjustment techniques used were coded 
as to whether background variables were used 
as covariates in a regression model, matching 
methods were used (e.g. propensity scores), pre-
intervention measures of the outcome were taken 
into account, or an econometric sample selection 
model was used.
Three sets of analyses were performed. Univariate 
analysis described the range of bias estimates 
across the studies in terms of annual earnings. 
Bivariate analyses then explored the influence 
of source of comparison group and adjustment 
analytic techniques on bias, expressed in annual 
earnings. Finally, multivariate regression assessed 
the independent impact of these variables on bias 
estimates. The authors acknowledged the relatively 
small number of constituent studies in the review 
as limiting the sophistication of their analysis. They 
therefore describe the results of the regression as 
being illustrative.
To explore whether averaging multiple effects from 
NRSs produced similar results to those obtained 
by well-designed RCTs, an aggregation exercise 
was conducted. The distribution of the 1150 bias 
estimates from the included studies was examined 
to see whether positive and negative bias estimates 
cancelled each other out.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Reviews of meta-analyses of randomised 
and non-randomised studies (n = 6)
Six reviews in which meta-analysis was used to 
explore the influence of selected variables on 
effects were identified. Few, if any, of these reviews 
could be considered as ‘standard’ systematic reviews 
of effectiveness. Their aim was not necessarily to 
summarise the effectiveness of interventions in 
a given area. Rather, they were methodological 
studies initiated specifically or in part to answer 
questions regarding the most appropriate and 
valid study designs to use to evaluate intervention 
programmes in given disciplines. Most reported 
highly structured and generally transparent 
methods for identifying, extracting and analysing 
primary studies. Although this transparency may 
fall short of what is currently considered to be 
accepted standards for synthesising evidence 
about effectiveness, it was generally adequate for 
methodological investigations, particularly in the 
current work where the purpose was to identify 
hypotheses for testing with new data.
The usual method for identifying primary 
evaluations included in these meta-analyses was 
to sample studies from authors’ own existing 
databases of studies, often used in previous meta-
analyses. For example, Shadish and Ragsdale74 
included 100 studies of marital and family 
psychotherapy or enrichment, the majority of 
which were sourced from their previous meta-
analysis published 3 years earlier.
All of the reviews reported inclusion criteria for 
primary studies, in varying detail. In general, 
studies had to report specific interventions (e.g. 
psychotherapy, or psychosocial treatment) for 
a particular purpose (e.g. preventing juvenile 
delinquency, or alcoholism). Some reviews specified 
use of a control/comparison group and reporting of 
method of allocation to study groups as inclusion 
criteria. The latter is particularly necessary to 
determine whether methods purporting to be 
randomised really were randomised. Primary 
studies also had to report sufficient data to allow 
effect sizes to be estimated, a necessary step in 
testing the influence of randomisation on study 
outcomes.
The number of constituent studies in the reviews 
varied from 90 to 382. In general, the number of 
studies included was relatively large, with three 
reviews each including over 300 studies. The 
greater the number of included studies, the more 
likely that meta-analyses will be a useful technique 
for examining associations between study design 
and effect size. The proportion of randomised 
and non-randomised studies included in the 
reviews varied. In one study only 15% of studies 
were randomised.42 In another the proportion of 
randomised studies reached 71%.87
Statistical procedures varied in complexity across 
the reviews. Average effect size estimates were used 
in most cases to express the influence of study 
and intervention variables on results. Methods 
for calculating effect sizes included standardised 
mean differences (SMDs), and d-scores. There 
were, however, a few exceptions. For example, 
Moyer and Finney87 noted the limitations of effect 
size calculations, namely that they exclude studies 
for which effect sizes cannot be calculated, and 
they average over a number of different types of 
outcome to create a single independent effect size 
for each study, which fails to take into account the 
‘strength of the competition’ with which treatments 
are compared or limits the studies to those with 
a standard treatment or a control condition. The 
authors suggested this is problematic in alcohol 
treatment trials where ‘no-treatment’ control 
conditions are rarely found. Instead, they measured 
the proportion of participants abstinent from 
alcohol and the proportion ‘improved’ (drinking 
moderately) following treatment.
In terms of analysis, some reviews analysed the 
results of randomised and non-randomised 
studies separately, comparing overall effect sizes 
between the two (e.g. Moyer and Finney,87 and 
Weisburd et al.42). Other reviews also pooled 
all studies together regardless of design, and 
examined the effect of randomisation alongside 
other mediating variables in predictive regression 
models. For example, Lipsey46 assessed the effect 
of potential confounding moderator variables in 
randomised and non-randomised studies. Firstly, 
it was speculated that certain study designs may 
be associated with higher or lower effect sizes. 
However, this may not necessarily be an artefact 
of design itself, but may reflect correlation 
between certain designs with particular types of 
intervention. To demonstrate this, the number 
of randomised and non-randomised designs that 
had been employed to evaluate ‘demonstration’ 
programmes (in which the researcher is involved 
in delivering or planning the intervention) 
and ‘routine practice’ programmes (in which 
interventions are delivered as part of routine 
services and evaluated externally) was mapped. 
Not surprisingly, randomised designs were 
more common in demonstration projects than 
in practice projects. Secondly, mean effect sizes Review of methodological literature
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were calculated for demonstration and routine 
practice programmes, and also stratified according 
to whether a randomised or non-randomised 
design was used. Finally, a range of other potential 
confounders were tabulated to demonstrate 
their relationship with study design and type of 
evaluation project. Significant associations were 
plotted in a table, with the effect size differential 
associated with variation in the moderator.
In another example, Shadish et al.75 analysed the 
relationship between studies judged clinically 
representative, moderating variables and effect 
sizes in a meta-analysis of 90 psychological therapy 
evaluations. The study was initiated due to a 
concern that the effect of psychological treatments, 
as estimated in previous meta-analyses, may 
be higher than would be found under routine 
clinical conditions. The aim was therefore to 
meta-analyse studies meeting a definition of 
clinical representativeness, taking into account 
the moderating effect of study design and other 
variables that might be associated with clinically 
representative studies.
Studies sourced from their previous meta-analysis 
(mostly conducted before the 1990s) were coded 
according to clinical representativeness criteria (e.g. 
the study population compared with those who 
might consult psychological services in practice; 
the intervention was delivered in a routine practice 
setting); effect size; treatment characteristics (e.g. 
number and duration of sessions); and study design 
(e.g. random or non-random allocation). A total 
of 1324 effect sizes (SMDs) were calculated from 
the 90 studies (range 1–168, and mean of 14.71 
per study) and aggregated using both random 
and fixed effects. The correlation between effect 
size and clinical representativeness scores was 
illustrated in a scatter plot, then broken down 
by source of studies, random or non-random 
assignment and year of publication. Multiple 
regression analysis was then used to predict effect 
size from coded variables. Through this analysis 
the authors were able to determine whether 
non-randomised designs have significantly 
higher clinical representativeness scores (on the 
assumption that NRSs are more likely to be carried 
out in ‘practice’ settings), and the extent to which 
this influences effect size.
In summary, these studies have used a range of 
methods to assess differences in effects between 
randomised and non-randomised studies. Studies 
have commonly been sourced from authors’ own 
data sets from their previous meta-analyses. They 
have been screened against methodological and 
topic-specific inclusion criteria, coded and in 
a minority of cases quality assessed. Statistical 
procedures have varied in complexity, although 
most studies have used multivariate regression 
analysis.
Synthesis of meta-analyses (n = 1)
The final approach, as employed by one study,76 
was a pooling of meta-analyses. This approach has 
been described as ‘meta-epidemiology’, whereby a 
substantial number of meta-analyses that contain 
both randomised and non-randomised evaluations 
are pooled to estimate differences in effect when 
randomisation is removed.40
Wilson and Lipsey76 sought to investigate the 
influence of a range of study methods relative 
to intervention characteristics, participant 
characteristics and measurement features on 
effects. Randomisation was one of a number 
of attributes examined. Following a search of a 
number of electronic databases they synthesised 
319 meta-analyses of psychological, behavioural 
and educational interventions, 76 of which 
contained both RCTs and non-randomised 
comparative studies. Rather than grouping 
together randomised and non-randomised 
studies of similar interventions and populations, 
a ‘lumping’ approach was adopted. Thus, studies 
of differing methods and intervention types were 
combined in a series of analyses, and the influence 
of different characteristics were explored.
For each meta-analysis the authors coded the total 
effect size variance around the grand mean effect 
size, and the effect size variance according to 
selected study features (e.g. type of research design, 
type of intervention, type of outcome measure, 
participant characteristics). They determined the 
proportion of effect size variance associated with 
the study features of interest for each meta-analysis 
using the eta-squared technique. Eta-squared is 
the ratio of the between-group sum of squares to 
the total sum of squares. In terms of study design 
they estimated variance according to randomised 
versus non-randomised controlled designs, 
and comparison group (randomised or non-
randomised controlled designs) versus one group 
pre–post test designs. They also carried out further 
analyses to examine the direction and strength of 
any relationships.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
31
Effect modifiers
Effect modifiers investigated
There were differences across the eight studies in 
the effect modifiers investigated (Table 3). In part 
this reflected variations in the overall aims of each 
study, with some studying differences in effect:
•  according to study design42
•  according to study design but also taking 
into account other variables that might be 
confounded with design46,72,74,87
•  according to methods (including design) 
and substantive factors (related to the 
intervention)76
•  according to some other variable of primary 
interest, but also assessing study design.75
The review of reviews by Glazerman et al.70,71 
did not aim to investigate the influence of effect 
modifiers, but did investigate differences between 
randomised and non-randomised methods, and 
the role of different techniques for comparing 
randomised and non-randomised groups within a 
single study.
In general the factors studied across the eight 
studies could be classified into one of four 
categories:
1.  population characteristics (e.g. age, gender, 
ethnicity, socioeconomic status, diagnosis)
2.  intervention characteristics (e.g. type, intensity, 
duration, standardisation, implementation)
3.  outcome features (e.g. specificity, self-report, 
outcome interval)
4.  design features (e.g. type of design, attrition, 
sample size, self-selection into study).
The factors falling outside of these categories were 
publication status46,72,74 and year of publication.74,75
Some studies gave a clear rationale for the variables 
they selected as potential effect modifiers,72,74 
and other studies gave detailed descriptions of 
each variable of interest. For example, Wilson 
and Lipsey76 within their four broad categories 
(respondent, treatment, measurement and design) 
clearly defined individual variables such as (1) 
age, gender, ethnicity and socioeconomic status 
of respondents; (2) treatment type, components, 
and dosage; (3) outcome constructs and how they 
are measured and source of outcome information; 
and (4) type of comparison group, design type, 
methodological quality and sample size.
Effect modifiers identified
In the study in which design was the main factor of 
interest, the authors concluded that the weaker the 
design the more likely it was for a study to report a 
result in favour of intervention and the less likely 
it was to report a harmful effect.42 When RCTs 
were compared with the ‘highest quality quasi-
experimental’ studies (defined as ‘studies in which 
intervention and comparison groups are compared, 
with other mediating factors controlled for/or with 
a matched comparison group’) the same pattern 
of results was maintained. The authors themselves 
note that the studies, although all in crime and 
justice, are very different and that very few of them 
examined a specific type of intervention. If the 
authors had explored the impact of study design 
on outcomes for specific types of intervention then 
different findings may have emerged.
The four studies that investigated the impact 
of study design on effect size but also took into 
account other variables that might be confounded 
with design46,72,74,87 reported conflicting findings. 
There were even discrepancies within studies 
when different techniques were used to examine 
differences in effect sizes.72
The study by Lipsey46 focused on interventions 
to prevent or reduce juvenile delinquency and 
reported larger effect sizes from NRSs. However, 
he went on to conclude that such a finding is valid 
only if randomised and non-randomised studies 
are otherwise similar in terms of characteristics 
(participants, interventions, outcomes and study 
methods) other than randomisation that might be 
related to effect size. In further analyses, Lipsey 
found that a range of moderator variables were 
associated with effect size, including participant 
(gender, ethnicity) and intervention characteristics 
(e.g. intervention type, duration, intensity), and 
that some methodological variables (e.g. attrition, 
sample size and duration of intervention) were 
also related to design. These findings suggest that 
great care has to be given to disentangling the 
relationships between moderators and identifying 
those that have independent relationships with 
effect sizes.
In contrast, two studies concluded that the effect 
sizes from RCTs were much larger than from 
NRSs.72,74 The interventions investigated were 
marital and family therapy,74 scholastic aptitude 
test coaching, ability grouping in classrooms, pre-
surgical education and drug abuse prevention.72 Review of methodological literature
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However, this finding was influenced by inclusion 
in the analysis of variables thought to be 
confounded with method of assignment (such as 
level of activity of intervention compared with 
control, pre-test effect size, self versus other 
selection into conditions). In both studies much of 
the discrepancy in effect size appeared to be due to 
design being confounded with other variables and, 
when the effects of the confounds were removed, 
the difference in effect size between randomised 
and non-randomised studies was much smaller.
The final study in this group of four found 
abstinence rates after intervention for alcohol 
use disorders to be similar for randomised and 
non-randomised studies.87 This effect remained 
after controlling for differences in features 
between randomised and non-randomised studies 
(application of inclusion/exclusion criteria, length 
of follow-up and follow-up rates).
The meta-epidemiological study in which 
design and intervention features were the 
factors of interest included 319 meta-analyses 
of psychological, behavioural and educational 
interventions.76 In the first analysis the authors 
were interested in estimating the proportion of 
total variance in observed effect sizes associated 
with study features. The authors found that 
different treatment types were associated with the 
largest proportion of effect size variability and 
that overall individual study features accounted 
for between 2% and 8% of effect size variance. 
Interestingly, the proportion of variance associated 
with study design was slightly smaller than that 
associated with most of the substantive features 
of the intervention, particularly measurement 
of the outcome. In further analyses the authors 
investigated both the direction and the strength of 
the relationship between effect size and individual 
study features. The authors concluded that there 
was little difference (on average) between the 
results from randomised and non-randomised 
studies, but that this should not be interpreted as 
evidence for the equivalence of randomised and 
non-randomised designs. Overall findings from 
this study suggest that effect sizes are to some 
extent a function of specific features of study 
methods and of the intervention itself.
Although the main factor of interest in the study 
by Shadish et al.75 was to what extent studies 
evaluating the effects of psychological therapies 
were ‘clinically representative’, the authors also 
compared effect sizes between randomised and 
non-randomised studies. They found significantly 
larger effect sizes from randomised studies, 
which they concluded was due to a bias caused 
by self-selection into treatment by participants in 
NRSs (explored using pre-test effect sizes). This 
misleadingly makes treatment appear less effective 
in NRSs. The authors explain this by suggesting 
that clients in the most psychological distress 
were more likely to self-select into intervention 
groups, leaving less distressed clients to form 
the control group. At baseline they tend to score 
worse than control group clients on measures of 
distress. Even if treatment is effective, the post-
treatment effect size for the intervention group 
is likely to be relatively small. Interestingly, they 
found that effect sizes for NRSs where clients self-
selected into groups were much lower than NRSs 
where allocation was conducted by researchers 
(e.g. alternate methods of allocation, matching of 
intervention/control participants). This suggests 
that NRSs that could be considered to be ‘quasi-
randomised’ are more likely to be associated with 
effects similar to those of RCTs. Finally, the study 
found that RCTs were less clinically representative 
than NRSs, although there were a substantial 
number of clinically representative RCTs. The 
fact that clinical representativeness is associated 
with lower effect sizes is probably an artefact of 
confounds such as self-selection bias in many NRSs 
that happen to be clinically effective.
The final study reviewed, by Glazerman et al.,70,71 
was cautious in its conclusions about differences 
between within-study randomised and non-
randomised estimates of effect. The review 
suggests that long-standing debates about the 
appropriateness of non-randomised methods 
cannot yet be resolved, at least within the area 
of welfare and employment programmes. Non-
randomised methods sometimes came close to 
replicating results generated by randomised 
methods, but sometimes they were dramatically 
different. In terms of the different methods of 
comparing randomised and non-randomised 
methods within single studies, the authors found 
that bias was lower when the comparison group 
was drawn from within the same evaluation, as 
opposed to a national data set. The same was 
found when the control group was locally matched 
to the treatment population, or drawn as a control 
group in an evaluation of a similar programme 
or the same programme at a different study site. 
In general, statistical adjustments to compensate 
for non-randomised methods reduced bias, but 
methods such as regression, propensity score 
matching or other forms of matching did not differ 
greatly in terms of bias reduction.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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The overall conclusion from this set of nine studies 
(Table 4) is that in some situations the results of 
randomised and non-randomised studies appear 
to differ and sometimes they appear similar, but, 
importantly, these differences may be linked to a 
range of other features that are confounded with 
design (see Table 3).
This is similar to the conclusion reached by 
Deeks et al.40 in their investigation of the results 
of randomised and non-randomised studies 
evaluating health-care interventions. However, the 
range of confounders investigated in the studies 
described here, with the exception of Weisburd et 
al.,42 appeared more diverse.
Summary and implications
We identified and analysed eight methodological 
studies, mostly meta-analyses, in the disciplines 
TABLE 3  Confounders of randomisation and effect size
Hypothetical confounders (see Chapter 3) of effect size Confounders indentified in the literature
Participants of the evaluation
Baseline characteristics
Attrition
Participant characteristics (gender, ethnicity)46
Clinical representativeness88
Self selection by participants72,74
Pre-test measures high72,74
Differential attrition42
The intervention
Theoretical underpinnings
Setting and boundaries of the intervention
Providers of the intervention
Intervention characteristics (e.g. intervention type, 
duration, intensity)46
Level of activity of intervention compared with 
control72,74
No treatment vs alternative treatment in control 
group76
Outcomes
Choice of outcome domains
Choice of outcome measures
Operationalisation of outcome measures76
Use of researcher-developed outcome measure76
Design of the evaluation
Sample size
Control group
Blinding
Follow-up
Clustering
Strength of study design42
Methodological variables (e.g. attrition, sample size and 
duration of intervention)46
Comparison group was drawn from within the same 
evaluation, locally matched or drawn from a national 
data set70,71
Quality of reporting
Publication bias42,72,74
beyond health. The studies have examined the 
influence of evaluation methodology, principally 
randomisation, on study outcomes, and the 
mediating effect of variables such as type of 
intervention or participant characteristics. In some 
cases these studies appear to have been instigated 
by researchers to improve the way meta-analyses 
address heterogeneity and mediating variables 
in the interpretation of effects. In other cases, 
studies are reported to appeal not just to the 
research community, but also to policy-makers and 
practitioners to underpin their decision-making 
around choice of intervention.
The studies varied in aims and scope, but in 
general they posed similar questions; notably, 
whether presence or absence of randomisation 
in a controlled evaluation significantly influences 
outcomes. From this, inferences may be made about 
the degree to which absence of randomisation 
causes bias. Statistical procedures also varied, Review of methodological literature
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TABLE 4  Study results 
Study Factors investigated Results Author conclusions
Review of within-study comparisons
Glazerman, 
200370,71
Source of comparison group (same 
labour marketb, control group from 
other siteb, national data set)
Statistical method (regressionb, 
matchingb, selection correction or 
instrumental variables, none)
Type of matching (propensity score: 
1 to 1b, propensity score: 1 to 
manyb, other matching technique, 
no matching)
Specification test result (not 
recommended, recommendedb, no 
testb)
Quality of background data: 
regression (poor set of controls, 
extensive set of controlsb, very 
extensive set of controlsb, 
regression not used)
Quality of background data: 
matching (poor set of covariates, 
extensive set of covariates, very 
extensive set of covariatesb, 
matching not used)
Quality of background data: overall 
(used prior earningsb, did not use 
prior earnings)
Experimental sample size (small: 
< 500 controls; medium: 500–1500 
controlsb; large: > 1500 controlsb)
Experimental impact finding 
(programme effective, programme 
ineffective, indeterminateb)
Bivariate analysisb
Multivariate analysis:
Estimated six regression models. 
Found that average bias reduced 
by similar amount when either 
regression or matching were used 
and by a further degree if both 
used. Baseline measures of the 
outcome (i.e. pre-programme 
earnings) were also important, 
as was use of a control group 
matched to the same geographic 
area or labour market. Use of 
national data sets tended to 
increase average bias. Using a 
control group from another site 
(i.e. the control group from the 
same RCT in anther area) reduced 
bias even further, but clearly such 
control groups will not readily be 
available to evaluators
Finally examined effect to which 
positive and negative biases could 
cancel each other out. Concluded 
that if a sufficiently high number of 
non-experimental estimators could 
be found the inference that could 
be drawn from such evidence 
might be improved but not in a 
predictable way
Those who plan and design 
new studies to evaluate 
the impacts of training or 
welfare programmes on 
participants earnings can use 
the empirical evidence to 
improve non-experimental 
designs, but not to justify 
their use
Also note that the various 
authors used different 
standards to assess the size 
of the bias and, in some 
cases, reached different 
conclusions with the same 
data. Their conclusions 
should be further probed 
than was possible here. Also 
some studies used more 
realistic replication than 
others of what would have 
happened in the absence of 
randomisation
‘Single’ meta-analyses
Weisburd, 
200142
Cross-tabulated SMS score with 
mean IRR to give an indication of 
intervention outcomes according 
to study design
RCTs had the lowest mean IRR 
(0.22, SD 0.70) and correlational 
studies the highest (0.80, SD 
0.42), suggesting a linear inverse 
relationship between study design 
and outcome
80% of correlational studies 
showed positive intervention 
effects compared with 65% of 
quasi-experimental studies and 
37% of RCTs
Authors believe their findings 
point to the possibility of an 
overall positive bias in non-
randomised criminal justice 
studies, although this may be 
confounded by publication 
bias or different attrition 
rates across designsDOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
35
Study Factors investigated Results Author conclusions
Shadish, 199674 Random vs non-random 
assignmenta
Pre-test effect sizea
Publication status (abut 
randomisation effect robust to 
publication status)
Attritiona
Use of matching – stratifying
Random assignment, no differential 
attrition vs non-random 
assignment plus matchinga
Internal vs external control group
Self vs other selection of 
participants
Specificity of outcome
Sample size
Effect size calculation method
Use of self-report outcome
Treatment standardisation
Active vs passive control group
Overall average effect size 
significantly higher for RCTs than 
for NRSs, and variance component 
smaller, although this may not be 
significant
Regression model showed 
significant but smaller effect of 
randomisation when combined 
with internal/external control 
group, self vs other selection 
of participants, specificity of 
outcome, sample size, effect 
size calculation method, use of 
self-report outcome, treatment 
standardisation and active vs 
passive control group. Effect 
size was significantly higher with 
published than with unpublished 
works, when pre-test effect size is 
high and when participants do not 
self-select
Authors suggest that 
although effect sizes of RCTs 
were significantly larger 
than those of NRSs, much 
of the discrepancy was due 
to confounding with other 
variables. When the effects 
of the confounders were 
removed the difference was 
halved. The importance 
of the finding depends on 
whether one is discussing 
meta-analysis or primary 
studies, how precise an 
answer is needed and 
whether some adjustment to 
the data from studies using 
non-random assignment is 
possible. Authors conclude 
that NRSs may produce 
acceptable approximations 
to RCTs under some 
circumstances but RCTs 
remain the gold standard
Heinsman, 
199672
Self vs other report
% differential attritiona
Specific vs general measure
Published vs unpublished
Passive vs active control groupa
Exact vs approximate effect sizea
Sample size
Pre-test effect sizea
Random vs non-random 
assignment
Standardised treatment vs not
Self vs other selection into 
conditionsa
Use of matching – stratifying or 
not
% total attritiona
Internal vs external control group
Overall average effect size higher 
for RCTs than NRSs; however, the 
size and direction of differences 
within the four areas varied 
considerably
Regression model showed no 
effect from method of assignment. 
Effect size was higher with low 
differential and total attrition, with 
passive controls with higher pre-
test effect sizes, when the selection 
mechanism did not involve 
self-selection of subjects into 
treatment and with exact effect 
size computation measures
Authors suggest that if RCTS 
and NRS were equally well 
designed they would yield 
roughly the same effect size
continued
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Study Factors investigated Results Author conclusions
Shadish, 200075 Clinical representativeness score
Year of publication
Length of therapy in minutesa
Total attrition
Differential attrition
Reactivity scale
Outcome specificitya
Matching
Internal control group
Passive control group
Self-selection
Did not use structure
Random assignment
Unpublished work
Adult presenting problem
Not brief therapy
Behavioural orientation
Weeks to post-test
Randomised studies tend to 
report larger effect sizes than non-
randomised studies (ascribed to 
selection bias in NRSs)
Clinical representativeness 
scores were significantly different 
across the three sources. NRSs 
had significantly higher clinical 
representativeness scores than 
RCTs. A significant negative 
correlation was seen between 
clinical representativeness scores 
and year of publication
Regression analysis found that 
effect sizes were larger the greater 
the dose of therapy, when highly 
specific measures were used, when 
internal control groups were used, 
when outcome was measured 
near the end of therapy, for 
behaviourally oriented therapies, 
with more representative clinical 
structure, for participants without 
clinically representative mental 
health problems and when therapy 
was not limited to a fixed number 
of sessions
Authors conclude that 
psychological therapies are 
robustly effective across 
conditions that range 
from research-oriented to 
clinically representative; 
previous findings that 
clinical representativeness 
leads to lower effect size 
are probably an artefact of 
other confounding variables, 
especially biased self-
selection; increased dose of 
therapy is associated with 
larger effect sizes; and larger 
effects are seen in studies 
using outcome measures 
closely tailored to treatment 
goals
Lipsey, 200346 Random vs non-random 
assignment
Research/demonstration vs 
practice programmes
Type of control
Attrition
Sample size
Official records
Outcome interval
Published
Gender
Age
Ethnicity
Adjudicated
Prior offences
Treatment type
Custodial
Amount
Intensity
Implementation problems
Mean effect size for research/
demonstration programmes was 
significantly larger than that for 
practice programmes within each 
design (randomised and non-
randomised). Within each type 
of programme, non-randomised 
designs are associated with larger 
effects than randomised designs. 
Smaller effect sizes for RCTs 
confounded with and accentuated 
by a difference between the mean 
effects for research/demonstration 
and practice programmes
Many moderator variables are 
associated with effect size, some 
quite strongly. A number of them 
are also related to type of design 
or type of programme or both. 
Effect size differences associated 
with moderator variables are 
generally as large as or larger than 
those associated with type of 
design
Great care must be taken 
when interpreting the 
relationship between a 
moderator variable and 
effect sizes in meta-analysis, 
especially if the relationship 
appears to have implications 
for practice or policy
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Study Factors investigated Results Author conclusions
Moyer, 200287 Random vs non-random 
assignment
Type of treatment
Participant characteristics
Other methodological features
RCTs were more likely to use 
recognised diagnostic criteria to 
characterise participants and to 
stringently implement treatment 
and assess outcomes. NRSs were 
more likely to assess outcomes in 
higher proportions of participants 
over longer follow-up periods and 
to have greater statistical power to 
detect treatment effects
Abstinence and improvement rates 
following active treatment were 
similar for the two types of design, 
even when differences in study 
features were controlled
The contrasting strengths 
and weaknesses of 
randomised and non-
randomised studies 
suggest that they 
should be considered as 
complementary forms of 
treatment evaluation in the 
alcohol treatment field and 
perhaps more generally
Petrosino, 200326 Random or potentially random vs 
non-random assignment
RCTs and potentially randomised 
trials as a percentage of outcome 
evaluation studies for each 
database: ERIC 16%, Criminal 
Justice Abstracts 19%, MEDLINE 
54%, NCCAN 12%, PsycINFO 21%, 
Sociofile 9%
Randomised studies are used 
in nearly 70% of childhood 
interventions in health care 
but probably in 6–15% of 
kindergarten to 12th grade 
interventions in education 
and juvenile justice
Meta-reviews
Wilson, 200176 Treatment features:
type
component
intensity/duration
Respondent features:
age
gender
ethnicity
socioeconomic status
diagnosis
ability group
Measurement features:
construct
operationalisation
source of information
researcher-developed measurea
Design features:
comparison group typea
design type: randomised vs non- 
randomiseda, comparison group vs 
pre–post testa
methodological quality
sample sizea
2% (95% CI 1 to 3) of overall 
effect size variance was associated 
with non-random allocation 
compared with 8% (95% CI 6 to 
10) associated with treatment 
type or 8% (95% CI 2 to 14) with 
operationalisation of outcome 
measures
Mean linear correlation of random 
allocation with effect size 0.04a (i.e. 
RCTs yielded slightly higher effect 
sizes), with a range from –0.60 
to 0.77, i.e. both large over- and 
underestimates were found from 
NRSs. Correlation was 0.18a for 
use of no treatment vs alternative 
treatment in control group, or 
0.10a for use of researcher-
developed outcome measure
Overall mean effect size 
difference for random allocation 
0.03 compared with 0.13a for 
researcher-developed outcome 
measure, 0.26a for no treatment 
control vs alternative treatment 
control, and –0.18a for sample size
Randomisation: findings 
cannot be taken as evidence 
of equivalence of RCTs and 
NRS designs, more likely that 
the selection bias in one NRS 
is offset by an opposite bias 
in another such comparison, 
i.e. neither consistent under- 
nor overestimate of effect 
size
Found that operationalisation 
of outcome measures is at 
least as important as type of 
design, if not more so
State design features and 
outcome operationalisations 
are often related to 
treatment type, duration, 
respondent characteristics 
and other substantive 
features of the interventions
CI, confidence interval; ERIC, Educational Resources Information Centre; IRR, investigator reported result; NCCAN, 
National Clearinghouse on Child Abuse and Neglect Information (NCCAN Clearinghouse); SD, standard deviation; SMS, 
scientific methods scale.
a  Indicates statistically significant effect (p < 0.05) in at least one analysis.
b  Indicates categories with lowest level of associated bias compared with other categories per explanatory variable.
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although most studies employed predictive meta-
regression models to identify associations.
The overall conclusions from this set of eight 
studies are that in some situations the results of 
randomised and non-randomised studies appear 
similar and sometimes they appear to differ. 
Importantly, these differences may be linked to 
a range of other features likely to be confounded 
with design, such as participant and intervention 
characteristics. Inter-relationships among variables 
make it difficult to determine the likely impact of 
any one factor, which is of vital importance when 
the findings have direct implications for policy or 
practice. Thus, in terms of providing answers to 
the questions posed in Chapter 3 about whether 
randomised and non-randomised studies lead to 
differences in effect sizes and whether any observed 
differences are due to randomisation per se or to 
other factors associated with randomisation, the 
findings from the methodological literature studied 
suggest that effect sizes from the two types of 
study may indeed differ and that these differences 
may well be associated with factors confounded 
with design. In the following chapter this issue is 
further investigated through a systematic review 
of systematic reviews that have evaluated (via 
randomised and non-randomised studies) the 
effects of policy interventions.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Aim
To search for, assess and synthesise systematic 
reviews that have:
•  compared the results of policy interventions 
estimated from randomised and non-
randomised studies 
•  described the methods used by reviewers 
to identify factors other than the use of 
randomisation that may have influenced the 
results of randomised and non-randomised 
studies
in order to identify any differences in average effect 
and/or variability between designs, and to identify 
any variables (confounders/moderators of effect) 
that might affect the above.
Methods
Selection of systematic reviews
Systematic reviews meeting the following criteria 
were eligible for inclusion:
•  completed or published between 1999 and 
2004 (limit applied to try and ensure the 
inclusion of reviews with up-to-date methods)
•  evaluated a policy intervention (see Chapter 1, 
Defining ‘policy intervention’)
•  included both randomised and non-
randomised studies and have estimated 
intervention effects separately according to 
design (or provide sufficient data to allow us to 
do so)
•  used quantitative synthesis (meta-analysis).
Reviews which either estimated intervention 
effects separately according to design but did 
not quantitatively synthesise the studies or used 
quantitative synthesis (meta-analysis) but did not 
estimate intervention effects separately according 
to design were excluded from the main analysis 
but are discussed briefly in Additional policy 
intervention reviews.
A flowchart of the inclusion process is presented 
in Figure 1. Each review potentially meeting 
inclusion criteria was screened by one reviewer 
using a predefined electronic form, and checked 
by a second reviewer. Disagreements were resolved 
by consensus, with reference to a third reviewer if 
necessary.
Literature searches 
and data sources
There are probably even fewer definitive terms 
available for ‘systematic reviews’ or equivalent in 
the wider literature than there are for primary 
evaluation or trial designs. Ideally, to ensure that 
the searches retrieved relevant references, the 
strategy would have included terms for ‘review’ 
or at least for ‘literature review’.89 However, 
attempts at searching using these terms on 
electronic databases (e.g. MEDLINE) produced an 
unmanageable number of references.
We therefore decided to search for all available 
references relating to policy interventions from 
databases that exclusively contain citations 
to reviews and systematic reviews. All reviews 
potentially relating to policy interventions available 
on the following databases were obtained: �Centre 
for Reviews and Dissemination DARE (Database 
of Abstracts of Reviews of Effects); the Cochrane 
Database of Systematic Reviews (CDSR), the 
Campbell Collaboration’s Database, C2 RIPE 
(Register of C2 Systematic Reviews of Interventions 
and Policy Evaluation); the EPPI-Centre DoPHER; 
and the (former) Health Development Agency 
Evidence Base Database.
A number of test searches were then completed in 
databases with a focus beyond health to estimate 
the feasibility of attempting a comprehensive 
search of the non-health literature for systematic 
reviews. The searches were restricted to very 
specific terms for ‘systematic review’, without using 
proximity operators, and were further restricted by 
date range (2003–4).
The following free-text terms and indexed 
keywords (if available) were used: meta-analysis, 
meta-analysis, systematic review, systematic 
overview, collaborative review, integrative research, 
integrative review, research integration, narrative 
Chapter 5  
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Cactus Design and Illustration Ltd
Figure Number: 1.ai   Title: HTA 06/90/22 Proof Stage:  2
Systematic reviews screened n = 174
Excluded:
Clinical setting n = 36 
RCTs or NRSs only n = 21
Included:
Meta-analysis performed
separating NRSs and RCTs n = 16
Excluded:
Meta-analysis performed without
separating NRSs and RCTs n = 19
Excluded:
Narrative synthesis only n = 55, plus
24 where RCTs and NRSs separate
Reviews with 
RCTs and NRSs n = 114
FIGURE 1  Flow chart of the inclusion process.
synthesis, evaluation synthesis, meta synthesis, 
realist synthesis, descriptive synthesis, explanatory 
synthesis and pool data.
The following databases were searched:
•  ASSIA
•  BEI
•  CareData
•  ERIC
•  HDA HealthPromis
•  PAIS International
•  SIGLE
•  SSCI
•  Sociological Abstracts.
The results of the test searches confirmed that it 
would not be worthwhile conducting thorough, 
comprehensive searches of databases with a 
focus beyond health for systematic reviews. For 
the year 2003–4 alone, a precise search without 
‘literature review’ identified 2494 records, and a 
more sensitive search with ‘literature review’ added 
identified 45,596 records. Full details of the search 
strategies can be found in Appendix 3.
Data extraction and analysis
A data extraction form for recording relevant 
information from each systematic review was 
designed and piloted. Full systematic reviews were 
pre-screened independently by two reviewers. 
Those meeting the inclusion criteria had data 
extracted by one reviewer and the completed data 
extraction forms checked against the full paper by 
a second reviewer. Any disagreements were resolved 
by consensus or by referral to a third reviewer if 
necessary.
The following information was extracted from each 
review:
•  details of literature search used to identify 
studies for inclusion, including databases 
searched, years and whether details of the 
search strategy were available
•  method of assessing studies for inclusion
•  details about quality assessment
•  number of studies/participants per design
•  method of synthesis used
•  results according to study design and other 
quality features.
Review methods and results were tabulated and 
discussed narratively. They were first classified 
into three groups according to the authors’ 
judgement regarding the equivalence or otherwise 
(‘similar’, ‘not similar’ or ‘mixed’) of the results of 
RCTs and NRSs. We focused on the following key 
methodological aspects:
•  Whether authors attempted to examine 
similarities or differences in the following 
aspects across study designs (or whether they 
provide sufficient study details to allow us to 
judge): study populations; interventions used 
(design and provider of intervention); design 
of evaluation; outcomes assessed; study dates 
(if NRSs have largely been conducted before 
RCTs they may be more likely to show positive 
effects, i.e. their positive results leading to 
the RCTs being commissioned in the first DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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place); and other aspects as recorded by review 
authors.
•  Whether authors tried to assess heterogeneity 
either across or within study designs, using 
statistical methods or other approaches to 
identifying heterogeneity.
•  What criteria were used to establish equivalence 
(or otherwise) of the results of RCTs and NRSs 
and whether these criteria were sensible and 
objective.
Details about these items were recorded so 
that any observed differences in the results of 
randomised and non-randomised studies could be 
considered and were not simply attributed to lack 
of randomisation.
Results
The results of test searches found that thorough, 
comprehensive searches of non-health databases 
for systematic reviews would not be worthwhile. 
Therefore the results reported here are for studies 
found through health-related databases alone.
Description of reviews
Sixteen reviews met inclusion criteria (Table 5 and 
Appendix 4).
Interventions
Eight reviews included children,90–97 usually in 
schools, and eight included adults, usually in 
hospitals.98–105 None of the included reviews 
assessed the effects of legislation and only one (the 
hospital falls prevention programme review)103 
included interventions aimed at modifying 
the environment. In terms of the scope of the 
intervention, the majority aimed to make changes 
within institutional settings, such as hospitals, 
schools or the workplace. Some of these also aimed 
to influence the wider community, in terms of 
multicomponent interventions based in schools, 
the home and community settings.
Study identification and inclusion
Information on the extent of searching was 
extracted to help determine whether the 
identification of included studies within the reviews 
was likely to be biased. Evaluations of publication 
bias have noted differences in the frequency of 
publication of randomised and observational 
studies.106 The extent of searching across the 
included reviews was variable, ranging from two 
electronic databases plus reference lists98,103 to more 
extensive searching in the majority of included 
reviews. Two of the reviews used specialised 
databases: Langhorne et al.102 used the Cochrane 
Stroke Group Specialised Register of Controlled 
Trials, and Mullen et al.93 used the Prevention 
Research Synthesis Project database. Four of the 
16 reviews restricted inclusion to English language 
publications.90,93,94,97 Included studies in other 
reviews all appeared to be English language. Some 
reviews specified that studies had to take place in 
the US, Canada or the UK, so restriction to English 
language was probably appropriate in these 
reviews.
Most reviews included fewer studies in the meta-
analysis than in the review overall; this is to be 
expected as not all included studies would report 
all outcomes of interest. The exception to this 
would be where a review specified only one or two 
outcomes of interest and restricted inclusion to 
studies that reported those outcomes.
Quality assessment
Information on quality assessment within the 
reviews was extracted to help determine whether 
validity was assessed appropriately for each 
study design, i.e. are we getting a true picture of 
whether the included studies were of good quality? 
Only three of the reviews did not assess study 
validity.91,93,100 In the others, a mixture of checklists, 
scales and components were used. Jacobs et al.92 
only assessed the validity of RCTs.
Synthesis methods
There were two approaches to meta-analysis. The 
first involved keeping RCTs and NRSs separate 
throughout the review and meta-analysis process, 
although the rationale for doing this was rarely 
explicit. This approach was used in eight of the 16 
reviews.91,92,94,99,101–104 Four of these reviews stated 
a priori that they would investigate potential 
moderators of effect.91,95,96,104
The alternative approach was to pool all studies 
in a meta-analysis, and then investigate potential 
moderators of effect (an aspect of the study that 
varies from one study to the next) including 
randomisation on the average estimate of effect. 
This approach was taken in the remaining eight 
reviews, and usually involved a large number 
of studies that varied enormously in terms of 
intervention, population, outcomes and outcome 
measures. Outcomes were converted to effect sizes 
to enable them to be pooled.90,92–94,96–98,100,101,105,106 
Six of these reviews stated which potential 
moderator variables they would be investigating Systematic review of systematic reviews
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TABLE 5  Summary of review methods (n = 16)
Method Category Total
Intervention type Rehabilitation/treatment 4
Hospital policy 2
Prevention 7
Health promotion 2
Criminal justice 1
Scope of implementation Policy for a nation 0
Policy for a region 0
Policy for a community 5
Policy for an institution 15
Search More than three electronic sources + reference lists 11
Three or fewer electronic sources + reference lists 5
Language restriction English only 4
No restriction 4
Not stated 8
Number using quality-related 
inclusion criteria
1 (NRS only)
Number using quality assessment Not conducted 3
Conducted 13 (1 RCT only)
Number of RCTs Median (IQR; range) 11.5 (3.5–16; 2–144)
Number not reported 2
Number of NRSs Median (IQR; range) 14.5 (8–25; 1–174)
Number not reported 2
IQR, interquartile range.
a priori, either by means of subgroup analysis 
(Tobler et al.,107 Davis and Gidycz90 and Mullen 
et al.93), regression analysis (Griffith et al.100 and 
Wilson et al.105) or using both sensitivity and 
subgroup analysis (Cambach et al.98). Wilson et 
al.96 used sensitivity analyses, and Wilson et al.97 
used multiple regression to investigate potential 
moderators of effects but these were not pre-stated 
investigations.
In the following sections we discuss the included 
reviews according to whether the authors judged 
the results of RCTs and NRSs to be ‘similar’, ‘non-
similar’ or ‘mixed’.
Review results: where authors 
judged results from RCTs and 
NRSs to be ‘similar’ (n = 5)
Five reviews are included in this section: Cameron 
et al.,99 Kwan and Sandercock,101 Langhorne et 
al.,102 Tobler et al.,107 and Wilson et al.105 (Table 6, 
Appendices 4.1–4.13).
Method of pooling
Only two reviews had a stated objective to 
investigate differential effects of randomisation 
(among other variables).105,107 Tobler et al.107 aimed 
to ‘empirically confirm that the inclusion of non-
randomised pre-test/post-test research designs 
does not overestimate intervention success’, while 
Wilson et al.105 aimed to investigate the influence of 
study design on findings. Both used the ‘lumping’ 
approach to meta-analysis, pooling all studies 
and then investigating potential moderators of 
effect, including randomisation (overall effect is 
reported for the subset of randomised studies in 
both reviews). Neither review discussed weaknesses 
with this approach. Both reviews investigated the 
magnitude of effect but neither reported assessing 
the variance associated with it, which ideally should 
be investigated for RCTs versus NRSs.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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TABLE 6  Summary of review findings
Total
n (%)
Results judged 
‘similar’
n (%)
Results judged ‘not 
similar’
n (%)
Results mixed
n (%)
Statistical 
heterogeneity 
identified by design?
Yes 4 (25) 2 (40) 2 (25) 0
No 11 (69) 3 (60) 5 (62.5) 3 (100)
Narrative only 1 (6.25) 0 1 (12.5) 0
Obvious differences 
between RCTs/NRSs 
(author or reviewers 
opinion)
Yes 4 (25) 1 (20) 3 (37.5) 0
No 12 (75) 4 (80) 5 (62.5) 3 (100)
Narrative only 0 0 0 0
Sources of 
heterogeneity 
investigated?
Population
Yes 2 (12.5) 1 (20) 1 (12.5) 0
No 14 (87.5) 4 (80) 7 (87.5) 3 (100)
Intervention
Yes 4 (25) 2 (40) 2 (25) 0
No 12 (75) 3 (60) 6 (75) 3 (100)
Comparator
Yes 2 (12.5) 2 (40) 0 0
No 14 (87.5) 3 (60) 8 (100) 3 (100)
Outcomes
Yes 1 (6.25) 1 (20) 0 0
No 15 (93.75) 4 (80) 8 (100) 3 (100)
Rationale for pooling 
approach given?
Yes 6 (37.5) 2 (40) 3 (37.5) 1 (33.3)
No 7 (44) 2 (40) 4 (50) 1 (33.3)
Partially? 3 (18.5) 1 (20) 1 (12.5) 1 (33.3)
Criteria to judge 
equivalence of study 
results by design 
given?
Yes 3 (18.5) 0 2 (25) 1 (33.3)
No 13 (81.5) 5 (100) 6 (75) 2 (66.7)
The other three reviews pooled RCTs and NRSs 
separately; only one of which101 provided any form 
of justification for this approach, stating in the 
discussion section that ‘non-randomised studies are 
highly susceptible to bias and there is significant 
statistical heterogeneity between the studies’.
None of the five reviews in this section reported 
the criteria that were used to judge equivalence 
between results of RCTs and NRSs (Appendix 4.2), 
so it is not clear whether equivalence was judged 
in a systematic or pre-specified way, or, if so, how 
sensible and objective were the criteria used.
Assessment of heterogeneity
Statistical heterogeneity was tested for separately by 
randomised and non-randomised study design in 
three of the five reviews in this section.99,101,102
None of the five reviews in this section 
described whether or not there was clinical 
and methodological heterogeneity between 
RCTs and NRSs in terms of participants, 
interventions, outcomes, methodology (other 
than randomisation) or any other aspect. Nor did 
they give sufficient information for us to make 
a strong judgement, although there did seem to 
be elements of the populations, interventions, 
comparators and outcomes measured that differed 
between randomised and non-randomised designs. 
As few details were provided, it is difficult to assess 
whether the RCTs and NRSs were sufficiently 
similar to allow a comparison to be made (i.e. 
whether like was being compared with like). The 
authors did not mention any obvious differences 
between RCTs and NRSs except for Kwan and 
Sandercock,101 who stated that the comparator was 
poorly described in NRSs. Based on the limited Systematic review of systematic reviews
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information presented about the included studies, 
we noted no obvious systematic differences between 
RCTs and NRSs.
Comparison of review results and 
authors’ conclusions regarding 
similarity between RCTs and NRSs
Appendix 4.3 gives the pooled results of the RCTs 
and NRSs separately, along with the results of any 
heterogeneity tests performed.
In one of the reviews102 there were clear differences 
in the results of RCTs and nRCTs for at least one 
outcome measure; however, study numbers were 
extremely small. In this review,102 two pooled 
RCTs indicated a significantly increased risk of 
death but in the single NRS there was a small 
but not significant drop in risk. The NRS also 
indicated a significant decrease in the number 
of patients admitted to hospital but the RCTs 
showed a non-significant increase. Significant 
statistical heterogeneity was seen in some outcomes 
in RCTs but, as there was only one NRS in the 
meta-analysis, there was no heterogeneity in NRS 
outcomes. The authors stated that considerable 
heterogeneity between trials made it difficult to 
draw specific conclusions.
Kwan and Sandercock101 found the results of RCTs 
indicated a trend towards longer hospital stay with 
the intervention whereas NRSs indicated a shorter 
stay, but neither effect was statistically significant 
at the 5% level. Significant statistical heterogeneity 
was seen for the outcome ‘duration of hospital stay’ 
in NRSs but not in RCTs. The authors identified 
that RCTs and NRSs were showing trends to 
give answers in opposite directions but that the 
differences were not statistically significant.
In the review by Tobler et al.,107 effect sizes were 
given without CIs, so it is difficult to judge whether 
there were differences between results of RCTs 
and NRSs. Pooled effect sizes were slightly smaller 
in the NRSs than in the RCTs. The authors 
commented that lack of random assignment 
does not seem to greatly bias results relative to 
other problems. Mean effect sizes for studies with 
random assignment and non-random assignment 
differed by only 0.03. Removing other sources of 
bias influenced the results far more.
For the remaining two reviews99,105 results for RCTs 
and NRSs were very similar in terms of magnitude 
and direction. In the review by Cameron et al.,99 
significant statistical heterogeneity was seen for 
length of hospital stay and mortality in RCTs 
but not in NRSs. Results of RCTs and NRSs were 
judged similar although the authors stated that for 
some outcomes there was greater heterogeneity 
between RCTs than between the pooled data from 
RCTs and that from cohort studies. Wilson et 
al.105 noted that the difference in results between 
randomised and non-randomised studies was 
unremarkable and not statistically significant.
Results of additional 
heterogeneity investigations
Cameron et al.99 and Kwan and Sandercock101 
did not carry out any further investigations of 
sources of heterogeneity. Cameron et al.99 state 
that both the experimental and the control 
interventions were complex and varied in nature, 
and propose that differences in case-mix within-
study populations may have led to heterogeneity 
as ‘it would be expected that… treatments and 
programmes targeting those most likely to benefit 
are most likely to demonstrate effectiveness’. Kwan 
and Sandercock101 identified that the definition of 
the intervention ‘care pathway’ may have been a 
source of variation, and further urge readers to be 
cautious when interpreting results, because of the 
presence of variation between studies and small 
numbers of participants.
Langhorne et al.102 carried out a sensitivity 
analysis to investigate heterogeneity in terms of 
intervention, trial design and patient follow-up. 
Details of the sensitivity analysis are not reported, 
other than that it did not alter the review’s 
conclusions.
Tobler et al.107 and Wilson et al.105 were the only 
reviews in this group to report the details of any 
further heterogeneity investigations. Both reviews 
used the lumping approach to synthesis, and 
use of random assignment was only one of many 
covariates investigated as a potential source of 
heterogeneity.
Tobler et al.107 analysed random assignment as 
one of many potential moderators of effect across 
a large meta-analysis (Appendix 4.4). Other 
potential moderators included design and provider 
of the intervention, design of the evaluation 
and population in terms of school grade, special 
populations and levels of drug use. The authors 
concluded that removing other potential sources 
of bias influenced the results of the review far more 
than removing studies without random assignment 
to the intervention.
Wilson et al.105 also analysed many potential 
moderators of effect across a large meta-analysis 
including intervention design and design of the DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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evaluation (Appendix 4.4). The authors concluded 
that positive findings may result from participant 
characteristics rather than any positive effect of the 
intervention itself.
Summary
It seems reasonable to conclude that overall we 
found no evidence for clear systematic differences 
in results of RCTs and NRSs in the examples 
reviewed, but there is insufficient evidence on 
which to base any wider conclusions.
In the reviews included in this section, other 
potential sources of confounding are suggested 
to be more important than randomisation, but 
it could be just chance that the RCTs/NRSs are 
similar in these examples.
Review results: where authors 
judged results from RCTs and 
NRSs to be ‘non-similar’ (n = 8)
Eight reviews are included in this section: Cambach 
et al.,98 Davis and Gidycz,90 Griffith et al.,100 Jacobs 
et al.,92 Mullen et al.,93 Oliver et al.,103 Smedslund et 
al.,104 and Wilson et al.96 (see Table 6, Appendices 
4.5–4.7).
Method of pooling
Three reviews90,93,98 had a stated objective to 
consider differences in intervention effect 
between RCTs and NRSs. In each review the 
use of randomisation was one of several other 
methodological characteristics investigated.
Five90,93,96,98,100 used the ‘lumping’ approach and 
three92,103,104 the ‘splitting’ approach to analysis.
Two reviews described the criteria that were 
used to judge equivalence between results of 
RCTs and NRSs. Griffith et al.100 stated that non-
overlapping 95% CIs would allow conclusions 
about the strength of one ‘predictor’ (including 
randomisation) in comparison with another to be 
drawn. Mullen et al.93 used a chi-squared statistic 
to assess the likelihood of the magnitude of the 
between-subgroup differences, in terms of both 
results of effect estimates and of heterogeneity.
Assessment of heterogeneity
Three of the eight reviews included in this section 
attempted to identify statistical heterogeneity 
separately for RCTs and NRSs.92,100,104 Only 
two reviews98,100 described any clinical and 
methodological heterogeneity between RCTs 
and NRSs in terms of interventions, participants, 
outcomes and methodology (other than 
randomisation).
Griffith et al.100 found statistically significant 
heterogeneity reported among NRSs but not 
among RCTs. They reported that several NRSs 
(but not RCTs) involved patients considered to be 
treatment failures.
Jacobs et al.92 found significant heterogeneity for 
three outcomes among RCTs but none for NRSs. 
The authors did not identify any possible causes of 
heterogeneity, although from our own assessment 
sample size seemed to be larger in NRSs than in 
RCTs. Smedslund et al.104 found no significant 
heterogeneity.
In Cambach et al.98 the NRSs were all undertaken 
in an outpatient setting, whereas the RCTs were in 
a mixture of settings. No further sources of within-
group heterogeneity for RCTs and NRSs were 
identified.
None of the remaining reviews in this 
section90,93,96,103 discussed clinical or methodological 
heterogeneity or reported sufficient detail of 
included studies for us to draw our own conclusions 
on the similarity or otherwise of the included 
studies.
Comparison of review results and 
authors’ conclusions regarding 
similarity between RCTs and NRSs
In five reviews, effect sizes were larger in NRSs 
than in RCTs.90,92,93,100,104 Davis and Gidycz90 
concluded that higher mean effect sizes were seen 
when studies did not use random assignment of 
participants. Other variables were also associated 
with increased effect size. The 95% CIs for the 
average estimates were not reported.
Griffith et al.100 found significant heterogeneity in 
NRSs but not RCTs, and concluded that studies 
without random assignment reported ‘better 
outcomes’ than those with random assignment. 
Smedslund et al.104 found no significant 
heterogeneity for RCTs or NRSs at the one time 
point at which a heterogeneity test was used. The 
authors concluded that NRSs showed larger effects 
than RCTs at all time points but that the RCTs were 
probably more reliable. In Griffith et al.100 the 95% 
CIs overlapped by 0.02, and in Smedslund et al.104 
CIs also overlapped.
In Mullen et al.93 95% CIs did not overlap and 
the authors reported that between-subgroup Systematic review of systematic reviews
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differences were not significantly different for 
random versus non-random assignment. Despite 
RCTs indicating a significant benefit and NRSs 
indicating no significant differences between 
the groups in this review, the authors found 
that random assignment versus non-random 
assignment when compared in the stratified 
subgroup analysis explained only 7.3% of the total 
heterogeneity.
Jacobs et al.92 found significant heterogeneity 
for some outcomes in RCTs but no significant 
heterogeneity for any outcome in NRSs. This 
review concluded that RCTs found a statistically 
significant change in two outcomes that was not 
found in cohort studies.
Two reviews96,103 found larger effect sizes in 
RCTs than in NRSs. In Oliver et al.,103 95% CIs 
overlapped, and in Wilson et al.96 they did not. 
Wilson et al.96 found a statistically significant 
difference in effect between RCTs and NRSs 
(p < 0.05) and concluded that randomised designs 
gave larger mean effects than non-randomised 
ones.
In one review,98 results of RCTs and NRSs were in 
opposite directions, although it is unclear which 
direction indicated a positive result. Ninety-five per 
cent CIs were not reported so we cannot tell if these 
overlap. The conclusions of Cambach et al.98 and 
of Oliver et al.103 with regard to similarity between 
findings of RCTs and NRSs were unclear.
Results of additional 
heterogeneity investigations
Cambach et al.98 carried out subgroup analyses 
using variables relating to study participants, 
interventions and comparators. They reported that 
outcomes were not significantly heterogeneous 
with regard to any of the variables investigated, 
including randomisation, although they also state 
that methodological quality may have biased 
the outcomes. Davis and Gidycz90 carried out 
subgroup analyses using variables relating to 
participant age, intervention design and provider, 
study methodology and publication status. They 
found that several participant, programme and 
methodology characteristics were significantly 
related to effect size, including age, number of 
intervention sessions, extent of active participation 
in the intervention and type of outcome measure. 
Wilson et al.96 carried out subgroup analyses using 
variables relating to methodology and population, 
and concluded that study design appeared to be 
related to observed effects, although inclusion of 
‘weak’ designs did not seem to increase effect sizes. 
Both intervention and population variables were 
reported to be moderators of effect size.
Griffith et al.100 investigated the effect of eight 
potential moderator variables on effect size; these 
included characteristics of intervention design, 
plus random assignment. They found that five 
of the eight variables, including randomisation, 
had a significant effect. Randomisation was 
associated with smaller effect sizes. Mullen et al.93 
investigated the effect of 13 potential moderator 
variables on effect size, including participants, 
aspects of intervention design, and provider 
and methodology. They found that eight of 13 
variables explained more than 5% of the observed 
heterogeneity, with ethnicity explaining more than 
two times the total heterogeneity of any other 
variable.
Jacobs et al.92 did not carry out statistical 
investigation of heterogeneity. They reported that 
the discrepancy in results for one outcome between 
RCTs and NRSs may reflect the differences between 
study populations in heterogeneity secondary to 
study design and/or bias. Oliver et al.103 did not 
carry out statistical investigations of heterogeneity 
and made no comment regarding potential 
moderators of effect. Smedslund et al.104 did not 
carry out statistical investigations of heterogeneity 
but commented that smoking cessation outcomes 
were influenced not only by the interventions but 
also by the settings and organisational context.
Summary
In reviews included in this section there was some 
evidence of dissimilar results arising from RCTs 
and NRSs but the CIs of the effect sizes overlapped 
in many cases. There was no real consideration 
of other differences between study designs that 
could contribute to these findings, although 
other variables were found to impact on overall 
intervention effects.
Review results: where authors 
judged results from RCTs and 
NRSs to be ‘mixed’ (n = 3)
Three reviews are included in this section: Guyatt et 
al.,91 Thomas et al.,94 and Wilson et al.97 (see Table 6, 
Appendices 4.8–4.10). In these reviews, similarity 
and differences between results of RCTs and NRSs 
varied across outcomes.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Method of pooling
Only one review91 had a stated objective to 
investigate differential effects of randomisation 
(among other variables). The ‘splitting’ approach 
to synthesis was taken in all three reviews but no 
justification for the approach was given.
A z-score was used to generate a p-value related 
to the null hypothesis that there were no real 
differences in results from RCTs and NRSs. The 
other two reviews did not state what criteria were 
used to judge equivalence of results between RCTs 
and NRSs so it is difficult to assess whether these 
were sensible and objective.
Assessment of heterogeneity
None of the reviews attempted to identify any 
statistical heterogeneity in RCTs and NRSs.
Only Guyatt et al.91 attempted to narratively assess 
clinical heterogeneity in terms of population, 
recruitment, intervention and duration of follow-
up. No obvious differences were reported between 
RCTs and NRSs.
There were no obvious differences between RCTs 
and NRSs expressed by Thomas et al.94 in terms 
of population, interventions and outcomes from 
the details provided. Wilson et al.97 did not report 
on clinical or methodological heterogeneity 
between included studies, and insufficient detail 
of included studies was given to enable the reader 
to judge whether there were obvious differences 
between RCTs and NRSs with regard to clinical or 
methodological features.
Comparison of review results and 
conclusions regarding similarity of 
results between RCTs and NRSs
Appendix 4.9 gives the pooled results of the RCTs 
and NRSs separately, along with the results of any 
heterogeneity tests performed.
In Guyatt et al.,91 no significant effects were seen 
for any outcome in RCTs; in NRSs significant 
effects were seen in five of eight outcomes assessed; 
however, not all were in the same direction. The 
authors reported that there were statistically 
significant differences between the findings of 
RCTs and NRSs for two outcomes. They stated that 
relying on the results from observational studies 
would lead to the conclusion that the interventions 
have a positive effect, while relying on the results 
of RCTs would lead to the conclusion that the 
interventions did not have an effect.
In Thomas et al.,94 significant effects were seen 
more often in RCTs than in NRSs, although these 
could go in either direction. The conclusions of this 
review regarding similarity of results between RCTs 
and NRSs are not clearly stated.
Wilson et al.97 reported that effect size was larger 
in RCTs than in NRSs for some outcomes (but not 
significantly so).
Results of additional 
heterogeneity investigations
Guyatt et al.91 investigated intervention design, 
methodological variables (random assignment and 
length of follow-up), gender and year of study as 
potential moderators of effect. They stated that 
interventions in RCTs and NRSs were similar in 
nature and intensity and that the studies were 
conducted at similar times and had similar lengths 
of follow-up. They concluded that it is likely that 
participants who received the intervention in the 
observational studies were more predisposed to a 
positive outcome.
Thomas et al.94 investigated inclusion of a physical 
activity component and overall quality assessment 
as potential moderators of effect. Results suggested 
that in some circumstances observed variability in 
effect size between studies might be explained in 
part by whether or not the interventions promoted 
physical activity as well as healthy eating. The 
investigation of quality assessment as a potential 
moderator of effect appeared to focus only on 
randomisation and outcome measurement, and 
the authors concluded that this did not have a 
significant effect.
Wilson et al.97 investigated aspects of intervention 
design and intervention provider, evaluation design 
and participants as potential moderators of effect. 
They found that, although there were no significant 
differences between RCTs and NRSs, other aspects 
of study design did seem to influence the outcome. 
Although significant differences in effect size 
between RCTs and NRSs were initially found, 
when other potential moderating or confounding 
variables were accounted for, differences were no 
longer significant.
Summary
In the three reviews in this section there were 
no consistent differences in effect size between 
NRSs and RCTs. Differences that were seen could 
be accounted for by other potential moderating 
variables.Systematic review of systematic reviews
48
Additional policy 
intervention reviews
Narrative reviews that summarised 
results separately by study design
Twenty-four systematic reviews contained both 
RCTs and NRSs and summarised results separately 
by study design, without using meta-analysis 
(Appendices 4.11 and 4.12).108–128,158–161 Not all of 
the reviews intended to separate RCTs and NRSs; 
in four reviews it is clear that studies are reported 
individually because so few were found. Seven 
reviews stated a priori an intention to separate 
RCTs and NRSs. In other reviews the separation 
occurred either because the reviewers deemed it 
inappropriate to pool studies due to heterogeneity 
among participants, interventions, outcomes 
and study designs, or because RCTs are one of a 
number of study designs classified as ‘good quality’, 
or no rationale was given for separation of RCTs 
and NRSs.
In four reviews, intervention effects appeared 
stronger in NRSs than in RCTs. The interventions 
reviewed were: immunisation; health education; 
feedback and audit; and tobacco sales. 
Interventions were mostly educational or 
administrative/legislative procedures aimed at 
health professionals or shop owners.
In five reviews, intervention effects appeared 
stronger in RCTs than in NRSs. The interventions 
reviewed were: service delivery and organisation; 
early rehabilitation; payments for health 
professionals (two reviews); rehabilitation; 
and psychosocial interventions (two reviews). 
Interventions were broader and aimed at 
communities, patients or recipients of services 
rather than at health or other professionals.
This pattern, if it is a pattern, was not seen in 
reviews that met the inclusion criteria, perhaps 
because NRSs were more similar to each other and 
RCTs were more similar to each other, and this is 
why they were pooled together in meta-analyses, in 
the included reviews.
In the other 15 reviews in this section, RCTs and 
NRSs appeared to have similar effects or it was not 
possible to tell whether or not they were similar.
Meta-analyses that pooled 
different study designs
Nineteen reviews contained both RCTs and NRSs 
and pooled the results without separating by 
study design (Appendix 4.13).129–147,162 None of the 
reviews gave a clear rationale for pooling the study 
designs together. In three reviews,131,141,146 potential 
moderators of effect including randomisation 
were investigated after pooling. Randomisation 
was not a moderator of effect in one review131 
and, in the other two reviews,141,146 the results of 
the investigation with regard to randomisation 
as a potential moderator of effect were not 
reported. In three reviews, only randomised and 
quasi- or pseudo-randomised study designs were 
included. When selecting reviews for inclusion in 
this evaluation, we considered studies described 
as quasi- or pseudo-randomised to be non-
randomised. However, a pseudo-, quasi- or non-
randomised controlled trial is not as different from 
a RCT as a non-randomised observational study 
would be.
Conclusions from additional 
policy intervention reviews
In reviews that discussed RCTs and NRSs 
separately but without meta-analysis, and in reviews 
that pooled both study designs together, it was 
unusual for review authors to explicitly state their 
rationale for doing so.
When a rationale was stated for not pooling, it 
usually related to RCTs being methodologically 
stronger study designs than NRSs, although other 
study designs could also be rated as ‘strong’ and 
combined with RCTs in some of these reviews (e.g. 
longitudinal designs in Reeves125).
When a rationale was not stated for pooling, it 
often seemed to be the case that other features of 
the included studies were expected to bring more 
heterogeneity to the results of the review than 
randomisation. Sometimes randomisation was 
investigated along with other study features as a 
potential moderator of effect.
Discussion
Inclusion criteria
This investigation of the effects of randomisation 
in evaluations of policy interventions was not 
as straightforward as the investigation by Deeks 
et al.40 for evaluating NRSs in health care. In 
their investigation many of the included reviews 
specifically aimed to investigate differences 
between RCTs and NRSs. If we used similar 
inclusion criteria to such reviews in the field of 
policy interventions, we would only have included 
reviews that were already included in the report 
by Deeks et al.40 Most of the reviews included in 
our investigation did not have a stated intention DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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of investigating differences between RCTs and 
NRSs. Most did not even have the stated intention 
of separating RCTs and NRSs in the analysis. 
Those that did have this intention did not always 
give a rationale for doing so. When a rationale 
was stated, it was either in order to separate 
more methodologically sound study designs 
(randomisation being one indicator of quality, but 
often not the only one), or to investigate potential 
moderators of effect. Potential moderators included 
randomisation and other features of study design, 
also aspects of the intervention, participants and 
outcomes measured.
Searches
Searching by study design is problematic even in 
MEDLINE: indexing of RCTs in MEDLINE by 
publication type and medical subject heading has 
improved in recent years but is still inadequate. 
Searching for NRSs is much more difficult; there 
are many study designs that could be classed 
as non-randomised and there is little definitive 
terminology. Comprehensive and consistent 
indexing according to study design is lacking. 
Databases beyond MEDLINE very often have poor 
indexing by study design, and these problems of 
definition become more pronounced in databases 
that are non-health related. Non-health databases 
in addition rarely have a thesaurus of keyword 
terms included; the records often lack an abstract 
and a number of databases only have rudimentary 
search capabilities. There are probably even fewer 
definitive terms available for ‘systematic reviews’ 
or equivalent in the non-health literature than 
there are for trial designs. Ideally, to ensure that 
the searches retrieved relevant references, the 
strategy would have included terms for ‘review’ or 
at least for ‘literature review’. However, attempts 
at searching using these terms produced an 
unmanageable number of references.
Results judged similar
Even in the reviews for which authors judged 
results from RCTs and NRSs to be ‘similar’, pooled 
results of NRSs tended to be more positive than 
RCTs in two of five reviews and more negative 
in one. Heterogeneity was assessed separately 
by design in three of the five reviews in this 
section: there was greater heterogeneity among 
RCTs in one review and among NRSs in another. 
Other potential confounders or moderators of 
effect in reviews in this section were population 
variables (three reviews) and intervention variables 
(two reviews). The two reviews that carried 
out secondary analysis of moderators of effect 
including randomisation concluded that other 
potential sources of bias influenced the results of 
the review more than randomisation.
Results judged not similar
In the eight reviews for which authors judged 
results were ‘not similar’ between RCTs and NRSs, 
six found that NRSs had more positive results than 
RCTs and two found that RCTs had more positive 
results than NRSs. In one review it was unclear 
which was more positive. Only three reviews in 
this section assessed heterogeneity by design; one 
found more heterogeneity in NRSs and one found 
more heterogeneity in RCTs. The third found no 
significant heterogeneity in either group.
Other potential confounders or moderators of 
effect in reviews in this section were population 
variables (four reviews), intervention variables 
(three reviews) and study design/methodological 
variables (three reviews). No review found that 
random assignment had a strong effect on 
outcomes – population variables seemed to be 
more important.
Potential confounding variables in the three reviews 
in which results of RCTs compared with NRSs were 
judged to be ‘mixed’ included participant and 
methodological variables. Wilson et al.97 found that 
other methodological variables were more likely 
than random assignment to influence outcome.
One possible reason for other variables influencing 
outcomes more than study design could be that 
in the reviews we found, randomised and non-
randomised study designs have been used in 
different types of populations/settings/interventions 
(i.e. the review authors have not set inclusion 
criteria restricting these other variables). In 
theory, if a randomised design is chosen, potential 
confounding variables should be distributed evenly 
between groups. In reality we cannot confirm 
this because we do not have reviews in which 
randomised and non-randomised designs have 
been applied to the same population/intervention/
setting, so we cannot compare them. There is too 
much heterogeneity between the included studies 
to isolate the effect of randomisation. This reflects 
the broad nature of many systematic reviews of 
policy interventions compared with reviews of 
more tightly defined health-care interventions 
(e.g. pharmacological interventions). And so, while 
within a review it might appear that other potential 
moderators of effect have a stronger effect than Systematic review of systematic reviews
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randomisation, within a single RCT this would 
hopefully not be the case. We cannot confirm or 
refute this based on the work we have done.
The results of this investigation show us that the 
‘state of the art’ in terms of systematic reviews 
of policy interventions does not yet answer the 
question of whether RCTs and NRSs are of similar 
validity in evaluating policy interventions. While it 
can be argued that RCTs can sometimes be difficult 
and/or unethical to conduct in certain settings, 
and that results are not always generalisable to 
‘real life’,15,16 it can also be argued that NRSs 
can be subject to so many biases as to make it 
doubtful whether it is useful to include them in 
systematic reviews at all.148 It seems clear that 
further investigation should be carried out in the 
form of properly conducted systematic reviews of 
policy interventions that include both RCTs and 
NRSs with the pre-stated objective of investigating 
differences between them. Methodological studies 
need to be indexed much more comprehensively in 
electronic databases.
Criteria used to judge 
equivalence of RCTs and NRSs
As in the study by Deeks et al.,40 the manner in 
which results were judged to be equivalent between 
study designs varied between the reviews (Table 
7). In the majority (13 out of 16) of the included 
reviews, the criteria used to judge the equivalence 
of the results were not described. None of the five 
reviews in which the authors judged the results 
of RCTs and NRSs to be similar described how it 
reached such a judgement.
Two of the eight reviews in which the authors 
judged the results of RCTs and NRSs to be 
TABLE 7  Equivalence criteria used in reviews of RCTs and NRSs
Review Equivalence criteria
Results judged similar
Cameron, 200099 None
Kwan, 2004101 None
Langhorne, 1999102 None
Tobler, 2000107 Not stated
Wilson, 2000105 Not stated
Results judged not similar
Cambach, 199998 None
Davis, 200090 None
Griffith, 2000100 Regression analysis examined effects of moderator variables on effect size, giving an estimate 
of between-groups variance (Qb). 95% CIs were calculated; non-overlapping CIs allowed 
conclusions to be drawn about the strength of one predictor in comparison with another
Jacobs, 200292 None
Mullen, 200293 The contribution of grouping variables to variation in the effect size estimates were examined 
using (1) the chi-squared statistic with Bonferroni correction (to assess likelihood of differences 
between subgroups) and (2) between-group heterogeneity (Qb), to assess the magnitude of 
any effect. A substantial contribution by a moderator variable to the overall heterogeneity was 
defined as ≥ 5%
Oliver, 2000103 None
Smedslund, 2004104 Not stated
Wilson, 200196 Not stated
Results judged mixed
Guyatt, 200091 A z-score was used to generate a p-value related to the null hypothesis that there were no real 
differences in results from observational studies and randomised trials
Thomas, 200394 Not stated
Wilson, 200397 Not statedDOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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dissimilar described their criteria for equivalence. 
One93 began by using the chi-squared statistic 
to identify potential moderating variables. Both 
calculated a measure of variance between groups 
(Qb) which was used to estimate the magnitude 
(or strength of contribution) of the potential 
moderator variables to the overall effect size. In 
one of the reviews100 95% CIs were then calculated 
for each potential moderator variable and non-
overlapping CIs were taken to indicate relative 
strength of moderator or predictor variables. In 
the other review93 a contribution of 5% or more 
by a proposed moderator variable to the overall 
heterogeneity surrounding the effect size was 
defined as a substantial contribution.
One of the three reviews in which results were 
judged to be mixed defined the criteria used to 
judge equivalence between the groups.91 This 
consisted of a p-value generated from a z-score 
based on the null hypothesis that there were no 
differences between results of RCTs and NRSs. 
This technique, while being less subjective than 
simply using authors’ judgement, does not examine 
the relative contribution of potential moderator 
variables other than randomisation to the overall 
effect size.
Given these findings it seems important to note 
that sensible and objective criteria to judge 
equivalence or otherwise of results of RCTs and 
NRSs should be included and applied in systematic 
reviews that include both study designs. These 
should be explicitly defined in the review protocol 
and, where possible, should use methods that take 
the effects of potential moderating variables other 
than randomisation into account.
Conclusions
Considerable variation in the studies pooled within 
reviews, in terms of population, intervention, 
outcome and other methodological details, makes 
it difficult to separate the potential effect of 
random assignment from the potential effects of all 
the other variables.
Not only should the magnitude of the pooled 
effect estimates be compared between RCTs and 
NRSs, but also the variability associated with them. 
However, most included reviews did not do this. 
Most did not state what criteria were used to judge 
equivalence between findings of RCTs and NRSs.
The existing systematic reviews of policy 
interventions do not help us to determine 
whether RCTs and NRSs give similar results when 
evaluating policy interventions. Further research 
should be carried out (see below).
Recommendations for research
Systematic reviews should be carried out with the 
intention of investigating differences in effects 
of policy interventions between RCTs and NRSs. 
Sensible and objective criteria that are supported 
by empirical evidence should be used to judge 
equivalence or otherwise of results of RCTs and 
NRSs in these investigations. Not only should 
the magnitude of the pooled effect estimates be 
compared between RCTs and NRSs, but also the 
variability associated with them. Methodological 
indexing terms should be developed to enable 
more fruitful searching of health and non-health 
electronic databases. DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Aims
The aims of this part of the study are: (1) to 
test our main hypothesis that RCTs produce 
different results when compared with other study 
designs and (2) to test whether this finding can 
be explained by the hypotheses developed in 
Chapters 3–5. These hypotheses outline possible 
relationships between various factors which might 
be associated with the use of randomisation and/
or the effect size of evaluations. These factors may 
therefore explain, confound, strengthen or weaken 
the conclusions drawn from (1).
We adopted three of the four possible approaches 
mentioned earlier (see Chapter 2):
•  Comparing controlled trials that are 
identical in all respects other than the use of 
randomisation, by ‘breaking’ the randomisation 
in a trial to create non-randomised trials. This 
approach uses original primary data from two 
RCTs of policy interventions in resampling 
studies.
•  Comparing similar controlled trials drawn 
from systematic reviews that include both 
randomised and non-randomised studies 
(i.e. analysing comparable field studies). This 
approach uses a series of systematic reviews 
of health promotion interventions conducted 
by the EPPI-Centre (all EPPI-Centre health 
promotion reviews available at the time of the 
current study).
•  Investigating associations between 
randomisation and effect size using a pool of 
more diverse studies within broadly similar 
areas. This meta-epidemiological approach 
uses the pooled data from the EPPI-Centre 
reviews mentioned above, and data from trials 
of interventions to support transition from 
school into adult life reviewed by Colorado 
State University.
As the methods of analyses for the second and 
third approach overlap, descriptions of methods 
and results are combined as a single meta-
epidemiological study.
Creating NRSs 
from RCT data
This part of the study builds on work conducted by 
Deeks et al.40 and explores the difference between 
randomised and non-randomised trials in a tightly 
controlled way through the use of statistics and 
primary data from RCTs. By generating non-
randomised trials from within an RCT we were able 
to look at differences between randomised and 
non-randomised trials in a population of studies 
that only differed by their method of allocation. 
Thus, in effect, we had a set of trials that we knew 
to be free of all the confounders that Chapters 3–5 
predict might moderate and mediate observed 
differences between RCTs and nRCTs.
We were fortunate to be given data from two RCTs 
(see Chapter 2). One evaluated postnatal support 
and the other evaluated the prevention of child 
physical abuse and neglect. These data preserved 
the anonymity of the trial participants, but 
contained baseline and outcome information for all 
individuals included in the original trial analyses.
Creating randomised and 
non-randomised trials
In order to replicate, as far as possible, 
circumstances that might lead to the creation of 
non-randomised trials by researchers working ‘in 
the field’, we created non-randomised trials based 
on the area in which participants lived. Each area 
had a number of participants who received the 
intervention, and a number who did not. Each 
area could therefore be considered to be a mini-
RCT. We had six such areas in Trial 1 and four in 
Trial 2 (after combining two small areas). We were 
then able to create non-randomised comparisons 
by comparing the people who received the 
intervention in one area with people who did not 
in other areas. Thus we were able to create 30 non-
randomised trials from Trial 1 and 12 from Trial 
2. We used all individuals in the selected areas, 
in contrast to Deeks et al.40 who drew randomised 
samples in the selected areas, because our RCTs 
had far fewer participants than those of Deeks et al.
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It is important to note that the average 
intervention effect in the mini-NRSs must equal the 
average intervention effect in the mini-RCTs. Our 
focus will therefore be on comparing the standard 
deviations of the intervention effects in mini-NRSs 
and in mini-RCTs. Our design does not allow for 
the possibility that real NRSs might induce bias 
by (consciously or not) assigning interventions to 
‘more promising’ areas.
Methods for analysis
We had three questions to answer in our re-analysis 
of the two trials:
1.  Do the results of the non-randomised trials 
differ from those of the randomised trials?
2.  Does matching areas on baseline characteristics 
enable non-randomised trials to approximate 
the results of the randomised trials?
3.  Can adjusting for baseline characteristics in 
the analysis enable non-randomised trials to 
approximate the results of the randomised 
trials?
For the first of the above analyses, we calculated 
the log odds ratios of the outcomes of interest in 
all randomised and non-randomised trials. In Trial 
1 we had 30 non-randomised and six randomised 
trials. In Trial 2 we had 12 non-randomised and 
four randomised trials.
In the second analysis we matched the intervention 
areas with control areas on baseline characteristics 
of the study participants. This gave us six non-
randomised trials from Trial 1 and four non-
randomised trials from Trial 2.
In the third analysis we took each possible 
comparison to create non-randomised trials, and 
adjusted for baseline differences in the analysis 
using logistic regression.
To answer our research questions in each of the 
above analyses, we tested for differences in the 
variances of the randomised and non-randomised 
trials using an F-test. Because this test wrongly 
assumes that all mini-NRSs are independent, the 
p-values produced are likely to be too small.
The results of the first re-analysis can be derived 
algebraically (see Appendix 5). A key quantity turns 
out to be a correlation coefficient r, derived by 
computing the observed log odds in each arm in 
each area, and forming the correlation between the 
log odds in the intervention arm and the log odds 
in the control arm. In the appendix we show that 
the standard deviation of the NRSs is greater than 
the standard deviation of the RCTs whenever r is 
greater than 0. It follows that we can test whether 
the standard deviation of the NRSs equals the 
standard deviation of the RCTs by testing whether 
r = 0.
Methods for analysing 
comparable field studies 
and meta-epidemiology
The aim of this part of the study was, first, to 
investigate whether study design influences a 
study’s effect sizes by analysing ‘comparable policy 
evaluations’ (i.e. evaluations of similar policies) 
from sets of studies with randomised and non-
randomised study designs selected from systematic 
reviews of policy interventions. The second aim 
was to test whether these findings can be explained 
by the hypotheses developed in Chapters 3–5, 
which were based on the findings of existing 
systematic reviews. This part of the study is based 
on examining differences in the effect sizes of 
individual studies across nine health promotion 
reviews.
Identification and description 
of policy intervention 
evaluations within reviews
Predetermined inclusion criteria and descriptive 
codes were applied to studies previously reviewed 
in depth. Reviewers inspected abstracts (where 
these were available) and previous coding for each 
study. Previous coding of the EPPI-Centre data 
set described outcome evaluations according to 
a standardised keyword system developed by the 
EPPI-Centre149 covering the type of study (e.g. 
outcome evaluation, survey, case–control study); 
the country where the study was carried out; the 
health focus of the study; the study population; 
and, for reports describing or evaluating 
interventions, the intervention site, intervention 
provider and intervention type. (These studies 
were also sometimes further classified with 
review-specific codes.) In addition, extracted data 
described in detail the population, development 
and delivery of the intervention, research design 
and methodological attributes, and the type 
of outcomes measured (when relevant). Where 
necessary, reviewers referred to the full reports 
of these evaluations. Standardised coding and 
extracted data were also available for inspection as 
part of the Colorado data set.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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The inclusion criteria distinguished policy 
intervention evaluations from evaluations of 
other kinds of intervention. Descriptive codes 
for this study classified evaluations according 
to our typology of policy interventions (setting 
of policy/strategies, legislation/regulation, 
provision/organisation of services, environmental 
modification, facilitating lay/public delivered 
support/education); the presence or absence of an 
explicit collective plan of action; the level at which 
policy was implemented (international, national, 
regional, community or institution); the attrition 
rate; and evaluation designs (RCT or other 
evaluation design) based on Deeks et al.’s40 coding 
framework.
Initially, reviewers worked separately on a subset 
of studies in the reviews so as to quickly assess 
the likely availability of policy intervention 
evaluations and to see how easy/useful it was 
to apply the inclusion criteria and descriptive 
codes. This subset was chosen so that it spanned 
a range of social and organisational settings. The 
reviewers’ independent responses were compared, 
discrepancies discussed, and amendments made 
relating either to descriptions of individual studies 
or to the definitions of the terms describing policy 
interventions. Ultimately, screening and coding 
for each outcome evaluations in the reviews was 
carried out independently by two reviewers, with 
discrepancies resolved through consensus.
The results were tabulated to describe the balance 
of policy intervention evaluations and other 
intervention evaluations found in each review, 
and the type of policy interventions (setting 
of policy/strategies, legislation/regulation, 
provision/organisation of services, environmental 
modification, facilitating lay/public delivered 
support/education), the level at which they operate 
(national, regional, community or institutional), 
and whether they were evaluated with an RCT or 
another design.
Analysis of each study
EPPI-Centre reviews
We calculated measures of effect for all studies. 
Given that many of the outcomes used different 
scales and different combinations of continuous 
and dichotomous data, we selected the SMD as 
being the only measure that would enable us to 
compare and combine results.150 Our software, 
EPPI-Reviewer, can calculate this quantity. To 
accommodate the inconsistent and incomplete 
reporting of quantitative data from controlled 
trials, EPPI-Reviewer has been adapted to calculate 
measures of effect from a minimum of available 
data. EPPI-Reviewer can also compute appropriate 
measures of effect and standard errors from cluster-
randomised trials comparing groups of individuals 
(e.g. classes or schools).
Outcomes were classified as being in one of 
four ‘outcome domains’: knowledge, attitudes, 
behaviour and health state. For studies that 
reported more than one outcome per domain, we 
included in our analysis only the outcome that was 
most commonly reported across all studies in that 
review. Thus each study had up to four outcomes 
calculated, though many did not report outcomes 
in all our domains.
Many authors did not report enough information 
to calculate an effect size. Some simply reported 
that ‘there were no significant differences 
between the groups’ and did not supply numeric 
information. In these cases we assumed a SMD of 
zero; the standard error was calculated because for 
the SMD it depends only on the sample sizes. A 
sensitivity analysis was conducted to examine the 
impact this had on our results by comparing the 
results obtained with and without the studies in 
question. Only 12 outcomes out of 376 fell into this 
category, and the sensitivity analysis revealed no 
differences in results as a result of this.
The intracluster correlation coefficient (ICC) for 
cluster trials was often not reported. We assumed 
an ICC of 0.02 for these trials and adjusted 
standard errors accordingly by inflating them by 
the square root of the design effect. All reported 
ICCs were in the range of 0.01 and 0.02, as were 
the ICCs we were able to calculate from primary 
data, so we felt confident in assuming this value. 
We were able to calculate an ICC for one sexual 
health study (0.01), and this value was assumed for 
the other trials in that review.
Colorado reviews
All the studies in the Colorado data set that met 
our inclusion criteria already had SMDs calculated. 
Unlike outcomes in the EPPI-Centre data set, only 
one effect size had been calculated for each study, 
and these outcomes were not split into different 
domains and are mostly concerned with social 
and education skills such as comprehension and 
communication.Methods for testing the hypotheses developed in Chapters 3–5
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Analysis combining studies: 
potential confounders
Any differences between the effect sizes of 
randomised and non-randomised studies may 
be explained by other variables that are also 
related to effect size. For instance, ‘hard outcomes’ 
provided by clinical data may be more easily 
obtained in trials set in clinical establishments 
where randomisation is also more acceptable to 
the community of researchers and practitioners. 
In contrast, ‘soft outcomes’ such as self-reported 
behaviour may be more optimistic and more 
commonly relied upon on in community settings 
where randomisation is less acceptable to the 
practitioners and researchers.
The first stage of analysis was therefore to test 
for associations between randomisation and 
any attributes of policy interventions or their 
evaluations where a theoretical argument may 
be mounted, or for associations that have been 
shown in other empirical studies, including results 
reported in Chapters 3–5. In order to explore 
these associations between randomisation and 
other attributes, we cross-tabulated the attribute 
of interest against study design and tested for 
statistical relationships using the chi-squared test. 
(Statistical tests for this analysis were carried out 
in �EPPI-Reviewer.) For some dimensions, e.g. 
intervention provider, the studies could have more 
than one attribute. In order to avoid recounting 
any studies that had more than one attribute in 
the chi-squared test, the ‘count’ for each study was 
calculated as one divided by the number of times 
the study appeared in the test. So, for a study with 
two different intervention providers, the value 
of the study was 0.5 in the two cells in which it 
appeared.
Analysis combining studies: 
comparing effect sizes 
of randomised and non-
randomised studies
The second stage of analysis investigated the 
differences between the observed effect sizes of 
randomised and non-randomised studies within 
the same systematic review. Because we had data 
from several systematic reviews, we also wanted 
to investigate whether or not any differences 
between the observed effect sizes of randomised 
and non-randomised studies were consistent across 
systematic reviews. The analysis was based on the 
estimated effect size for each study in each outcome 
domain and allowed for random error in those 
estimated effect sizes, as expressed by the standard 
errors. We have controlled for the variation that 
might be introduced by longer term follow-up by 
always selecting the outcomes measured as soon as 
possible after the intervention.
Model for one review
Our model for the estimated intervention effects 
incorporates the following features:
•  the overall intervention effect may be different 
in each review
•  NRSs and RCTs may differ systematically
•  the systematic difference between NRSs and 
RCTs may be different in each review
•  random error in each estimated intervention 
effect is captured by its standard error, but 
there may be additional heterogeneity between 
intervention effects
•  this additional heterogeneity between 
intervention effects may differ in magnitude 
between RCTs and NRSs.
Formally, our model is:
yij = δi + bi tij + uij + eij  (1)
where yij is the estimated intervention effect in 
the jth study in the ith review; δi is the average 
true intervention effect in the ith review; bi is the 
average difference between RCTs and NRSs in the 
ith review – the ‘bias term’; tij is 0 if the jth study in 
the ith review is a RCT and 1 if it is an nRCT; uij is 
a study-specific random effect that has mean 0 and 
standard deviation σiR if the study is a RCT and σiN 
if the study is an NRS; and eij is random error that 
has mean 0 and standard deviation equal to the 
calculated standard error sij.
Model (1) was fitted separately for each review 
and for each outcome domain (in the EPPI-Centre 
reviews). Estimation was carried out in two ways. 
Firstly, we fitted separate random-effects meta-
analysis models to the RCTs and to the NRSs, 
and we estimated bi as the difference in estimated 
intervention effects, with squared standard error 
equal to the sum of the squared standard errors 
of the separate estimated intervention effects. 
Secondly, we used meta-regression,150 which 
additionally assumed equal variances (σiR = σiN). We 
also explored whether the data were consistent with 
equality of variances using a likelihood ratio test 
between a single meta-regression model and a pair 
of meta-regression models.
In this model, our main interest is in whether bi is 
zero or not. However, there is typically substantial DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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uncertainty about a single bi, and it is therefore 
useful to combine the bi in a second stage model.
Model for all reviews
In the second stage model, the bias term bi is 
assumed to follow a normal distribution across 
reviews:
bi ~ N(β,Φ2)  (2)
where β expresses the average bias of nRCTs 
(presupposes common direction of estimated 
intervention effects) and Φ expresses review-specific 
bias.
If β and Φ are both zero then NRSs do not differ 
systematically from RCTs in any policy area. 
If β is non-zero but Φ is zero then NRSs differ 
systematically from RCTs and the difference is the 
same across different policy areas. If Φ is non-zero 
then NRSs differ systematically from RCTs and the 
difference is different across different policy areas 
(so that the difference is likely to be small or zero in 
some policy areas but not in others).
Model (2) was fitted separately for each outcome 
domain (in the EPPI-Centre reviews). The model 
was fitted by applying a standard random-effects 
meta-analysis model to the estimates of bi and its 
standard error from fitting Model (1).
To explore which other study factors are associated 
with estimated intervention effects, we repeated the 
above analysis with tij redefined as each other study 
factor in turn.
Meta-confounding
As different study characteristics were likely to 
be correlated, we estimated independent effects 
by combining statistically significant (p < 0.05) 
variables from the above univariate analysis 
in a multivariate meta-regression.150 These 
variables covered public involvement, settings 
and boundaries of the intervention, intervention 
provider (clinician) and reporting quality. This 
analysis allowed for us to investigate the possibility 
of meta-confounding while keeping the number of 
tests to a reasonable number in order to minimise 
the chances of false positive results. The aim of 
this analysis was to discover whether these other 
factors strengthen, weaken or otherwise change 
the result of testing our main hypothesis. We 
acknowledge, however, that this approach risks 
excluding potentially relevant interactions as it was 
based on a subset of the possible range of variables 
that could have been included. All statistical tests 
in this analysis were carried out using the metareg 
command in stata.
Data
Given that some studies appeared in more than 
one review (for example, studies concerned with 
children and physical activity sometimes also 
had a component on healthy eating) and there 
was a danger that some studies could appear in 
the analysis twice, we organised the reviews into 
chronological order and excluded studies from 
reviews if they had already appeared in an earlier 
review. Table 8 reports the number of policy 
interventions in each review and the number of 
non-overlapping policy interventions included in 
the analysis, and Tables 9–21 show characteristics of 
the studies in the EPPI-Centre reviews. A sensitivity 
analysis that included all studies in all reviews 
showed us that, even though the number of studies 
appearing in some reviews was greatly diminished, 
our results were unaffected by this decision. There 
was no overlap between the studies in the EPPI-
Centre reviews and the Colorado data set, so no 
action needed to be taken between data sets.Methods for testing the hypotheses developed in Chapters 3–5
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TABLE 8  Number of studies analysed across whole set of EPPI-Centre reviews
Review
Total number of policy 
interventions in this review Number in this analysis
1. Workplace health promotion152 46 46
2. Peer-delivered health promotion153 47 47
3. Preventing cervical cancer154 29 26
4. Young people: physical activity28 13 12
5. Young people: healthy eating27 22 9
6. Young people: mental health155 4 4
7. Children: physical activity156 19 16
8. Children: healthy eating94 30 26
9. Men who have sex with men157 10 10
TABLE 9  Types of study (n = 176)
Type of study Number
RCT 97
nRCT 79
TABLE 10  Whether or not interventions were based on an explicit theoretical model
No Yes Total
RCT 27 70 97
nRCT 41 38 79
Total 68 108 176
TABLE 11  Whether interventions were based on explicit public involvement
Explicit public involvement No explicit public involvement/not stated Total
RCT 12 85 97
nRCT 14 65 79
Total 26 150 176
TABLE 12  Identification of aims
Aims indentified by target 
population
Aims: not stated/unclear/other than target 
population Total
RCT 4 93 97
nRCT 4 75 79
Total 8 168 176DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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TABLE 13  Were lay people involved in developing the intervention?
Yes No Total
RCT 24 73 97
nRCT 26 53 79
Total 50 126 176
TABLE 14  Intervention site (not mutually exclusive categories)
Community Institution Total
RCT 31 82 113
nRCT 24 68 92
Total 55 150 205
TABLE 15  Intervention provider (not mutually exclusive categories)
Community Lay Researcher Practitioner Total
RCT 12 44 8 58 122
nRCT 14 39 11 51 115
Total 26 83 19 109 237
TABLE 16  Choice of measurement tool (not mutually exclusive categories)
Clinical test Non-clinical test Total
RCT 24 93 117
nRCT 10 79 89
Total 34 172 206
TABLE 17  Choice of outcome measures (not mutually exclusive categories)
Clinical risk factor/health problem or state Other outcome Total
RCT 26 95 121
nRCT 14 79 93
Total 40 174 214Methods for testing the hypotheses developed in Chapters 3–5
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TABLE 18  Intervention provider (not mutually exclusive categories)
RCT nRCT Total
Not stated 11 10 21
Unclear 6 1 7
Not relevant (e.g. mass media) 1 2 3
Community 2 5 7
Community worker 6 5 11
Counsellor 3 2 5
Health professional (specify) 16 12 28
Health promotion/education practitioner 16 7 23
Lay therapist 0 1 1
Parent 7 7 14
Peer (specify) 33 30 63
Psychologist 4 1 5
Researcher 7 9 16
Residential worker 0 0 0
Social worker 1 3 4
Teacher/lecturer 34 33 67
Other (specify) 14 14 28
Total 161 142 303
TABLE 19  Was the allocation to intervention and control/comparison groups performed blind?
RCT nRCT Total
Not relevant (study not a trial) 0 0 0
Not stated 88 39 127
Unclear (please specify) 3 3 6
Yes 5 1 6
No 1 36 37
Total 97 79 176
TABLE 20  Were participants aware which group they were in for the evaluation?
RCT nRCT Total
Not relevant (study not a trial) 0 0 0
Not stated 76 51 127
Unclear 9 15 24
Yes 10 11 21
No 3 2 5
Total 98 79 177DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
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TABLE 21  Was outcome measurement performed blind?
RCT nRCT Total
Not relevant (study not a trial) 0 0 0
Not stated 84 59 143
Unclear 3 11 14
Yes 10 1 11
No 2 8 10
Total 99 79 178DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
63
Chapter 7  
Results: testing our main hypothesis 
that RCTs are the same as NRSs
H
ypothesised relationships between 
randomisation, effect size and potential 
moderators, or confounders were translated into 
null hypotheses for empirical testing. This chapter 
reports the results of testing our principal null 
hypothesis that, based on previous research,40 there 
is no detectable difference in effect size between 
RCTs and NRSs, but that the variance of NRSs is 
greater than that for RCTs.
This hypothesis is tested with data from the two 
reconstructed RCTs, the nine EPPI-Centre reviews 
(separately and pooled) and the Colorado data set 
of policy evaluations reviewed in depth.
Results from creating 
randomised and non-
randomised trials 
from two RCTs
Using the Social Support and Family Health 
Trial (Trial 1),47 we created six RCTs, based on 
the participants in six areas, and 30 nRCTs (by 
comparing the intervention groups in each area 
with the control groups from every other area). 
There were 731 participants in this trial: 367 in the 
intervention group and 364 in the control group. 
The same technique in Trial 2 gave us 12 nRCTs 
and four RCTs. There were 160 participants in 
this trial: 88 in the intention group and 72 in the 
control group.
The three main outcomes in Trial 1 were smoking, 
depression [Edinburgh Postnatal Depression Score 
(EPDS) score  12] and whether or not the child had 
had an accident in the last year. All were binary 
outcomes, so we were able to use the same methods 
for all three. We calculated odds ratios, comparing 
the odds, for example, of smoking in the 
intervention group with the odds of smoking in the 
control group. We then plotted the results obtained 
from the RCTs and nRCTs on dotplots (Figure 2).
We then compared the variances of the RCTs and 
nRCTs. As can be seen from Table 22, the variances 
of the log odds ratios were also very similar 
between the different types of studies. Using the 
stata sdtest, we found that none of the differences 
were statistically significant with p-values ranging 
from 0.6807 for smoking to 0.9998 for maternal 
depression. We therefore do not have any evidence 
to support our hypothesis that the variance of the 
effect sizes of nRCTs can be expected to be greater 
than that for RCTs.
The standard deviations are surprisingly similar for 
smoking, EPDS and accidents. This is explained 
by the small values of the correlations between 
intervention and control arm log odds in different 
areas, which are 0.32, 0.13 and 0.32 respectively 
(see the formulae in Appendix 5).
Analysis of the primary outcomes in Trial 2,48 
‘neglect’ and ‘physical abuse’, yielded similar 
results (Figure 3). The tests for variance were also 
not significant (p = 0.4 and p = 0.5).
We also tested two further ways of comparing 
randomised with non-randomised trials: matching 
areas and adjusting on baseline variables. We 
matched each of the intervention groups in the six 
areas in the Social Support Study against a control 
group from another area on three variables: lone 
parenthood, type of housing and ethnic group.
Areas in the home visitation trial (Trial 2)48 were 
matched on a measure of deprivation developed 
for the trial. Figure 4 shows the dotplot for this 
analysis. As before, there were no significant 
differences in variance using the stata sdtest with 
p-values of 0.89 (smoking), 0.85 (EPDS) and 0.97 
(accidents). Figure 5 shows the dotplot for this 
analysis in Trial 2. For the outcome ‘physical abuse’ 
there was no statistical difference between the two 
types of studies (p = 0.40). However, for neglect, 
nRCTs showed significantly smaller log odds ratios 
than the RCTs (p = 0.018).
Our final analysis consisted of using logistic 
regression to adjust the results of the trials 
according to the same baseline characteristics 
on which we used to match areas in the previous Results: testing our main hypothesis that RCTs are the same as NRSs
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FIGURE 3  Trial 2 dotplots for the two main outcomes.
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FIGURE 2  Trial 1 dotplots for the three main outcomes. EPDS, Edinburgh Postnatal Depression Score.
TABLE 22  Standard deviations of log odds ratio for different outcomes in Trial 1
Trial type Smoking EPDS Accidents
RCT 0.632 0.397 0.663
nRCT 0.732 0.397 0.674
Test of equality p = 0.53 p = 0.81 p = 0.53
EPDS, Edinburgh Postnatal Depression Score.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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FIGURE 4  Trial 1 dotplots for the three main outcomes. EPDS, Edinburgh Postnatal Depression Score.
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FIGURE 5  Trial 2 dotplots for the two main outcomes.Results: testing our main hypothesis that RCTs are the same as NRSs
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analysis. We used the same methods as described 
above to generate non-randomised comparisons 
and compared 30 non-randomised trials with six 
RCTs in Trial 1 and 12 non-randomised trials with 
four RCTs in Trial 2.
Dotplots for this analysis in Trial 1 are shown in 
Figure 6 and for Trial 2 in Figure 7. Again, tests 
for differences in variance showed no significant 
differences between the two types of trial.
Results from the EPPI-
Centre reviews
Presented here are the findings that resulted from 
examining the data in the EPPI-Centre reviews 
to answer our main research question: do RCTs 
have the same effect sizes as nRCTs? As Deeks et 
al.40 found, the answer to this question has two 
aspects: (1) the overall average size of effect and 
(2) the range of different effect sizes covered by the 
different study types (their variance). As one of the 
inclusion criteria for the EPPI-Centre reviews was 
the presence of a control group, the comparison 
made here is between RCTs and nRCTs.
Because variance is an important part of our 
question, we fitted the model described in Chapter 
6 separately for RCTs and nRCTs. First, we 
conducted a random-effects meta-analysis (stata: 
metan) separately for the RCTs and nRCTs in 
each review in each outcome domain (knowledge, 
attitudes, behaviour, health state). This gave us 
two overall effect sizes and standard errors for 
each review in each outcome domain. We then 
calculated the bias term b as the difference between 
the RCTs and nRCTs in each review with a standard 
error calculated as  se se se = +
1
2
2
2  where se1 and se2 
are the standard errors of the overall effect sizes 
for the RCTs and nRCTs. This gave us a bias term 
(the difference between the effect sizes of RCTs 
and nRCTs) and a standard error in each outcome 
domain for each review. The final stage in this 
analysis was to combine the bias terms for each 
review in a random-effects meta-analysis (stata: 
metan). The direction of effect from this analysis 
tells us if, overall, RCTs have larger or smaller 
effect sizes than nRCTs, and each point on the 
forest plots below represents the results from one 
review.
The pooled effect size of –0.28 (95% CI 0.64 
to 0.09) indicates that the nRCTs have bigger 
effect sizes than the RCTs, but this result is not 
statistically significant (p = 0.14). However, there is 
a high degree of heterogeneity between the reviews 
[Q = 24.86, degrees of freedom (df) = 7, p < 0.001]. 
Taken together, these results suggest that the 
nRCTs have bigger effect sizes than the RCTs in 
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FIGURE 8  Forest plot of outcome domain: knowledge. HP, health promotion; YP, young people.
some reviews (e.g. reviews 3154 and 6155) but not in 
others, and they may even have smaller effect sizes 
than the RCTs in some reviews (e.g. review 7156).
The pooled effect size of –0.166 (95% CI –0.319 to 
0.012) indicates that the nRCTs have bigger effect 
sizes than the RCTs, and this result is statistically 
significant (p = 0.034). The results in this outcome 
domain are more homogeneous than knowledge 
(Q = 6.45, df = 6, p = 0.37).
The pooled effect size of –0.111 (95% CI –0.199 
to –0.023) is statistically significant, indicating that 
for behaviour nRCTs have bigger effect sizes than 
RCTs. The results are also homogeneous in this 
outcome domain (Q = 5.46, df = 7, p = 0.60).
The pooled effect size for health state is not 
statistically significant –0.084 (95% CI –0.234 to 
0.066) and indicates a very slightly larger value for Results: testing our main hypothesis that RCTs are the same as NRSs
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FIGURE 9  Forest plot of outcome domain: attitudes. HP, health promotion; YP, young people.
FIGURE 10  Forest plot of outcome domain: behaviour. HP, health promotion; MSM, men who have sex with men;  YP, young people.
the nRCTs than for the RCTs. The results are not as 
homogeneous as those for attitudes and behaviour 
(Q = 9.88, df = 6, p = 0.13).
We also ran the same analyses presented above 
using standard meta-regression, which assumes 
equal variances. The result of this analysis was 
very similar to the above analysis, suggesting that 
the variances are not so different that we cannot 
proceed to a multivariate meta-regression in the 
next chapter.
Results from the 
Colorado studies
We followed exactly the same methods for the 
Colorado studies as for the studies in the EPPI-
Centre reviews. Given that this data set of 126 
studies is regarded as being a single albeit broad 
review, we did not need to calculate separate effects 
for each review or separate effects for different 
outcome domains. However, the Colorado data 
set does contain a wider variety of study designs DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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FIGURE 11  Forest plot of outcome domain: health state. HP, health promotion; YP, young people.
than the EPPI-Centre data, so we are able to 
compare RCTs with nRCTs (as above) and also 
with experiments without control groups (e.g. 
before-and-after studies). Three studies were 
found to have extremely large effect sizes: SMDs 
of approximately five or more. These studies had 
a disproportionate effect on the analyses and were 
therefore excluded as effect sizes of this magnitude 
are extremely rare and implausible.
We found different results in the Colorado studies 
than in the EPPI-Centre studies. Here, RCTs were 
found to have much larger effect sizes than non-
randomised trials, by a statistically significant 0.368 
(95% CI 0.134 to 0.603) of a standard deviation. 
However, there was no significant difference 
between the RCTs and the non-controlled studies, 
0.044 (95% CI –0.134 to 0.222), although the 
direction of effect is for RCTs to have slightly 
smaller effect sizes.
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Testing for variance (stata: sdtest), we find that 
the RCTs have a smaller, but not significantly 
different, variance than the nRCTs (p = 0.12), and 
that RCTs have a much smaller variance than 
the non-controlled studies (p = 0.0006). We also 
tested for variance by running the regression using 
traditional meta-regression (stata: metareg) and 
obtained very similar results to the above. This 
suggests that, while the test for different variances 
suggests there is a difference, we should treat 
this result cautiously, especially as the test is very 
sensitive to non-normality, and the interquartile 
ranges of the study types are not all that dissimilar.
Conclusion
The results from this part of the study give mixed 
answers to our principal research question. The 
statistical exercise involving the re-analysis of 
data from two trials suggests that nRCTs can give 
the same effect sizes as RCTs. This was a tightly 
controlled examination in which the only factor 
that was different between the RCTs and nRCTs 
was randomisation. However, we could by chance 
have chosen two trials in whichever area was not an 
important predictor of outcome, so generalisation 
from these two trials is difficult.
In the examination of trials sampled from 
systematic reviews we found considerable variation 
with RCTs having smaller effect sizes than non-
randomised controlled studies in the EPPI-
Centre reviews, and larger effect sizes than non-
randomised controlled studies in the Colorado 
studies. The EPPI-Centre and Colorado data sets 
are very different, however, and we shall explore 
some of the possible reasons for these different 
results in Chapter 8. These findings show that 
NRSs can differ systematically from RCTs, but that 
the direction and existence of the difference can 
differ across policy areas.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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E
arlier chapters have highlighted that it is 
difficult to state definitively whether RCTs 
produce different effect sizes to other study 
designs as this depends on the circumstances. 
The previous chapter sought to establish whether 
differences between types of study were discernible 
in their results using three types of data: nRCTs 
constructed artificially from RCTs, trials sampled 
from systematic reviews and trials spanning broad 
sections of policy sector literature. The re-analysis 
of trials showed that, in two situations in which the 
selection of an non-randomised control group was 
genuinely unbiased, the results of the nRCTs were 
very similar to those of the RCTs. However, when 
we moved on to examine real trials in the field, we 
found that, in one data set (RCTs and nRCTs of 
health promotion policy interventions) for some 
outcomes, RCTs had smaller effect sizes, whereas 
in another data set (RCTs and NRSs of transition 
policy interventions) we found the opposite.
The aim of this chapter is to explore some of 
these contradictions and attempt to unpick the 
reasons why we, and previous studies, have found 
conflicting results. We shall test the hypotheses, 
developed in previous chapters, in order to see 
whether RCTs produce different effect sizes 
to nRCTs because they are used in different 
circumstances, with different types of interventions 
and with different participants. These hypotheses 
will also serve to explore differences in the 
findings between the EPPI-Centre and Colorado 
data sets. Some differences between the data 
sets are apparent from the outset. The average 
size of the samples is very different. In the EPPI-
Centre studies, the average sample size for RCTs 
is 990 and for nRCTs it is 535 – not a statistically 
significant difference when the standard deviations 
are taken into consideration (p = 0.27). In the 
Colorado studies, on the other hand, RCTs have a 
mean sample size of 35 and nRCTs a mean of 84. 
This difference is statistically significant (p = 0.03). 
The non-control group studies are also larger than 
the RCTs with a mean sample size of 74 (p = 0.03).
The methods we use in this chapter were described 
in detail in Chapter 6, Methods for analysing 
comparable field studies and meta-epidemiology. 
Briefly, in order to test the association between 
different study characteristics (such as the 
theoretical underpinnings of the intervention) and 
the use of random assignment, we cross-tabulated 
study type against the characteristic in question 
and carried out chi-squared tests. We then tested 
the same characteristic to see whether theoretical 
framework, for instance, was associated with 
larger effect sizes by using the two stage model 
described in Chapter 6, Methods for analysing 
comparable field studies and meta-epidemiology, 
which preserves distinct variances for the different 
characteristics under investigation. Finally, if a 
characteristic was found to be associated with 
statistically significant differences in effect sizes, the 
characteristic was entered into a multivariate meta-
regression in order to see whether it strengthened 
or weakened the findings presented in Chapter 7.
We present the findings below, following a 
reminder of the hypotheses being tested in each 
case. p-values are reported for the chi-squared tests 
and SMDs with CIs for the univariate regression.
Participants
Baseline characteristics
We considered baseline characteristics to be an 
important variable to explore because of the 
possible impact of differences in groups on the 
intervention and evaluation. Groups may differ 
at baseline because: recipients of the intervention 
have self-selected or those who declined to 
participate have been assigned to the control/
comparison group; or recruitment favoured those 
most amenable to participation or those in most 
need, or excluded older people or those with 
multiple disadvantages (comorbidities in health, 
multidimensional identities in social research). 
Non-randomised controlled trials are more likely 
to have more heterogeneous populations and non-
equivalence between groups. Heterogeneity and 
non-equivalence at baseline may influence the 
calculated effect size and variance.
Chapter 8  
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We found that nRCTs were far more likely to 
report that they had non-equivalent groups at 
baseline than RCTs in both the EPPI-Centre data 
set (p = 0.0002) and among the Colorado studies 
(p < 0.001). However, in neither the EPPI-Centre 
nor the Colorado studies did this difference 
translate into an association with effect size.
Attrition
Higher attrition may be expected in community 
and home settings than in organisational settings 
and may be expected in transient populations 
(e.g. commercial sex workers, asylum seekers and 
socially excluded people). It is easier to employ 
randomisation and have good follow-up for trials 
carried out in organisations. High attrition may 
be associated with losing a disproportionate 
number of socially disadvantaged people who are 
more resistant to health promotion/public health 
initiatives.
We did not find that attrition rates were associated 
with study type in either of our data sets and, 
using meta-regression, we also found that different 
attrition rates were not associated with different 
effect sizes.
Intervention
Theoretical underpinnings 
of the intervention
Logically, interventions underpinned by theory 
should be more effective. The lack of theoretically 
based policy interventions has been noted in 
the fields of changing professional practice and 
suggested as an explanation for the lack of effective 
interventions.151
In another field, we understand that public health 
triallists value experimental methodologies more 
than do health promotion specialists, who place 
more emphasis on involving the community 
in developing and delivering the intervention, 
and we expected to find that experimental 
methodologies in public health are associated with 
randomisation.21 We also expected to find that 
health promotion is associated with community 
development but not randomisation.
However, we found in the EPPI-Centre data set 
that RCTs were more likely to have stated or 
recognisable theories than nRCTs (p = 0.0011), 
and there were no significant differences among 
the Colorado studies (p = 0.6930). The presence, 
or absence, of a theoretical framework was not 
associated with effect size in either data set. The 
differences between the results for the Colorado 
and EPPI-Centre studies may be connected with 
different data extraction questions. The EPPI-
Centre question allows reviewers to infer the 
theoretical framework, whereas the Colorado 
question asks whether the authors stated what their 
framework was.
Public involvement in 
developing the evaluation
Empowerment theories attribute responsibility 
to people not for the existence of a problem, but 
for finding a solution to it. The goal of ‘full and 
organised community participation and ultimate 
self-reliance’55 is a feature of social work such as 
community development and youth work, rather 
than a feature of public health and randomised 
experiments. Successful interventions specifically 
aimed at reducing health differentials include 
ensuring interventions address the expressed 
or identified needs of the target population 
and the involvement of peers in the delivery of 
interventions.56
Because of its different data extraction strategy, 
the EPPI-Centre data set had more relevant 
information in this area. We found no association 
between the people who identified the aims of 
the intervention and whether or not random 
assignment was employed, or between this variable 
and the effect size reported by studies (p = 0.7660).
We also found no relationship between the use 
of needs assessments and whether or not a study 
employed randomisation (p = 0.3198); and 
for outcome domain knowledge, attitudes and 
health state, the use of needs assessments also 
had no relationship with effect size. However, 
for behaviour outcomes (the outcome with the 
most data) we found that, by 0.171 of a standard 
deviation (95% CI 0.049 to 0.293), interventions 
based on needs assessments did worse than those 
which were not. The addition of interventions 
based on needs assessments to the multivariate 
meta-regression did not change our findings with 
regard to whether RCTs have different effect sizes 
to nRCTs.
We had a similar result when examining the 
issue of whether or not lay people were involved 
in developing the intervention. Approximately 
the same proportions of randomised and non-
randomised studies had involved lay people in DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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developing their interventions and those studies 
which did not involve lay people had better 
results by 0.210 of a standard deviation (95% 
CI 0.036 to 0.383) for the behaviour outcome 
domain. The other domains did not show any 
significant difference. Including this variable in 
the multivariate meta-regression appeared both to 
strengthen the importance of study type and lay 
involvement in the model.
As part of our coding for policy interventions, 
we also collected data on whether or not 
interventions described specific collective plans 
of action to achieve the intervention’s goals and 
also on whether the intervention involved the 
facilitation of lay/public delivered support or 
education. Non-randomised controlled trials were 
significantly more likely to have explicit action 
plans (p = 0.0416) among the EPPI-Centre studies, 
but were not associated with effect size. There were 
insufficient data available in the Colorado data set 
to make a judgement about explicit action plans. 
There was also no association between lay/public 
support and type of study or between lay/public 
support and the effect size of the intervention.
Setting and boundaries 
of the intervention
Interventions with a broader reach (communities, 
regions, nations) have more diffuse boundaries 
than those set within institutions. We expected to 
see randomisation applied less often to community, 
regional or national interventions. Clustered 
trials are more appropriate for these and some 
organisational level interventions. Attrition may 
be greater in larger scale interventions, where 
tracking of individuals is more difficult than within 
an organisation (see Attrition). Clustering reduces 
the power of a trial, so clustered evaluations are 
less likely to show effectiveness. Standardised 
implementation of interventions may be more 
difficult across large communities, regions or whole 
countries than in single organisations and therefore 
may be less effective.
We collected data on whether there was an explicit 
formal record of the policy (at institutional, 
community or regional level), the level at which 
policy was being enacted (international, national, 
regional, institutional, community) and whether 
an intervention was delivered to recipients 
individually, but we did not find any relationship 
between these factors and study design or 
randomisation.
We did find in the EPPI-Centre studies, however, 
that only nRCTs allocated people by region, with 
RCTs much more likely to allocate individuals. 
The relationship between study design and unit of 
allocation was significant (p = 0.0117) and, when 
comparing individual assignment with assignment 
by group, studies that allocated by group had 
smaller effects on attitudes than those allocating by 
individuals by 0.281 of a standard deviation (95% 
CI 0.035 to 0.526). The Colorado studies and the 
other outcome domains in the EPPI-Centre data 
set showed no significant differences.
The question on unit of allocation was categorised 
into individuals, family, group/class (e.g. tutor 
group), institution, community and region. We then 
carried out a meta-regression on this variable and 
found that, for attitudes (p = 0.012) and behaviour 
(p = 0.033), the size of the allocation unit was 
negatively correlated with effect size – i.e. that the 
larger units of allocation had smaller effect sizes [by 
–0.081 (95% CI –0.144 to –0.018) and –0.051 (95% 
CI –0.099 to –0.004) respectively]. We then added 
type of study into the regression finding that this 
strengthened the size and statistical significance of 
the associations – both for allocation unit and study 
type.
We also looked at differences between interventions 
sited in institutions and those located in the 
community. RCTs and nRCTs used both settings 
as much as one another and, possibly looking at 
the unit of allocation issue from another angle, 
we also found that community interventions had 
smaller effect sizes than institutional interventions 
by –0.159 of a standard deviation (95% CI –0.273 
to 0.046).
Provider of the intervention: 
community/peer provider/
practitioner
Community development and peer-delivery 
specialists value health promotion theory 
and process evaluations more than RCTs so 
these interventions may be found to have less 
randomisation. Theories underpinning community 
development and peer-delivery anticipate more 
effective interventions through their greater 
relevance, and there is empirical evidence to 
support this.56
To explore the influence of different types of 
people delivering or providing interventions, 
we categorised the intervention providers into Results: testing the hypotheses developed in Chapters 3–5
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community, lay, researcher and practitioner 
providers. Both RCTs and nRCTs used the same 
ranges and ratios of providers. Community 
providers had a significantly worse impact 
on knowledge (SMD = –0.404, p = 0.003) and 
behaviour (SMD = –0.247, p = 0.000), and the 
direction of the other two outcome domains was 
also negative. Lay providers, often peers, had more 
mixed results: better than the other providers in 
changing health states (SMD = 0.276, p = 0.000), 
similar for influencing attitudes and behaviour, but 
worse for knowledge (SMD = –0.236, p = 0.024). 
There were no significant results in either direction 
for practitioner providers.
Researcher provider
Researchers have more control over the 
intervention and evaluation and so, theoretically, 
the researcher would therefore be better able to 
randomise. Interventions will be found to be more 
consistently implemented by enthusiasts, and 
therefore be more effective.
This factor was explored using the same 
categorisation as ‘practitioner’ (see above). Judging 
by effect sizes, researchers appear to be better 
providers for influencing behavioural outcomes 
(SMD = 0.22, p = 0.045) and about the same as 
other providers for the other influencing outcome 
domains.
Outcomes
Choice of outcome domains
Health outcomes are more readily measured in 
clinical settings; clinical settings are more likely 
to mount RCTs, and have clinical providers and 
long-term follow-up. With regard to clinical 
outcomes being more resistant to change, the 
health state domain has the lowest overall effect 
size of 0.123 (95% CI 0.060 to 0.185), compared 
with 0.251 (95% CI 0.201 to 0.302) for behaviour, 
0.306 (95% CI 0.193 to 0.418) for attitudes  
and 0.449 (95% CI 0.356 to 0.543) for knowledge. 
Meta-regression also suggests this ordering of 
outcomes is significant (p = 0.000).This ordering 
of effect size in relation to domains supports the 
hierarchy of outcomes proposed by Kirkpatrick63 
and Munro et al.64
Choice of outcome measures
Clinical outcomes are more commonly found 
in clinical settings. The choice of ‘hard’ or ‘soft’ 
outcomes can be associated with randomisation. If 
clinicians favour RCTs, clinical outcome measure 
may be associated with greater randomisation. 
Clinical outcomes will be found to be more resistant 
to change than ‘softer’ outcomes such as reported 
behaviour
In terms of the choice of outcome measure, there 
is some suggestion in the EPPI-Centre data set that 
RCTs use clinical tests more than nRCTs, but this is 
not quite statistically significant (p = 0.0849).
Evaluation design
Sample size
Sample size may be related to the choice of study 
design. Logically, larger sample sizes may be more 
likely in nRCTs and smaller sample sizes are more 
likely to give spurious results; of these, those with 
positive results are more likely to be published.
As suggested in the above hypotheses, the larger 
units of allocation provide smaller effect sizes. 
However, when we regress sample size and effect 
size in the EPPI-Centre data set, we find no 
association – although the ‘direction’ is that smaller 
samples have larger effect sizes (p = 0.221). The 
Colorado data set has the same characteristics, 
with a suggestion of smaller effect sizes in the 
larger studies which does not quite reach statistical 
significance (p = 0.058). When the two data sets 
are combined, we have a set of studies with a much 
larger spread of sample sizes, and the association 
between sample size and effect size is more 
pronounced (p = 0.03).
Control group
Control groups are always found in RCTs, but only 
sometimes in NRSs. We expected to find that the 
use of a control group leads to smaller effect sizes 
than are found in uncontrolled evaluations.
As the EPPI-Centre data set did not contain any 
studies without control groups, this analysis could 
only be conducted with the Colorado studies. A 
simple comparison of studies with control groups 
against studies without does not identify any 
significant differences. However, combining RCTs 
with nRCTs conceals differences within the studies 
that have control groups. The Colorado data set 
has large effect sizes for RCTs, medium effect sizes 
for nRCTs and large effect sizes for the non-control 
group studies. This means that we might expect 
differences between the nRCTs and the non-control DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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group studies but not between the RCTs and the 
non-control group studies. If the above hypothesis 
is correct – that uncontrolled evaluations have 
larger effect sizes (and the comparison between 
nRCTs and non-control group studies is consistent 
with this: p = 0.014) – then the question that 
remains is why do the RCTs in the Colorado data 
set have such large effect sizes?
Blinding
Blinding of participants, recruiters, 
intervention providers and outcome assessors 
to the intervention allocation is easier for 
some interventions with randomisation. Poor 
concealment, common in nRCTs, will be associated 
with greater effect sizes.
We assessed blinding in three ways in the EPPI-
Centre data set: allocation concealment, participant 
awareness and outcome measurement. RCTs 
were significantly more likely to use allocation 
concealment (p = 0.000) and blinded outcome 
measurement (p = 0.002) than nRCTs. However, 
nRCTs were equally likely to conceal allocation 
from the intervention participants. These results 
are based on small numbers of RCTs and nRCTs 
(fewer than 40). As our regression analyses are 
by outcome domain within each review, there 
were insufficient studies to carry this out to assess 
blinding.
The Colorado data set did not record concealment 
of allocation.
Follow-up
Length of follow-up periods is linked with study 
design; long follow-up may be easier within 
institutions, where randomisation is also easier. We 
expected that long follow-up would be associated 
with declining effect size.
Despite the expectation that longer follow-ups 
would lead to smaller effect sizes, we did not find 
any evidence of this in either data set. There was 
also no association with effect size.
Clustering
Clustered trials with few clusters are more likely to 
be ‘natural experiments’. Natural experiments do 
not include randomisation. Natural experiments 
are more likely to lack blinding and to have 
enthusiasts supporting the intervention and non-
enthusiasts supporting the comparisons, and 
therefore lead to greater effect sizes. Testing this 
hypothesis was beyond the capacity of this project.
Quality of the reporting
Quality of reporting specific elements of a study 
is associated with researchers’ disciplines. Better 
reporting (of pre- and postintervention data) may 
be seen to be associated with triallists who also 
support randomisation.72 Reporting of pre- and 
postintervention data precludes effect sizes inflated 
by differences between groups.
We collected data on a range of aspects of 
reporting quality in the EPPI-Centre data set: pre-
intervention information on sociodemographic 
variables; pre-intervention data on outcome 
variables; names of measurement tools; 
postintervention data on outcome variables; 
whether there were any obvious shortcomings in 
the numerical reporting; and whether the study 
was replicable based on the report. None of the 
categorical answers was found to be associated with 
study type: RCTs seem to be as well (or as poorly) 
reported as nRCTs. Some statistically significant 
results were found when relating the above factors 
with effect size, but no obvious pattern emerges:
•  Studies that provided full information on pre-
intervention sociodemographic variables had 
higher effect sizes for knowledge: 0.291 of a 
standard deviation (95% CI 0.030 to 0.551); 
this variable was not significant in uni- or 
multivariate meta-regression.
•  Studies without obvious shortcomings in their 
reporting have better results for knowledge by 
0.434 of a standard deviation (95% CI 0.261 
to 0.607), but no difference for other outcome 
domains; when combined in a multivariate 
meta-regression with study type, this variable 
was significant (p = 0.001) and moved study 
type from p = 0.183 to p = 0.053.
•  Studies giving enough information or 
providing a further source of information on 
evaluation design are not as effective as those 
that do not at changing people’s knowledge by 
0.433 of a standard deviation (95% CI 0.046 to 
0.821); this variable was not significant in uni- 
or multivariate meta-regression.
•  Studies that do not give sufficient information 
to ensure that the content of the intervention 
is replicable do better in the attitudes domain 
by 0.559 of a standard deviation (95% CI 0.371 
to 0.747) than those that do give sufficient 
information. When combined in a multivariate 
meta-regression with study type, this variable Results: testing the hypotheses developed in Chapters 3–5
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TABLE 23  Summary of the results of the univariate (unadjusted) and multivariate (adjusted) regressions. A negative value indicates that 
RCTs had smaller effect sizes than nRCTs
Unadjusted (95% CI) Adjusted (95% CI)
Knowledge –0.275 (–0.641 to 0.091) –0.269 (–0.465 to –0.073) 
Attitudes –0.166 (–0.319 to –0.012) –0.165 (–0.369 to 0.040)
Behaviour –0.111 (–0.199 to –0.023) –0.192 (–0.330 to –0.053)
Health state –0.084 (–0.234 to 0.066) 0.052 (–0.149 to 0.254)
was significant (p = 0.000) and moved study 
type from p = 0.059 to p = 0.163.
We examined the Colorado data set on two aspects 
of reporting quality: replicability and the naming 
of measurement tools. Neither of these issues was 
seen to be associated with type of study and, again, 
we had a scattering of statistically significant results 
without any clear pattern:
•  The meta-regression comparing those studies 
that rated highly on replicability with those 
that rated poorly suggests that effect size 
decreases as replicability reduces, but the result 
is not quite statistically significant at p = 0.052.
•  Studies that named their measurement tools 
did significantly worse than those that did not 
by 0.3319 of a standard deviation (95% CI 
0.5283 to 0.1355).
The multivariate regression
After testing each of the above factors in turn for 
associations with effect size, we placed those that 
were significant in the univariate analysis of EPPI-
Centre studies into a multivariate model to explore 
independent effects. In order to avoid confounding 
by review, review was included in the model as a 
fixed effect. The factors that we explored were: 
public involvement, settings and boundaries, 
intervention provider (clinician) and reporting 
quality. When all factors are placed in the meta-
regression, many lose statistical significance. Table 
23 records how the regression affects our overall 
hypothesis.
Knowledge
The result of exploring the outcome domain 
knowledge with relation to study type suggested 
that there was a non-significant effect in favour of 
smaller effects for RCTs: –0.275 (95% CI –0.641 
to 0.091). After taking all the above factors into 
account in the multivariate regression, the meta-
regression now suggests that there is a significant 
effect in favour of smaller effects for RCTs: –0.269 
(95% CI –0.465 to –0.073), p = 0.007.
Attitudes
The previous analysis suggested that RCTs had 
significantly smaller effect sizes: –0.166 (95% CI 
–0.319 to 0.012). After taking all the above factors 
into account, the meta-regression suggests that the 
direction and quantity of the effect is the same, but 
it is no longer significant (p = 0.115).
Behaviour
The previous analysis suggested that RCTs had 
significantly smaller effects: –0.111 ( 95% CI–0.199 
to –0.023). The meta-regression suggests that the 
amount by which nRCTs overstate their effects is 
slightly larger: –0.192 ( 95% CI–0.330 to –0.053), 
and the statistical significance of this has increased 
(p = 0.007).
Health state
The previous analysis suggested that there was 
very little difference between RCTs and nRCTs: 
–0.084 (95% CI –0.234 to 0.066). The multivariate 
meta-regression confirms this (p = 0.611) with the 
direction of effect now marginally in favour of 
larger effects in the RCTs.
Conclusion from 
EPPI-Centre data
RCTs have statistically significantly smaller effect 
sizes than nRCTs for behavioural outcomes – and 
the indications are that this holds true for attitudes 
and knowledge too. In spite of taking many 
possible confounding factors into account, the 
type of study still explains some differences in the 
observed effect sizes in this data set.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Summary of findings
In two particular cases, trials that are identical in 
all respects except randomisation (constructed 
from resampling randomised and non-randomised 
comparisons from RCT data) led to similar effect 
sizes, but sometimes with greater variance in the 
absence of randomisation. In the field, however, 
effect sizes can differ, yet extensive empirical 
investigations fail to predict the direction of these 
differences or the circumstances in which they 
happen.
We found randomisation to be associated with 
greater equivalence of groups at baseline, explicit 
theoretical underpinning of interventions in one 
data set but not the other, allocation of individuals 
(rather than groups), allocation concealment 
and blinded outcome measurement. We found 
randomisation to be negatively associated with 
reporting of specific collective plans of action to 
achieve the intervention’s goals. We found no 
association between randomisation and individual 
or group interventions, public involvement, 
institutional or community settings, type of 
intervention provider, attrition and quality of 
reporting.
Strengths and weaknesses 
of study methods
This study employed well-established research 
methods both for assessing what is already known 
about randomisation and effect size, and for 
analysing direct and indirect relationships between 
randomisation and effect size.
To assess what was already known, we systematically 
sought and analysed prior studies incorporating 
the strengths of systematic review methodology 
(systematic searches and reviewers working 
independently to analyse each study). Electronic 
searches were limited by the poor indexing of 
methodological studies, and the value of meta-
analyses that included randomised and non-
randomised studies without the explicit aim 
of comparing the two. In these circumstances, 
exhaustive searching was not possible; however, 
systematic electronic searches were complemented 
by approaches to key methodologists in the area 
and by searching the World Wide Web. The 
broad range of methods and contexts of the 
studies identified was a challenge to assessing 
their methodological quality. In the absence of 
clear quality criteria spanning the full range of 
studies, we chose not to rely on their methods and 
findings but to use these to design our own original 
analyses which took into account the strengths and 
weaknesses of earlier work.
We built on this earlier evidence (see Chapters 
4 and 5), and on our understanding of policy 
evaluation (see Chapter 3), to construct tightly 
defined predetermined hypotheses for testing 
with our own data. We hypothesised first that 
randomisation would lead to differences in effect 
size and, second, that these differences might be 
mediated by a number of confounders. We adopted 
two key methods (resampling studies within single 
RCTs and meta-regression within reviews) to 
triangulate the findings of the two approaches. For 
each of these approaches we used two data sets: the 
first being data generated by a trial and systematic 
reviews conducted at the Social Science Research 
Unit, in the UK, where we were very familiar with 
the definitions and their application in earlier 
analyses; and another data set, where we relied 
on other people’s data and their definitions in a 
Canadian trial and international studies reviewed 
by American researchers.
For the resampling studies we chose to limit our 
resampling to comparing groups of data that could 
reasonably be expected to arise from sampling 
decisions in the field, rather than calculating 
numerous effect sizes from resampling thousands 
of times, as Deeks et al.40 had done.
For analysing review data, we overcame 
shortcomings of previous studies and went to 
greater lengths to compare like with like. We 
nested results within original reviews within which 
each study shared a set of desired outcomes. 
This approach minimised differences other 
than randomisation, compared with other meta-
epidemiological studies that relied on a more 
diverse set of studies. The EPPI-Centre data set 
Chapter 9  
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includes a fairly narrow set of study types (RCTs 
and nRCTs), in which the non-randomised studies 
would have employed the same methods if only 
randomisation had been applied. In order to 
compare like with like as much as possible, we did 
not calculate an ‘average’ outcome for each study, 
but used up to four domains of outcomes per study.
Reviews of previous studies have reported analyses 
that relied on different ratios of randomised 
and non-randomised studies. In one study only 
15% of studies were randomised.42 In another, 
the proportion of randomised studies reached 
71%.87 Our EPPI-Centre data study had fairly 
similar numbers (97 RCTs and 79 nRCTs), making 
comparisons of studies easier. Our Colorado data 
set was less balanced, with 16 non-randomised 
studies and 46 randomised or quasi-randomised 
studies of policy interventions.
With this data we conducted a very fine-grained 
analysis, first within reviews, then across reviews to 
thoroughly investigate factors that may confound 
the relationship between randomisation and effect 
size.
Although assumptions about bias and directions of 
bias arising from various sources have been made 
(e.g. theoretical underpinnings of intervention and 
many of the other non-medical hypotheses from 
Chapter 3), according to our research this is the 
first time those assumptions have been empirically 
tested.
Findings from 
different data sets
Using the EPPI-Centre data of health promotion 
evaluations, we found that non-randomised trials 
resulted in larger effect sizes than randomised 
trials (statistically significant for two out of four 
outcomes, and direction of effect the same in the 
other two). In comparison, using the Colorado 
data, randomised trials and studies without control 
groups both resulted in larger effect sizes than non-
randomised trials (statistically significant across 
the pooled outcomes). These differences may be 
explained by differences in the data sets.
The EPPI-Centre data were a rich source of 
controlled before-and-after studies (n = 50) and 
non-randomised trials (n = 23). Many of these 
(n = 47 and n = 20 respectively) were clustered 
studies where the intervention and control were 
allocated to groups rather than individuals, as 
in ‘natural experiments’ of policy interventions. 
Many RCTs (n = 75) were also clustered in classes, 
institutions or communities. The outcome domains 
were matched for comparisons. The design features 
of the included studies, and the opportunity 
to match outcome domains, made this data set 
particularly appropriate for fair comparisons of 
effect sizes with and without randomisation.
In comparison, the Colorado data set included 
fewer studies. These studies were more diverse 
in their designs and had a smaller number of 
RCTs and nRCTs for comparison. There was no 
opportunity to compare matched outcomes, as 
effect sizes were only available for one outcome 
per study. These differences meant there was 
less opportunity to compare like with like. The 
unexpectedly large effect sizes resulting from RCTs 
may be explained by the small size of the studies: 
small studies are more likely to produce spurious 
results, and publication bias leads to greater 
publication of studies with positive findings. 
Another explanation may be the different nature of 
the interventions in this data set. A high proportion 
of the interventions in the Colorado data were 
based on information and communications 
technology (e.g. computers, captioned television, 
�videoconferences). Half of the RCTs evaluated 
computer-based interventions, whereas 
approximately one quarter of the non-randomised 
trials or studies without control groups did the 
same. In summary, the Colorado data set was 
dominated by small-scale computer-based studies, 
and was therefore very different from the natural 
experiments of large-scale policy interventions, or 
comparable randomised evaluations found in the 
EPPI-Centre data.
There was a lack of useable data about ‘blinding’ 
of allocation in either data set. There was very 
little blinding of allocation in randomised or non-
randomised studies in the EPPI-Centre data set: 
such low numbers preclude further investigation. 
The data available in the Colorado data set refer 
to blinding of the participants and not blinding of 
allocation. As blinding can influence effect size,69 
this lack of data is frustrating.
Early in our study we excluded reviews by 
education review groups allied to the EPPI-Centre 
as suitable sources of policy interventions because 
few of these reviews included both randomised and DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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non-randomised studies. On reflection, they may 
have been a poor source of ‘natural experiments’ 
because three of the eight eligible reviews were of 
computer-based interventions.
All in all, the EPPI-Centre data proved much more 
suitable for comparative analysis of randomised 
and non-randomised studies, so we are more 
confident of our conclusions from this data, that 
NRSs of policy interventions inflate effect sizes in 
the field in ways that we cannot fully explain.
Weaknesses in the Colorado data and the excluded 
education reviews mean that our conclusions are 
restricted to health promotion policy, and that we 
have no corroborating evidence from the main 
stream education sector or the social services sector.
Comparison with 
other studies
Our systematic review of empirical comparisons 
(see Chapter 5) of randomised and non-
randomised evaluations of policy interventions 
revealed inconsistent relationships between 
randomisation and effect size: randomisation was 
associated with similar, dissimilar and variable 
effect sizes in different studies. As these studies did 
not aim to explore the causes of these differences, 
they offer little illumination other than to confirm 
that the design of evaluations is important in 
assessing effects of policy interventions.
Even methodological studies which did aim to 
investigate the role of randomisation in assessing 
effects of policy interventions were inconsistent in 
their conclusions (see Chapter 4). Our conclusion 
that RCTs lead to smaller effect sizes than 
nRCTs is supported by investigations of juvenile 
delinquency42,46 and psychological interventions.76 
However, RCTs lead to larger effect sizes of marital 
and family therapy74 and scholastic aptitude test 
coaching, ability grouping in classrooms, pre-
surgical education and drug abuse prevention.72 
As in our own study, these differences could not 
be fully explained by differences in populations, 
interventions or evaluations.
Our study has shown that carefully designed meta-
epidemiological studies can help us to understand 
bias resulting from study design and that they are 
particularly powerful alongside other techniques. 
The re-analyses of data from RCTs shows us what 
a population of randomised and non-randomised 
trials might look like; meta-epidemiology enables 
us to examine actual populations. Without the 
knowledge gained from the re-analyses of trials, 
we would be starting from a weaker reference point 
when exploring whether RCTs and nRCTs have 
different results in the field. Knowing that non-
randomised trials with unbiased control groups do 
not differ in effect size (on the whole) to RCTs, we 
can be sure that any differences observed are due 
either to experimenter bias (arising from the non-
randomisation) or to the different types of study 
being used to evaluate different interventions and/
or different populations and/or different outcomes. 
(The meta-regression was then able to test these 
different possible confounders.)
The results of our re-analyses of trial data come 
to much the same conclusions as Deeks et al.,40 
with both studies finding that the size of effect 
did not differ between study types, as a whole. 
However, Deeks et al. found an increase in variance 
among their nRCTs, whereas we did not find 
any statistically significant difference. This may 
be due to the fact that Deeks et al. constructed 
their comparison groups from different regions 
and cities, while our comparisons were much 
closer, geographically, some being within the 
same London borough. This might lead us 
to recommend that, if a study cannot employ 
randomisation, selecting nearby areas will offer 
a better comparison than, for example, ‘similar’ 
areas in another city. However, this may limit the 
generalisability of the findings. Also, when critically 
appraising nRCTs, the closeness of the comparison 
areas might be something to bear in mind.
Conclusions
Randomisation does not, according to our 
reconstructed RCTs and nRCTs, directly influence 
the effect size of interventions as a whole. Yet, while 
the many examples reviewed and the new analyses 
in the current study reveal that randomisation is 
indeed associated with changes in effect sizes in 
trials of policy interventions, these differences 
can lead to larger effect sizes in some cases and 
smaller ones in others; their direction is difficult to 
predict. Despite extensive analysis testing of many 
predefined hypotheses that might have explained 
this difference, we have failed to identify consistent 
explanations for these differences. We have 
tested the possibility that the type of participants, Discussion
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interventions, selection and measurement of 
outcomes, and evaluation design might account 
for the observed differences, but have not found 
a more consistent predictor of the effect size of 
interventions than whether or not the evaluation 
employed random assignment.
Two possibilities could explain the different 
conclusions arising from the meta-regression 
and our re-analyses of trials. First, our sample of 
nRCTs may be biased, possibly because nRCTs 
are less likely to be published than RCTs when 
results are not ‘exciting’. Second, the nRCTs of 
policy interventions in the field may have larger 
effect sizes because of conscious or unconscious 
experimenter bias when control groups are 
selected: interventions may be allocated to 
enthusiastic institutions. As we are unlikely to come 
to a closer explanation of possible differences than 
this, decision-makers need to treat the results of 
nRCTs with caution. Researchers mounting new 
evaluations need to avoid, wherever possible, 
allocation bias.
Our study identified 45 evaluations of policy 
interventions where institutions were allocated 
randomly to intervention or comparison groups. 
Such RCTs must be the preferred design for 
cautious assessment of effects given the feasibility 
of randomising institutions, and the lower effect 
sizes of randomised studies. Fewer studies allocated 
communities or regions, randomly or not, to 
evaluate the effects of policy interventions.
Recommendations for 
research to evaluate 
the effects of policy 
interventions
1.  Policy evaluations should adopt randomised 
designs wherever possible.
2.  Policy evaluations should also adopt other 
standard procedures for minimising bias and 
conducting high-quality assessment of effects of 
intervention, particularly blinded allocation of 
either individuals or groups, and the avoidance 
of small sample sizes.
3.  Feasibility studies of randomising geographical 
areas, communities and regions should be 
carried out for evaluating policy interventions 
in a range of sectors, implemented within 
interventions, communities and across regions.
4.  Feasibility studies of blinded allocation 
should be carried out for policy interventions 
in a range of sectors, implemented within 
interventions, communities and across regions.
5.  Clear descriptions should be included 
in systematic reviews of how judgements 
of equivalence (or otherwise) have been 
reached when comparing the effects found in 
randomised and non-randomised studies of 
policy interventions.
6.  Research is required into the reasons for 
choosing randomisation or not, particularly 
in the presence and absence of an explicit 
collective plan of action.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Appendix 1  
Complex interventions
F
rom the MRC 2000. A framework for 
development and evaluation of RCTs for 
complex interventions to improve health.
What is a complex intervention?
Complex interventions are built up from a number 
of components, which may act both independently 
and interdependently. The components usually 
include behaviours, parameters of behaviours (e.g. 
frequency, timing) and methods of organising 
and delivering those behaviours [e.g. type(s) of 
practitioner, setting and location]. It is not easy 
to define precisely the ‘active ingredients’ of a 
complex intervention. For example, although 
research suggests that stroke units work, what, 
exactly, is a stroke unit? What are the active 
ingredients that make it work? The physical 
setup? The mix of care providers? The skills of 
the providers? The technologies available? The 
organisational arrangements?
Health services have to evaluate a wide array of 
existing and newly proposed complex packages, 
so that the service can learn what is effective about 
any given intervention so that it can be more widely 
applied throughout the service. Some complex 
interventions are intended as improvements in 
the form of direct interventions at the level of 
individual patient care; for example, a novel form of 
cognitive behavioural therapy. Other interventions, 
although ultimately intended to improve patient 
care, are actually delivered in the form of an 
organisational or service modification; for example, 
the introduction of a physiotherapist or Parkinson’s 
disease nurse into primary care services. A third 
type of complex intervention is further removed 
again from individual patient care, although 
ultimately intended just as much to impact there, 
when an intervention is targeted on the health 
professional; for example, educational interventions 
in the form of treatment guidelines, protocols or 
decision-aids. Finally, many complex interventions 
are delivered at a population level; for example, in 
the form of media-delivered health promotion 
campaigns.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Effectiveness of interventions 
in the workplace: a review
This systematic review aimed to evaluate the 
potential for using the workplace as a setting for 
improving adult health.152 This was seen as an 
important potential argument owing to the large 
number of people it would be possible to access, 
the probable high levels of participations and peer 
support, and the likely low level of attrition.
Most studies identified were targeted at 
individuals with varying degrees of environmental 
modification. No clear evidence of effectiveness was 
found for type of intervention, topic of intervention 
or interventions delivered by a particular category 
of people. Trends of effectiveness were found 
for comprehensive programmes that combined 
screening and risk assessment with a range of 
education programmes, and/or environmental 
changes. However, these were found in few 
studies, so replicability cannot be relied upon. 
Least effective were the weight-loss programmes 
combining education and financial incentives. No 
conclusive evidence was found for the effectiveness 
of peer support.
Due to the general low level of methodological 
evaluation, data supporting workplace site 
interventions are not definitive. However, 
suggestions were made for future research. These 
included the suggestion that employees should 
be involved at all levels in the planning and 
implementation of the activity, the intervention 
should be supported by top management should 
be tailor-made to the characteristics of the group. 
Finally, the quality of reporting should be higher; 
evaluation in particular should be included in the 
interventions and a range of outcome measures 
should be included.
A review of the effectiveness 
and appropriateness of peer-
delivered health promotion 
interventions for young people
This systematic review synthesised evidence 
to examine the claim that the peer-delivered 
approach is a more appropriate an effective 
method of promoting young people’s health (aged 
11–24 years) than more traditional approaches.153
The most common focus for the outcome 
evaluations was drugs (including alcohol and 
smoking), and for the process evaluations it was 
sexual health. Of the methodologically sound 
interventions most found clear effectiveness for 
behavioural outcomes. Studies comparing peers 
and teachers found equivocal results with regard to 
effectiveness.
Overall, the review found some evidence to 
support the effectiveness of peer-delivered health 
promotion for young people. More than half of the 
sound studies showed a positive effect at least on 
behavioural outcome. However, this may be in part 
because of the scarcity of sounds studies, and lack 
of good reporting. This report does not encourage 
peer-delivered health promotion, because there 
is relatively little sound evidence to support this 
intuitively appealing idea.
Some suggestions made for future research 
included implementing health promotion on the 
basis of a thorough assessment of both self-defined 
health needs and young people’s views on what 
would be most effective.
Interventions for encouraging 
sexual lifestyles and 
behaviours intended to 
prevent cervical cancer
This review aimed to determine the effectiveness of 
health education interventions to promote sexual 
risk reduction behaviours among women in order 
to reduce transmission of human papillomavirus.154 
Studies were included if they evaluated educational 
interventions targeting women only, and measured 
the impact on either behavioural or clinical 
outcomes. This was the first review to address 
cervical cancer prevention in terms of sexual 
behaviour risk reduction.
All of these included outcome evaluations had the 
primary aim of preventing HIV and other sexually 
transmitted diseases rather than preventing 
cervical cancer. Each of the methodologically sound 
studies showed a statistically significant positive 
effect on sexual risk reduction, typically with 
increased use of condoms for vaginal intercourse. 
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This positive effect was found to be sustained up to 
3 months after intervention.
The review drew the following conclusions: that 
educational interventions targeting socially and 
economically disadvantaged women including 
sexual negotiation skill development encouraged 
at least short-term sexual risk reduction behaviour. 
This has the potential to reduce the transmission of 
human papillomavirus and thus possibly reduce the 
incidence of cervical carcinoma. Health education 
interventions in which factual information was 
presented alongside skill development and 
motivation building was found to achieve short-
term increases in reported condom use for vaginal 
intercourse.
Suggestions for further research included the need 
for greater attention to gender and culture issues, 
for interventions need to be sensitive to local 
culture and context in order to enable women to 
identify with the health education messages, and 
that interventions that address power imbalances 
in relationships are essential for successful 
implementation. It was also suggested that longer 
term interventions may show greater effects.
Young people and mental health: 
a systematic review of research 
on barriers and facilitators
This systematic review aimed to synthesise evidence 
on barriers and facilitators of good mental health 
in young people (aged 11–21 years).155 A search of 
systematic reviews was carried out. The findings 
from this suggested that interventions to promote 
self-esteem, and those to prevent suicide, were 
limited in their effectiveness. Some effective 
interventions were those that addressed young 
people’s concerns about teachers, parental divorce, 
bereavement and peer rejection.
The in-depth review of outcome evaluations also 
revealed limited effects for the promotion of self-
esteem. Interventions targeting depression also 
showed no long-term effects, despite some short-
term increases in knowledge about symptoms. 
The in-depth review of young people’s views 
revealed some unexpected findings: that mental 
health tended to be equated with mental illness 
and thus not be relevant to the respondents; that 
young people had surprisingly sophisticated 
understandings of coping strategies and had wide 
concerns about mental health. The findings also 
suggested how irrelevant many health promotion 
materials are to young people’s worries.
The synthesis found some major gaps in the 
research, including interventions that address 
young people’s concerns about workload, academic 
achievement, future unemployment, violence and 
bullying, and physical appearance (among others). 
These were suggested as possible future directions 
for research.
Young people and physical 
activity: a systematic 
review of research on 
barriers and facilitators
This systematic review aimed to synthesise the 
evidence assessing barriers to and facilitators of 
physical activity among young people (aged 11–16 
years), especially those pertaining to socially 
excluded groups.28 This was deemed an important 
subpopulation as particularly low levels of physical 
activity, which have been linked with other health-
damaging behaviours, are found within this group.
The in-depth review, following a wide mapping 
stage, comprised 12 outcome evaluations 
which assessed the effect on health behaviour 
of interventions aimed at a community/society 
level. Most were delivered in a school or other 
educational setting by teachers.
A review of views’ studies was also conducted. Some 
important barriers to physical activity identified 
were those related to the self and other people 
(e.g. incompetence, self-consciousness), practical 
and material resources/circumstances such as 
lack of money, and the school (negative physical 
education teachers). Facilitators identified included 
activity being good for losing weight, and parental 
support. Many suggestions were made about how 
to increase levels of activity by young people, like 
making activities more affordable and emphasising 
their ‘fun’ side.
These views and a cross-studies synthesis identified 
many matches between concerns and evaluations. 
A need was identified for greater concentration 
on non-traditional activities, such as aerobics, and 
evaluations specifically targeting young women.
Young people and healthy eating: 
a systematic review of research 
on barriers and facilitators
This systematic review aimed to synthesise 
the evidence from outcome evaluations of 
interventions, and from the views of young people 
(aged 11–21 years) to inform readers on barriers to 
and facilitators of healthy eating.27DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Most evaluated interventions were carried out 
in school, so potentially a large proportion of 
socially excluded young people were missed. This 
subpopulation was specifically addressed by less 
than a quarter of identified studies.
The in-depth review focused on interventions 
aiming to make a change at a community or society 
level. Most were based in primary or secondary 
school settings and were delivered by teachers. 
Some school-based settings were found to be 
effective at increasing knowledge and improving 
health behaviour.
The views’ study identified the following barriers 
to healthy eating: costs and wide availability of/
preference for fast food. Facilitators were given 
as a reduction in costs of healthy food, better 
availability of healthy food and family support, 
among others.
Most of the gaps identified in the research by the 
synthesis were found to have been addressed. 
However, a need for better nutrition information 
was suggested, and in general more rigorous 
research in this area is needed.
Children and physical activity: 
a systematic review of 
barriers and facilitators
This systematic review aimed to describe the 
number, types and quality attributes of existing 
research studies on the barriers to and facilitators 
of physical activity among children aged 4–10 
years.156 Both a views’ study and an evaluation of 
relevant interventions were carried out.
The interventions investigated were extremely 
diverse, making it difficult to assess patterns of 
effectiveness. Most were school-based, all involved 
parents to varying degrees, but some aimed to 
tackle sedentary behaviour, and others to increase 
participation in physical activity.
Studies on children’s views about physical activity 
were scarce. The five that were found focused on 
barriers to physical activity for children. Twenty 
distinct barriers were identified, which followed 
three main themes: preferences and priorities 
(e.g. a preference for doing other things), family 
life and parental support, and restricted access 
to opportunities for participation. Fourteen 
facilitators to physical activity were also identified, 
which clustered around the following themes: 
aspects of physical activity that children value, 
family life and parental support, and greater 
access to opportunities for participating in physical 
activity.
The synthesis found that few health promotion 
evaluations targeted physical activity outside the 
physical education lesson, and that children’s views 
rarely informed the development of interventions. 
These were identified as possible directions for 
future research.
Children and healthy eating: 
a systematic review of 
barriers and facilitators
This systematic review aimed to find out what 
was known about barriers to and facilitators of 
healthy eating in children aged 4–10 years.94 The 
review was the first systematic review to rigorously 
integrate the findings from a meta-analysis with a 
qualitative systematic review.
The in-depth review focused on the barriers to 
and facilitators of children’s consumption of fruit 
and vegetables. Studies that measured fruit and 
vegetable outcomes were included, as were those 
studies that examined children’s own perspectives 
on food and eating.
A substantial amount of research was identified. 
The relevant outcome evaluations were largely 
school-based, and often combined learning about 
the health benefits of fruit and vegetables with 
hands-on experience. Some interventions also 
included types of environmental modification, and 
some targeted multiple outcomes (for instance, 
body mass index, knowledge, fat intake, physical 
activity.) These types of interventions were found 
to have a small but significant positive effect. The 
larger effect sizes were associated with targeted 
interventions for parents with risk factors for 
cardiovascular disease, and with those that focused 
purely on trying to increase fruit and vegetable 
increase, rather than ‘diluting’ the effect by 
promoting, for example, physical activity.
The main messages from this section were that 
promoting health eating can be an integral 
part of a school curriculum, and that effective 
implementation requires skill, time and support 
from a wide range of people.
The views’ studies comprised eight studies 
involving children aged 5–11 years and their 
mothers. From these analyses, the following 
issues were identified: children do not see it as 
their role to be interested in health; children do 
not see health-related messages as relevant or Appendix 2
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credible; children understand fruit, vegetables 
and confectionary very differently; children 
want to exercise choice over their food, eating is 
valued as a social occasion, and children note the 
distinction between advice proffered and observed 
adult behaviour. The synthesis of views and 
outcome evaluations revealed that opportunities 
for developing interventions to increase children’s 
consumption of fruit and vegetables included 
branding fruit and vegetables as tasty, rather than 
healthy, and making health messages credible for 
children.
Suggestions for further research included the need 
to target interventions towards socially excluded 
groups and reducing health inequality in general.
HIV health promotion and 
men who have sex with men: a 
systematic review of research 
relevant to the development and 
implementation of effective and 
appropriate interventions
This review aims to systematically pull together 
findings from studies of MSM’s views and integrate 
them with findings from effectiveness studies.157 
The views’ studies focused especially on young men 
(aged 16–25 years), men who sell sex to other men 
and HIV-positive men. The outcome evaluations 
all had a comparison or control group, discussed 
interventions delivered during or after 1996 and 
measured as the outcome of most importance sero-
discordant or unknown status unprotected anal 
intercourse (sdUAI).
The meta-analysis of the outcome evaluations 
suggested that counselling or workshops based on 
cognitive–behavioural techniques for MSM at high 
risk appear to be more effective at reducing the 
number of men reporting sdUAI than standard 
counselling. However, this effect was only found 
where men were recruited from clinic attendance 
lists, as opposed to adverts or outreach. The 
narrative synthesis found no evidence for any effect 
of interventions targeting sdUAI, although none 
of the evaluations reported knowledge/awareness/
attitudes at sufficient quality to be able to assess 
these effects. Peer-delivered community-based 
interventions appeared to have no effect on sdUAI.
Suggestions for future research included 
supporting future interventions such as counselling 
based on cognitive–behavioural techniques, and 
that further rigorously conducted and reported 
primary and secondary research was required on 
views of all groups of MSM.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Literature search to identify 
methodological studies 
comparing RCTs with nRCTs 
beyond health (see Chapter 4)
It was felt that, although the research team had an 
extensive knowledge of the existing methodological 
literature comparing the results of RCTs with 
nRCTs in health, not enough was known about 
similar methodological studies in the non-health 
field (social care, education, criminal justice, 
housing, etc.). An attempt was therefore made 
to search non-health databases to identify this 
methodological literature.
Database searches
Although the searches appeared to be fairly 
straightforward methodological research 
comparing two types of study design, a number of 
problems were encountered.
In the first instance, searching by study design 
is problematic. Indexing of RCTs in MEDLINE 
by publication type and medical subject heading 
has improved in recent years, allowing for more 
accurate searching, but there is still room for 
improvement. Searching for NRSs is more difficult. 
There are many study designs that could be classed 
as non-randomised, and there is as yet little 
definitive terminology. It is difficult for the indexer 
to be sure what type of study design has been used, 
and so comprehensive and consistent indexing 
according to study design is lacking. These 
complications are a major issue in MEDLINE; 
databases beyond MEDLINE often have poorer 
indexing by study design. These problems of 
definition and indexing become more pronounced 
in databases that are non-health related. As well 
as poor indexing, there is rarely a thesaurus of 
keyword terms included, the records often lack 
an abstract, and a number of databases have only 
rudimentary search capabilities.
Initial attempts at searching for a combination 
of terms (indexed and free-text) for RCT with 
nRCT proved unsuccessful. The number of records 
retrieved was unwieldy, and the percentage of 
useful studies within these results was very small. 
A third search facet was introduced for ‘outcomes’ 
(bias, effect size, overestimated results, etc.) in an 
attempt to refine the strategy. This helped a little 
but not significantly.
The final search strategy used few terms for RCT 
(and did not include broader terms for ‘study 
design/methodology’), reduced the non-random 
terms by rejecting actual study design types 
(observational, longitudinal, cohort study, cross-
sectional, case series, etc.) and used simply ‘non-
random’ and equivalent terms (non-experimental, 
pseudorandom, semi-random, etc.) alongside a 
precise ‘outcomes’ facet, where fewer search terms 
were used or aligned using restrictive proximity 
operators.
It was decided that a more sensitive search 
using ‘non-random’ study design names, and 
broader terms for research design should also be 
completed. This set of results could be referred to 
in the event that little of relevance was identified in 
the precise search results.
The following databases were searched:
•  ASSIA
•  AEI
•  BEI
•  CareData
•  Dissertation Abstracts
•  EconLIT
•  ERIC
•  IBSS
•  ISI Proceedings: Social Sciences and 
Humanities
•  PAIS International
•  PsycINFO
•  SIGLE
•  SSCI
•  Sociological Abstracts
Additional searches
Citation searching was undertaken in SSCI for 
authors known to the research team. Internet 
searches were also undertaken. It was expected 
that there would be more success looking at 
potentially relevant sites associated with research 
methodology and prominent sites in the non-
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health area. In most cases any procedural guides 
identified referred to broader analysis of research, 
recommending the type of research design to 
be used, and debating whether or not to use 
randomisation. The public catalogues of the British 
Library and the Library of Congress were searched 
briefly. Finally, a search of the Internet using 
general search engines (Copernic and Google) and 
the information gateway (SOSIG; Social Science 
Information Gateway) was undertaken. These 
searches were fairly restricted, as any attempt at 
combining RCT terms with nRCT terms inevitably 
found health- and clinical-related sites and studies.
Literature search to identify 
systematic reviews with RCTs 
and nRCTs in the non-health-
care setting (see Chapter 5)
It was decided that it would be easier to retrieve 
all of the references available on review specific 
databases rather than attempt any searches for 
reviews with both RCTs and nRCTs included. All 
of the reviews available on the following databases 
were obtained: DARE, CDSR, DoPHER and 
the Health Development Agency Evidence Base 
database.
There are probably even less definitive terms 
available for ‘systematic reviews’ or equivalent 
in the non-health literature than there are for 
trial designs. Ideally, to ensure that the searches 
retrieved relevant references, the strategy would 
have included terms for ‘review’ or at least for 
‘literature review’. However, attempts at searching 
using these terms produced an unmanageable 
number of references.
A number of test searches were completed in 
broader non-health databases to estimate the 
feasibility of attempting a comprehensive search 
of the non-health literature for systematic reviews. 
The searches were restricted to specific terms 
for ‘systematic review’, without using proximity 
operators, and were further restricted by date 
range (2003–4).
The following free-text terms and indexed 
keywords (if available) were used: meta analysis, 
metaanalysis, systematic review, systematic 
overview, collaborative review, integrative research, 
integrative review, research integration, narrative 
synthesis, evaluation synthesis, meta synthesis, 
realist synthesis, descriptive synthesis, explanatory 
synthesis, pool data.
The following databases were searched:
•  ASSIA
•  BEI
•  CareData
•  ERIC
•  HDA HealthPromis
•  PAIS International
•  SIGLE
•  SSCI
•  Sociological Abstracts
The results of the test searches confirmed that it 
would not be worthwhile conducting thorough, 
comprehensive searches of non-health databases 
for systematic reviews.
Searches
The databases searched are listed below with 
the dates searched and the number of records 
retrieved. The search strategies used in ASSIA have 
been listed in full. Full details of the other search 
strategies used are available from the Centre for 
Reviews and Dissemination at the University of 
York.
Methodological studies 
(see Chapter 4)
Precise methodological searches
ASSIA: Cambridge Scientific Abstracts 
(CSA). 1987–2004. 28 June 2004
The ASSIA search covered the date range 1987–
2004. The search identified 96 records.
((KW = (experiment* group*) or (true 
experiment*) or (experiment* study) or 
(experiment* trial*) or (experiment* control*) or 
(random* or RCT* or GRT*) or DE = (randomized 
controlled trials)) and ((KW = (non-experiment* or 
quasiexperiment* or quasi-experiment*) or (quasi-
random* or quasirandom* or nonexperiment*) or 
(quasi-random* or semi-random* or semirandom*) 
or (non-random* or nonrandom* or pseudo-
random)) and ((KW = (error* or confound*) 
or (overexaggerate* or validity or variable*) or 
(inaccurate or inaccuracy or exaggerate*) or 
(reliable or reliability or accuracy) or (disparity 
or discrepanc* or accurate) or (overestimate* 
or underestimate* or deviat*) or (outcome* 
or compar* or estimat*) or (bias* or size* or 
reliability))DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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AEI: Dialog. 1976–2004/3. 29 June 2004
The AEI search covered the date range 1976 to 
March 2004. The search identified six records.
BEI: Dialog. 1976–2004/3. 29 June 2004
The BEI search covered the date range 1976 to 
March 2004. The search identified 33 records.
CareData. Internet. 2 July 2004
www.elsc.org.uk/caredata/caredata.htm
CareData produced 25 unique records. The search 
interface available for CareData does not allow 
for sophisticated search strategies. A first attempt 
to search using the keyword ‘Research methods’ 
identified over 1500 references. A second attempt 
to combine terms and search in the abstract field 
only retrieved eight references. Finally, a search 
for ‘random*’ was undertaken in the abstract field 
and the resultant 469 references browsed for any of 
potential usefulness.
Dissertation Abstracts. Internet. 
2002–4. 2 July 2004
wwwlib.global.umi.com/dissertations/
Dissertation Abstracts was searched using simple 
phrase searches for ‘random’ and ‘non-random’ 
and identified no records.
EconLIT: Ovid WebSPIRS. 
1969–2004/5. 2 July 2004
The EconLIT search covered the date range 1969 
to May 2004. The search identified seven records.
ERIC: Dialog. 1966–
2004/3. 28 June 2004
The ERIC search covered the date range 1966 to 
March 2004. The search identified 93 records.
IBSS: BIDS. 1951–2004. 2 July 2004
The IBSS search covered the date range 1951–
2004. The search identified 13 records.
ISI Proceedings: Social Sciences and 
Humanities. ISI Web of Knowledge. 
1990–2004/6. 30 June 2004
The Social Sciences and Humanities Proceedings 
search covered the date range 1990 to June 2004. 
The search identified 48 records.
PAIS International: Ovid WebSPIRS. 
1972–2004/4. 2 July 2004
The PAIS search covered the date range 1972 to 
April 2004. The search identified one record.
PsycINFO: BIDS. Internet. 
1872–2004/6. 30 June 2004
The PsycINFO search covered the date range 1872 
to June 2004. The search identified 33 records.
SIGLE: Ovid WebSPIRS. 
1980–2003/12. 2 July 2004
The SIGLE search covered the date range 1980–
2003. Zero records were identified.
SSCI: Web of Science. 1981–
2004/6. 29 June 2004
The SSCI search covered the date range 1981 to 
June 2004. The search identified 107 records.
Sociological Abstracts: WebSPIRS. 
1963–2004/6. 2 July 2004
The Sociological Abstracts search covered the date 
range 1963 to June 2004. The search identified 99 
records.
Sensitive methodological searches
The sensitive searches sometimes used two 
strategies separately. This enabled the use of more 
nRCT terms in one strategy, and the broader 
‘research design’ terms in combination with a more 
precise ‘outcomes’ facet.
ASSIA: CSA. 1987–2004. 5 July 2004
The ASSIA searches covered the date range 1987–
2004. The searches identified 371 records. Two 
search strategies were devised: one used broader 
terms for nRCTs and combined the RCT, nRCT 
and outcomes facets; the second strategy combined 
‘research design’ terms with a more precise 
‘outcomes’ facet. The results were then combined 
and duplicate records removed.
((KW = (study design*) or (study type*) or (study 
method*) or (trial* design*) or (trial* type*) or 
(trial* method*) or (experiment* design*) or 
(experiment* type*) or (experiment* method*) or 
(research design*) or (research type*) or (research 
method*)) and ((KW = (validity within 2 efficac*) 
or (validity within 2 size*) or (validity within 2 
therap*) or (validity within 2 benefit*) or (validity 
within 2 effect*) or (validity within 2 impact*) or 
(validity within 2 outcome*) or (validity within 
2 treatment*) or (validity within 2 finding*) or 
(validity within 2 evidence*) or (validity within 
2 harm*) or (validity within 2 bias*) or (validity 
within 2 error*) or (validity within 2 result*) or 
(compar* within 2 efficac*) or (compar* within 2 
size*) or (compar* within 2 therap*) or (compar* 
within 2 benefit*) orAppendix 3
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(compar* within 2 effect*) or (compar* within 
2 impact*) or (compar* within 2 outcome*) or 
(compar* within 2 treatment*) or (compar* within 
2 finding*) or (compar* within 2 evidence*) or 
(compar* within 2 harm*) or (evaluat* within 2 
efficac*) or (evaluat* within 2 size*) or (evaluat* 
within 2 therap*) or (evaluat* within 2 benefit*) 
or (evaluat* within 2 effect*) or (evaluat* within 
2 impact*) or (evaluat* within 2 outcome*) or 
(evaluat* within 2 treatment*) or (evaluat* within 
2 finding*) or (evaluat* within 2 evidence*) or 
(evaluat* within 2 harm*) or (evaluat* within 2 
bias*) or (evaluat* within 2 error*) or (evaluat* 
within 2 result*) or (exaggerate* within 2 efficac*) 
or (exaggerate* within 2 size*) or (exaggerate* 
within 2 therap*) or (exaggerate* within 2 
benefit*) or (exaggerate* within 2 effect*) or 
(exaggerate* within 2 impact*) or (exaggerate* 
within 2 outcome*) or (exaggerate* within 2 
treatment*) or (exaggerate* within 2 finding*) or 
(exaggerate* within 2 evidence*) or (exaggerate* 
within 2 harm*) or (inaccura* within 2 efficac*) 
or (inaccura* within 2 size*) or (inaccura* within 
2 impact*) or (inaccura* within 2 outcome*) or 
(inaccura* within 2 treatment*) or (inaccura* 
within 2 finding*) or (inaccura* within 2 evidence*) 
or (inaccura* within 2 harm*) or (inaccura* within 
2 bias*) or (inaccura* within 2 error*) or (inaccura* 
within 2 result*) or (accura* within 2 finding*) 
or (accura* within 2 evidence*) or (accura* 
within 2 harm*) or (accura* within 2 efficac*) 
or (accura* within 2 size*) or (accura* within 2 
therap*) or (accura* within 2 benefit*) or (accura* 
within 2 effect*) or (accura* within 2 impact*) or 
(accura* within 2 outcome*) or (accura* within 2 
treatment*) or (accura* within 2 bias*) or (accura* 
within 2 error*) or (accura* within 2 result*) or 
(reliab* within 2 efficac*) or (reliab* within 2 size*) 
or (reliab* within 2 therap*) or (reliab* within 2 
benefit*) or (reliab* within 2 effect*) or (reliab* 
within 2 impact*) or (reliab* within 2 outcome*) 
or (reliab* within 2 treatment*) or (reliab* within 
2 finding*) or (reliab* within 2 evidence*) or 
(reliab* within 2 harm*) or (reliab* within 2 bias*) 
or (reliab* within 2 error*) or (reliab* within 
2 result*) or (difference* within 2 efficac*) or 
(difference* within 2 size*) or (difference* within 
2 therap*) or (difference* within 2 benefit*) or 
(difference* within 2 effect*) or (difference* within 
2 impact*) or (difference* within 2 outcome*) or 
(difference* within 2 treatment*) or (difference* 
within 2 finding*) or (difference* within 2 
evidence*) or (difference* within 2 harm*) or 
(difference* within 2 bias*) or (difference* within 
2 error*) or (difference* within 2 result*) or 
(underestimate* within 2 efficac* within 2 therap* 
within 2 impact* within 2 finding* within 2 bias*) 
or (underestimate* within 2 size* within 2 benefit* 
within 2 outcome* within 2 evidence* within 2 
error*) or (* within 2 effect* within 2 treatment* 
within 2 harm* within 2 result*) or (underestimate* 
within 2 therap* within 2 impact* within 2 finding* 
within 2 bias*) or (underestimate* within 2 benefit* 
within 2 outcome* within 2 evidence* within 2 
error*) or (underestimate* within 2 effect* within 
2 treatment* within 2 harm* within 2 result*) 
or (underestimate* within 2 impact* within 2 
finding* within 2 bias*) or (underestimate* within 
2 outcome* within 2 evidence* within 2 error*) 
or (underestimate* within 2 treatment* within 2 
harm* within 2 result*) or (underestimate* within 2 
finding* within 2 bias*) or (underestimate* within 
2 evidence* within 2 error*) or (underestimate* 
within 2 harm* within 2 result*) or (underestimate* 
within 2 bias*) or (underestimate* within 2 
error*) or (underestimate* within 2 result*) or 
(overestimate* within 2 efficac* within 2 therap* 
within 2 impact*) or (overestimate* within 2 size* 
within 2 benefit* within 2 outcome* within 2 
evidence* within 2 error*) or (overestimate* within 
2 therap* within 2 impact*) or (overestimate* 
within 2 benefit* within 2 outcome* within 2 
evidence* within 2 error*) or (overestimate* within 
2 effect* within 2 treatment* within 2 harm* within 
2 result*) or (overestimate* within 2 impact*) 
or (overestimate* within 2 outcome* within 2 
evidence* within 2 error*) or (overestimate* 
within 2 treatment* within 2 harm* within 2 
result*) or (overestimate* within 2 finding*) or 
(overestimate* within 2 evidence* within 2 error*) 
or (overestimate* within 2 harm* within 2 result*) 
or (overestimate* within 2 bias*) or (overestimate* 
within 2 error*) or (overestimate* within 2 result*) 
or (estimate* within 2 bias*) or (estimate* within 
2 error*) or (compar* within 2 random*) or 
(estimate* within 2 result*) or (estimate* within 
2 finding*) or (estimate* within 2 evidence*) or 
(estimate* within 2 harm*) or (estimate* within 
2 impact*) or (estimate* within 2 outcome*) or 
(estimate* within 2 treatment*) or (estimate* within 
2 therap*) or (estimate* within 2 benefit*) or 
(estimate* within 2 effect*) or (estimate* within 2 
efficac*) or (estimate* within 2 size*))
((KW = (true experiment*) or (random* or 
RCT* or GRT*) or DE = (randomized controlled 
trials)) and ((KW = (matched pair*) or (paired 
comparison) or (single case) or (single-case) or 
(time series) or time-series) or (cross sectional) or 
(cross-sectional) or (cross over*) or (cross-over*) DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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or (case stud*) or (case-stud*) or (case control*) 
or (case-control*) or (historic* control*) or 
(retrospective or prospective) or (observational 
or cohort or longitudinal) or (pre post) or (pre-
post) or (prepost) or (post test) or (post-test) or 
(posttest) or (pre test) or (pre-test) or (pretest) 
or (natural experiment*) or (quasi experiment*) 
or (quasi-experiment*) or (quasiexperiment*) 
or (non experiment*) or (non-experiment*) or 
(nonexperiment*) or (without within 3 random*) 
or (pseudo random*) or (pseudo-random*) or 
(pseudorandom*) or (semi random*) or (semi-
random*) or (semirandom*) or (quasi random*) 
or (quasi-random*) or (quasirandom*) or (non 
random*) or (non-random*) or (nonrandom*) 
or DE = (cross-sectional studies) or (retrospective 
studies) or (case studies) or (case controlled 
studies) or (historical analysis) or (prospective 
controlled trials) or (observational research) 
or (cohort analysis) or (longitudinal studies)) 
and ((KW = confound* or (treatment within 2 
effect*) or (treatment within 2 estimate*) or 
(treatment within 2 size*) or (variable*) or (sample 
size*) or (statistically significan*) or (error* or 
(measurement*) or (validity) or (exaggerate*) or 
(overexaggerate*) or (accuracy) or (inaccurate) 
or (inaccuracy) or (reliability) or (reliable) or 
(accurate) or (discrepanc*) or (disparity) or 
(deviat*) or (underestimate*) or (estimate*) or 
(difference*) or (characteristic*) or (estimate*) or 
(overestimate*) or (compar* within 3 evidence) or 
(compar* within 3 effect*) or (bias*) or (outcome*) 
or (effect* size*) or DE = (confounding factors) or 
(outcomes) or (estimates) or (bias) or (effect size) or 
(reliability))
AEI: Dialog. 1976–2004/3. 5 July 2004
The AEI searches covered the date range 1976 to 
March 2004. The search identified 69 records.
BEI: Dialog. 1976–2004/3. 5 July 2004
The BEI search covered the date range 1976 to 
March 2004. The search identified 73 records. The 
original ‘precise’ search strategy for BEI was quite 
sensitive, and so only the ‘research design’ strategy 
was required for the ‘sensitive’ searches.
CareData. Internet. 5 July 2004
www.elsc.org.uk/caredata/caredata.htm
The original ‘precise’ search of CareData involved 
a simple sensitive single word search, and so a 
further ‘sensitive’ search was not required.
Dissertation Abstracts. Internet. 
2002–4. 5 July 2004
wwwlib.global.umi.com/dissertations/
The original ‘precise’ search of Dissertation 
Abstracts involved a simple sensitive single word 
search, and so a further ‘sensitive’ search was not 
required.
EconLIT: Ovid WebSPIRS. 
1969–2004/5. 5 July 2004
The EconLIT search covered the date range 1969 
to May 2004. The search identified 99 records.
ERIC: Dialog. 1966–2004/3. 5 July 2004
The ERIC search covered the date range 1966 to 
March 2004. The search identified 1507 records.
IBSS: BIDS. 1951–2004. 5 July 2004
The IBSS searches covered the date range 1951–
2004. The search identified 263 records.
ISI Proceedings: Social Sciences and 
Humanities. ISI Web of Knowledge. 
1990–2004/6. 5th July 2004
The Social Sciences and Humanities Proceedings 
searches covered the date range 1990 to June 2004. 
The search identified 462 records.
PAIS International: Ovid WebSPIRS. 
1972–2004/4. 5 July 2004
The PAIS search covered the date range 1972 to 
April 2004. The search identified seven records.
PsycINFO: BIDS. 1872–
2004/6. 5 July 2004
The PsycINFO search covered the date range 1872 
to June 2004. The search identified 1661 records.
SIGLE: Ovid WebSPIRS. 
1980–2003/12. 5 July 2004
The SIGLE search covered the date range 1980 to 
December 2003. The search identified 16 records.
SSCI: Web of Science. 1981–
2004/6. 5 July 2004.
The SSCI search covered the date range 1981 to 
June 2004. The search identified 181 records.
Sociological Abstracts: WebSPIRS. 
1963–2004/6. 5 July 2004.
The Sociological Abstracts search covered the date 
range 1963 to June 2004. The search identified 
231 records.Appendix 3
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Internet searches
The following internet sites were searched.
electronic Library for 
Social Care (eLSC)
7 July 2004.
www.elsc.org.uk/
Social Care Institute for 
Excellence (SCIE)
7 July 2004.
www.scie.org.uk/
Centre for Evidence-
Based Social Services
University of Exeter. 7 July 2004.
www.ex.ac.uk/cebss/
SOSIG
7 July 2004.
www.sosig.ac.uk/
Regard. Economic and Social 
Research Council (ESRC)
7 July 2004.
www.regard.ac.uk/regard/home/index_html?
The Campbell Collaboration
7 July 2004.
www.campbellcollaboration.org/
British Library Public Catalogue
7 July 2004.
blpc.bl.uk/
Library of Congress Online Catalog
7 July 2004.
www.loc.gov/
Copernic (meta-search engine)
7 July 2004.
www.copernic.com
Google (general search engine)
7 July 2004.
www.google.com/
Systematic review test 
searches (see Chapter 5)
ASSIA: CSA. 2003–2004. 20 July 2004
The ASSIA search covered the date range 2003–4. 
The precise search without ‘literature review’ 
identified 303 records. With ‘literature review’ the 
search identified 4387. (Without date limits the 
precise search identified 1885.)
(Pool* data) or (Realist synth*) or (Descriptive 
synth*) or (Explanatory synth*) or (Narrative 
synth*) or (Evaluation synth*) or (Meta synth*) or 
(Integrative research) or (Integrative review*) or 
(Research integration) or (Collaborative review*) 
or (Collaborative review*) or (Systematic review*) 
or (Systematic overview*) or (Meta analy*) or 
Metaanly* or Metanaly* or KW = ((systematic 
reviews) or (meta analysis))
BEI: Dialog. 2003–4/3. 20 July 2004
The BEI search covered the date range 2003 to 
March 2004. The precise search without ‘literature 
review’ identified 10 records. With ‘literature 
review’ added the search identified 85. (Without 
date limits the precise search identified 54.)
CareData. Internet. 20 July 2004
www.elsc.org.uk/caredata/caredata.htm
The CareData search covered the date range 2003 
to March 2004. The searches were conducted 
using the ‘abstract’ field option. The precise search 
without ‘literature review’ identified 44 records. 
With ‘literature review’ added the search identified 
330. (Without date limits the precise search 
identified 120.)
ERIC: Dialog. 2003–2004/3. 20 July 2004
The ERIC search covered the date range 2003 to 
March 2004. The precise search without ‘literature 
review’ identified 57 records. With ‘literature 
review’ added the search identified 21,288. 
(Without date limits the precise search identified 
2214.)
PAIS International: Ovid WebSPIRS. 
2003–2004/4. 20 July 2004
The PAIS search covered the date range 2003 to 
April 2004. The precise search without ‘literature 
review’ identified one record. With ‘literature 
review’ added the search identified 158. (Without 
date limits the precise search identified 55.)
SIGLE: Ovid WebSPIRS. 2003–
2003/12. 20th July 2004
The SIGLE search covered the date range 2003 
to December 2003. The precise search without 
‘literature review’ identified 15 records. With 
‘literature review’ added the search identified 843. 
(Without date limits the precise search identified 
281.)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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SSCI: Web of Science. 2003–
2004/6. 20th July 2004
The SSCI search covered the date range 2003 to 
June 2004. The precise search without ‘literature 
review’ identified 2032 records. With ‘literature 
review’ added the search identified 12,566. 
(Without date limits the precise search identified 
9725.)
Sociological Abstracts: WebSPIRS. 
2003–2004/6. 20th July 2004
The Sociological Abstracts search covered the 
date range 2003 to June 2004. The precise search 
without ‘literature review’ identified 32 records. 
With ‘literature review’ added the search identified 
5939. (Without date limits the precise search 
identified 521.)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Data for systematic review of 
systematic reviews (see Chapter 5)Appendix 4
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Cambach, 
199998
Policy for an 
institution
Policy for a 
community
Pulmonary 
rehabilitation in patients 
with asthma and 
chronic obstructive 
pulmonary disease
Patients with asthma 
and/or chronic 
obstructive pulmonary 
disease older than 18 
years
MEDLINE
Current contents
Reference lists
English, Dutch or 
German included 
only
Checklist n = 14/n = 6 n = 4/n = 1 No No
Cameron, 
200099
Policy for an 
institution
Geriatric rehabilitation 
following fractures in 
older people
Patients aged 65 years 
or older with any 
fracture of the lower 
limbs, pelvis, upper 
limbs or spine which 
required hospital care 
either as an inpatient or 
in ambulatory care
MEDLINE
EMBASE
CINAHL
Personal reference collections
Reference lists
Personal contact/contact with 
authors
No language 
restrictions 
Scale (nine-item 
methodological 
quality score was 
devised by the 
authors)
n = 14/2–4 studies 
per outcome
n = 27/1–5 studies 
per outcome
All cohort 
(concurrent and 
historical) studies 
Yes No
Davis, 200090 Policy for an 
institution
Child sexual abuse 
prevention programs (in 
schools)
Children aged 3 –13 
years
MEDLINE
PsycLIT/PsycINFO
Dissertation abstracts online
ERIC
HealthStar
Reference lists
Hand searching
English language 
only
Components Not reported Not reported No No
Griffith, 
2000100
Policy for a 
community 
Contingency 
management in 
outpatient methadone 
treatment
Patients receiving 
outpatient methadone 
treatment. Mean age 34
MEDLINE
PsycLIT/PsycINFO
SSCI
Science Citation Index
Reference lists
Personal contact/contact with 
authors
Hand searching
Not stated  Quality not 
assessed
n = 17/n = 17 n = 13/n = 13 Yes Yes (none)
Jacobs, 200292 Policy for an 
institution
The newborn 
individualized 
developmental care and 
assessment programme
Preterm infants < 37 
weeks gestation or 
< 2500 g at birth
MEDLINE
PsycLIT/PsycINFO 
Cochrane Library (CCTR/Central)
EMBASE
CINAHL
Reference lists
Personal contact/contact with 
authors
No language 
restrictions 
Quality of cohort 
studies not 
assessed
RCTs: Jadad Scale
Checklist
Criteria developed 
by the Neonatal 
Cochrane review 
group
n = 5/1–4 studies 
per outcome
n = 3/1–4 studies 
per outcome
Yes No
Kwan, 2004101 Policy for an 
institution
In-hospital care 
pathways for stroke
Patients who had been 
admitted to hospital 
with a new neurological 
deficit consistent with 
a clinical diagnosis of 
stroke
MEDLINE
Cochrane Library (CCTR/Central)
EMBASE
CINAHL
Index to Scientific and Technical 
Proceedings (ISTP)
HealthSTAR
Cochrane Stroke Group Specialised 
Trials Register
Reference lists
Personal contact/contact with 
authors
Hand searching
Not stated  Did not use 
preprinted 
‘selection’ forms 
(presume they 
mean quality 
assessment 
forms) or an 
overall scoring 
system but noted 
important aspects 
of methodological 
quality
n = 3/n = 2 (for one 
outcome only)
n = 7/1–4 
depending on 
outcome
Yes
forest plots 
only
Yes
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Cambach, 
199998
Policy for an 
institution
Policy for a 
community
Pulmonary 
rehabilitation in patients 
with asthma and 
chronic obstructive 
pulmonary disease
Patients with asthma 
and/or chronic 
obstructive pulmonary 
disease older than 18 
years
MEDLINE
Current contents
Reference lists
English, Dutch or 
German included 
only
Checklist n = 14/n = 6 n = 4/n = 1 No No
Cameron, 
200099
Policy for an 
institution
Geriatric rehabilitation 
following fractures in 
older people
Patients aged 65 years 
or older with any 
fracture of the lower 
limbs, pelvis, upper 
limbs or spine which 
required hospital care 
either as an inpatient or 
in ambulatory care
MEDLINE
EMBASE
CINAHL
Personal reference collections
Reference lists
Personal contact/contact with 
authors
No language 
restrictions 
Scale (nine-item 
methodological 
quality score was 
devised by the 
authors)
n = 14/2–4 studies 
per outcome
n = 27/1–5 studies 
per outcome
All cohort 
(concurrent and 
historical) studies 
Yes No
Davis, 200090 Policy for an 
institution
Child sexual abuse 
prevention programs (in 
schools)
Children aged 3 –13 
years
MEDLINE
PsycLIT/PsycINFO
Dissertation abstracts online
ERIC
HealthStar
Reference lists
Hand searching
English language 
only
Components Not reported Not reported No No
Griffith, 
2000100
Policy for a 
community 
Contingency 
management in 
outpatient methadone 
treatment
Patients receiving 
outpatient methadone 
treatment. Mean age 34
MEDLINE
PsycLIT/PsycINFO
SSCI
Science Citation Index
Reference lists
Personal contact/contact with 
authors
Hand searching
Not stated  Quality not 
assessed
n = 17/n = 17 n = 13/n = 13 Yes Yes (none)
Jacobs, 200292 Policy for an 
institution
The newborn 
individualized 
developmental care and 
assessment programme
Preterm infants < 37 
weeks gestation or 
< 2500 g at birth
MEDLINE
PsycLIT/PsycINFO 
Cochrane Library (CCTR/Central)
EMBASE
CINAHL
Reference lists
Personal contact/contact with 
authors
No language 
restrictions 
Quality of cohort 
studies not 
assessed
RCTs: Jadad Scale
Checklist
Criteria developed 
by the Neonatal 
Cochrane review 
group
n = 5/1–4 studies 
per outcome
n = 3/1–4 studies 
per outcome
Yes No
Kwan, 2004101 Policy for an 
institution
In-hospital care 
pathways for stroke
Patients who had been 
admitted to hospital 
with a new neurological 
deficit consistent with 
a clinical diagnosis of 
stroke
MEDLINE
Cochrane Library (CCTR/Central)
EMBASE
CINAHL
Index to Scientific and Technical 
Proceedings (ISTP)
HealthSTAR
Cochrane Stroke Group Specialised 
Trials Register
Reference lists
Personal contact/contact with 
authors
Hand searching
Not stated  Did not use 
preprinted 
‘selection’ forms 
(presume they 
mean quality 
assessment 
forms) or an 
overall scoring 
system but noted 
important aspects 
of methodological 
quality
n = 3/n = 2 (for one 
outcome only)
n = 7/1–4 
depending on 
outcome
Yes
forest plots 
only
YesAppendix 4
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Langhorne, 
1999102
Policy for an 
institution
Services for helping 
acute stroke patients 
avoid hospital admission
Stroke patients 
with a clinical 
definition of stroke 
(focal neurological 
deficit caused by 
cerebrovascular 
disease). No specific 
limit on stroke severity 
or on the duration 
between stroke and 
recruitment into a trial
Cochrane Stroke Group Specialised 
Register of Controlled Trials
Personal contact/contact with 
authors
Not stated  Components: no 
specific quality 
assessment tool 
reported
n = 3/1 or 2 per 
outcome
n = 1/n = 1 Yes No
Mullen, 200293 Policy for an 
institution
Behavioural 
HIV prevention 
interventions for 
sexually experienced 
adolescents in the US
Adolescents of middle 
or high school age (13–
19 years) in the US
Prevention Research Synthesis 
project database – a cumulative 
database constructed using manual 
searches, contacts with experts 
and searches of databases to obtain 
published and unpublished reports 
through 1998 relevant to HIV 
prevention
English language 
only
Quality not 
assessed
Non-randomised 
studies met 
eligibility criteria 
only if they 
included pre-test 
measures and 
either reported 
no baseline 
differences 
between 
study groups 
or controlled 
statistically for 
such differences
n = 10 according 
to Table 1, Table 3 
suggests 9/n = 10 
according to Table 
1, Table 3 suggests 
9
n = 10 according 
to Table 1, Table 3 
suggests 11/n = 6 
according to Table 
1, 7 according to 
Table 3
No No
Oliver, 2000103 Policy for an 
institution
Hospital fall prevention 
programmes
Inclusion criteria 
‘hospital setting’
Taken from settings 
including geriatric, 
rehabilitation, 
psychiatry, neurology, 
general medicine, 
orthopaedic, oncology, 
surgery
MEDLINE
CINAHL
Reference lists
Not stated  Components: the 
authors do not 
state that quality 
was assessed but 
discuss aspects 
of quality at the 
end of the results 
section
n = 2/n = 2 n = 19/n = 8 No No
Guyatt, 200091 Policy for an 
institution
Policy for a 
community
Interventions for 
adolescent pregnancy 
prevention
Adolescents aged 18 
years or less. Studies 
had to have been 
conducted in the US, 
Australia, New Zealand, 
the UK, Europe 
(excluding Eastern 
Europe) or Scandinavia
MEDLINE
PsycLIT/PsycINFO 
EMBASE
Dissertation abstracts online
ERIC
Popline
CINAHL
Sociological Abstracts
CATLINE (CATalog onLINE)
Conference Papers
Index
NTIS (National Technical 
Information Services)
Reference lists
Personal contact/contact with 
authors
Hand searching 
No language 
restrictions 
Quality not 
assessed
n = 13/females: 
between 7 and 
9 depending on 
outcome; males: 3 
or 4 depending on 
outcome
n = 17/females: 6 
or 11 depending 
on outcome; 
males: between 2 
and 6 depending 
on outcome
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Langhorne, 
1999102
Policy for an 
institution
Services for helping 
acute stroke patients 
avoid hospital admission
Stroke patients 
with a clinical 
definition of stroke 
(focal neurological 
deficit caused by 
cerebrovascular 
disease). No specific 
limit on stroke severity 
or on the duration 
between stroke and 
recruitment into a trial
Cochrane Stroke Group Specialised 
Register of Controlled Trials
Personal contact/contact with 
authors
Not stated  Components: no 
specific quality 
assessment tool 
reported
n = 3/1 or 2 per 
outcome
n = 1/n = 1 Yes No
Mullen, 200293 Policy for an 
institution
Behavioural 
HIV prevention 
interventions for 
sexually experienced 
adolescents in the US
Adolescents of middle 
or high school age (13–
19 years) in the US
Prevention Research Synthesis 
project database – a cumulative 
database constructed using manual 
searches, contacts with experts 
and searches of databases to obtain 
published and unpublished reports 
through 1998 relevant to HIV 
prevention
English language 
only
Quality not 
assessed
Non-randomised 
studies met 
eligibility criteria 
only if they 
included pre-test 
measures and 
either reported 
no baseline 
differences 
between 
study groups 
or controlled 
statistically for 
such differences
n = 10 according 
to Table 1, Table 3 
suggests 9/n = 10 
according to Table 
1, Table 3 suggests 
9
n = 10 according 
to Table 1, Table 3 
suggests 11/n = 6 
according to Table 
1, 7 according to 
Table 3
No No
Oliver, 2000103 Policy for an 
institution
Hospital fall prevention 
programmes
Inclusion criteria 
‘hospital setting’
Taken from settings 
including geriatric, 
rehabilitation, 
psychiatry, neurology, 
general medicine, 
orthopaedic, oncology, 
surgery
MEDLINE
CINAHL
Reference lists
Not stated  Components: the 
authors do not 
state that quality 
was assessed but 
discuss aspects 
of quality at the 
end of the results 
section
n = 2/n = 2 n = 19/n = 8 No No
Guyatt, 200091 Policy for an 
institution
Policy for a 
community
Interventions for 
adolescent pregnancy 
prevention
Adolescents aged 18 
years or less. Studies 
had to have been 
conducted in the US, 
Australia, New Zealand, 
the UK, Europe 
(excluding Eastern 
Europe) or Scandinavia
MEDLINE
PsycLIT/PsycINFO 
EMBASE
Dissertation abstracts online
ERIC
Popline
CINAHL
Sociological Abstracts
CATLINE (CATalog onLINE)
Conference Papers
Index
NTIS (National Technical 
Information Services)
Reference lists
Personal contact/contact with 
authors
Hand searching 
No language 
restrictions 
Quality not 
assessed
n = 13/females: 
between 7 and 
9 depending on 
outcome; males: 3 
or 4 depending on 
outcome
n = 17/females: 6 
or 11 depending 
on outcome; 
males: between 2 
and 6 depending 
on outcome
No NoAppendix 4
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Smedslund, 
2004104
Policy for an 
institution
Workplace smoking 
cessation programmes
Smokers in the 
workplace
MEDLINE
PsycLIT/PsycINFO 
SSCI
Dissertation abstracts online
ERIC
Sociological Abstracts
ABI/Inform
BRS
Combined Health
Information Database
Occupational Health and Safety 
Database
Smoking and Health Database
Reference lists
Not stated  Components n = unclear (states 
9 in text, 8 in Table 
1, and 10 in Table 
3)/n appears to 
be 8
n = 11 according 
to Table 1, 9 
according to Table 
3/n appears to 
be 10
Yes No
Thomas, 
200394
Policy for an 
institution
Policy for a 
community
Barriers and facilitators 
to healthy eating in 
children
Children whose average 
age was between 4 and 
10 years
MEDLINE
PsycLIT/PsycINFO 
Cochrane Library (CCTR/Central) 
also DARE and CDSR
Bibliomap
HealthPromis (HEA/HDA)
SSCI
EMBASE
ERIC
CINAHL PrevRev Cochrane Heart 
Group internal trials register
Reference lists
Personal contact/contact with 
authors
Hand searching
English language 
only
Components n = 17/n = 2–7 
depending on 
outcome
n = 16/n = 3–6 
depending on 
outcome
No No
Tobler, 2000107 Policy for an 
institution
Policy for a 
community
School-based 
adolescent drug 
prevention programmes
All members of the 
student body, which 
may have included but 
did not specifically 
target high risk youth. 
Involved school grades 
6 –12
Electronic databases not reported
Reference lists
Personal contact/contact with 
authors
Not stated  Components: 
coded but not 
reported
n = 144/n = unclear 
– 144 in Table 6, 
141 in text p. 320
n = 63/n = unclear 
– 63 in Table 6, 66 
in text p. 320
No No
Wilson, 2000105 Policy for an 
institution
Corrections-based 
education, vocation and 
work programmes for 
adult offenders
Convicted adults or 
persons identified by 
the criminal justice 
system (court) and 
placed in a prison or 
jail, or diverted to 
another corrections-
based programme, such 
as probation
PsycLIT/PsycINFO 
Dissertation abstracts online
ERIC
Sociological Abstracts
Criminal Justice Periodical Index
NCJRS
Social SciSearch
Social Sciences Abstracts
Reference lists
Personal contact/contact with 
authors
Not stated Components n = 3/n = 3 n = 30/n = 30 No NoDOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Smedslund, 
2004104
Policy for an 
institution
Workplace smoking 
cessation programmes
Smokers in the 
workplace
MEDLINE
PsycLIT/PsycINFO 
SSCI
Dissertation abstracts online
ERIC
Sociological Abstracts
ABI/Inform
BRS
Combined Health
Information Database
Occupational Health and Safety 
Database
Smoking and Health Database
Reference lists
Not stated  Components n = unclear (states 
9 in text, 8 in Table 
1, and 10 in Table 
3)/n appears to 
be 8
n = 11 according 
to Table 1, 9 
according to Table 
3/n appears to 
be 10
Yes No
Thomas, 
200394
Policy for an 
institution
Policy for a 
community
Barriers and facilitators 
to healthy eating in 
children
Children whose average 
age was between 4 and 
10 years
MEDLINE
PsycLIT/PsycINFO 
Cochrane Library (CCTR/Central) 
also DARE and CDSR
Bibliomap
HealthPromis (HEA/HDA)
SSCI
EMBASE
ERIC
CINAHL PrevRev Cochrane Heart 
Group internal trials register
Reference lists
Personal contact/contact with 
authors
Hand searching
English language 
only
Components n = 17/n = 2–7 
depending on 
outcome
n = 16/n = 3–6 
depending on 
outcome
No No
Tobler, 2000107 Policy for an 
institution
Policy for a 
community
School-based 
adolescent drug 
prevention programmes
All members of the 
student body, which 
may have included but 
did not specifically 
target high risk youth. 
Involved school grades 
6 –12
Electronic databases not reported
Reference lists
Personal contact/contact with 
authors
Not stated  Components: 
coded but not 
reported
n = 144/n = unclear 
– 144 in Table 6, 
141 in text p. 320
n = 63/n = unclear 
– 63 in Table 6, 66 
in text p. 320
No No
Wilson, 2000105 Policy for an 
institution
Corrections-based 
education, vocation and 
work programmes for 
adult offenders
Convicted adults or 
persons identified by 
the criminal justice 
system (court) and 
placed in a prison or 
jail, or diverted to 
another corrections-
based programme, such 
as probation
PsycLIT/PsycINFO 
Dissertation abstracts online
ERIC
Sociological Abstracts
Criminal Justice Periodical Index
NCJRS
Social SciSearch
Social Sciences Abstracts
Reference lists
Personal contact/contact with 
authors
Not stated Components n = 3/n = 3 n = 30/n = 30 No NoAppendix 4
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Wilson, 200196 Policy for an 
institution
School-based 
prevention of problem 
behaviours
General student 
population. Some 
restricted to student 
population identified 
as high risk for 
problem behaviours or 
delinquency
PsycLIT/PsycINFO 
ERIC
Sociological Abstracts (listed as 
examples)
Personal collections
Reference lists
Not stated  Scale: 5-point 
Scientific Methods 
Score – informed 
by answers to the 
method rigour 
items
Components
n = 42/n = 42 
(comparisons not 
studies)
n = 174/n = 174 
(comparisons not 
studies)
No No
Wilson, 200397 Policy for an 
institution
School-based 
intervention 
programmes for 
aggressive behaviour
Preschool–12th grade 
children
MEDLINE
PsycLIT/PsycINFO 
ERIC
Dissertation Abstracts
International
US Government
Printing Office
Publications
National Criminal Justice Reference 
Service
Reference lists
Hand searching
English language 
only
Components: 
study quality not 
specified, but 
coded information 
for each study 
that described 
the methods 
and procedures, 
including details of 
design, measures 
and attrition
179 groups (NOT 
studies)/not 
reported
343 groups (NOT 
studies)/not 
reported
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Review
Type of 
intervention
Description of 
intervention Target group Search strategy
Language 
restrictions
Validity 
assessment tool
Number of studies per design
Number in review/number in 
meta-analysis
Heterogeneity identified by 
design?
RCTs  NRSs Statistical Clinical/method
Wilson, 200196 Policy for an 
institution
School-based 
prevention of problem 
behaviours
General student 
population. Some 
restricted to student 
population identified 
as high risk for 
problem behaviours or 
delinquency
PsycLIT/PsycINFO 
ERIC
Sociological Abstracts (listed as 
examples)
Personal collections
Reference lists
Not stated  Scale: 5-point 
Scientific Methods 
Score – informed 
by answers to the 
method rigour 
items
Components
n = 42/n = 42 
(comparisons not 
studies)
n = 174/n = 174 
(comparisons not 
studies)
No No
Wilson, 200397 Policy for an 
institution
School-based 
intervention 
programmes for 
aggressive behaviour
Preschool–12th grade 
children
MEDLINE
PsycLIT/PsycINFO 
ERIC
Dissertation Abstracts
International
US Government
Printing Office
Publications
National Criminal Justice Reference 
Service
Reference lists
Hand searching
English language 
only
Components: 
study quality not 
specified, but 
coded information 
for each study 
that described 
the methods 
and procedures, 
including details of 
design, measures 
and attrition
179 groups (NOT 
studies)/not 
reported
343 groups (NOT 
studies)/not 
reported
No NoAppendix 4
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Appendix 4.2: Similarity of RCTs and NRSs, where authors judged results  
to be SIMILAR
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Cameron, 
200099
None Not stated None Yes (Yes)
Kwan, 
2004101
1/3 RCTs included only patients 
with ischaemic stroke as opposed 
to all stroke
5/7 NRSs included only patients 
with ischaemic stroke
None of RCTs reported major 
differences in observed baseline 
characteristics between groups 
although in some studies only 
limited details were given (e.g. 
for subtype of stroke, pre-stroke 
disability or handicap)
For the NRSs, baseline 
characteristics were reported to 
be similar between groups in two 
studies, different in certain aspects 
(race, gender, % haemorrhagic 
stroke) in four studies, and not 
reported in one study
RCTs – interventions well 
described – common elements 
of care included: involvement 
of multiple disciplines setting 
of predefined patient goals and 
therapeutic activities regular 
multidisciplinary team meetings
NRSs – interventions less well 
described – common elements 
of care: involvement of multiple 
disciplines care planning with 
specific care protocol
RCTs – care pathways were 
computer generated (1) paper 
format (1) or not reported (1)
NRSs – care pathways were paper 
format (5) or not reported (2)
RCTs – pathways were for stroke 
rehabilitation (2 studies) or acute 
care and stroke rehabilitation (1 
study)
NRSs – pathways were for acute 
stroke (5 studies) or acute care 
and stroke rehabilitation (2 
studies)
RCTs – control group care 
poorly defined – described as 
multidisciplinary care with regular 
team meetings to discuss patients 
progress (two studies)
NRSs – very poorly described in 
all studies
The paper states that that the 
comparator was poorly described 
in NRSs
Only 8/24 (5/21 in meta-
analysis) outcomes were 
reported in both RCTs and 
NRSs
Outcomes only reported 
in RCTs were: patient and 
carer satisfaction, dead or 
dependent at end of follow-
up and quality of life
Outcomes only reported 
in NRSs were: death in 
hospital, death in hospital 
or discharge to institutional 
care, complications including 
pneumonia, urinary 
tract infection, deep vein 
thrombosis, dehydration, fluid 
and electrolyte imbalance, 
seizures, skin breakdown, 
falls or fractures, myocardial 
infarction, first or second CT 
scan, carotid duplex study, 
and electrocardiography
(from Discussion) ‘non-
randomised studies are 
highly susceptible to bias and 
there is significant statistical 
heterogeneity between the 
studies’
None RCTs show a trend towards longer 
stay with the intervention, while 
NRSs show shorter stay with 
intervention
(But text says significantly shorter 
and meta-analysis says non-
significantly shorter)
Langhorne, 
1999102
Country: UK
Services 
for helping 
acute stroke 
patients 
avoid 
hospital 
admission
Not clear – studies recruited 
patients from various sources
Interventions varied from 
prevention of admission to 
hospital to early discharge from 
hospital to community. Varied 
between all studies regardless of 
study designs
Publication dates: the one included 
NRS was published at least 10 
years before the three included 
RCTs
NRSs compared area with 
access to home care stroke 
team to one without access. Is 
not clear whether the eligible 
patients would all come from 
the community and if so what 
treatment options were available. 
For the RCTs the control group 
care could include inpatient care 
but not in all cases
Not stated None Unclear – in discussion states that 
the trials are ‘characterised by 
considerable heterogeneity which 
makes it difficult to draw specific 
conclusions’
(Unclear – death: trend towards 
higher mortality in intervention 
group within the RCTs)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Tobler, 
2000107
Country: US
Universal 
school-
based drug 
prevention 
programmes
Not possible to tell, insufficient 
data
To empirically confirm 
that the inclusion of non-
randomised pre-test/
post-test research designs 
does not overestimate 
intervention success and to 
eliminate other sources of 
bias, a subset of high quality 
evaluations was selected. 
These were randomised, and 
also met other criteria
Not stated The lack of random assignment 
does not seem to greatly bias the 
studies, relative to other problems. 
The means for random assignment 
vs non-random assignment in 
the large set with problematic 
variations differ by 0.03. An 
intermediate set with problematic 
evaluations removed (e.g. those 
with cross-sectional research, fewer 
than 3 hours of intervention etc.) 
compared for results on random 
vs non-random assignment differ 
by 0.06. Removing other sources 
of bias influences the results far 
more than does lack of random 
assignment.
(Unclear CIs not reported)
Wilson, 
2000105
Country: US
Correction-
based 
education 
on future 
offending 
behaviour 
of adult 
criminals
Insufficient detail given to judge Randomised and non-
randomised studies 
were pooled. Study type 
(randomised vs non-
randomised) was investigated 
as an influence on findings, 
and whether poorer quality 
studies were driving the 
positive findings
Not stated For randomised vs non-randomised 
studies, the authors state that the 
difference is unremarkable and 
statistically non-significant
[Little difference between odds 
ratios for randomised and non-
randomised comparisons. CIs are 
not reported, but the authors note 
that there were no statistically 
significant differences under an 
inverse variance-weighted random-
effects model. Note small number 
of randomised comparisons (3) 
compared with number of non-
randomised comparisons (50)]DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
117
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Tobler, 
2000107
Country: US
Universal 
school-
based drug 
prevention 
programmes
Not possible to tell, insufficient 
data
To empirically confirm 
that the inclusion of non-
randomised pre-test/
post-test research designs 
does not overestimate 
intervention success and to 
eliminate other sources of 
bias, a subset of high quality 
evaluations was selected. 
These were randomised, and 
also met other criteria
Not stated The lack of random assignment 
does not seem to greatly bias the 
studies, relative to other problems. 
The means for random assignment 
vs non-random assignment in 
the large set with problematic 
variations differ by 0.03. An 
intermediate set with problematic 
evaluations removed (e.g. those 
with cross-sectional research, fewer 
than 3 hours of intervention etc.) 
compared for results on random 
vs non-random assignment differ 
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of bias influences the results far 
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of adult 
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Insufficient detail given to judge Randomised and non-
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(randomised vs non-
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as an influence on findings, 
and whether poorer quality 
studies were driving the 
positive findings
Not stated For randomised vs non-randomised 
studies, the authors state that the 
difference is unremarkable and 
statistically non-significant
[Little difference between odds 
ratios for randomised and non-
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Appendix 4.3 Results of RCTs and NRSs, where authors judged results  
to be SIMILAR
Review
Outcomes with at least one 
RCT and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Cameron, 200099
Country:   Australia
Programmes of 
care following acute 
management of 
fractures in older 
people
Length of hospital stay, GORU vs 
orthopaedic unit, WMD
(n = 3) 1.631 (95% CI –27.98 to 
31.25)
χ2 26.26, df = 2a  (n = 1) –0.900 (95% CI –4.549 
to 2.749)
χ2 0.00, df = 0 Authors state that for some outcomes (e.g. length of stay 
in evaluation of GORUs) there is greater heterogeneity 
between RCTs than between the pooled data from RCTs 
and that from cohort studies, but data not presented
Residential status (return home), 
GORU vs orthopaedic unit, OR:
(n = 4) 1.36 (95% CI 0.86 to 
2.13)
χ2 5.04, df = 3a (n = 3) 0.85 (95% CI 0.24 to 
2.98)
χ2 28.86, df = 2a
Residential status (return home), 
GHFP vs orthopaedic unit, OR:
(n = 2) 2.06 (95% CI 1.08 to 
3.93)
χ2 0.32, df = 1 (n = 2) 1.89 (95% CI 1.10 to 
3.24)
χ2 0.31, df = 1
Mortality (death by 1 year), GORU 
vs orthopaedic unit, OR:
(n = 4) 0.92 (95% CI 0.57 to 
1.48)
χ2 5.00, df = 3a (n = 3) 1.44 (95% CI 1.00 to 
2.08)
χ2 1.20, df = 2
Mortality (death by 1 year), GHFP 
vs orthopaedic unit, OR:
(n = 2) 0.85 (95% CI 0.48 to 
1.51)
χ2 5.00, df = 1a (n = 2) 1.18 (95% CI 0.47 to 
2.93)
χ2 0.00, df = 1
Mortality (death by 1 year), ESD vs 
orthopaedic unit, OR:
(n = 1) 1.01 (95% CI 0.37 to 
2.81)
χ2 0.00, df = 0 (n = 5) 0.93 (95% CI 0.65 to 
1.33)
χ2 1.62, df = 4
Kwan, 2004101
Country: UK
Care pathways vs 
standard medical 
care in acute stroke
Duration of hospital stay, WMD 3.99 (95% CI –0.29 to 8.27) χ2 0.15, df = 1, p = 0.70 –2.08 (95% CI –4.36, 0.20) (n = 2): χ2 3.10, df = 1, p = 0.08a Authors state that the definition of ‘care pathway’ may have 
been a source of variation and urge readers to be cautious 
when interpreting results, owing to presence of variation 
between studies and small numbers of participants
Death by end of follow-up Insufficient studies Not assesseda
Discharged to institutional care Insufficient studies (n = 4): χ2 6.16, df = 3, 
p = 0.1039
Discharged to home Insufficient studies χ2 7.40, df = 3, p = 0.060a
Re-admission or emergency 
department attendance
Insufficient studies Not assesseda
Langhorne, 1999102
Country: UK
Services for helping 
acute stroke patients 
avoid hospital 
admission
Death: OR
Death or institutional care: OR
7.76 (95% CI 1.65 to 36.57) (n = 2) χ2 0.00, df 1, p = 0.97 0.85 (95% CI 0.65, 1.11) NRSs: not reported/not 
applicable/not assessed – only 
one NRS in meta–analyses
Sensitivity analysis carried out to accommodate variations 
in trial design, intervention and patient follow-up.   Authors 
state that ‘all the conclusions reported above are not 
altered when sensitivity analyses are carried out to 
accommodate variations in trial design, intervention, and 
patient follow up’
3.07 (95% CI 0.76 to 12.43) (n = 2) χ2 0.49, df = 1, p = 0.48 0.89 (95% CI 0.68, 1.16)
Death or dependency: OR 1.91 (95% CI 0.58 to 6.24) N/A 0.88 (95% CI 0.65 to 1.18)
Activities of daily living: WMD –1.07 (95% CI –2.85 to 0.71) (n = 2): χ2 0.11, df = 1, p = 0.74 0.40 (95% CI –0.52 to 1.32)
Extended ADL: WMD –0.020 (95% CI –8.24 to 7.84) N/A 0.10 (95% CI –2.06 to 2.26)
Subjective health status – patient: 
WMD
–4.30 (95% CI –9.98 to 1.38) (n = 2): χ2 0.96, df = 1, p = 0.33 N/A
Subjective health status – carer: 
WMD
–1.42 (95% CI –3.83 to 0.99) N/A –0.60 (95% CI –3.16 to 1.96)
Number of patients admitted to 
hospital: OR
3.99 (95% CI 0.56 to 28.40) N/A 0.57 (95% CI 0.42 to 0.78)
Length of total hospital stay: WMD 8.00 (95% CI –11.70 to 27.70) N/A 4.10 (95% CI –2.02 to 10.22)
Tobler, 2000107
Country: US
School-based 
drug prevention 
programmes
RCTs: full set, with problematic 
evaluationsb
n = 141, WES = 0.19 Not assessed separately for 
NRSs and RCTs
n = 66, WES = 0.16 Not assessed separately for 
NRSs and RCTs
Intermediate set (n = 139), with 
problematic evaluations removedb
n = 94, WES = 0.20 n = 45, WES = 0.14
Wilson, 2000105
Country: US
Correction-based 
education and future 
offending behaviour 
of adult criminals
Programme comparison contrasts (n = 3) OR 1.50 (95% CI not 
reported)
Not assessed (n = 50): OR 1.53 (95% CI not 
reported)
Not statistically significantly 
different under an inverse 
variance-weighted random-
effects model
Not assessed
ADL,   Activities of daily living; ESD, early supported discharge; GHFP, geriatric hip fracture programme; GORU, geriatric 
orthopaedic rehabilitation unit; N/A, not applicable; OR, odds ratio; WES, weighted effect size; WMD, weighted mean 
difference.
a  Indicates statistically significant.
b  Problematic evaluations are those with cross-sectional research, fewer than 3 hours of intervention, etc.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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a  Indicates statistically significant.
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Appendix 4.5: Similarity of RCTs and NRSs, where authors judged results  
to be NOT SIMILAR
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Cambach, 199998
Country: the 
Netherlands
Pulmonary 
rehabilitation in 
patients with asthma 
and chronic obstructive 
pulmonary disease
The four NRSs 
were all outpatient 
settings, whereas 
the RCTs were a 
mixture of outpatient, 
inpatient, home-based 
and physiotherapy 
practice-based settings
Randomised vs non-randomised design 
was stated a priori as a potential source 
of heterogeneity
Appears that all study designs were 
pooled and subgroup analyses then 
carried out, including elements of study 
design (randomised vs non-randomised 
controlled trial) to examine influence 
on effect size
None Unclear
(No)
Davis, 200090
Country: US
School-based 
child sexual 
abuse prevention 
programmes 
Cannot tell No rationale was stated.   All studies 
were included in a meta-analysis, and 
methodological quality and effect 
size were assessed by using multiple 
regression; random assignment was 
included
None Authors state that subset analysis found 
higher mean effect sizes when studies, 
did not use random assignment of 
participants and used a waitlist control 
instead of an unrelated alternate 
programme that would control for 
amount of experimenter contact.   Also, 
studies that used pre-tests to examine 
initial control group and experiment 
group equivalence found higher effect 
sizes than those using only post tests. 
Studies with more items on outcome 
measures found higher effect sizes.
[No, effect size larger in NRS. With one 
NRS removed, the difference in effect 
sizes is reduced (0.725 vs 0.826)]
Griffith, 2000100
Country: US
Contingency 
management (system 
of incentives and 
disincentives) for 
reducing illicit drug use 
during treatment
Several studies in 
which non-random 
assignment was used 
involved patients 
considered to be 
treatment failures
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
Randomised and non-randomised 
studies were pooled (does not specify 
what constitutes non-randomised). Eight 
moderators were examined, including 
assignment of participants
No rationale stated as to why 
assignment was investigated, although 
authors state that non-randomised 
studies may involve greater staff 
expectations and greater baseline levels 
of use
‘The effects of the moderator 
variables were examined by regressing 
moderator variables on the effect size, 
which yields an estimate of between-
groups variance (Qb). In comparing 
the relative strength of levels within 
moderators, 95% CIs were calculated. 
Non-overlapping CIs allow conclusions 
about the strength of one predictor in 
comparison to another while limiting 
the overall error rate to 5%’
No
(No, states that studies employing 
non-random assignment reported 
better outcomes than those employing 
random assignment)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Appendix 4.5: Similarity of RCTs and NRSs, where authors judged results  
to be NOT SIMILAR
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Cambach, 199998
Country: the 
Netherlands
Pulmonary 
rehabilitation in 
patients with asthma 
and chronic obstructive 
pulmonary disease
The four NRSs 
were all outpatient 
settings, whereas 
the RCTs were a 
mixture of outpatient, 
inpatient, home-based 
and physiotherapy 
practice-based settings
Randomised vs non-randomised design 
was stated a priori as a potential source 
of heterogeneity
Appears that all study designs were 
pooled and subgroup analyses then 
carried out, including elements of study 
design (randomised vs non-randomised 
controlled trial) to examine influence 
on effect size
None Unclear
(No)
Davis, 200090
Country: US
School-based 
child sexual 
abuse prevention 
programmes 
Cannot tell No rationale was stated.   All studies 
were included in a meta-analysis, and 
methodological quality and effect 
size were assessed by using multiple 
regression; random assignment was 
included
None Authors state that subset analysis found 
higher mean effect sizes when studies, 
did not use random assignment of 
participants and used a waitlist control 
instead of an unrelated alternate 
programme that would control for 
amount of experimenter contact.   Also, 
studies that used pre-tests to examine 
initial control group and experiment 
group equivalence found higher effect 
sizes than those using only post tests. 
Studies with more items on outcome 
measures found higher effect sizes.
[No, effect size larger in NRS. With one 
NRS removed, the difference in effect 
sizes is reduced (0.725 vs 0.826)]
Griffith, 2000100
Country: US
Contingency 
management (system 
of incentives and 
disincentives) for 
reducing illicit drug use 
during treatment
Several studies in 
which non-random 
assignment was used 
involved patients 
considered to be 
treatment failures
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
No obvious 
differences (but 
insufficient study 
details reported to be 
able to tell)
Randomised and non-randomised 
studies were pooled (does not specify 
what constitutes non-randomised). Eight 
moderators were examined, including 
assignment of participants
No rationale stated as to why 
assignment was investigated, although 
authors state that non-randomised 
studies may involve greater staff 
expectations and greater baseline levels 
of use
‘The effects of the moderator 
variables were examined by regressing 
moderator variables on the effect size, 
which yields an estimate of between-
groups variance (Qb). In comparing 
the relative strength of levels within 
moderators, 95% CIs were calculated. 
Non-overlapping CIs allow conclusions 
about the strength of one predictor in 
comparison to another while limiting 
the overall error rate to 5%’
No
(No, states that studies employing 
non-random assignment reported 
better outcomes than those employing 
random assignment)Appendix 4
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Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Jacobs, 200292
Country: Canada
Objective: The 
Newborn Individualised 
Developmental Care 
and assessment 
Program compared 
with conventional 
care for improving 
long-term 
neurodevelopmental 
outcomes in pre-term 
and/or low birth weight 
infants
Insufficient detail to 
assess any obvious 
differences in study 
design, but sample 
sizes tended to be 
larger in the cohort 
studies
Separate meta-analyses were carried 
out for RCTs and for cohort studies: no 
rationale reported
None RCTs and non RCTs were similar on 
11 outcomes. Cohort studies found a 
statistically significant change that was 
not found by RCTs for two outcomes
RCTs found a statistically significant 
change that was not found by cohort 
studies in two studies
The authors state in the discussion that 
‘there was a discrepancy in results for 
the duration of mechanical ventilation 
and supplemental oxygen for RCTs vs 
cohort studies, which may reflect true 
differences between study populations 
or heterogeneity secondary to study 
design and/or bias’. However, the result 
section states ‘ both RCTs and cohort 
studies reported a significant reduction 
in requirement for supplemental 
oxygen’
Mullen, 200293
Country: US
Interventions for 
sexual risk behaviours 
for HIV among 
sexually experienced 
adolescents in the US
No obvious 
differences
Included randomised and non-
randomised studies in the meta-analysis. 
Then carried out stratified analyses 
(including RCTs vs NRSs) to examine 
variation in size of effects
Two criteria were used to evaluate the 
contribution of the grouping variables 
for explaining the variation in the 
estimation of the summary odds ratios
Assessed the likelihood of the 
magnitude of the between-subgroup 
differences using a chi-squared statistic 
Q; degrees of freedom, number of 
subgroups minus 1. Because 12 stratified 
comparisons were performed, a 
Bonferroni correction was used
Estimated the magnitude of the 
contribution as represented by the 
percentage of the total heterogeneity, 
Q, explained by the between-group 
heterogeneity, Qb. Defined substantial 
contribution of the variance explained 
by a stratification variable as ≥ 5%, the 
larger this percentage, the larger the 
difference between the subgroups than 
the differences within subgroups
No, the RCTs indicate a significant 
effect of the intervention, while the 
nRCTs indicate no significant effect
(Between-subgroup differences were 
not significantly different for random vs 
non-random assignment: Q statistic 2.40 
(1 df), p = 0.12.   Assignment (random 
vs non-random) explained 7.3% of the 
total heterogeneity.   Assignment was one 
of eight variables making a substantial 
contribution of the variance (meeting 
the criterion of explaining more than 
5% of the total heterogeneity)
Oliver, 2000103
Falls prevention in 
hospitals
Interventions 
appeared to be 
different
No rationale given None No
(Unclear)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Jacobs, 200292
Country: Canada
Objective: The 
Newborn Individualised 
Developmental Care 
and assessment 
Program compared 
with conventional 
care for improving 
long-term 
neurodevelopmental 
outcomes in pre-term 
and/or low birth weight 
infants
Insufficient detail to 
assess any obvious 
differences in study 
design, but sample 
sizes tended to be 
larger in the cohort 
studies
Separate meta-analyses were carried 
out for RCTs and for cohort studies: no 
rationale reported
None RCTs and non RCTs were similar on 
11 outcomes. Cohort studies found a 
statistically significant change that was 
not found by RCTs for two outcomes
RCTs found a statistically significant 
change that was not found by cohort 
studies in two studies
The authors state in the discussion that 
‘there was a discrepancy in results for 
the duration of mechanical ventilation 
and supplemental oxygen for RCTs vs 
cohort studies, which may reflect true 
differences between study populations 
or heterogeneity secondary to study 
design and/or bias’. However, the result 
section states ‘ both RCTs and cohort 
studies reported a significant reduction 
in requirement for supplemental 
oxygen’
Mullen, 200293
Country: US
Interventions for 
sexual risk behaviours 
for HIV among 
sexually experienced 
adolescents in the US
No obvious 
differences
Included randomised and non-
randomised studies in the meta-analysis. 
Then carried out stratified analyses 
(including RCTs vs NRSs) to examine 
variation in size of effects
Two criteria were used to evaluate the 
contribution of the grouping variables 
for explaining the variation in the 
estimation of the summary odds ratios
Assessed the likelihood of the 
magnitude of the between-subgroup 
differences using a chi-squared statistic 
Q; degrees of freedom, number of 
subgroups minus 1. Because 12 stratified 
comparisons were performed, a 
Bonferroni correction was used
Estimated the magnitude of the 
contribution as represented by the 
percentage of the total heterogeneity, 
Q, explained by the between-group 
heterogeneity, Qb. Defined substantial 
contribution of the variance explained 
by a stratification variable as ≥ 5%, the 
larger this percentage, the larger the 
difference between the subgroups than 
the differences within subgroups
No, the RCTs indicate a significant 
effect of the intervention, while the 
nRCTs indicate no significant effect
(Between-subgroup differences were 
not significantly different for random vs 
non-random assignment: Q statistic 2.40 
(1 df), p = 0.12.   Assignment (random 
vs non-random) explained 7.3% of the 
total heterogeneity.   Assignment was one 
of eight variables making a substantial 
contribution of the variance (meeting 
the criterion of explaining more than 
5% of the total heterogeneity)
Oliver, 2000103
Falls prevention in 
hospitals
Interventions 
appeared to be 
different
No rationale given None No
(Unclear)Appendix 4
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Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Smedslund, 2004104
Country: Norway
Worksite smoking 
cessation programmes 
Insufficient detail given Randomised and non-randomised trials 
were analysed separately. No rationale 
was given as to why
Not stated Unclear.   Authors state that at all three 
follow-up points, the non-randomised 
studies showed larger effects and 
that ‘the randomised results are 
probably closer to the truth, as the 
nonrandomised studies are probably 
overestimating the effects’
(Yes. Effect sizes for NRSs are larger 
than RCTs, but they are in the same 
direction and confidence intervals 
overlap)
Wilson, 200196
Country: US
School-based 
prevention of crime, 
substance use, dropout/
non-attendance 
and other conduct 
problems
Insufficient detail given Carried out a meta-analysis of both 
randomised and non-randomised 
studies. This was then investigated as 
an explanatory source of variation in 
effect size
Not stated No, p ≤ 0.05 (statistically significant 
difference between NRSs and RCTs). ‘It 
is interesting to note that randomised 
designs yielded larger mean effects than 
the nonrandomised designs’
(No, smaller effect size in NRSs than 
RCTs, although direction of effect was 
the same. Confidence intervals do not 
overlap)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion?
Rationale for pooling RCTs and 
NRSs separately Criteria used to judge equivalence
Authors’ conclusions regarding 
similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Smedslund, 2004104
Country: Norway
Worksite smoking 
cessation programmes 
Insufficient detail given Randomised and non-randomised trials 
were analysed separately. No rationale 
was given as to why
Not stated Unclear.   Authors state that at all three 
follow-up points, the non-randomised 
studies showed larger effects and 
that ‘the randomised results are 
probably closer to the truth, as the 
nonrandomised studies are probably 
overestimating the effects’
(Yes. Effect sizes for NRSs are larger 
than RCTs, but they are in the same 
direction and confidence intervals 
overlap)
Wilson, 200196
Country: US
School-based 
prevention of crime, 
substance use, dropout/
non-attendance 
and other conduct 
problems
Insufficient detail given Carried out a meta-analysis of both 
randomised and non-randomised 
studies. This was then investigated as 
an explanatory source of variation in 
effect size
Not stated No, p ≤ 0.05 (statistically significant 
difference between NRSs and RCTs). ‘It 
is interesting to note that randomised 
designs yielded larger mean effects than 
the nonrandomised designs’
(No, smaller effect size in NRSs than 
RCTs, although direction of effect was 
the same. Confidence intervals do not 
overlap)Appendix 4
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Appendix 4.6: Results of RCTs and NRSs, where authors judged results  
to be NOT SIMILAR
Review
Outcomes with at least one RCT 
and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Cambach, 199998
Country: the Netherlands
Pulmonary rehabilitation in patients 
with asthma and chronic obstructive 
pulmonary disease
Endurance time (n = 6)
Effect size 1.4 (95% CI not reported), 
p < 0.0001
Not reported (n = 1)
Effect size –1.7 (95% CI not 
reported), p = 0.003
Not reported
Davis, 200090
Country: US
School-based child sexual abuse 
prevention programmes 
Overall effect With Nemerofsky 1994: D = 0.725
Without Nemerofsky 1994: D = 0.725
Not reported With Nemerofsky 1994: D = 1.131
Without Nemerofsky 1994: 
D = 0.826
Not reported
Griffith, 2000100
Country: US
Contingency management (system 
of incentives and disincentives) 
for reducing illicit drug use during 
treatment
Overall effect r = 0.22 (95% CI 0.16 to 0.28) Not statistically significant 
Qw = 25.63, p = not 
statistically significant
r = 0.36 (95% CI 0.26 to 0.46) Statistically significant 
Qw = 85.56, p < 0.001
Jacobs, 200292
Country: Canada
Objective: The Newborn Individualised 
Developmental Care and assessment 
Program (NIDCAP) compared with 
conventional care for improving long-
term neurodevelopmental outcomes 
in pre-term and/or low birth weight 
infants
Intraventricular haemorrhage (any) RR 0.52 (95% CI 0.13 to 2.05), RD –0.14 
(95% CI –0.42 to 0.14)
Statistically significant
Values not reported, but 
significant heterogeneity 
for the following outcomes 
meant that the random effect 
model was used:
Intraventricular haemorrhage 
(any)
Retinopathy of prematurity 
(any)
Chronic lung disease (at 36 
weeks)
RR 1.20 (95% CI 0.71 to 2.01), RD 
0.05 (95% CI –0.08 to 0.18)
Not statistically significant
Values not reported, but 
random-effects model not 
used for any outcome, 
therefore it can be assumed 
that there was no significant 
statistical heterogeneity
Intraventricular haemorrhage (severe) RR 0.39 (95% CI 0.15 to 1.00), RD –0.13 
(95% CI –0.26 to –0.01)
RR 0.93 (95% CI 0.17 to 5.17), RD 
–0.001 (95% CI –0.05 to 0.05)
Patent ductus arteriosus RR 0.95 (95% CI 0.65 to 1.41), RD –0.02 
(95% CI –0.20 to 0.16)
RR 0.71 (95% CI 0.35 to 1.42), RD 
–0.07 (95% CI –0.21 to 0.07)
Necrotising enterocolitis RR 0.21 (95% CI 0.01 to 4.10), RD –0.07 
(95% CI –0.19 to 0.06)
RR 0.48 (95% CI 0.13 to 1.85), RD 
–0.05 (95% CI –0.14 to 0.04)
Retinopathy of prematurity (any) RR 0.84 (95% CI 0.64 to 1.12), RD –0.09 
(95% CI –0.24 to 0.06)
RR 5.16 (95% CI 1.58 to 16.84), RD 
0.21 (95% CI 0.08 to 0.33)
Retinopathy of prematurity (severe) RR 0.75 (95% CI 0.41 to 1.37), RD –0.07 
(95% CI –0.21 to 0.07)
RR 0.97 (95% CI 0.06 to 15.14), RD 
–0.001 (95% CI –0.05 to 0.04)
Pneumothorax RR 0.15 (95% CI 0.02 to 1.13), RD –0.28 
(95% CI –0.52 to –0.05)
RR 0.65 (95% CI 0.11 to 3.73), RD 
–0.02 (95% CI –0.09 to 0.05)
Chronic lung disease (28 days) RR 1.08 (95% CI 0.84 to 1.39), RD 0.04 
(95% CI –0.09 to 0.16)
RR 0.50 (95% CI 0.30 to 0.83), RD 
–0.17 (95% CI –0.28 to –0.05)
Chronic lung disease (36 weeks) RR 0.26 (95% CI 0.00 to 25.40), RD 
–0.39 (95% CI –1.04 to 0.26)
RR 0.65 (95% CI 0.11 to 3.73), RD 
–0.02 (95% CI –0.09 to 0.05)
Neurodevelopment 9–12 months 
(cognitive)
WMD 16.58 (95% CI 9.33 to 23.82) MD 45.24 (95% CI 35.92 to 54.56)
Neurodevelopment 9–12 months 
(motor)
WMD 9.24 (95% CI 0.68 to 17.81) MD 13.70 (95% CI –0.34 to 27.74)
Duration (days) ventilation WMD –25.70 (95% CI –43.94 to –7.46) WMD –4.67 (95% CI –10.85 to 
1.51)
Duration (days) supplemental oxygen WMD –41.06 (95% CI –65.29 to –16.83) WMD –6.64 (95% CI –12.73 to 
–0.55)
Duration (days) hospitalization WMD –18.38 (95% CI –44.13 to 7.37) WMD –4.83 (95% CI –12.82 to 
3.16)
Weight gain (g/day) WMD 3.24 (95% CI 0.57 to 5.92) MD –3.46 (95% CI –6.69 to –0.23)
Days to full oral feeds MD –44.90 (95% CI –86.12 to –3.68) WMD –14.73 (95% CI –23.45 to 
–6.02)
Gestation at discharge WMD –0.41(95% CI –1.28 to 0.47) WMD –0.13 (95% CI –1.14 to 0.88)DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Appendix 4.6: Results of RCTs and NRSs, where authors judged results  
to be NOT SIMILAR
Review
Outcomes with at least one RCT 
and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Cambach, 199998
Country: the Netherlands
Pulmonary rehabilitation in patients 
with asthma and chronic obstructive 
pulmonary disease
Endurance time (n = 6)
Effect size 1.4 (95% CI not reported), 
p < 0.0001
Not reported (n = 1)
Effect size –1.7 (95% CI not 
reported), p = 0.003
Not reported
Davis, 200090
Country: US
School-based child sexual abuse 
prevention programmes 
Overall effect With Nemerofsky 1994: D = 0.725
Without Nemerofsky 1994: D = 0.725
Not reported With Nemerofsky 1994: D = 1.131
Without Nemerofsky 1994: 
D = 0.826
Not reported
Griffith, 2000100
Country: US
Contingency management (system 
of incentives and disincentives) 
for reducing illicit drug use during 
treatment
Overall effect r = 0.22 (95% CI 0.16 to 0.28) Not statistically significant 
Qw = 25.63, p = not 
statistically significant
r = 0.36 (95% CI 0.26 to 0.46) Statistically significant 
Qw = 85.56, p < 0.001
Jacobs, 200292
Country: Canada
Objective: The Newborn Individualised 
Developmental Care and assessment 
Program (NIDCAP) compared with 
conventional care for improving long-
term neurodevelopmental outcomes 
in pre-term and/or low birth weight 
infants
Intraventricular haemorrhage (any) RR 0.52 (95% CI 0.13 to 2.05), RD –0.14 
(95% CI –0.42 to 0.14)
Statistically significant
Values not reported, but 
significant heterogeneity 
for the following outcomes 
meant that the random effect 
model was used:
Intraventricular haemorrhage 
(any)
Retinopathy of prematurity 
(any)
Chronic lung disease (at 36 
weeks)
RR 1.20 (95% CI 0.71 to 2.01), RD 
0.05 (95% CI –0.08 to 0.18)
Not statistically significant
Values not reported, but 
random-effects model not 
used for any outcome, 
therefore it can be assumed 
that there was no significant 
statistical heterogeneity
Intraventricular haemorrhage (severe) RR 0.39 (95% CI 0.15 to 1.00), RD –0.13 
(95% CI –0.26 to –0.01)
RR 0.93 (95% CI 0.17 to 5.17), RD 
–0.001 (95% CI –0.05 to 0.05)
Patent ductus arteriosus RR 0.95 (95% CI 0.65 to 1.41), RD –0.02 
(95% CI –0.20 to 0.16)
RR 0.71 (95% CI 0.35 to 1.42), RD 
–0.07 (95% CI –0.21 to 0.07)
Necrotising enterocolitis RR 0.21 (95% CI 0.01 to 4.10), RD –0.07 
(95% CI –0.19 to 0.06)
RR 0.48 (95% CI 0.13 to 1.85), RD 
–0.05 (95% CI –0.14 to 0.04)
Retinopathy of prematurity (any) RR 0.84 (95% CI 0.64 to 1.12), RD –0.09 
(95% CI –0.24 to 0.06)
RR 5.16 (95% CI 1.58 to 16.84), RD 
0.21 (95% CI 0.08 to 0.33)
Retinopathy of prematurity (severe) RR 0.75 (95% CI 0.41 to 1.37), RD –0.07 
(95% CI –0.21 to 0.07)
RR 0.97 (95% CI 0.06 to 15.14), RD 
–0.001 (95% CI –0.05 to 0.04)
Pneumothorax RR 0.15 (95% CI 0.02 to 1.13), RD –0.28 
(95% CI –0.52 to –0.05)
RR 0.65 (95% CI 0.11 to 3.73), RD 
–0.02 (95% CI –0.09 to 0.05)
Chronic lung disease (28 days) RR 1.08 (95% CI 0.84 to 1.39), RD 0.04 
(95% CI –0.09 to 0.16)
RR 0.50 (95% CI 0.30 to 0.83), RD 
–0.17 (95% CI –0.28 to –0.05)
Chronic lung disease (36 weeks) RR 0.26 (95% CI 0.00 to 25.40), RD 
–0.39 (95% CI –1.04 to 0.26)
RR 0.65 (95% CI 0.11 to 3.73), RD 
–0.02 (95% CI –0.09 to 0.05)
Neurodevelopment 9–12 months 
(cognitive)
WMD 16.58 (95% CI 9.33 to 23.82) MD 45.24 (95% CI 35.92 to 54.56)
Neurodevelopment 9–12 months 
(motor)
WMD 9.24 (95% CI 0.68 to 17.81) MD 13.70 (95% CI –0.34 to 27.74)
Duration (days) ventilation WMD –25.70 (95% CI –43.94 to –7.46) WMD –4.67 (95% CI –10.85 to 
1.51)
Duration (days) supplemental oxygen WMD –41.06 (95% CI –65.29 to –16.83) WMD –6.64 (95% CI –12.73 to 
–0.55)
Duration (days) hospitalization WMD –18.38 (95% CI –44.13 to 7.37) WMD –4.83 (95% CI –12.82 to 
3.16)
Weight gain (g/day) WMD 3.24 (95% CI 0.57 to 5.92) MD –3.46 (95% CI –6.69 to –0.23)
Days to full oral feeds MD –44.90 (95% CI –86.12 to –3.68) WMD –14.73 (95% CI –23.45 to 
–6.02)
Gestation at discharge WMD –0.41(95% CI –1.28 to 0.47) WMD –0.13 (95% CI –1.14 to 0.88)Appendix 4
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Review
Outcomes with at least one RCT 
and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Mullen, 200293
Country: US
Interventions for sexual risk behaviours 
for HIV among sexually experienced 
adolescents in the US
Composite behavioural risk variable OR 0.58 (95% CI 0.42 to 0.81), p < 0.01 Not reported OR 0.75 (95% CI 0.48 to 1.16), 
p = 0.20
Not reported
Oliver, 2000103
Falls prevention in hospitals
Falls RR 1.0 (95% CI 0.6 to 1.68) Not reported RR 0.76 (95% CI 0.65 to 0.88) Not reported
Smedslund, 2004104
Country: Norway
Worksite smoking cessation 
programmes
6-month follow-up OR 1.74 (95% CI 1.26 to 2.40) Chi-squared test showed 
homogeneity at 6-month 
follow-up
OR 4.65 (95% CI 1.92 to 11.28) Chi-squared test showed 
homogeneity at 6-month 
follow-up
12-month follow-up OR 1.36 (95% CI 1.09 to 1.69) OR 2.58 (95% CI 1.37 to 4.86)
More than 12-month follow-up OR 1.26 (95% CI 0.86 to 1.88) OR 1.38 (95% CI 0.80 to 2.39)
Wilson 200196
Country: US
School-based prevention of crime, 
substance use, dropout/non-attendance 
and other conduct problems
Overall effect size d (42 comparisons) 0.25 (95% CI 0.17 to 
0.33)
Not reported (174 comparisons) 0.08 (95% CI 
0.05 to 0.10)
Not reported
MD, mean difference; OR, odds ratio; RD, risk difference; RR, relative risk; WMD, weighted mean difference.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Outcomes with at least one RCT 
and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Mullen, 200293
Country: US
Interventions for sexual risk behaviours 
for HIV among sexually experienced 
adolescents in the US
Composite behavioural risk variable OR 0.58 (95% CI 0.42 to 0.81), p < 0.01 Not reported OR 0.75 (95% CI 0.48 to 1.16), 
p = 0.20
Not reported
Oliver, 2000103
Falls prevention in hospitals
Falls RR 1.0 (95% CI 0.6 to 1.68) Not reported RR 0.76 (95% CI 0.65 to 0.88) Not reported
Smedslund, 2004104
Country: Norway
Worksite smoking cessation 
programmes
6-month follow-up OR 1.74 (95% CI 1.26 to 2.40) Chi-squared test showed 
homogeneity at 6-month 
follow-up
OR 4.65 (95% CI 1.92 to 11.28) Chi-squared test showed 
homogeneity at 6-month 
follow-up
12-month follow-up OR 1.36 (95% CI 1.09 to 1.69) OR 2.58 (95% CI 1.37 to 4.86)
More than 12-month follow-up OR 1.26 (95% CI 0.86 to 1.88) OR 1.38 (95% CI 0.80 to 2.39)
Wilson 200196
Country: US
School-based prevention of crime, 
substance use, dropout/non-attendance 
and other conduct problems
Overall effect size d (42 comparisons) 0.25 (95% CI 0.17 to 
0.33)
Not reported (174 comparisons) 0.08 (95% CI 
0.05 to 0.10)
Not reported
MD, mean difference; OR, odds ratio; RD, risk difference; RR, relative risk; WMD, weighted mean difference.Appendix 4
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Appendix 4.8: Similarity of RCTs and NRSs, where 
authors judged results to be MIXED
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Guyatt, 200091
Country: Canada
Interventions to 
prevent adolescent 
pregnancy
No No No No Authors discuss 
differences between 
randomised and non-
randomised studies and 
stated a priori to explore 
study design as a possible 
determinant of outcome
A z-score was used 
to generate a p-value 
related to the null 
hypothesis that there 
were no real differences 
in results from 
observational studies 
and randomised trials
No. Observational studies give significant result for six of eight 
outcomes: initiation of intercourse and responsible sexual behaviour 
(males and females) and pregnancy and birth control use (females), 
where randomised trials do not 
(No. Statistically significant differences observed between randomised 
and non-randomised designs for: females: initiation of intercourse 
(p = 0.01), pregnancy (p = 0.02); males: no significant differences were 
found)
Authors state that relying on observational studies leads to the 
conclusion that the interventions have a positive effect, while relying 
on results from RCTs leads to the conclusion that the evidence does 
not support a positive effect on any outcome
Thomas, 200394
Country: UK
Barriers to and 
facilitators of 
healthy eating
No obvious differences No rationale stated No rationale stated Yes
Children’s knowledge of fruit and vegetables: ‘no significant differential 
effect size, with negligible heterogeneity (Q = 0.146, df = 1, p = 0.702) 
being explained by this subdivision of studies’
Children’s self efficacy: increased effect size for RCTs compared with 
CTs, but the analogue to the ANOVA does not show that significant 
heterogeneity was explained by this subgroup analysis (Q = 1.292, 
df = 1, p = 0.257) so no conclusions can be drawn
Children’s consumption of vegetables: heterogeneity not explained 
by subdivision by randomisation (Q = 0.801, df = 1, p = 0.371). 
Consumption of fruit and vegetables: ‘little difference between the 
two groups of studies… no significant difference is explained by this 
analysis (Q = 0.061, df = 1, p = 0.805), with significant heterogeneity still 
remaining’
No
Children’s consumption of fruit: very little effect reported by the 
seven RCTs, whereas the three CTs increased fruit consumption by 
nearly two thirds of a serving per day. Heterogeneity explained by 
subgroup analysis is significant at p < 0.1 (Q = 3.738, df = 1, p = 0.0523), 
leaving less residual heterogeneity within the groups (Q = 9.398, df = 8, 
p = 0.31). However, numbers are small for definitive conclusions
[Yes
Knowledge of fruit and vegetables
Consumption of fruit and vegetables
No
Self-efficacy – greater effect in RCTs
Consumption of fruit – greater effect in NRSs
Consumption of vegetables – greater effect in NRSs
Unclear
Preferences for fruit and vegetables (small number of studies)]DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
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Appendix 4.8: Similarity of RCTs and NRSs, where 
authors judged results to be MIXED
Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Guyatt, 200091
Country: Canada
Interventions to 
prevent adolescent 
pregnancy
No No No No Authors discuss 
differences between 
randomised and non-
randomised studies and 
stated a priori to explore 
study design as a possible 
determinant of outcome
A z-score was used 
to generate a p-value 
related to the null 
hypothesis that there 
were no real differences 
in results from 
observational studies 
and randomised trials
No. Observational studies give significant result for six of eight 
outcomes: initiation of intercourse and responsible sexual behaviour 
(males and females) and pregnancy and birth control use (females), 
where randomised trials do not 
(No. Statistically significant differences observed between randomised 
and non-randomised designs for: females: initiation of intercourse 
(p = 0.01), pregnancy (p = 0.02); males: no significant differences were 
found)
Authors state that relying on observational studies leads to the 
conclusion that the interventions have a positive effect, while relying 
on results from RCTs leads to the conclusion that the evidence does 
not support a positive effect on any outcome
Thomas, 200394
Country: UK
Barriers to and 
facilitators of 
healthy eating
No obvious differences No rationale stated No rationale stated Yes
Children’s knowledge of fruit and vegetables: ‘no significant differential 
effect size, with negligible heterogeneity (Q = 0.146, df = 1, p = 0.702) 
being explained by this subdivision of studies’
Children’s self efficacy: increased effect size for RCTs compared with 
CTs, but the analogue to the ANOVA does not show that significant 
heterogeneity was explained by this subgroup analysis (Q = 1.292, 
df = 1, p = 0.257) so no conclusions can be drawn
Children’s consumption of vegetables: heterogeneity not explained 
by subdivision by randomisation (Q = 0.801, df = 1, p = 0.371). 
Consumption of fruit and vegetables: ‘little difference between the 
two groups of studies… no significant difference is explained by this 
analysis (Q = 0.061, df = 1, p = 0.805), with significant heterogeneity still 
remaining’
No
Children’s consumption of fruit: very little effect reported by the 
seven RCTs, whereas the three CTs increased fruit consumption by 
nearly two thirds of a serving per day. Heterogeneity explained by 
subgroup analysis is significant at p < 0.1 (Q = 3.738, df = 1, p = 0.0523), 
leaving less residual heterogeneity within the groups (Q = 9.398, df = 8, 
p = 0.31). However, numbers are small for definitive conclusions
[Yes
Knowledge of fruit and vegetables
Consumption of fruit and vegetables
No
Self-efficacy – greater effect in RCTs
Consumption of fruit – greater effect in NRSs
Consumption of vegetables – greater effect in NRSs
Unclear
Preferences for fruit and vegetables (small number of studies)]Appendix 4
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Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Wilson, 200397
Country: US
Objective: school-
based intervention 
programmes for 
preventing or 
reducing aggressive 
behaviour
Insufficient detail given Randomised, quasi-
randomised (meaning 
non-randomised 
controlled study) and 
before–after (pre–post 
test) studies all pooled in 
the same analysis
Study design was 
investigated as a 
moderator variable in 
regression analysis
Not stated Yes
‘The final reduced regression model accounted for 28% of the 
variance in re-post-test change effect sizes for subject samples 
receiving intervention.   Among the variables relating to study method 
and procedure, two variables representing the different study designs 
were included in the model, randomized designs and one-group 
designs. One-group designs were associated with larger pre-post-
test effect sizes (in comparison to nonrandomized designs, but the 
randomized design variable was not significant. That is, with the 
other variables in the model held constant, randomized designs did 
not produce different effect sizes than nonrandomized designs. The 
nonrandomized designs produce results for both observed and 
equated effect estimates that generally agree with the randomized 
results for social competence training with a cognitive-behavioural 
component’
No
‘However, the nonrandomized designs yield lower effect estimates 
than the randomized designs for social competence training without a 
cognitive-behavioural component and higher estimates for behavioural 
strategies, creating inconsistent patterns for each’
(Yes for some outcomes
No for some outcomes)
ANOVA, analysis of variance; CT, computed tomography.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
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Review
Obvious differences between RCTs and NRSs, in reviewers’/authors’ opinion? Rationale for pooling 
RCTs and NRSs 
separately
Criteria used to 
judge equivalence 
Authors’ conclusions regarding similarity of RCTs and NRSs 
(reviewer’s opinion) Population Intervention Comparator Outcomes
Wilson, 200397
Country: US
Objective: school-
based intervention 
programmes for 
preventing or 
reducing aggressive 
behaviour
Insufficient detail given Randomised, quasi-
randomised (meaning 
non-randomised 
controlled study) and 
before–after (pre–post 
test) studies all pooled in 
the same analysis
Study design was 
investigated as a 
moderator variable in 
regression analysis
Not stated Yes
‘The final reduced regression model accounted for 28% of the 
variance in re-post-test change effect sizes for subject samples 
receiving intervention.   Among the variables relating to study method 
and procedure, two variables representing the different study designs 
were included in the model, randomized designs and one-group 
designs. One-group designs were associated with larger pre-post-
test effect sizes (in comparison to nonrandomized designs, but the 
randomized design variable was not significant. That is, with the 
other variables in the model held constant, randomized designs did 
not produce different effect sizes than nonrandomized designs. The 
nonrandomized designs produce results for both observed and 
equated effect estimates that generally agree with the randomized 
results for social competence training with a cognitive-behavioural 
component’
No
‘However, the nonrandomized designs yield lower effect estimates 
than the randomized designs for social competence training without a 
cognitive-behavioural component and higher estimates for behavioural 
strategies, creating inconsistent patterns for each’
(Yes for some outcomes
No for some outcomes)
ANOVA, analysis of variance; CT, computed tomography.Appendix 4
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Appendix 4.9: Results of RCTs and NRSs, where authors judged results  
to be MIXED
Review
Outcomes with at least 
one RCT and NRS Results of RCTs Heterogeneity test Results of NRSs Heterogeneity test Author comment
Guyatt, 200091
Country: Canada
Interventions to prevent 
adolescent pregnancy
Females: Not investigated Not investigated
Initiation of intercourse Pooled OR 1.09 (95% CI 0.90 to 1.32) Pooled OR 0.64 (95% CI 0.44 to 0.93)
Pregnancy Pooled OR 1.08 (95% CI 0.91 to 1.27) Pooled OR 0.74 (95% CI 0.56 to 0.98)
Responsible sexual behaviour Pooled OR 1.01 (95% CI 0.75 to 1.36) Pooled OR 1.27 (95% CI 1.10 to 1.46)
Birth control use Pooled OR 0.99 (95% CI 0.64 to 1.54) Pooled OR 1.38 (95% CI 1.18 to 1.60)
Males:
Initiation of intercourse Pooled OR 0.81 (95% CI 0.35 to 1.90) Pooled OR 0.71 (95% CI 0.52 to 0.98)
Pregnancy Pooled OR 0.97 (95% CI 0.62 to 1.51) Pooled OR 0.85 (95% CI 0.68 to 1.06)
Responsible sexual behaviour Pooled OR 0.94 (95% CI 0.55 to 1.60) Pooled OR 1.21 (95% CI 1.04 to 1.42)
Birth control use Pooled OR 0.91 (95% CI 0.71 to 1.18) Pooled OR 0.82 (95% CI 0.35 to 1.91)
Thomas, 200394
Country: UK
Barriers to and 
facilitators of healthy 
eating
Children’s knowledge of fruit 
and vegetables
Effect size 0.68 Not reported Effect size 0.63 Not reported
Children’s self-efficacy Effect size 0.12 (95% CI 0.02 to 0.22) Effect size 0.09 (95% CI 0.00 to 0.16)
Children’s consumption of 
fruit
Effect size 0.09 (95% CI 0.02 to 0.16) Effect size 0.38 (95% CI 0.09 to 0.67)
Children’s consumption of 
vegetables
Effect size 0.18 (95% CI 0.11 to 0.26) Effect size 0.27 (95% CI 0.10 to 0.43)
Consumption of fruit and 
vegetables
Effect size 0.16 (95% CI 0.08 to 0.24) Effect size 0.14 (95% CI 0.00 to 0.27)
Wilson, 200397
Country: US
Objective: school-
based intervention 
programmes for 
preventing or reducing 
aggressive behaviour
Overall effect size
ES – Control (n), ES – 
Intervention (n)
Difference observed, equated:
0.32 (p < 0.05)
Focal randomised studies effect size 0.31 
(p < 0.05)
Not reported 0.16 (p < 0.05)
Focal non-randomised effect size 0.16 
(p < 0.05)
Not reported Heterogeneity for all studies was 
statistically significant ‘using fixed effects 
q tests, we found that none of the ES 
distributions represented in the means 
were homogeneous’
Social competence, no 
cognitive behavioural
–0.02 (15), 0.33 (15), 0.35, 0.30 –0.00 (37), 0.07 (37), 0.07, 0.15
Social competence, cognitive 
behavioural
0.01 (26), 0.37 (26) 0.36, 0.24 –0.14 (17), 0.09 (17), 0.23, 0.34
Behavioural, classroom 
management
0.25 (11), 0.43 (11), 0.18, 0.08 –0.19 (7), 0.24 (7), 0.43, 0.37
Therapy, counselling –0.04 (11), 0.25 (11), 0.29, 0.34 0.14 (5), 0.43 (5), 0.29, 0.34
Multimodal –0.02 (1), –0.15 (1), –0.13, –0.04 –0.01 (16), 0.03 (16), 0.04, 0.20
ES, effect size; OR, odds ratio.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
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Country: US
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based intervention 
programmes for 
preventing or reducing 
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Overall effect size
ES – Control (n), ES – 
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Difference observed, equated:
0.32 (p < 0.05)
Focal randomised studies effect size 0.31 
(p < 0.05)
Not reported 0.16 (p < 0.05)
Focal non-randomised effect size 0.16 
(p < 0.05)
Not reported Heterogeneity for all studies was 
statistically significant ‘using fixed effects 
q tests, we found that none of the ES 
distributions represented in the means 
were homogeneous’
Social competence, no 
cognitive behavioural
–0.02 (15), 0.33 (15), 0.35, 0.30 –0.00 (37), 0.07 (37), 0.07, 0.15
Social competence, cognitive 
behavioural
0.01 (26), 0.37 (26) 0.36, 0.24 –0.14 (17), 0.09 (17), 0.23, 0.34
Behavioural, classroom 
management
0.25 (11), 0.43 (11), 0.18, 0.08 –0.19 (7), 0.24 (7), 0.43, 0.37
Therapy, counselling –0.04 (11), 0.25 (11), 0.29, 0.34 0.14 (5), 0.43 (5), 0.29, 0.34
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c
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h
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o
 
t
e
l
l
 
a
s
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n
t
e
r
v
e
n
t
i
o
n
s
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d
 
o
u
t
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o
m
e
s
 
d
i
f
f
e
r
e
d
 
b
e
t
w
e
e
n
 
a
l
l
 
s
t
u
d
i
e
s
A
u
t
h
o
r
s
 
c
h
o
s
e
 
n
a
r
r
a
t
i
v
e
,
 
r
a
t
h
e
r
 
t
h
a
n
 
q
u
a
n
t
i
t
a
t
i
v
e
,
 
s
y
n
t
h
e
s
i
s
 
b
e
c
a
u
s
e
 
t
h
e
y
 
e
x
p
e
c
t
e
d
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
i
n
 
t
h
e
 
s
t
u
d
y
 
d
e
s
i
g
n
s
,
 
t
y
p
e
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
a
n
d
 
o
u
t
c
o
m
e
s
 
m
e
a
s
u
r
e
d
.
 
T
h
e
y
 
s
t
a
t
e
 
t
h
a
t
 
g
r
e
a
t
e
r
 
w
e
i
g
h
t
 
w
a
s
 
g
i
v
e
n
 
t
o
 
c
o
n
t
r
o
l
l
e
d
 
s
t
u
d
i
e
s
W
e
i
g
a
n
d
,
 
2
0
0
1
1
6
0
1
 
R
C
T
2
 
c
a
s
e
-
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n
d
i
n
g
 
s
t
u
d
i
e
s
F
a
l
l
 
p
r
e
v
e
n
t
i
o
n
 
p
r
o
g
r
a
m
m
e
s
P
o
l
i
c
y
 
f
o
r
 
a
n
 
i
n
s
t
i
t
u
t
i
o
n
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e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
E
m
e
r
g
e
n
c
y
 
d
e
p
a
r
t
m
e
n
t
 
p
a
t
i
e
n
t
s
 
>
 
6
4
 
y
e
a
r
s
N
o
 
d
e
t
a
i
l
s
.
 
T
h
e
 
R
C
T
 
w
a
s
 
a
b
o
u
t
 
p
r
e
v
e
n
t
i
n
g
 
f
a
l
l
s
 
i
n
 
p
a
t
i
e
n
t
s
 
w
h
o
 
h
a
d
 
a
l
r
e
a
d
y
 
e
x
p
e
r
i
e
n
c
e
d
 
a
 
f
a
l
l
;
 
t
h
e
 
t
w
o
 
c
a
s
e
-
fi
n
d
i
n
g
 
s
t
u
d
i
e
s
 
w
e
r
e
 
a
b
o
u
t
 
i
d
e
n
t
i
f
y
i
n
g
 
p
a
t
i
e
n
t
s
 
a
t
 
r
i
s
k
 
o
f
 
f
a
l
l
i
n
g
N
o
 
r
a
t
i
o
n
a
l
e
 
s
t
a
t
e
d
W
e
i
r
,
 
1
9
9
9
1
6
1
1
1
 
R
C
T
s
5
 
N
R
S
s
(
+
3
 
c
o
s
t
 
s
t
u
d
i
e
s
)
E
a
r
l
y
 
d
i
s
c
h
a
r
g
e
 
a
n
d
 
c
o
m
m
u
n
i
t
y
 
s
u
p
p
o
r
t
 
i
n
 
t
h
e
 
m
a
n
a
g
e
m
e
n
t
 
o
f
 
p
a
t
i
e
n
t
s
 
f
o
l
l
o
w
i
n
g
 
a
 
s
t
r
o
k
e
P
o
l
i
c
y
 
f
o
r
 
a
 
c
o
m
m
u
n
i
t
y
/
i
n
s
t
i
t
u
t
i
o
n
P
a
t
i
e
n
t
s
 
w
h
o
 
h
a
v
e
 
h
a
d
 
a
 
s
t
r
o
k
e
,
 
a
n
d
 
t
h
e
i
r
 
c
a
r
e
g
i
v
e
r
s
N
o
,
 
b
u
t
 
n
o
t
 
m
a
n
y
 
d
e
t
a
i
l
s
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
 
g
i
v
e
n
 
s
o
 
c
a
n
n
o
t
 
b
e
 
s
u
r
e
.
 
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
s
a
m
p
l
e
 
s
i
z
e
 
o
r
 
l
e
n
g
t
h
 
o
f
 
f
o
l
l
o
w
-
u
p
N
o
 
r
a
t
i
o
n
a
l
e
 
s
t
a
t
e
d
 
f
o
r
 
n
o
t
 
p
o
o
l
i
n
g
 
s
t
u
d
y
 
d
e
s
i
g
n
s
.
 
S
t
a
t
e
s
 
t
h
a
t
 
a
l
t
h
o
u
g
h
 
R
C
T
s
 
a
r
e
 
u
s
u
a
l
l
y
 
b
e
s
t
 
a
b
l
e
 
t
o
 
r
e
d
u
c
e
 
e
f
f
e
c
t
s
 
o
f
 
b
i
a
s
 
a
n
d
 
c
o
n
f
o
u
n
d
i
n
g
,
 
t
h
e
 
m
o
s
t
 
i
m
p
o
r
t
a
n
t
 
d
e
t
e
r
m
i
n
a
n
t
 
o
f
 
s
t
u
d
y
 
v
a
l
i
d
i
t
y
 
i
s
 
t
h
e
 
r
i
g
o
u
r
 
a
p
p
l
i
e
d
 
t
o
 
i
t
s
 
d
e
s
i
g
n
 
a
n
d
 
a
n
a
l
y
s
i
s
 
a
n
d
 
n
o
t
 
n
e
c
e
s
s
a
r
i
l
y
 
t
h
e
 
t
y
p
e
 
o
f
 
s
t
u
d
y
 
d
e
s
i
g
n
 
u
s
e
d
.
 
A
l
s
o
,
 
c
e
r
t
a
i
n
 
s
t
u
d
y
 
d
e
s
i
g
n
s
 
a
r
e
 
m
o
r
e
 
a
p
p
r
o
p
r
i
a
t
e
 
f
o
r
 
p
a
r
t
i
c
u
l
a
r
 
i
s
s
u
e
s
C
C
T
,
 
c
l
i
n
i
c
a
l
 
c
o
n
t
r
o
l
l
e
d
 
t
r
i
a
l
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–
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R
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s
u
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–
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R
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s
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e
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t
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r
e
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i
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w
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/
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o
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S
u
f
fi
c
i
e
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t
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a
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a
l
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e
k
k
e
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,
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t
h
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r
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e
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p
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e
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f
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s
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r
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e
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o
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a
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s
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k
i
n
g
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s
p
a
r
a
t
e
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e
c
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s
,
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n
d
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h
o
w
 
t
h
e
 
i
m
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o
r
t
a
n
c
e
 
o
f
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h
e
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o
n
t
e
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t
 
a
n
d
 
s
o
c
i
a
l
 
i
n
fl
u
e
n
c
e
s
 
o
n
 
i
n
d
i
v
i
d
u
a
l
’
s
 
d
e
c
i
s
i
o
n
-
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k
i
n
g
N
o
t
 
r
e
p
o
r
t
e
d
 
f
o
r
 
N
R
S
(
R
e
v
i
e
w
e
r
)
 
C
a
n
n
o
t
 
t
e
l
l
(
A
u
t
h
o
r
)
 
N
o
t
 
s
t
a
t
e
d
N
o
B
o
r
d
l
e
y
,
 
2
0
0
0
1
0
9
C
h
i
l
d
r
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:
 
o
n
e
 
R
C
T
 
f
o
u
n
d
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
s
A
d
u
l
t
s
:
 
t
h
r
e
e
 
o
f
 
f
o
u
r
 
R
C
T
s
 
r
e
p
o
r
t
e
d
 
p
o
s
i
t
i
v
e
 
e
f
f
e
c
t
s
C
h
i
l
d
r
e
n
:
 
f
o
u
r
 
N
R
S
s
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
A
d
u
l
t
s
:
 
fi
v
e
 
o
f
 
s
i
x
 
N
R
S
s
 
r
e
p
o
r
t
e
d
 
p
o
s
i
t
i
v
e
 
e
f
f
e
c
t
s
(
R
e
v
i
e
w
e
r
)
 
N
R
S
s
 
t
e
n
d
e
d
 
t
o
 
h
a
v
e
 
l
a
r
g
e
 
%
 
i
n
c
r
e
a
s
e
s
 
i
n
 
i
m
m
u
n
i
s
a
t
i
o
n
 
r
a
t
e
s
 
(
e
.
g
.
 
+
 
5
0
%
 
i
n
 
o
n
e
 
s
t
u
d
y
)
.
 
R
C
T
s
 
h
a
d
 
m
o
d
e
s
t
 
i
n
c
r
e
a
s
e
s
 
i
n
 
c
o
m
p
a
r
i
s
o
n
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o
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r
o
l
s
 
(
t
y
p
i
c
a
l
l
y
 
u
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o
 
2
0
%
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r
e
n
c
e
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.
 
B
u
t
 
c
o
m
p
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r
i
s
o
n
 
w
a
s
 
d
i
f
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c
u
l
t
 
a
s
 
n
o
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e
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f
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e
 
N
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S
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d
 
c
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l
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u
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A
u
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h
o
r
)
 
N
o
t
 
s
t
a
t
e
d
P
r
o
b
a
b
l
y
 
n
o
t
.
 
 
A
b
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o
l
u
t
e
 
c
h
a
n
g
e
s
 
i
n
 
i
m
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u
n
i
s
a
t
i
o
n
 
r
a
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p
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e
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u
d
y
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o
u
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,
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n
 
t
e
r
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s
 
o
f
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e
r
c
e
n
t
a
g
e
s
.
 
P
r
o
b
a
b
l
y
 
w
o
u
l
d
 
n
e
e
d
 
t
h
e
 
n
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s
 
t
o
 
b
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e
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r
e
-
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n
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y
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l
l
e
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1
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1
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c
a
t
e
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r
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u
d
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p
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p
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c
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p
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b
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p
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c
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c
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c
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c
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c
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p
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c
a
s
e
s
 
a
t
t
i
t
u
d
e
s
 
a
n
d
 
s
u
n
 
p
r
o
t
e
c
t
i
o
n
 
b
e
h
a
v
i
o
u
r
M
u
l
t
i
-
u
n
i
t
 
p
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c
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p
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c
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c
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c
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r
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c
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i
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w
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p
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w
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p
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s
.
 
W
h
e
r
e
 
t
h
e
y
 
d
i
d
 
a
f
f
e
c
t
 
t
h
e
 
r
e
s
u
l
t
s
 
i
t
 
w
a
s
 
o
f
t
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n
 
i
n
 
l
e
s
s
e
n
i
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g
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e
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r
 
s
i
g
n
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n
c
e
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r
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e
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u
c
i
n
g
 
t
h
e
 
m
a
g
n
i
t
u
d
e
 
o
f
 
t
h
e
 
fi
n
d
i
n
g
’
Y
e
s
.
 
M
e
a
n
s
 
(
S
D
s
)
 
g
i
v
e
n
 
f
o
r
 
R
C
T
s
 
a
n
d
 
n
o
n
 
R
C
T
s
 
(
s
e
e
 
p
a
g
e
s
 
5
9
/
6
0
)
R
e
g
r
e
s
s
i
o
n
 
a
n
a
l
y
s
i
s
 
a
l
s
o
 
p
e
r
f
o
r
m
e
d
 
s
t
r
a
t
i
fi
e
d
 
a
c
c
o
r
d
i
n
g
 
t
o
 
R
C
T
/
n
R
C
T
 
e
x
p
l
o
r
i
n
g
 
e
f
f
e
c
t
 
o
f
 
d
u
r
a
t
i
o
n
 
o
f
 
f
o
l
l
o
w
-
u
p
 
a
n
d
 
y
e
a
r
 
o
f
 
p
u
b
l
i
c
a
t
i
o
n
A
p
p
e
n
d
i
x
 
4
.
1
2
:
 
R
e
s
u
l
t
s
 
o
f
 
s
y
s
t
e
m
a
t
i
c
 
r
e
v
i
e
w
s
 
o
f
 
p
o
l
i
c
y
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
r
e
p
o
r
t
i
n
g
 
n
a
r
r
a
t
i
v
e
 
s
y
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t
h
e
s
e
s
 
o
f
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o
t
h
 
R
C
T
s
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n
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R
e
v
i
e
w
R
e
s
u
l
t
s
 
–
 
R
C
T
s
R
e
s
u
l
t
s
 
–
 
N
R
S
s
R
e
s
u
l
t
s
 
j
u
d
g
e
d
 
e
q
u
i
v
a
l
e
n
t
 
(
r
e
v
i
e
w
e
r
/
a
u
t
h
o
r
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
C
h
e
s
n
u
t
,
 
1
9
9
9
1
1
2
I
n
 
s
t
u
d
i
e
s
 
o
f
 
c
o
g
n
i
t
i
v
e
 
r
e
h
a
b
i
l
i
t
a
t
i
o
n
,
 
R
C
T
s
 
s
u
p
p
o
r
t
e
d
 
u
s
e
 
o
f
 
a
i
d
s
 
t
o
 
m
e
m
o
r
y
I
n
 
s
t
u
d
i
e
s
 
o
f
 
c
o
g
n
i
t
i
v
e
 
r
e
h
a
b
i
l
i
t
a
t
i
o
n
,
 
t
r
i
a
l
s
 
h
a
d
 
‘
m
i
x
e
d
 
r
e
s
u
l
t
s
’
.
 
W
e
a
k
 
e
v
i
d
e
n
c
e
 
t
h
a
t
 
e
a
r
l
y
 
r
e
h
a
b
i
l
i
t
a
t
i
o
n
 
d
u
r
i
n
g
 
a
c
u
t
e
 
a
d
m
i
s
s
i
o
n
 
r
e
d
u
c
e
s
 
r
e
h
a
b
i
l
i
t
a
t
i
o
n
 
l
e
n
g
t
h
 
o
f
 
s
t
a
y
.
 
P
r
o
s
p
e
c
t
i
v
e
 
o
b
s
e
r
v
a
t
i
o
n
a
l
 
s
t
u
d
i
e
s
 
s
u
p
p
o
r
t
 
u
s
e
 
o
f
 
s
u
p
p
o
r
t
e
d
 
e
m
p
l
o
y
m
e
n
t
.
 
M
i
x
e
d
 
r
e
s
u
l
t
s
 
f
o
r
 
c
a
s
e
 
m
a
n
a
g
e
m
e
n
t
(
A
u
t
h
o
r
s
)
 
N
o
(
R
e
v
i
e
w
e
r
s
)
 
N
o
N
o
 
(
n
o
t
 
a
l
l
 
s
t
u
d
i
e
s
 
l
i
s
t
e
d
 
i
n
 
d
a
t
a
 
e
x
t
r
a
c
t
i
o
n
 
t
a
b
l
e
s
)
D
i
G
u
i
s
e
p
p
i
,
 
2
0
0
0
1
1
3
S
m
o
k
e
 
a
l
a
r
m
 
o
w
n
e
r
s
h
i
p
 
a
t
 
f
o
l
l
o
w
-
u
p
 
a
p
p
e
a
r
e
d
 
s
o
m
e
w
h
a
t
 
m
o
r
e
 
l
i
k
e
l
y
 
i
n
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
 
g
r
o
u
p
 
(
O
R
 
=
 
1
.
2
6
;
 
9
5
%
 
C
I
 
0
.
8
7
 
t
o
 
1
.
8
2
)
.
 
S
i
m
i
l
a
r
l
y
 
m
o
d
e
s
t
 
p
o
s
i
t
i
v
e
,
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
n
o
n
-
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
s
 
o
n
 
f
u
n
c
t
i
o
n
i
n
g
 
s
m
o
k
e
 
a
l
a
r
m
s
,
 
a
n
d
 
o
n
 
n
e
w
 
a
c
q
u
i
s
i
t
i
o
n
s
 
o
f
 
s
m
o
k
e
 
a
l
a
r
m
s
 
a
n
d
 
f
u
n
c
t
i
o
n
i
n
g
 
s
m
o
k
e
 
a
l
a
r
m
s
,
 
w
e
r
e
 
f
o
u
n
d
.
 
 
A
s
s
u
m
p
t
i
o
n
s
 
o
f
 
a
l
l
 
p
o
s
i
t
i
v
e
 
o
r
 
a
l
l
 
n
e
g
a
t
i
v
e
 
o
u
t
c
o
m
e
s
 
r
e
s
u
l
t
e
d
 
i
n
 
s
i
m
i
l
a
r
 
o
r
 
e
v
e
n
 
s
m
a
l
l
e
r
 
e
f
f
e
c
t
 
e
s
t
i
m
a
t
e
s
F
i
v
e
 
c
o
m
p
l
e
t
e
d
 
N
R
S
s
 
r
e
p
o
r
t
e
d
 
s
m
o
k
e
 
a
l
a
r
m
 
o
u
t
c
o
m
e
s
.
 
T
w
o
 
i
n
v
o
l
v
e
d
 
s
a
f
e
t
y
 
a
d
v
i
c
e
 
d
u
r
i
n
g
 
r
o
u
t
i
n
e
 
c
h
i
l
d
 
h
e
a
l
t
h
 
s
u
r
v
e
i
l
l
a
n
c
e
.
 
R
e
s
u
l
t
s
 
o
f
 
o
n
e
 
o
f
 
t
h
e
s
e
 
w
e
r
e
 
s
i
m
i
l
a
r
 
t
o
 
t
h
o
s
e
 
f
r
o
m
 
r
a
n
d
o
m
i
s
e
d
 
t
r
i
a
l
s
 
r
e
p
o
r
t
e
d
.
 
T
h
e
 
o
t
h
e
r
 
t
r
i
a
l
 
r
e
p
o
r
t
e
d
 
m
o
d
e
s
t
 
e
f
f
e
c
t
s
 
f
r
o
m
 
f
r
e
e
 
s
m
o
k
e
 
a
l
a
r
m
s
 
b
u
t
 
n
o
n
e
 
f
r
o
m
 
c
o
u
n
s
e
l
l
i
n
g
 
a
l
o
n
e
.
 
T
w
o
 
t
r
i
a
l
s
 
o
f
 
c
o
m
m
u
n
i
t
y
 
w
i
d
e
 
e
d
u
c
a
t
i
o
n
 
r
e
p
o
r
t
e
d
 
n
o
 
e
f
f
e
c
t
s
 
o
n
 
a
l
a
r
m
 
o
w
n
e
r
s
h
i
p
 
o
r
 
i
n
s
t
a
l
l
a
t
i
o
n
,
 
b
u
t
,
 
i
n
 
a
 
t
h
i
r
d
 
t
r
i
a
l
,
 
i
n
s
t
a
l
l
a
t
i
o
n
 
o
f
 
f
r
e
e
 
s
m
o
k
e
 
a
l
a
r
m
s
 
i
n
c
r
e
a
s
e
d
 
t
h
e
 
p
r
e
v
a
l
e
n
c
e
 
o
f
 
f
u
n
c
t
i
o
n
i
n
g
 
s
m
o
k
e
 
a
l
a
r
m
s
 
b
y
 
1
9
%
(
R
e
v
i
e
w
e
r
)
 
N
o
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
s
 
w
e
r
e
 
s
e
e
n
 
i
n
 
R
C
T
s
,
 
a
n
d
 
o
n
l
y
 
m
o
d
e
s
t
 
e
f
f
e
c
t
s
 
i
n
 
N
R
S
s
(
A
u
t
h
o
r
)
 
‘
E
v
i
d
e
n
c
e
 
f
r
o
m
 
r
a
n
d
o
m
i
s
e
d
 
c
o
n
t
r
o
l
l
e
d
 
t
r
i
a
l
s
 
i
n
d
i
c
a
t
e
s
 
t
h
a
t
,
 
i
n
 
g
e
n
e
r
a
l
,
 
c
o
u
n
s
e
l
l
i
n
g
 
o
r
 
e
d
u
c
a
t
i
o
n
 
t
o
 
p
r
o
m
o
t
e
 
s
m
o
k
e
 
a
l
a
r
m
s
 
i
s
 
l
i
k
e
l
y
 
t
o
 
h
a
v
e
 
o
n
l
y
 
a
 
m
o
d
e
s
t
 
e
f
f
e
c
t
,
 
i
f
 
a
n
y
,
 
o
n
 
s
m
o
k
e
 
a
l
a
r
m
 
o
w
n
e
r
s
h
i
p
,
 
f
u
n
c
t
i
o
n
,
 
o
r
 
a
c
q
u
i
s
i
t
i
o
n
’
‘
A
l
t
h
o
u
g
h
 
o
b
s
e
r
v
a
t
i
o
n
a
l
 
s
t
u
d
i
e
s
 
s
u
p
p
o
r
t
 
a
 
s
u
b
s
t
a
n
t
i
a
l
 
b
e
n
e
fi
c
i
a
l
 
e
f
f
e
c
t
 
o
f
 
s
m
o
k
e
 
a
l
a
r
m
 
o
w
n
e
r
s
h
i
p
 
o
n
 
fi
r
e
-
r
e
l
a
t
e
d
 
i
n
j
u
r
i
e
s
 
t
h
e
r
e
 
w
e
r
e
 
n
o
 
d
a
t
a
 
f
r
o
m
 
r
a
n
d
o
m
i
s
e
d
 
c
o
n
t
r
o
l
l
e
d
 
t
r
i
a
l
s
 
o
n
 
t
h
e
 
e
f
f
e
c
t
s
 
o
f
 
c
o
u
n
s
e
l
l
i
n
g
 
o
r
 
e
d
u
c
a
t
i
o
n
 
o
n
 
fi
r
e
-
r
e
l
a
t
e
d
 
i
n
j
u
r
i
e
s
’
Y
e
s
:
 
o
w
n
e
r
s
h
i
p
/
i
n
s
t
a
l
l
a
t
i
o
n
 
r
a
t
e
s
 
p
r
o
v
i
d
e
d
 
i
n
 
t
a
b
l
e
s
 
f
o
r
 
N
R
S
s
 
(
n
u
m
b
e
r
s
/
p
e
r
c
e
n
t
a
g
e
s
)
.
 
R
C
T
s
 
w
e
r
e
 
p
o
o
l
e
d
 
a
n
y
w
a
y
D
o
b
b
i
n
s
,
 
1
9
9
9
1
2
6
N
/
A
N
/
A
C
a
n
n
o
t
 
t
e
l
l
N
o
 
(
c
a
n
n
o
t
 
t
e
l
l
 
w
h
i
c
h
 
s
t
u
d
i
e
s
 
w
e
r
e
 
R
C
T
s
 
a
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d
 
w
h
i
c
h
 
N
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S
s
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D
r
a
p
e
r
,
 
2
0
0
0
1
1
5
O
f
 
t
h
r
e
e
 
t
r
i
a
l
s
 
i
n
 
p
e
o
p
l
e
 
n
o
t
 
r
e
f
e
r
r
e
d
 
f
o
r
 
m
e
n
t
a
l
 
d
i
s
o
r
d
e
r
s
,
 
t
w
o
 
s
h
o
w
e
d
 
a
 
p
o
s
i
t
i
v
e
 
e
f
f
e
c
t
.
 
O
f
 
s
i
x
 
t
r
i
a
l
s
 
i
n
 
p
e
o
p
l
e
 
w
i
t
h
 
m
e
n
t
a
l
 
d
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s
o
r
d
e
r
s
,
 
f
o
u
r
 
s
h
o
w
e
d
 
a
 
p
o
s
i
t
i
v
e
 
e
f
f
e
c
t
I
n
 
a
l
l
 
s
t
u
d
i
e
s
,
 
i
m
p
r
o
v
e
m
e
n
t
 
w
a
s
 
s
e
e
n
 
i
n
 
d
e
p
r
e
s
s
e
d
 
p
a
t
i
e
n
t
s
I
n
 
t
h
r
e
e
 
s
t
u
d
i
e
s
,
 
p
a
t
i
e
n
t
s
 
w
i
t
h
 
d
e
m
e
n
t
i
a
 
d
i
d
 
n
o
t
 
i
m
p
r
o
v
e
 
o
r
 
o
n
l
y
 
i
m
p
r
o
v
e
d
 
s
l
i
g
h
t
l
y
(
A
u
t
h
o
r
)
 
‘
I
n
 
s
u
m
m
a
r
y
,
 
t
h
e
 
m
a
j
o
r
i
t
y
 
o
f
 
R
C
T
s
 
a
n
d
 
a
u
d
i
t
s
 
o
f
 
a
c
u
t
e
 
t
r
e
a
t
m
e
n
t
 
o
u
t
c
o
m
e
s
 
i
n
d
i
c
a
t
e
 
t
h
a
t
 
c
o
m
m
u
n
i
t
y
 
o
l
d
 
a
g
e
 
p
s
y
c
h
i
a
t
r
y
 
s
e
r
v
i
c
e
s
 
a
r
e
 
e
f
f
e
c
t
i
v
e
’
(
R
e
v
i
e
w
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r
)
 
N
R
S
s
 
s
e
e
m
 
t
o
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o
w
 
a
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r
e
 
c
o
n
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n
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R
e
v
i
e
w
R
e
s
u
l
t
s
 
–
 
R
C
T
s
R
e
s
u
l
t
s
 
–
 
N
R
S
s
R
e
s
u
l
t
s
 
j
u
d
g
e
d
 
e
q
u
i
v
a
l
e
n
t
 
(
r
e
v
i
e
w
e
r
/
a
u
t
h
o
r
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
E
m
m
o
n
s
,
 
2
0
0
1
1
1
6
M
i
x
e
d
 
r
e
s
u
l
t
s
.
 
O
n
e
 
R
C
T
 
r
e
p
o
r
t
e
d
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
s
 
o
n
 
s
e
l
f
-
r
e
p
o
r
t
e
d
 
e
x
p
o
s
u
r
e
 
r
e
d
u
c
t
i
o
n
,
 
t
h
e
 
o
t
h
e
r
 
t
w
o
 
r
e
p
o
r
t
e
d
 
n
o
 
d
i
f
f
e
r
e
n
c
e
 
i
n
 
o
u
t
c
o
m
e
s
M
i
x
e
d
 
r
e
s
u
l
t
s
.
 
O
n
e
 
N
R
S
 
r
e
p
o
r
t
e
d
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
o
u
t
c
o
m
e
.
 
T
h
e
 
o
t
h
e
r
 
r
e
p
o
r
t
e
d
 
r
e
d
u
c
t
i
o
n
s
 
i
n
 
e
x
p
o
s
u
r
e
(
R
e
v
i
e
w
e
r
)
 
C
a
n
n
o
t
 
t
e
l
l
,
 
s
e
e
m
 
q
u
i
t
e
 
s
i
m
i
l
a
r
(
A
u
t
h
o
r
)
 
N
o
t
 
r
e
p
o
r
t
e
d
N
o
F
a
i
r
b
a
n
k
,
 
2
0
0
0
1
1
7
H
e
a
l
t
h
 
e
d
u
c
a
t
i
o
n
:
 
e
i
g
h
t
 
R
C
T
s
 
r
e
p
o
r
t
i
n
g
 
p
r
i
m
a
r
y
 
o
u
t
c
o
m
e
 
–
 
t
h
r
e
e
 
s
i
g
n
i
fi
c
a
n
t
l
y
 
i
n
 
f
a
v
o
u
r
,
 
f
o
u
r
 
n
o
n
-
s
i
g
n
i
fi
c
a
n
t
 
t
r
e
n
d
 
i
n
 
f
a
v
o
u
r
,
 
o
n
e
 
u
n
c
l
e
a
r
H
e
a
l
t
h
 
s
e
c
t
o
r
 
i
n
i
t
i
a
t
i
v
e
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
(
H
S
I
s
)
 
(
g
e
n
e
r
a
l
)
:
 
o
n
e
 
R
C
T
 
–
 
s
i
g
n
i
fi
c
a
n
t
 
i
n
c
r
e
a
s
e
H
S
I
 
(
U
S
 
W
o
m
e
n
 
I
n
f
a
n
t
s
 
a
n
d
 
C
h
i
l
d
r
e
n
 
P
r
o
g
r
a
m
m
e
)
:
 
t
w
o
 
R
C
T
s
,
 
b
o
t
h
 
s
i
g
n
i
fi
c
a
n
t
l
y
 
i
n
 
f
a
v
o
u
r
H
e
a
l
t
h
 
e
d
u
c
a
t
i
o
n
:
 
f
o
u
r
 
N
R
S
s
 
–
 
t
h
r
e
e
 
o
f
 
f
o
u
r
 
r
e
p
o
r
t
i
n
g
 
p
r
i
m
a
r
y
 
o
u
t
c
o
m
e
 
s
h
o
w
e
d
 
n
o
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
g
r
o
u
p
s
.
 
T
h
r
e
e
 
b
e
f
o
r
e
–
a
f
t
e
r
 
s
t
u
d
i
e
s
 
s
h
o
w
e
d
 
n
o
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
s
H
S
I
s
 
(
g
e
n
e
r
a
l
)
:
 
t
w
o
 
o
f
 
t
h
r
e
e
 
N
R
S
s
 
s
i
g
n
i
fi
c
a
n
t
,
 
o
n
e
 
o
f
 
t
w
o
 
b
e
f
o
r
e
–
a
f
t
e
r
 
s
t
u
d
i
e
s
 
s
i
g
n
i
fi
c
a
n
t
H
S
I
 
(
U
S
 
W
o
m
e
n
 
I
n
f
a
n
t
s
 
a
n
d
 
C
h
i
l
d
r
e
n
 
P
r
o
g
r
a
m
m
e
)
:
 
t
w
o
 
o
f
 
t
h
r
e
e
 
N
R
S
s
 
s
i
g
n
i
fi
c
a
n
t
.
 
F
i
v
e
 
b
e
f
o
r
e
–
a
f
t
e
r
 
s
t
u
d
i
e
s
 
‘
s
u
p
p
o
r
t
e
d
 
fi
n
d
i
n
g
s
 
f
r
o
m
 
t
h
e
 
R
C
T
s
 
a
n
d
 
n
R
C
T
s
’
 
(
n
o
n
e
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
)
(
R
e
v
i
e
w
e
r
)
 
T
h
e
 
r
e
s
u
l
t
s
 
f
o
r
 
R
C
T
s
 
o
f
 
h
e
a
l
t
h
 
e
d
u
c
a
t
i
o
n
 
s
e
e
m
 
t
o
 
b
e
 
m
o
r
e
 
i
n
 
f
a
v
o
u
r
 
o
f
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
 
t
h
a
n
 
t
h
e
 
r
e
s
u
l
t
s
 
o
f
 
N
R
S
s
(
A
u
t
h
o
r
)
 
N
o
t
 
r
e
p
o
r
t
e
d
Y
e
s
 
(
f
o
r
e
s
t
 
p
l
o
t
s
 
p
r
e
s
e
n
t
e
d
 
w
i
t
h
o
u
t
 
p
o
o
l
i
n
g
)
G
i
u
f
f
r
i
d
a
,
 
2
0
0
4
1
1
8
T
h
e
 
P
C
P
s
 
r
e
c
e
i
v
i
n
g
 
t
h
e
 
t
a
r
g
e
t
 
p
a
y
m
e
n
t
 
h
a
d
 
a
n
 
i
n
fl
u
e
n
z
a
 
v
a
c
c
i
n
a
t
i
o
n
 
r
a
t
e
 
5
.
9
%
 
h
i
g
h
e
r
 
t
h
a
n
 
t
h
e
 
c
o
n
t
r
o
l
 
g
r
o
u
p
 
(
t
h
e
 
r
e
l
a
t
i
v
e
 
d
i
f
f
e
r
e
n
c
e
 
w
i
t
h
 
t
h
e
 
c
o
n
t
r
o
l
 
g
r
o
u
p
 
w
a
s
 
9
.
4
%
)
,
 
b
u
t
 
t
h
e
 
d
i
f
f
e
r
e
n
c
e
 
w
a
s
 
n
o
t
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
.
 
T
h
e
 
s
t
u
d
y
 
a
l
s
o
 
r
e
p
o
r
t
e
d
 
t
h
a
t
 
t
h
e
 
c
h
a
n
g
e
 
i
n
 
i
n
fl
u
e
n
z
a
 
v
a
c
c
i
n
a
t
i
o
n
 
r
a
t
e
 
f
r
o
m
 
b
a
s
e
l
i
n
e
 
w
a
s
 
l
a
r
g
e
r
 
i
n
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
 
g
r
o
u
p
.
 
T
h
e
 
d
i
f
f
e
r
e
n
c
e
 
i
n
 
a
b
s
o
l
u
t
e
 
c
h
a
n
g
e
 
f
r
o
m
 
b
a
s
e
l
i
n
e
 
b
e
t
w
e
e
n
 
i
n
t
e
r
v
e
n
t
i
o
n
 
a
n
d
 
c
o
n
t
r
o
l
 
g
r
o
u
p
 
w
a
s
 
6
.
8
%
 
(
9
.
4
%
 
w
a
s
 
t
h
e
 
r
e
l
a
t
i
v
e
 
p
e
r
c
e
n
t
a
g
e
 
c
h
a
n
g
e
)
 
a
n
d
 
w
a
s
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
R
e
p
o
r
t
e
d
 
a
n
 
i
m
p
r
o
v
e
m
e
n
t
 
i
n
 
p
r
i
m
a
r
y
 
a
n
d
 
p
r
e
-
s
c
h
o
o
l
 
i
m
m
u
n
i
s
a
t
i
o
n
 
r
a
t
e
s
 
a
f
t
e
r
 
t
h
e
 
i
n
t
r
o
d
u
c
t
i
o
n
 
o
f
 
t
h
e
 
t
a
r
g
e
t
 
p
a
y
m
e
n
t
 
r
e
m
u
n
e
r
a
t
i
o
n
 
s
y
s
t
e
m
 
i
n
 
t
h
e
 
G
r
a
m
p
i
a
n
 
r
e
g
i
o
n
.
 
F
o
r
 
p
r
i
m
a
r
y
 
i
m
m
u
n
i
s
a
t
i
o
n
s
 
t
h
e
 
p
r
o
p
o
r
t
i
o
n
 
o
f
 
g
e
n
e
r
a
l
 
p
r
a
c
t
i
c
e
s
 
i
m
m
u
n
i
s
i
n
g
 
a
t
 
l
e
a
s
t
 
9
5
%
 
a
n
d
 
9
0
%
 
o
f
 
t
h
e
i
r
 
e
l
i
g
i
b
l
e
 
p
o
p
u
l
a
t
i
o
n
s
 
i
m
p
r
o
v
e
d
 
b
y
 
5
0
%
 
a
n
d
 
2
0
%
 
r
e
s
p
e
c
t
i
v
e
l
y
(
R
e
v
i
e
w
e
r
)
 
C
a
n
n
o
t
 
t
e
l
l
.
 
D
i
f
fi
c
u
l
t
 
t
o
 
c
o
m
p
a
r
e
 
r
e
s
u
l
t
s
 
a
s
 
t
h
e
 
N
R
S
 
w
a
s
 
a
n
 
i
n
t
e
r
r
u
p
t
e
d
 
t
i
m
e
 
s
e
r
i
e
s
 
a
n
d
 
d
o
e
s
 
n
o
t
 
h
a
v
e
 
a
 
c
o
n
t
r
o
l
/
c
o
m
p
a
r
i
s
o
n
 
g
r
o
u
p
(
A
u
t
h
o
r
)
 
‘
T
h
e
 
s
t
u
d
i
e
s
 
s
h
o
w
e
d
 
p
o
s
i
t
i
v
e
 
e
f
f
e
c
t
s
 
f
o
l
l
o
w
i
n
g
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
s
,
 
b
u
t
 
t
h
e
 
i
m
p
r
o
v
e
m
e
n
t
s
 
w
e
r
e
,
 
i
n
 
m
o
s
t
 
o
f
 
t
h
e
 
c
a
s
e
s
,
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
n
o
n
-
s
i
g
n
i
fi
c
a
n
t
,
 
w
h
i
c
h
 
m
a
y
 
b
e
 
i
n
 
p
a
r
t
 
d
u
e
 
t
o
 
t
h
e
 
l
o
w
 
p
o
w
e
r
 
o
f
 
t
h
e
 
s
t
u
d
i
e
s
’
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R
e
v
i
e
w
R
e
s
u
l
t
s
 
–
 
R
C
T
s
R
e
s
u
l
t
s
 
–
 
N
R
S
s
R
e
s
u
l
t
s
 
j
u
d
g
e
d
 
e
q
u
i
v
a
l
e
n
t
 
(
r
e
v
i
e
w
e
r
/
a
u
t
h
o
r
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
G
o
s
d
e
n
,
 
2
0
0
0
1
1
9
C
a
p
i
t
a
t
i
o
n
 
p
a
y
m
e
n
t
 
v
s
 
F
F
S
:
O
n
e
 
R
C
T
 
s
h
o
w
e
d
 
n
o
 
e
f
f
e
c
t
 
o
n
 
P
C
P
 
v
i
s
i
t
s
/
c
o
n
t
a
c
t
s
,
 
d
e
c
r
e
a
s
e
d
 
r
e
f
e
r
r
a
l
s
 
t
o
 
s
p
e
c
i
a
l
i
s
t
s
 
a
n
d
 
h
o
s
p
i
t
a
l
s
 
i
n
 
t
h
e
 
c
a
p
i
t
a
t
i
o
n
 
g
r
o
u
p
 
o
n
l
y
,
 
i
n
c
r
e
a
s
e
d
 
v
i
s
i
t
s
 
t
o
 
h
e
a
l
t
h
 
a
n
d
 
e
m
e
r
g
e
n
c
y
 
d
e
p
a
r
t
m
e
n
t
s
,
 
d
e
c
r
e
a
s
e
d
 
h
o
s
p
i
t
a
l
i
s
a
t
i
o
n
,
 
a
n
d
 
h
i
g
h
e
r
 
e
x
p
e
n
d
i
t
u
r
e
S
a
l
a
r
y
 
p
a
y
m
e
n
t
 
v
s
 
F
F
S
:
O
n
e
 
R
C
T
 
s
h
o
w
e
d
 
n
o
 
d
i
f
f
e
r
e
n
c
e
 
i
n
 
p
a
t
i
e
n
t
 
v
i
s
i
t
s
 
a
p
a
r
t
 
f
r
o
m
 
e
m
e
r
g
e
n
c
y
 
v
i
s
i
t
s
 
w
h
i
c
h
 
w
e
r
e
 
h
i
g
h
e
r
 
i
n
 
s
a
l
a
r
i
e
d
 
t
h
a
n
 
F
F
S
 
P
C
P
s
.
 
F
o
r
 
s
a
l
a
r
i
e
d
 
P
C
P
s
,
 
t
h
e
 
n
u
m
b
e
r
 
o
f
 
p
a
t
i
e
n
t
s
 
e
n
r
o
l
l
e
d
 
a
n
d
 
a
c
c
e
s
s
 
t
o
 
P
C
P
 
w
a
s
 
h
i
g
h
e
r
,
 
c
o
n
t
i
n
u
i
t
y
 
o
f
 
c
a
r
e
 
w
a
s
 
l
o
w
e
r
C
a
p
i
t
a
t
i
o
n
 
p
a
y
m
e
n
t
 
v
s
 
F
F
S
:
O
n
e
 
N
R
S
 
s
h
o
w
e
d
 
i
n
c
r
e
a
s
e
d
 
v
i
s
i
t
s
/
c
o
n
t
a
c
t
s
,
 
p
r
o
v
i
s
i
o
n
 
o
f
 
d
i
a
g
n
o
s
t
i
c
 
a
n
d
 
c
u
r
a
t
i
v
e
 
s
e
r
v
i
c
e
s
,
 
a
n
d
 
r
e
d
u
c
e
d
 
p
r
e
s
c
r
i
p
t
i
o
n
 
r
e
n
e
w
a
l
s
 
a
n
d
 
r
e
f
e
r
r
a
l
s
 
t
o
 
s
p
e
c
i
a
l
i
s
t
s
 
a
n
d
 
h
o
s
p
i
t
a
l
s
M
i
x
e
d
 
c
a
p
i
t
a
t
i
o
n
 
s
y
s
t
e
m
s
 
v
s
 
F
F
S
:
O
n
e
 
N
R
S
 
s
h
o
w
e
d
 
n
o
 
d
i
f
f
e
r
e
n
c
e
 
b
e
t
w
e
e
n
 
g
r
o
u
p
s
(
A
u
t
h
o
r
)
 
N
o
t
 
r
e
p
o
r
t
e
d
(
R
e
v
i
e
w
e
r
)
 
N
o
 
o
b
v
i
o
u
s
 
s
y
s
t
e
m
a
t
i
c
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
r
e
s
u
l
t
s
;
 
R
C
T
s
 
s
e
e
m
 
t
o
 
r
e
p
o
r
t
 
a
 
w
i
d
e
r
 
r
a
n
g
e
 
o
f
 
o
u
t
c
o
m
e
s
 
t
h
e
n
 
N
R
S
s
N
o
 
(
s
o
m
e
 
d
a
t
a
 
a
r
e
 
r
e
p
o
r
t
e
d
 
i
n
 
t
a
b
l
e
s
,
 
a
c
c
o
r
d
i
n
g
 
t
o
 
d
i
f
f
e
r
e
n
t
 
o
u
t
c
o
m
e
 
m
e
a
s
u
r
e
s
,
 
b
u
t
 
n
e
v
e
r
 
f
o
r
 
>
 
1
 
R
C
T
 
o
r
 
>
 
1
 
n
R
C
T
 
w
i
t
h
i
n
 
e
a
c
h
 
o
u
t
c
o
m
e
 
m
e
a
s
u
r
e
)
H
u
t
t
,
 
2
0
0
4
1
2
1
2
 
(
o
f
 
1
4
)
 
l
a
r
g
e
 
R
C
T
s
 
r
e
p
o
r
t
e
d
 
s
i
g
n
i
fi
c
a
n
t
 
r
e
d
u
c
t
i
o
n
s
 
i
n
 
h
o
s
p
i
t
a
l
 
u
s
e
T
h
r
e
e
 
o
f
 
fi
v
e
 
o
t
h
e
r
 
s
t
u
d
i
e
s
 
r
e
p
o
r
t
e
d
 
s
i
g
n
i
fi
c
a
n
t
 
r
e
d
u
c
t
i
o
n
s
 
i
n
 
h
o
s
p
i
t
a
l
 
u
s
e
(
R
e
v
i
e
w
e
r
)
 
N
R
S
 
m
o
r
e
 
l
i
k
e
l
y
 
t
o
 
s
h
o
w
 
a
 
r
e
d
u
c
t
i
o
n
 
i
n
 
h
o
s
p
i
t
a
l
 
u
s
e
(
A
u
t
h
o
r
)
 
N
o
t
 
r
e
p
o
r
t
e
d
N
o
 
(
n
o
 
d
a
t
a
 
e
x
t
r
a
c
t
i
o
n
 
t
a
b
l
e
s
)
H
u
l
s
c
h
e
r
,
 
2
0
0
1
1
2
0
5
/
8
 
R
C
T
s
 
e
v
a
l
u
a
t
i
n
g
 
i
n
f
o
r
m
a
t
i
o
n
 
t
r
a
n
s
f
e
r
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
 
R
C
T
 
o
f
 
l
e
a
r
n
i
n
g
 
t
h
r
o
u
g
h
 
s
o
c
i
a
l
 
i
n
fl
u
e
n
c
e
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
9
/
9
 
R
C
T
s
 
o
f
 
p
h
y
s
i
c
i
a
n
 
r
e
m
i
n
d
e
r
s
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
2
/
1
4
 
R
C
T
s
 
o
f
 
m
u
l
t
i
f
a
c
e
t
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
2
/
2
 
R
C
T
s
 
o
f
 
l
e
a
r
n
i
n
g
 
t
h
r
o
u
g
h
 
s
o
c
i
a
l
 
i
n
fl
u
e
n
c
e
 
v
s
 
e
d
u
c
a
t
i
o
n
a
l
 
m
a
t
e
r
i
a
l
s
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
 
R
C
T
 
f
o
u
n
d
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
 
o
f
 
f
e
e
d
b
a
c
k
1
 
R
C
T
 
s
h
o
w
e
d
 
a
 
s
m
a
l
l
 
e
f
f
e
c
t
 
o
f
 
o
r
g
a
n
i
s
a
t
i
o
n
a
l
 
v
s
 
‘
o
t
h
e
r
’
 
i
n
t
e
r
v
e
n
t
i
o
n
s
6
/
7
 
r
a
n
d
o
m
i
s
e
d
 
c
o
m
p
a
r
i
s
o
n
s
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
 
o
f
 
m
u
l
t
i
f
a
c
e
t
e
d
 
v
s
 
o
t
h
e
r
 
i
n
t
e
r
v
e
n
t
i
o
n
s
5
/
6
 
R
C
T
s
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
 
o
f
 
m
u
l
t
i
f
a
c
e
t
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
v
s
 
g
r
o
u
p
 
e
d
u
c
a
t
i
o
n
2
/
2
 
R
C
T
s
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
 
o
f
 
m
u
l
t
i
f
a
c
e
t
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
v
s
 
p
h
y
s
i
c
i
a
n
 
r
e
m
i
n
d
e
r
s
2
/
3
 
N
R
S
s
 
o
f
 
f
e
e
d
b
a
c
k
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
/
2
 
N
R
S
s
 
o
f
 
p
h
y
s
i
c
i
a
n
 
r
e
m
i
n
d
e
r
s
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
 
N
R
S
 
o
f
 
o
r
g
a
n
i
s
a
t
i
o
n
a
l
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
7
/
1
0
 
N
R
S
s
 
o
f
 
m
u
l
t
i
f
a
c
e
t
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
v
s
 
n
o
 
i
n
t
e
r
v
e
n
t
i
o
n
 
f
o
u
n
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
1
 
N
R
S
 
f
o
u
n
d
 
n
o
 
s
i
g
n
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o
n
d
e
r
s
’
 
w
i
t
h
 
i
n
t
e
r
v
e
n
t
i
o
n
(
R
e
v
i
e
w
e
r
)
 
O
f
 
t
h
e
 
R
C
T
s
 
a
n
d
 
N
R
S
 
t
h
a
t
 
i
n
v
e
s
t
i
g
a
t
e
 
s
i
m
i
l
a
r
 
i
n
t
e
r
v
e
n
t
i
o
n
s
,
 
b
o
t
h
 
r
e
p
o
r
t
 
m
i
x
e
d
 
b
u
t
 
s
i
m
i
l
a
r
 
r
e
s
u
l
t
s
 
d
e
p
e
n
d
i
n
g
 
o
n
 
o
u
t
c
o
m
e
s
 
a
s
s
e
s
s
e
d
A
u
t
h
o
r
s
 
d
o
 
n
o
t
 
c
o
m
p
a
r
e
 
r
e
s
u
l
t
s
 
o
f
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
b
u
t
 
s
t
a
t
e
 
‘
fi
n
d
i
n
g
s
 
a
r
e
 
d
i
f
fi
c
u
l
t
 
t
o
 
i
n
t
e
r
p
r
e
t
 
a
n
d
 
s
u
m
m
a
r
i
s
e
 
d
u
e
 
t
o
 
(
a
)
 
i
n
h
e
r
e
n
t
 
p
r
o
b
l
e
m
s
 
w
i
t
h
 
t
h
e
 
d
e
s
i
g
n
 
o
f
 
i
n
d
i
v
i
d
u
a
l
 
s
t
u
d
i
e
s
,
 
a
n
d
 
(
b
)
 
t
h
e
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
o
f
 
t
h
e
i
r
 
a
i
m
s
,
 
s
t
u
d
y
 
d
e
s
i
g
n
s
,
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
a
n
d
 
c
o
n
t
r
o
l
s
,
 
p
a
t
i
e
n
t
 
p
o
p
u
l
a
t
i
o
n
s
,
 
o
u
t
c
o
m
e
s
,
 
a
s
s
e
s
s
m
e
n
t
 
i
n
s
t
r
u
m
e
n
t
s
,
 
a
n
d
 
m
e
t
h
o
d
s
 
o
f
 
a
n
a
l
y
s
i
s
’
N
o
S
t
e
a
d
,
 
2
0
0
5
1
2
8
D
e
c
r
e
a
s
e
d
 
s
a
l
e
s
:
 
t
h
r
e
e
 
R
C
T
s
 
f
o
u
n
d
 
s
i
g
n
i
fi
c
a
n
t
 
r
e
d
u
c
t
i
o
n
 
i
n
 
s
a
l
e
s
 
t
o
 
m
i
n
o
r
s
,
 
t
h
r
e
e
 
f
o
u
n
d
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
E
a
s
e
 
o
f
 
a
c
c
e
s
s
:
 
o
n
e
 
R
C
T
 
t
h
a
t
 
a
s
s
e
s
s
e
d
 
e
a
s
e
 
o
f
 
a
c
c
e
s
s
 
f
o
u
n
d
 
t
h
a
t
 
p
u
r
c
h
a
s
e
 
a
t
t
e
m
p
t
s
 
d
e
c
r
e
a
s
e
d
 
i
n
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
 
c
o
m
m
u
n
i
t
i
e
s
 
a
n
d
 
i
n
c
r
e
a
s
e
d
 
i
n
 
t
h
e
 
c
o
n
t
r
o
l
 
c
o
m
m
u
n
i
t
i
e
s
T
o
b
a
c
c
o
 
u
s
e
:
 
o
n
e
 
R
C
T
 
t
h
a
t
 
a
s
s
e
s
s
e
d
 
t
o
b
a
c
c
o
 
u
s
e
 
f
o
u
n
d
 
a
 
l
o
w
e
r
 
r
a
t
e
 
o
f
 
i
n
c
r
e
a
s
e
 
i
n
 
i
n
t
e
r
v
e
n
t
i
o
n
 
c
o
m
m
u
n
i
t
i
e
s
D
e
c
r
e
a
s
e
d
 
s
a
l
e
s
:
 
t
w
o
 
N
R
S
s
 
r
e
p
o
r
t
e
d
 
s
i
g
n
i
fi
c
a
n
t
 
r
e
d
u
c
t
i
o
n
 
i
n
 
s
a
l
e
s
 
t
o
 
m
i
n
o
r
s
,
 
a
l
l
 
o
t
h
e
r
s
 
s
h
o
w
e
d
 
n
o
 
s
i
g
n
i
fi
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
E
a
s
e
 
o
f
 
a
c
c
e
s
s
:
 
fi
v
e
 
o
f
 
s
i
x
 
N
R
S
s
 
t
h
a
t
 
a
s
s
e
s
s
e
d
 
e
a
s
e
 
o
f
 
a
c
c
e
s
s
 
f
o
u
n
d
 
i
t
 
w
a
s
 
r
e
d
u
c
e
d
 
f
o
l
l
o
w
i
n
g
 
t
h
e
 
i
n
t
e
r
v
e
n
t
i
o
n
T
o
b
a
c
c
o
 
u
s
e
:
 
fi
v
e
 
o
f
 
s
e
v
e
n
 
N
R
S
s
 
r
e
p
o
r
t
e
d
 
l
o
w
e
r
 
p
r
e
v
a
l
e
n
c
e
 
o
f
 
t
o
b
a
c
c
o
 
u
s
e
 
f
o
l
l
o
w
i
n
g
 
i
n
t
e
r
v
e
n
t
i
o
n
(
R
e
v
i
e
w
e
r
)
 
F
o
r
 
t
h
e
 
o
u
t
c
o
m
e
 
o
f
 
d
e
c
r
e
a
s
e
d
 
t
o
b
a
c
c
o
 
s
a
l
e
s
,
 
t
h
e
 
R
C
T
s
 
s
e
e
m
 
t
o
 
h
a
v
e
 
m
o
r
e
 
p
o
s
i
t
i
v
e
 
r
e
s
u
l
t
s
 
t
h
a
n
 
t
h
e
 
N
R
S
s
 
(
t
a
k
i
n
g
 
a
 
v
o
t
e
-
c
o
u
n
t
i
n
g
 
a
p
p
r
o
a
c
h
)
A
u
t
h
o
r
s
 
d
o
 
n
o
t
 
c
o
m
p
a
r
e
 
r
e
s
u
l
t
s
 
o
f
 
N
R
S
s
 
a
n
d
 
R
C
T
s
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R
e
v
i
e
w
R
e
s
u
l
t
s
 
–
 
R
C
T
s
R
e
s
u
l
t
s
 
–
 
N
R
S
s
R
e
s
u
l
t
s
 
j
u
d
g
e
d
 
e
q
u
i
v
a
l
e
n
t
 
(
r
e
v
i
e
w
e
r
/
a
u
t
h
o
r
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
W
e
i
g
a
n
d
,
 
2
0
0
1
1
6
0
A
 
s
t
r
u
c
t
u
r
e
d
 
i
n
t
e
r
d
i
s
c
i
p
l
i
n
a
r
y
 
a
p
p
r
o
a
c
h
 
s
i
g
n
i
fi
c
a
n
t
l
y
 
r
e
d
u
c
e
d
 
n
u
m
b
e
r
 
o
f
 
f
a
l
l
s
C
a
s
e
-
fi
n
d
i
n
g
 
s
t
u
d
i
e
s
 
s
h
o
w
e
d
 
i
t
 
w
a
s
 
p
o
s
s
i
b
l
e
 
t
o
 
i
d
e
n
t
i
f
y
 
p
a
t
i
e
n
t
s
 
a
t
 
r
i
s
k
 
o
f
 
f
a
l
l
s
N
o
 
c
o
m
m
e
n
t
 
f
r
o
m
 
a
u
t
h
o
r
(
R
e
v
i
e
w
e
r
)
 
T
h
e
 
R
C
T
 
a
n
d
 
t
w
o
 
c
a
s
e
-
fi
n
d
i
n
g
 
s
t
u
d
i
e
s
 
h
a
d
 
d
i
f
f
e
r
e
n
t
 
a
i
m
s
 
a
n
d
 
o
u
t
c
o
m
e
s
,
 
t
h
e
r
e
f
o
r
e
 
c
a
n
n
o
t
 
b
e
 
c
o
m
p
a
r
e
d
N
o
W
e
i
r
,
 
1
9
9
9
1
6
1
2
/
5
 
R
C
T
s
 
s
u
p
p
o
r
t
e
d
 
o
c
c
u
p
a
t
i
o
n
a
l
 
t
h
e
r
a
p
y
 
s
e
r
v
i
c
e
s
 
i
n
 
d
o
m
i
c
i
l
i
a
r
y
 
s
e
t
t
i
n
g
E
f
f
e
c
t
 
o
n
 
c
a
r
e
g
i
v
e
r
 
–
 
o
n
e
 
o
f
 
t
w
o
 
R
C
T
s
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
S
i
x
 
N
R
S
s
 
o
f
 
s
p
e
c
i
fi
c
 
c
o
m
m
u
n
i
t
y
-
b
a
s
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
p
r
o
d
u
c
e
d
 
i
n
c
o
n
s
i
s
t
e
n
t
 
r
e
s
u
l
t
s
E
f
f
e
c
t
 
o
n
 
c
a
r
e
g
i
v
e
r
 
–
 
o
n
e
 
o
f
 
t
w
o
 
N
R
S
 
s
h
o
w
e
d
 
a
 
s
i
g
n
i
fi
c
a
n
t
 
e
f
f
e
c
t
C
o
m
m
u
n
i
t
y
 
b
a
s
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
(
R
e
v
i
e
w
e
r
)
 
N
o
(
A
u
t
h
o
r
)
 
N
o
 
–
 
c
o
n
c
l
u
d
e
 
t
h
a
t
 
g
r
e
a
t
e
r
 
c
r
e
d
e
n
c
e
 
s
h
o
u
l
d
 
b
e
 
p
l
a
c
e
d
 
o
n
 
t
h
e
 
R
C
T
s
.
 
N
R
S
s
 
p
r
o
d
u
c
e
d
 
c
o
n
fl
i
c
t
i
n
g
 
r
e
s
u
l
t
s
 
a
n
d
 
s
h
o
u
l
d
 
b
e
 
i
n
t
e
r
p
r
e
t
e
d
 
w
i
t
h
 
c
a
u
t
i
o
n
E
f
f
e
c
t
 
o
n
 
c
a
r
e
g
i
v
e
r
:
(
R
e
v
i
e
w
e
r
)
 
E
q
u
i
v
a
l
e
n
t
 
(
s
o
m
e
 
e
v
i
d
e
n
c
e
 
b
u
t
 
n
o
t
 
c
o
n
c
l
u
s
i
v
e
)
(
A
u
t
h
o
r
)
 
N
o
t
 
r
e
p
o
r
t
e
d
N
o
C
C
T
,
 
c
o
n
t
r
o
l
l
e
d
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
;
 
F
F
S
,
 
f
e
e
 
f
o
r
 
s
e
r
v
i
c
e
;
 
N
/
A
,
 
n
o
t
 
a
p
p
l
i
c
a
b
l
e
;
 
O
R
,
 
o
d
d
s
 
r
a
t
i
o
;
 
P
C
P
,
 
p
r
i
m
a
r
y
 
c
a
r
e
 
p
h
y
s
i
c
i
a
n
;
 
S
D
,
 
s
t
a
n
d
a
r
d
 
d
e
v
i
a
t
i
o
n
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A
p
p
e
n
d
i
x
 
4
.
1
3
:
 
S
u
m
m
a
r
y
 
t
a
b
l
e
 
o
f
 
p
o
l
i
c
y
 
i
n
t
e
r
v
e
n
t
i
o
n
 
r
e
v
i
e
w
s
 
t
h
a
t
 
p
o
o
l
e
d
 
r
a
n
d
o
m
i
s
e
d
 
a
n
d
 
n
o
n
-
r
a
n
d
o
m
i
s
e
d
 
d
e
s
i
g
n
s
 
 
i
n
 
a
 
m
e
t
a
-
a
n
a
l
y
s
i
s
R
e
v
i
e
w
 
d
e
t
a
i
l
s
D
e
s
c
r
i
p
t
i
o
n
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
P
o
l
i
c
y
 
l
e
v
e
l
T
a
r
g
e
t
 
g
r
o
u
p
R
a
t
i
o
n
a
l
e
 
g
i
v
e
n
 
b
y
 
a
u
t
h
o
r
s
 
f
o
r
 
p
o
o
l
i
n
g
O
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
(
r
e
v
i
e
w
e
r
s
’
 
j
u
d
g
e
m
e
n
t
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
 
(
y
e
s
/
n
o
)
K
e
n
d
r
i
c
k
,
 
2
0
0
0
1
3
7
1
4
 
R
C
T
s
3
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
/
n
o
n
-
r
a
n
d
o
m
i
s
e
d
 
s
t
u
d
i
e
s
H
o
m
e
 
v
i
s
i
t
i
n
g
 
t
o
 
i
m
p
r
o
v
e
 
p
a
r
e
n
t
i
n
g
 
a
n
d
 
t
h
e
 
q
u
a
l
i
t
y
 
o
f
 
t
h
e
 
h
o
m
e
 
e
n
v
i
r
o
n
m
e
n
t
H
e
a
l
t
h
 
p
r
o
m
o
t
i
o
n
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
M
o
t
h
e
r
 
a
n
d
 
c
h
i
l
d
A
l
l
 
s
t
u
d
i
e
s
 
t
h
a
t
 
r
e
p
o
r
t
e
d
 
‘
h
o
m
e
 
o
b
s
e
r
v
a
t
i
o
n
 
f
o
r
 
m
e
a
s
u
r
e
m
e
n
t
 
o
f
 
t
h
e
 
e
n
v
i
r
o
n
m
e
n
t
 
i
n
v
e
n
t
o
r
y
’
 
s
c
o
r
e
s
 
(
m
e
a
n
 
a
n
d
 
s
t
a
n
d
a
r
d
 
d
e
v
i
a
t
i
o
n
 
o
r
 
p
-
v
a
l
u
e
)
 
w
e
r
e
 
i
n
c
l
u
d
e
d
 
i
n
 
t
h
e
 
m
e
t
a
-
a
n
a
l
y
s
i
s
.
 
 
A
n
a
l
y
s
i
s
 
w
a
s
 
r
e
p
e
a
t
e
d
 
r
e
s
t
r
i
c
t
i
n
g
 
t
o
 
R
C
T
s
 
a
n
d
 
t
o
 
s
t
u
d
i
e
s
 
w
i
t
h
 
a
 
q
u
a
l
i
t
y
 
s
c
o
r
e
 
o
f
 
0
.
5
 
o
r
 
a
b
o
v
e
N
o
 
r
a
t
i
o
n
a
l
e
 
w
a
s
 
g
i
v
e
n
 
b
y
 
t
h
e
 
a
u
t
h
o
r
s
I
n
 
t
w
o
 
o
f
 
t
h
e
 
t
h
r
e
e
 
N
R
S
s
,
 
f
a
m
i
l
i
e
s
 
w
e
r
e
 
r
e
f
e
r
r
e
d
 
f
o
r
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
o
r
 
h
a
d
 
p
s
y
c
h
o
s
o
c
i
a
l
 
p
r
o
b
l
e
m
s
N
o
E
l
k
a
n
,
 
2
0
0
0
1
3
2
1
3
 
R
C
T
s
2
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
 
s
t
u
d
i
e
s
H
o
m
e
 
v
i
s
i
t
i
n
g
 
p
r
o
g
r
a
m
m
e
s
 
t
h
a
t
 
o
f
f
e
r
 
h
e
a
l
t
h
 
p
r
o
m
o
t
i
o
n
 
a
n
d
 
p
r
e
v
e
n
t
i
v
e
 
c
a
r
e
H
e
a
l
t
h
 
p
r
o
m
o
t
i
o
n
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
O
l
d
e
r
 
p
e
o
p
l
e
 
l
i
v
i
n
g
 
a
t
 
h
o
m
e
M
e
t
a
-
a
n
a
l
y
s
i
s
 
w
a
s
 
p
e
r
f
o
r
m
e
d
 
o
n
 
R
C
T
s
 
o
n
l
y
;
 
N
R
S
s
 
w
e
r
e
 
n
o
t
 
i
n
c
l
u
d
e
d
 
i
n
 
t
h
e
 
a
n
a
l
y
s
i
s
.
 
N
o
 
r
a
t
i
o
n
a
l
e
 
f
o
r
 
p
o
o
l
i
n
g
 
i
s
 
g
i
v
e
n
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
N
o
P
o
s
a
v
a
c
,
 
1
9
9
9
1
4
1
1
4
 
R
C
T
s
2
2
 
N
R
S
s
P
e
e
r
-
b
a
s
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
d
e
s
i
g
n
e
d
 
t
o
 
c
h
a
n
g
e
 
a
t
t
i
t
u
d
e
s
,
 
b
e
h
a
v
i
o
u
r
s
,
 
k
n
o
w
l
e
d
g
e
 
a
n
d
 
s
k
i
l
l
s
 
i
n
 
w
a
y
s
 
t
h
o
u
g
h
t
 
t
o
 
i
m
p
r
o
v
e
 
h
e
a
l
t
h
H
e
a
l
t
h
 
p
r
o
m
o
t
i
o
n
/
e
d
u
c
a
t
i
o
n
A
n
y
 
p
o
p
u
l
a
t
i
o
n
N
o
n
e
 
g
i
v
e
n
.
 
 
A
u
t
h
o
r
s
 
d
o
 
n
o
t
e
 
t
h
a
t
 
‘
g
i
v
e
n
 
t
h
e
 
l
a
r
g
e
 
s
a
m
p
l
e
s
 
i
n
 
m
a
n
y
 
o
f
 
t
h
e
s
e
 
s
t
u
d
i
e
s
,
 
e
v
e
n
 
v
e
r
y
 
s
m
a
l
l
 
d
i
f
f
e
r
e
n
c
e
s
 
a
r
e
 
s
t
a
t
i
s
t
i
c
a
l
l
y
 
s
i
g
n
i
fi
c
a
n
t
…
 
t
h
e
r
e
f
o
r
e
 
a
 
m
o
r
e
 
i
m
p
o
r
t
a
n
t
 
i
s
s
u
e
 
t
o
 
c
o
n
s
i
d
e
r
 
i
s
 
w
h
e
t
h
e
r
 
t
h
e
 
e
f
f
e
c
t
 
o
f
 
a
 
p
r
o
g
r
a
m
m
e
,
 
g
i
v
e
n
 
i
t
s
 
c
o
s
t
,
 
i
s
 
o
f
 
p
r
a
c
t
i
c
a
l
 
o
r
 
s
u
b
s
t
a
n
t
i
v
e
 
s
i
g
n
i
fi
c
a
n
c
e
’
.
 
 
A
l
s
o
 
‘
t
h
e
s
e
 
s
t
u
d
i
e
s
 
d
i
f
f
e
r
e
d
 
g
r
e
a
t
l
y
 
f
r
o
m
 
e
a
c
h
 
o
t
h
e
r
;
 
t
h
e
 
f
o
c
u
s
 
o
f
 
t
h
e
 
m
e
t
a
-
a
n
a
l
y
s
i
s
 
w
a
s
 
o
n
 
t
h
e
 
e
f
f
e
c
t
i
v
e
n
e
s
s
 
o
f
 
p
e
e
r
-
b
a
s
e
d
 
h
e
a
l
t
h
 
e
d
u
c
a
t
i
o
n
,
 
n
o
t
 
o
n
 
a
 
p
a
r
t
i
c
u
l
a
r
 
f
o
r
m
 
o
f
 
p
e
e
r
-
b
a
s
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
’
.
 
R
a
n
d
o
m
i
s
a
t
i
o
n
 
w
a
s
 
o
n
e
 
o
f
 
t
h
e
 
v
a
r
i
a
b
l
e
s
 
c
o
d
e
d
 
b
u
t
 
w
a
s
 
n
o
t
 
u
s
e
d
 
t
o
 
i
n
v
e
s
t
i
g
a
t
e
 
h
e
t
e
r
o
g
e
n
e
i
t
y
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
(
n
o
 
d
e
t
a
i
l
s
 
p
r
e
s
e
n
t
e
d
 
s
o
 
c
a
n
n
o
t
 
t
e
l
l
)
N
oAppendix 4
160
DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
161
R
e
v
i
e
w
 
d
e
t
a
i
l
s
D
e
s
c
r
i
p
t
i
o
n
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
P
o
l
i
c
y
 
l
e
v
e
l
T
a
r
g
e
t
 
g
r
o
u
p
R
a
t
i
o
n
a
l
e
 
g
i
v
e
n
 
b
y
 
a
u
t
h
o
r
s
 
f
o
r
 
p
o
o
l
i
n
g
O
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
(
r
e
v
i
e
w
e
r
s
’
 
j
u
d
g
e
m
e
n
t
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
 
(
y
e
s
/
n
o
)
D
u
s
s
e
l
d
o
r
p
,
 
1
9
9
9
1
3
1
2
8
 
R
C
T
s
9
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
 
s
t
u
d
i
e
s
P
s
y
c
h
o
e
d
u
c
a
t
i
o
n
a
l
 
p
r
o
g
r
a
m
m
e
s
 
f
o
r
 
c
a
r
d
i
a
c
 
r
e
h
a
b
i
l
i
t
a
t
i
o
n
P
o
l
i
c
y
 
f
o
r
 
a
n
 
i
n
s
t
i
t
u
t
i
o
n
C
o
r
o
n
a
r
y
 
h
e
a
r
t
 
d
i
s
e
a
s
e
 
p
a
t
i
e
n
t
s
N
o
t
 
g
i
v
e
n
‘
Q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
s
 
w
e
r
e
 
i
n
c
l
u
d
e
d
 
o
n
l
y
 
w
h
e
n
 
s
a
m
p
l
e
s
 
w
h
e
r
e
 
s
t
r
a
t
i
fi
e
d
 
o
r
 
m
a
t
c
h
e
d
 
p
a
i
r
w
i
s
e
,
 
o
r
 
w
h
e
n
 
a
 
c
e
r
t
a
i
n
 
t
i
m
e
 
p
e
r
i
o
d
 
w
a
s
 
u
s
e
d
 
a
s
 
a
n
 
a
s
s
i
g
n
m
e
n
t
 
r
u
l
e
 
f
o
r
 
p
a
t
i
e
n
t
s
 
f
r
o
m
 
t
h
e
 
s
a
m
e
 
h
o
s
p
i
t
a
l
’
.
 
 
A
u
t
h
o
r
s
’
 
v
i
e
w
:
 
i
n
 
b
o
t
h
 
R
C
T
s
 
a
n
d
 
N
R
S
s
,
 
p
o
p
u
l
a
t
i
o
n
 
e
f
f
e
c
t
 
s
i
z
e
 
e
s
t
i
m
a
t
e
s
 
w
i
l
l
 
b
e
 
m
o
r
e
 
a
c
c
u
r
a
t
e
 
w
h
e
n
 
p
r
e
-
t
e
s
t
 
d
i
f
f
e
r
e
n
c
e
s
 
a
r
e
 
t
a
k
e
n
 
i
n
t
o
 
a
c
c
o
u
n
t
.
 
T
h
e
 
r
e
v
i
e
w
 
e
x
p
l
o
r
e
s
 
m
o
d
e
r
a
t
i
n
g
 
e
f
f
e
c
t
 
o
f
 
s
t
u
d
y
 
f
e
a
t
u
r
e
s
:
 
r
a
n
d
o
m
i
s
a
t
i
o
n
 
w
a
s
 
n
o
t
 
a
 
m
o
d
e
r
a
t
o
r
 
o
f
 
t
r
e
a
t
m
e
n
t
 
s
u
c
c
e
s
s
N
o
 
R
C
T
s
 
w
e
r
e
 
c
o
n
d
u
c
t
e
d
 
o
n
 
h
e
a
l
t
h
 
e
d
u
c
a
t
i
o
n
 
a
n
d
 
e
x
e
r
c
i
s
e
 
t
r
a
i
n
i
n
g
 
e
v
a
l
u
a
t
i
o
n
s
.
 
O
t
h
e
r
w
i
s
e
,
 
n
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
N
o
G
r
u
e
n
,
 
2
0
0
3
1
3
3
5
 
R
C
T
s
2
 
C
B
A
s
2
 
I
T
S
s
S
p
e
c
i
a
l
i
s
t
 
o
u
t
r
e
a
c
h
 
c
l
i
n
i
c
s
 
i
n
 
p
r
i
m
a
r
y
 
c
a
r
e
 
a
n
d
 
r
u
r
a
l
 
h
o
s
p
i
t
a
l
 
s
e
t
t
i
n
g
s
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
P
a
t
i
e
n
t
s
 
e
l
i
g
i
b
l
e
 
f
o
r
 
s
p
e
c
i
a
l
i
s
t
 
c
a
r
e
,
 
p
r
i
m
a
r
y
 
h
e
a
l
t
h
-
c
a
r
e
 
p
r
a
c
t
i
t
i
o
n
e
r
s
 
a
n
d
 
s
p
e
c
i
a
l
i
s
t
s
N
o
t
 
g
i
v
e
n
‘
O
n
l
y
 
s
t
u
d
i
e
s
 
t
h
a
t
 
w
e
r
e
 
s
i
m
i
l
a
r
 
i
n
 
t
e
r
m
s
 
o
f
 
s
e
t
t
i
n
g
,
 
i
n
t
e
r
v
e
n
t
i
o
n
 
a
n
d
 
o
u
t
c
o
m
e
 
a
s
s
e
s
s
m
e
n
t
 
w
e
r
e
 
s
u
b
j
e
c
t
e
d
 
t
o
 
s
t
a
t
i
s
t
i
c
a
l
 
m
e
t
a
-
a
n
a
l
y
s
i
s
’
.
 
O
n
l
y
 
t
h
r
e
e
 
s
t
u
d
i
e
s
 
w
e
r
e
 
p
o
o
l
e
d
,
 
a
l
l
 
w
e
r
e
 
R
C
T
s
.
 
S
h
o
u
l
d
 
w
e
 
e
x
c
l
u
d
e
 
i
t
 
t
h
e
n
?
D
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
a
l
l
 
s
t
u
d
i
e
s
,
 
n
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
Y
e
s
 
(
s
m
a
l
l
 
n
u
m
b
e
r
 
o
f
 
s
t
u
d
i
e
s
 
f
o
r
 
e
a
c
h
 
o
u
t
c
o
m
e
)
H
i
g
g
i
n
s
o
n
,
 
2
0
0
2
1
3
4
1
 
R
C
T
1
 
p
r
o
s
p
e
c
t
i
v
e
 
s
t
u
d
y
 
w
i
t
h
 
c
o
m
p
a
r
i
s
o
n
 
g
r
o
u
p
1
1
 
r
e
t
r
o
s
p
e
c
t
i
v
e
/
o
b
s
e
r
v
a
t
i
o
n
a
l
/
c
r
o
s
s
-
s
e
c
t
i
o
n
a
l
H
o
s
p
i
t
a
l
-
b
a
s
e
d
 
p
a
l
l
i
a
t
i
v
e
 
c
a
r
e
 
t
e
a
m
s
I
n
s
t
i
t
u
t
i
o
n
a
l
 
p
o
l
i
c
y
P
a
t
i
e
n
t
s
 
w
i
t
h
 
p
r
o
g
r
e
s
s
i
v
e
 
l
i
f
e
-
t
h
r
e
a
t
e
n
i
n
g
 
i
l
l
n
e
s
s
 
a
n
d
 
t
h
e
i
r
 
f
a
m
i
l
i
e
s
,
 
c
a
r
e
r
s
 
o
r
 
c
l
o
s
e
 
f
r
i
e
n
d
s
N
o
t
 
g
i
v
e
n
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
s
a
m
p
l
e
 
s
i
z
e
,
 
s
e
t
t
i
n
g
 
o
r
 
i
n
t
e
r
v
e
n
t
i
o
n
.
 
N
o
 
f
u
r
t
h
e
r
 
d
a
t
a
 
p
r
e
s
e
n
t
e
d
E
f
f
e
c
t
 
s
i
z
e
s
 
f
o
r
 
i
n
d
i
v
i
d
u
a
l
 
s
t
u
d
i
e
s
 
p
r
e
s
e
n
t
e
d
.
 
C
I
s
 
n
o
t
 
g
i
v
e
n
H
y
d
e
,
 
2
0
0
0
1
3
5
7
 
R
C
T
s
 
(
b
u
t
 
n
o
 
d
e
t
a
i
l
s
 
o
f
 
r
a
n
d
o
m
i
s
a
t
i
o
n
 
p
r
o
c
e
s
s
 
i
n
 
5
 
o
f
 
t
h
e
s
e
)
2
 
q
u
a
s
i
-
r
a
n
d
o
m
i
s
e
d
S
u
p
p
o
r
t
i
n
g
 
d
i
s
c
h
a
r
g
e
 
f
r
o
m
 
h
o
s
p
i
t
a
l
 
t
o
 
h
o
m
e
I
n
s
t
i
t
u
t
i
o
n
a
l
 
p
o
l
i
c
y
O
l
d
e
r
 
p
e
o
p
l
e
N
o
t
 
g
i
v
e
n
B
u
t
 
o
n
l
y
 
i
n
c
l
u
d
e
d
 
r
a
n
d
o
m
i
s
e
d
 
o
r
 
q
u
a
s
i
-
r
a
n
d
o
m
i
s
e
d
 
t
r
i
a
l
s
 
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
Y
e
s
 
(
f
o
r
e
s
t
 
p
l
o
t
 
w
i
t
h
 
d
a
t
a
 
p
r
e
s
e
n
t
e
d
)
.
 
J
o
h
n
s
o
n
,
 
2
0
0
3
1
3
6
1
2
 
R
C
T
s
1
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
 
s
t
u
d
y
M
o
d
i
f
y
i
n
g
 
s
e
x
u
a
l
 
r
i
s
k
 
b
e
h
a
v
i
o
u
r
s
 
f
o
r
 
p
r
e
v
e
n
t
i
n
g
 
H
I
V
 
i
n
f
e
c
t
i
o
n
P
o
l
i
c
y
 
f
o
r
 
a
 
c
o
m
m
u
n
i
t
y
M
e
n
 
w
h
o
 
h
a
v
e
 
s
e
x
 
w
i
t
h
 
m
e
n
N
o
t
 
g
i
v
e
n
B
u
t
 
o
n
l
y
 
i
n
c
l
u
d
e
d
 
R
C
T
s
 
o
r
 
‘
s
t
r
o
n
g
’
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
 
s
t
u
d
i
e
s
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
Y
e
s
,
 
f
o
r
 
o
n
e
 
o
u
t
c
o
m
eAppendix 4
160
DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
161
R
e
v
i
e
w
 
d
e
t
a
i
l
s
D
e
s
c
r
i
p
t
i
o
n
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
P
o
l
i
c
y
 
l
e
v
e
l
T
a
r
g
e
t
 
g
r
o
u
p
R
a
t
i
o
n
a
l
e
 
g
i
v
e
n
 
b
y
 
a
u
t
h
o
r
s
 
f
o
r
 
p
o
o
l
i
n
g
O
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
(
r
e
v
i
e
w
e
r
s
’
 
j
u
d
g
e
m
e
n
t
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
 
(
y
e
s
/
n
o
)
L
e
g
l
e
r
,
 
2
0
0
2
1
3
8
T
o
t
a
l
 
3
8
N
o
 
o
f
 
d
e
s
i
g
n
s
 
u
n
c
l
e
a
r
I
n
t
e
r
v
e
n
t
i
o
n
s
 
t
o
 
p
r
o
m
o
t
e
 
m
a
m
m
o
g
r
a
p
h
y
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
W
o
m
e
n
 
w
i
t
h
 
h
i
s
t
o
r
i
c
a
l
l
y
 
l
o
w
e
r
 
r
a
t
e
s
 
o
f
 
s
c
r
e
e
n
i
n
g
N
o
t
 
g
i
v
e
n
N
o
t
 
p
o
s
s
i
b
l
e
 
t
o
 
t
e
l
l
,
 
a
s
 
s
t
u
d
y
 
d
e
s
i
g
n
 
n
o
t
 
i
n
d
i
c
a
t
e
d
N
o
.
 
U
n
a
b
l
e
 
t
o
 
i
d
e
n
t
i
f
y
 
d
e
s
i
g
n
 
o
f
 
i
n
c
l
u
d
e
d
 
s
t
u
d
i
e
s
M
o
n
n
i
n
k
h
o
f
,
 
2
0
0
2
1
3
9
8
 
R
C
T
s
1
 
C
C
T
S
e
l
f
 
m
a
n
a
g
e
m
e
n
t
 
e
d
u
c
a
t
i
o
n
 
f
o
r
 
C
O
P
D
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
P
a
t
i
e
n
t
s
 
w
i
t
h
 
C
O
P
D
N
o
t
 
g
i
v
e
n
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
N
o
.
 
T
h
e
 
C
C
T
 
i
s
 
n
o
t
 
i
n
c
l
u
d
e
d
 
i
n
 
a
n
y
 
f
o
r
e
s
t
 
p
l
o
t
 
(
d
i
f
f
e
r
e
n
t
 
o
u
t
c
o
m
e
s
)
 
T
h
o
m
p
s
o
n
 
O
’
B
r
i
e
n
,
 
2
0
0
1
1
6
2
3
0
 
R
C
T
s
2
 
n
o
n
-
e
q
u
i
v
a
l
e
n
t
 
g
r
o
u
p
 
d
e
s
i
g
n
s
 
(
a
l
l
o
c
a
t
i
o
n
 
b
y
 
a
 
n
o
n
-
r
a
n
d
o
m
 
p
r
o
c
e
s
s
 
o
t
h
e
r
 
t
h
a
n
 
p
a
r
t
i
c
i
p
a
n
t
 
c
h
o
i
c
e
,
 
d
a
t
a
 
c
o
l
l
e
c
t
i
o
n
 
c
o
n
t
e
m
p
o
r
a
n
e
o
u
s
,
 
a
n
d
 
c
h
o
i
c
e
 
o
f
 
c
o
n
t
r
o
l
 
s
i
t
e
/
a
c
t
i
v
i
t
y
 
a
p
p
e
a
r
e
d
 
a
p
p
r
o
p
r
i
a
t
e
)
P
l
a
n
n
e
d
 
e
d
u
c
a
t
i
o
n
a
l
 
a
c
t
i
v
i
t
i
e
s
:
 
m
e
e
t
i
n
g
s
,
 
c
o
n
f
e
r
e
n
c
e
s
,
 
l
e
c
t
u
r
e
s
,
 
w
o
r
k
s
h
o
p
s
,
 
s
e
m
i
n
a
r
s
,
 
s
y
m
p
o
s
i
a
 
a
n
d
 
c
o
u
r
s
e
s
 
t
h
a
t
 
o
c
c
u
r
r
e
d
 
o
f
f
-
s
i
t
e
 
f
r
o
m
 
t
h
e
 
p
r
a
c
t
i
c
e
 
s
e
t
t
i
n
g
H
e
a
l
t
h
 
p
r
o
f
e
s
s
i
o
n
a
l
 
e
d
u
c
a
t
i
o
n
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
Q
u
a
l
i
fi
e
d
 
h
e
a
l
t
h
 
p
r
o
f
e
s
s
i
o
n
a
l
s
 
o
r
 
h
e
a
l
t
h
 
p
r
o
f
e
s
s
i
o
n
a
l
s
 
i
n
 
p
o
s
t
g
r
a
d
u
a
t
e
 
t
r
a
i
n
i
n
g
N
o
 
e
x
p
l
i
c
i
t
 
s
t
a
t
e
m
e
n
t
s
.
 
H
o
w
e
v
e
r
,
 
i
n
 
t
h
e
 
t
w
o
 
N
E
G
D
s
 
p
r
o
t
e
c
t
i
o
n
 
a
g
a
i
n
s
t
 
b
i
a
s
 
w
a
s
 
s
c
o
r
e
d
 
a
s
 
‘
m
o
d
e
r
a
t
e
’
 
b
e
c
a
u
s
e
 
o
f
 
a
d
e
q
u
a
t
e
 
b
l
i
n
d
i
n
g
 
a
n
d
 
f
o
l
l
o
w
-
u
p
 
e
v
e
n
 
t
h
o
u
g
h
 
t
h
e
 
g
r
o
u
p
s
 
w
e
r
e
 
n
o
t
 
r
a
n
d
o
m
l
y
 
a
s
s
i
g
n
e
d
.
 
I
n
 
t
h
e
 
R
C
T
s
,
 
s
e
v
e
n
 
s
c
o
r
e
d
 
a
s
 
h
i
g
h
 
a
n
d
 
2
4
 
a
s
 
m
o
d
e
r
a
t
e
 
p
r
o
t
e
c
t
i
o
n
 
a
g
a
i
n
s
t
 
b
i
a
s
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
N
o
Z
i
g
u
r
a
s
,
 
2
0
0
0
1
4
7
3
5
 
R
C
T
s
9
 
c
o
n
t
r
o
l
l
e
d
 
s
t
u
d
i
e
s
M
e
n
t
a
l
 
h
e
a
l
t
h
 
c
a
s
e
 
m
a
n
a
g
e
m
e
n
t
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
/
p
o
l
i
c
y
 
f
o
r
 
a
 
c
o
m
m
u
n
i
t
y
A
d
u
l
t
s
 
w
i
t
h
 
s
e
r
i
o
u
s
 
m
e
n
t
a
l
 
i
l
l
n
e
s
s
N
o
t
 
g
i
v
e
n
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
i
n
 
s
a
m
p
l
e
 
s
i
z
e
,
 
m
o
d
e
l
 
o
r
 
o
u
t
c
o
m
e
 
d
o
m
a
i
n
.
 
N
o
 
f
u
r
t
h
e
r
 
i
n
f
o
r
m
a
t
i
o
n
N
o
S
z
i
l
a
g
y
i
,
 
2
0
0
2
1
4
3
4
2
 
R
C
T
s
3
 
C
B
A
s
(
l
a
t
e
s
t
 
v
e
r
s
i
o
n
)
I
n
t
e
r
v
e
n
t
i
o
n
s
 
a
i
m
e
d
 
a
t
 
i
m
p
r
o
v
i
n
g
 
i
m
m
u
n
i
s
a
t
i
o
n
 
r
a
t
e
s
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
H
e
a
l
t
h
-
c
a
r
e
 
p
e
r
s
o
n
n
e
l
 
w
h
o
 
d
e
l
i
v
e
r
 
i
m
m
u
n
i
s
a
t
i
o
n
s
 
a
n
d
 
c
h
i
l
d
r
e
n
 
o
r
 
a
d
u
l
t
s
 
w
h
o
 
r
e
c
e
i
v
e
 
i
m
m
u
n
i
s
a
t
i
o
n
s
 
i
n
 
a
n
y
 
s
e
t
t
i
n
g
N
o
t
 
g
i
v
e
n
.
 
L
o
o
k
s
 
l
i
k
e
 
o
n
l
y
 
R
C
T
s
 
w
e
r
e
 
i
n
c
l
u
d
e
d
 
i
n
 
t
h
e
 
m
e
t
a
-
a
n
a
l
y
s
e
s
 
i
n
 
t
h
e
 
l
a
t
e
s
t
 
v
e
r
s
i
o
n
.
 
E
x
c
l
u
d
e
?
D
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
a
l
l
 
s
t
u
d
i
e
s
 
i
n
 
p
a
r
t
i
c
i
p
a
n
t
s
 
a
n
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
,
 
b
u
t
 
n
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
Y
e
sAppendix 4
162
DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
163
R
e
v
i
e
w
 
d
e
t
a
i
l
s
D
e
s
c
r
i
p
t
i
o
n
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
P
o
l
i
c
y
 
l
e
v
e
l
T
a
r
g
e
t
 
g
r
o
u
p
R
a
t
i
o
n
a
l
e
 
g
i
v
e
n
 
b
y
 
a
u
t
h
o
r
s
 
f
o
r
 
p
o
o
l
i
n
g
O
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
(
r
e
v
i
e
w
e
r
s
’
 
j
u
d
g
e
m
e
n
t
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
 
(
y
e
s
/
n
o
)
C
u
i
j
p
e
r
s
,
 
2
0
0
2
1
3
0
1
1
 
R
C
T
s
1
 
N
R
S
S
c
h
o
o
l
-
b
a
s
e
d
 
d
r
u
g
 
p
r
e
v
e
n
t
i
o
n
 
p
r
o
g
r
a
m
m
e
s
 
–
 
s
t
u
d
i
e
s
 
h
a
d
 
t
o
 
c
o
m
p
a
r
e
 
p
e
e
r
-
l
e
d
 
t
o
 
a
d
u
l
t
-
l
e
d
 
p
r
o
g
r
a
m
m
e
s
I
n
s
t
i
t
u
t
i
o
n
 
(
s
c
h
o
o
l
)
E
d
u
c
a
t
i
o
n
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
S
c
h
o
o
l
c
h
i
l
d
r
e
n
N
o
 
s
t
a
t
e
d
 
r
a
t
i
o
n
a
l
e
 
b
u
t
 
‘
a
s
 
t
h
e
 
e
x
a
m
i
n
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
d
i
f
f
e
r
e
d
 
c
o
n
s
i
d
e
r
a
b
l
y
,
 
a
s
 
w
e
l
l
 
a
s
 
o
t
h
e
r
 
c
h
a
r
a
c
t
e
r
i
s
t
i
c
s
 
o
f
 
t
h
e
 
s
t
u
d
i
e
s
,
 
t
h
e
 
r
a
n
d
o
m
 
e
f
f
e
c
t
s
 
m
o
d
e
l
 
w
a
s
 
c
h
o
s
e
n
’
T
h
e
 
o
n
e
 
N
R
S
 
w
a
s
 
m
u
c
h
 
s
m
a
l
l
e
r
 
t
h
a
n
 
t
h
e
 
R
C
T
s
 
a
n
d
 
h
a
d
 
s
h
o
r
t
e
r
 
f
o
l
l
o
w
-
u
p
Y
e
s
P
r
e
n
d
e
r
g
a
s
t
,
 
2
0
0
0
1
4
2
1
2
 
R
C
T
s
1
3
1
 
N
R
S
s
D
r
u
g
 
d
e
p
e
n
d
e
n
c
e
 
t
r
e
a
t
m
e
n
t
 
p
r
o
g
r
a
m
m
e
s
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
/
o
r
g
a
n
i
s
a
t
i
o
n
A
d
u
l
t
s
 
w
i
t
h
 
d
r
u
g
 
d
e
p
e
n
d
e
n
c
e
 
i
n
 
t
h
e
 
U
S
 
o
r
 
C
a
n
a
d
a
N
o
 
s
t
a
t
e
d
 
r
a
t
i
o
n
a
l
e
 
b
u
t
 
‘
b
e
c
a
u
s
e
 
o
f
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
a
m
o
n
g
 
s
t
u
d
i
e
s
,
 
t
h
e
 
d
a
t
a
 
a
r
e
 
a
n
a
l
y
s
e
d
 
i
n
 
t
e
r
m
s
 
o
f
 
t
y
p
e
 
o
f
 
o
u
t
c
o
m
e
 
v
a
r
i
a
b
l
e
 
(
d
r
u
g
 
u
s
e
 
a
n
d
 
c
r
i
m
e
)
,
 
t
y
p
e
 
o
f
 
d
e
s
i
g
n
 
(
s
i
n
g
l
e
-
g
r
o
u
p
 
a
n
d
 
c
o
m
p
a
r
i
s
o
n
 
g
r
o
u
p
)
 
a
n
d
 
t
y
p
e
 
o
f
 
t
r
e
a
t
m
e
n
t
’
.
 
S
e
p
a
r
a
t
e
s
 
c
o
n
t
r
o
l
l
e
d
 
a
n
d
 
u
n
c
o
n
t
r
o
l
l
e
d
 
s
t
u
d
i
e
s
,
 
b
u
t
 
n
o
t
 
R
C
T
s
 
a
n
d
 
N
R
S
s
N
o
t
 
p
o
s
s
i
b
l
e
 
t
o
 
t
e
l
l
,
 
d
a
t
a
 
n
o
t
 
p
r
o
v
i
d
e
d
N
o
P
a
r
k
e
r
,
 
2
0
0
0
1
4
0
A
l
l
 
r
a
n
d
o
m
i
s
e
d
 
o
r
 
p
s
e
u
d
o
-
r
a
n
d
o
m
i
s
e
d
 
(
n
u
m
b
e
r
s
 
o
f
 
e
a
c
h
 
n
o
t
 
g
i
v
e
n
,
 
4
5
 
i
n
 
t
o
t
a
l
)
C
o
m
p
a
r
e
s
 
d
i
f
f
e
r
e
n
t
 
l
o
c
a
t
i
o
n
s
 
o
f
 
c
a
r
e
 
f
o
r
 
o
l
d
e
r
 
p
a
t
i
e
n
t
s
I
n
s
t
i
t
u
t
i
o
n
 
a
n
d
 
c
o
m
m
u
n
i
t
y
O
l
d
e
r
 
(
6
5
+
 
y
e
a
r
s
)
 
p
e
o
p
l
e
N
o
 
r
a
t
i
o
n
a
l
e
.
 
S
t
u
d
i
e
s
 
w
e
r
e
 
a
l
l
 
r
a
n
d
o
m
i
s
e
d
 
o
r
 
p
s
e
u
d
o
-
r
a
n
d
o
m
i
s
e
d
.
 
 
A
u
t
h
o
r
s
 
s
t
a
t
e
 
t
h
a
t
 
o
p
p
o
r
t
u
n
i
t
i
e
s
 
f
o
r
 
m
e
a
n
i
n
g
f
u
l
 
m
e
t
a
-
a
n
a
l
y
s
i
s
 
w
e
r
e
 
l
i
m
i
t
e
d
.
 
W
h
e
r
e
 
s
i
g
n
i
fi
c
a
n
t
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
w
a
s
 
e
v
i
d
e
n
t
,
 
O
R
s
 
w
e
r
e
 
r
e
c
a
l
c
u
l
a
t
e
d
 
u
s
i
n
g
 
a
 
r
a
n
d
o
m
 
e
f
f
e
c
t
 
m
o
d
e
l
N
o
t
 
p
o
s
s
i
b
l
e
 
t
o
 
t
e
l
l
N
o
A
l
l
a
b
y
,
 
1
9
9
9
1
2
9
2
 
R
C
T
s
7
 
N
R
S
s
 
(
6
 
w
i
t
h
 
c
o
n
t
r
o
l
s
,
 
1
 
b
e
f
o
r
e
-
a
f
t
e
r
 
s
t
u
d
y
)
A
n
t
e
n
a
t
a
l
 
a
n
t
i
-
D
 
p
r
o
p
h
y
l
a
x
i
s
I
n
s
t
i
t
u
t
i
o
n
 
(
h
o
s
p
i
t
a
l
)
R
h
e
s
u
s
-
D
 
n
e
g
a
t
i
v
e
 
w
o
m
e
n
 
w
h
o
 
b
o
r
e
 
r
h
e
s
u
s
-
D
 
p
o
s
i
t
i
v
e
 
b
a
b
i
e
s
B
e
f
o
r
e
 
p
o
o
l
i
n
g
,
 
a
u
t
h
o
r
s
 
s
t
a
t
e
 
t
h
a
t
 
b
e
c
a
u
s
e
 
o
n
l
y
 
o
n
e
 
o
f
 
t
h
e
 
R
C
T
s
 
u
s
e
d
 
a
 
d
o
s
a
g
e
 
r
e
g
i
m
e
n
 
t
h
a
t
 
i
s
 
c
u
r
r
e
n
t
l
y
 
c
o
n
s
i
d
e
r
e
d
 
a
p
p
r
o
p
r
i
a
t
e
,
 
t
h
e
 
N
R
S
s
 
h
a
v
e
 
b
e
e
n
 
r
e
t
a
i
n
e
d
 
f
o
r
 
f
u
r
t
h
e
r
 
c
o
n
s
i
d
e
r
a
t
i
o
n
.
 
 
A
f
t
e
r
 
p
o
o
l
i
n
g
,
 
a
u
t
h
o
r
s
 
s
t
a
t
e
 
t
h
a
t
 
r
e
s
u
l
t
s
 
o
f
 
t
h
e
 
N
R
S
s
 
a
r
e
 
v
e
r
y
 
s
i
m
i
l
a
r
 
t
o
 
t
h
o
s
e
 
o
f
 
t
h
e
 
o
n
e
 
r
a
n
d
o
m
i
s
e
d
 
s
t
u
d
y
 
t
h
a
t
 
u
s
e
d
 
a
 
c
u
r
r
e
n
t
l
y
 
r
e
c
o
m
m
e
n
d
e
d
 
d
o
s
e
 
o
f
 
a
n
t
i
-
D
,
 
w
h
i
c
h
 
s
u
g
g
e
s
t
s
 
t
h
a
t
 
t
h
e
 
N
R
S
s
 
a
r
e
 
u
n
l
i
k
e
l
y
 
t
o
 
b
e
 
s
e
r
i
o
u
s
l
y
 
b
i
a
s
e
d
O
n
l
y
 
o
n
e
 
o
f
 
t
w
o
 
R
C
T
s
 
u
s
e
d
 
a
 
d
o
s
a
g
e
 
c
u
r
r
e
n
t
l
y
 
c
o
n
s
i
d
e
r
e
d
 
a
p
p
r
o
p
r
i
a
t
e
Y
e
sAppendix 4
162
DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
163
R
e
v
i
e
w
 
d
e
t
a
i
l
s
D
e
s
c
r
i
p
t
i
o
n
 
o
f
 
i
n
t
e
r
v
e
n
t
i
o
n
P
o
l
i
c
y
 
l
e
v
e
l
T
a
r
g
e
t
 
g
r
o
u
p
R
a
t
i
o
n
a
l
e
 
g
i
v
e
n
 
b
y
 
a
u
t
h
o
r
s
 
f
o
r
 
p
o
o
l
i
n
g
O
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
 
b
e
t
w
e
e
n
 
R
C
T
s
 
a
n
d
 
N
R
S
s
 
(
r
e
v
i
e
w
e
r
s
’
 
j
u
d
g
e
m
e
n
t
)
S
u
f
fi
c
i
e
n
t
 
d
e
t
a
i
l
 
f
o
r
 
r
e
-
a
n
a
l
y
s
i
s
?
 
(
y
e
s
/
n
o
)
Y
i
n
,
 
2
0
0
2
1
4
6
1
7
 
R
C
T
s
9
 
N
R
S
s
G
r
o
u
p
 
a
n
d
 
i
n
d
i
v
i
d
u
a
l
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
t
o
 
r
e
d
u
c
e
 
b
u
r
d
e
n
 
o
n
 
c
a
r
e
g
i
v
e
r
s
 
o
f
 
t
h
e
 
f
r
a
i
l
 
e
l
d
e
r
l
y
C
o
m
m
u
n
i
t
y
F
a
m
i
l
y
 
c
a
r
e
g
i
v
e
r
s
 
o
f
 
e
l
d
e
r
l
y
 
p
e
r
s
o
n
s
N
o
 
c
l
e
a
r
 
r
a
t
i
o
n
a
l
e
 
g
i
v
e
n
.
 
T
h
e
y
 
s
a
y
 
t
h
a
t
 
t
h
e
y
 
i
n
c
l
u
d
e
d
 
b
o
t
h
 
t
r
u
e
 
e
x
p
e
r
i
m
e
n
t
a
l
 
(
r
a
n
d
o
m
 
a
s
s
i
g
n
m
e
n
t
)
 
a
n
d
 
q
u
a
s
i
-
e
x
p
e
r
i
m
e
n
t
a
l
 
d
e
s
i
g
n
s
 
w
i
t
h
 
a
 
c
o
n
t
r
o
l
 
g
r
o
u
p
 
(
c
o
n
v
e
n
i
e
n
t
 
a
s
s
i
g
n
m
e
n
t
)
.
 
T
h
e
r
e
 
i
s
 
s
o
m
e
 
i
n
v
e
s
t
i
g
a
t
i
o
n
 
o
f
 
r
a
n
d
o
m
 
a
s
s
i
g
n
m
e
n
t
 
a
s
 
a
 
p
o
t
e
n
t
i
a
l
 
m
o
d
e
r
a
t
o
r
 
i
n
 
h
e
t
e
r
o
g
e
n
e
i
t
y
 
i
n
v
e
s
t
i
g
a
t
i
o
n
,
 
b
u
t
 
o
n
l
y
 
f
o
r
 
g
r
o
u
p
 
i
n
t
e
r
v
e
n
t
i
o
n
s
.
 
I
n
d
i
v
i
d
u
a
l
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
h
a
d
 
a
 
n
o
n
-
s
i
g
n
i
fi
c
a
n
t
 
Q
 
s
t
a
t
i
s
t
i
c
,
 
i
n
d
i
c
a
t
i
n
g
 
h
o
m
o
g
e
n
e
i
t
y
,
 
t
h
e
r
e
f
o
r
e
 
n
o
 
f
u
r
t
h
e
r
 
s
e
a
r
c
h
i
n
g
 
f
o
r
 
p
o
t
e
n
t
i
a
l
 
m
o
d
e
r
a
t
o
r
s
 
w
a
s
 
p
e
r
f
o
r
m
e
d
N
o
 
o
b
v
i
o
u
s
 
d
i
f
f
e
r
e
n
c
e
s
N
o
 
(
g
i
v
e
s
 
e
f
f
e
c
t
 
s
i
z
e
 
o
n
l
y
 
f
o
r
 
e
a
c
h
 
s
t
u
d
y
,
 
n
o
 
v
a
r
i
a
n
c
e
)
Y
a
b
r
o
f
f
,
 
2
0
0
1
1
4
5
5
4
 
R
C
T
s
1
2
 
N
R
S
s
P
a
t
i
e
n
t
 
t
a
r
g
e
t
e
d
 
i
n
t
e
r
v
e
n
t
i
o
n
s
 
t
o
 
i
n
c
r
e
a
s
e
 
m
a
m
m
o
g
r
a
p
h
y
 
u
s
e
 
b
o
t
h
 
o
u
t
s
i
d
e
 
a
n
d
 
i
n
s
i
d
e
 
t
h
e
 
p
r
i
m
a
r
y
 
c
a
r
e
 
m
e
d
i
c
a
l
 
s
e
t
t
i
n
g
H
e
a
l
t
h
-
c
a
r
e
 
p
r
o
v
i
s
i
o
n
 
o
r
g
a
n
i
s
a
t
i
o
n
C
o
m
m
u
n
i
t
y
W
o
m
e
n
 
i
n
 
t
h
e
 
U
S
 
e
l
i
g
i
b
l
e
 
f
o
r
 
m
a
m
m
o
g
r
a
p
h
y
N
o
 
r
a
t
i
o
n
a
l
e
 
s
t
a
t
e
d
.
 
O
n
l
y
 
i
n
c
l
u
d
e
d
 
r
a
n
d
o
m
i
s
e
d
 
o
r
 
‘
c
o
n
c
u
r
r
e
n
t
l
y
 
c
o
n
t
r
o
l
l
e
d
’
 
s
t
u
d
i
e
s
.
 
E
f
f
e
c
t
 
s
i
z
e
s
 
c
a
l
c
u
l
a
t
e
d
 
a
s
 
e
n
d
p
o
i
n
t
 
d
i
f
f
e
r
e
n
c
e
s
 
f
o
r
 
R
C
T
s
 
a
n
d
 
c
h
a
n
g
e
 
s
c
o
r
e
 
d
i
f
f
e
r
e
n
c
e
s
 
f
o
r
 
N
R
S
s
,
 
b
u
t
 
t
h
e
n
 
c
o
m
b
i
n
e
d
N
o
t
 
p
o
s
s
i
b
l
e
 
t
o
 
t
e
l
l
,
 
d
a
t
a
 
n
o
t
 
p
r
o
v
i
d
e
d
N
o
C
B
A
,
 
c
o
n
t
r
o
l
l
e
d
 
b
e
f
o
r
e
/
a
f
t
e
r
 
s
t
u
d
y
;
 
C
C
T
,
 
c
o
n
t
r
o
l
l
e
d
 
c
l
i
n
i
c
a
l
 
t
r
i
a
l
;
 
C
O
P
D
,
 
c
h
r
o
n
i
c
 
o
b
s
t
r
u
c
t
i
v
e
 
p
u
l
m
o
n
a
r
y
 
d
i
s
e
a
s
e
;
 
I
T
S
,
 
i
n
t
e
r
r
u
p
t
e
d
 
t
i
m
e
 
s
e
r
i
e
s
;
 
N
E
G
D
,
 
n
o
n
-
e
q
u
i
v
a
l
e
n
t
 
g
r
o
u
p
 
d
e
s
i
g
n
.DOI: 10.3310/hta14160  Health Technology Assessment 2010; Vol. 14: No. 16
© 2010 Queen’s Printer and Controller of HMSO. All rights reserved.
165
Appendix 5  
Additional information on 
variance in our analyses
H
ere we find algebraic expressions for the 
standard deviations of nRCTs and RCTs 
resampled from RCT data. We let y1i and y2i be the 
log odds in area i in the intervention and control 
arms respectively; for a quantitative outcome, they 
would be the means. We let n be the number of 
areas, so that there are n RCTs and n(n – 1) nRCTs. 
We define
d y y
ij j i = − ( )
2 1 , the intervention effect in a 
resampled study
d y y = − ( )
2 1 , the average intervention effect
SS d d
RCT ii
i
n
= ( )
= ∑ –
2
1 , the sum of squares for the 
intervention effects in all RCTs
SS d d
ALL ii
j
n
i
n
= ( )
= = ∑ ∑ –
2
1 1 , the sum of squares for 
the intervention effects in all resampled studies
S
n
y y
Bk ki k
i
n
2 2
1
1
=
= ∑( – )
, the variance between areas 
in arm k
S
n
y y y y
B i i
i
n
12 1 1 2 2
1
1
= − −
= ∑( )( )
, the covariance 
between arms
r s s s
B B B =
12 1 2 / , the correlation between arms
Note that in this work we define all variances using 
n rather than (n – 1) as denominator. A little algebra 
then shows that
SS n s s rs s
SS n s s
RCT B B B B
ALL B B
= + −
= +
( )
( )
1
2
2
2
1 2
2
1
2
2
2
2
and hence the variances VRCT and VnRCT in RCTs 
and nRCTs are given by
V SS n s s rs s
RCT RCT B B B B = = + − /
1
2
2
2
1 2 2
V SS SS
n n s s
nRCT ALL RCT
B B
= −
− ( )= +
( )/
1
1
2
2
2 + +
−
2
1
1 2 n
rs s
B B
It follows that the variances in RCTs and nRCTs are 
equal if, and only if, r = 0, so that a significance test 
of VRCT = VnRCT is performed by testing r = 0.
For the covariate-adjusted analysis, we propose 
performing an approximate significance test 
of VRCT = VnRCT by a two-stage procedure. In the 
first stage, we fit the logistic regression model 
logoddskil = aki+b xkil, where logoddskil is the log 
odds in the lth individual in the ith area in arm k 
and xkil is that individual’s covariate vector. In the 
second stage, we compute an adjusted correlation 
radj using the aki in place of the yki above. The 
approximate p-value for the test of VRCT = VnRCT is 
the p-value for testing radj = 0.
We have used the whole of the sampled areas in 
the resampled studies, but Deeks et al.43 sampled 
m individuals with replacement from each selected 
area. This adds an additional term V2 to the above 
results:
V V V
V V V
RCT RCT
nRCT nRCT
*
*
= +
= +
2
2
where V
n
s s
W i W i
i
n
2 1
2
2
2
1
1
= +
= ∑( )
and  s
Wki
2  = variance of sampled log odds in 
arm k and i
=
−
1
1 mp p
ki ki ( )
where pki = observed proportion in k area i
This does not affect the result that the variances in 
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Feedback
The HTA programme and the authors would like to know 
your views about this report.
The Correspondence Page on the HTA website 
(www.hta.ac.uk) is a convenient way to publish  
your comments. If you prefer, you can send your comments  
to the address below, telling us whether you would like  
us to transfer them to the website.
We look forward to hearing from you.